
<html lang="en"     class="pb-page"  data-request-id="b8d5769a-aa44-4da0-89f2-10636b1cfba8"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/acs.jmedchem.0c00242;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2020.63.issue-20;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Fragment Linking Strategies for Structure-Based Drug Design" /></meta><meta name="dc.Creator" content="Alexandre  Bancet" /></meta><meta name="dc.Creator" content="Claire  Raingeval" /></meta><meta name="dc.Creator" content="Thierry  Lomberget" /></meta><meta name="dc.Creator" content="Marc  Le Borgne" /></meta><meta name="dc.Creator" content="Jean-François  Guichou" /></meta><meta name="dc.Creator" content="Isabelle  Krimm" /></meta><meta name="dc.Description" content="Fragment-based drug discovery is a strategy widely used in both academia and pharmaceutical companies to generate small-molecule protein inhibitors and drug candidates. Among the approaches reporte..." /></meta><meta name="Description" content="Fragment-based drug discovery is a strategy widely used in both academia and pharmaceutical companies to generate small-molecule protein inhibitors and drug candidates. Among the approaches reporte..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 15, 2020" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c00242" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00242" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c00242" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00242" /></link>
        
    
    

<title>Fragment Linking Strategies for Structure-Based Drug Design | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c00242" /></meta><meta property="og:title" content="Fragment Linking Strategies for Structure-Based Drug Design" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c00242/20201019/images/large/jm0c00242_0008.jpeg" /></meta><meta property="og:description" content="Fragment-based drug discovery is a strategy widely used in both academia and pharmaceutical companies to generate small-molecule protein inhibitors and drug candidates. Among the approaches reported in the literature (growing, linking, and merging), the linking approach theoretically offers the opportunity to rapidly gain in binding energy. Nevertheless, this approach is poorly represented when considering the compounds currently in clinical trials. Here, we report an exhaustive view of the cases published so far in the literature, together with the methods used to identify the two initial fragments either simultaneously or successively. We review the different types of linkers published and discuss how these linkers are designed to obtain the lead compound. Mixing merging and linking methods, where the linker is duplicated from a known inhibitor, appears as an interesting strategy. To reach superadditivity, we propose to grow one of the fragments in order to minimize the distance between the two binders and then link the resulting compounds using flexible alkyl-derived linkers." /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta><meta name="twitter:description" content="Fragment-based drug discovery is a strategy widely used in both academia and pharmaceutical companies to generate small-molecule protein inhibitors and drug candidates. Among the approaches reported in the literature (growing, linking, and merging), the linking approach theoretically offers the opportunity to rapidly gain in binding energy. Nevertheless, this approach is poorly represented when considering the compounds currently in clinical trials. Here, we report an exhaustive view of the cases published so far in the literature, together with the methods used to identify the two initial fragments either simultaneously or successively. We review the different types of linkers published and discuss how these linkers are designed to obtain the lead compound. Mixing merging and linking methods, where the linker is duplicated from a known inhibitor, appears as an interesting strategy. To reach superadditivity, we propose to grow one of the fragments in order to minimize the distance between the two binders and then link the resulting compounds using flexible alkyl-derived linkers." /></meta><meta name="twitter:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c00242/20201019/images/large/jm0c00242_0008.jpeg" /></meta><meta name="twitter:title" content="Fragment Linking Strategies for Structure-Based Drug Design" /></meta>
        
            <meta property="og:type" content="Article" /></meta>
        

        
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c00242"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/ke1q~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-6ee29527b3d8ff00a106.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00242">
            
        





































    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-12/achre4.2021.54.issue-12/20210615/achre4.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-6/amrcda.2021.2.issue-6/20210625/amrcda.2021.2.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-6/aabmcb.2021.4.issue-6/20210621/aabmcb.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-6/aaembp.2021.3.issue-6/20210622/aaembp.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-6/aaemcq.2021.4.issue-6/20210628/aaemcq.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-25/aamick.2021.13.issue-25/20210630/aamick.2021.13.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-6/aanmf6.2021.4.issue-6/20210625/aanmf6.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-6/aapmcd.2021.3.issue-6/20210611/aapmcd.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-6/abseba.2021.7.issue-6/20210614/abseba.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-12/accacs.2021.11.issue-12/20210618/accacs.2021.11.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-6/acscii.2021.7.issue-6/20210623/acscii.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-6/acbcct.2021.16.issue-6/20210618/acbcct.2021.16.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-3/achsc5.2021.28.issue-3/20210524/achsc5.2021.28.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-12/acncdm.2021.12.issue-12/20210616/acncdm.2021.12.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-6/aesccq.2021.5.issue-6/20210617/aesccq.2021.5.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-6/aelccp.2021.6.issue-6/20210611/aelccp.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-6/aeecco.2021.1.issue-6/20210611/aeecco.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-6/aewcaa.2021.1.issue-6/20210611/aewcaa.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-5/afsthl.2021.1.issue-5/20210618/afsthl.2021.1.issue-5.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-6/aidcbc.2021.7.issue-6/20210611/aidcbc.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-6/amlccd.2021.10.issue-6/20210615/amlccd.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-6/amlcef.2021.3.issue-6/20210607/amlcef.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-6/amclct.2021.12.issue-6/20210610/amclct.2021.12.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-6/ancac3.2021.15.issue-6/20210622/ancac3.2021.15.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-25/acsodf.2021.6.issue-25/20210629/acsodf.2021.6.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-6/apchd5.2021.8.issue-6/20210616/apchd5.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-6/ascefj.2021.6.issue-6/20210625/ascefj.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-25/ascecg.2021.9.issue-25/20210628/ascecg.2021.9.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-6/asbcd6.2021.10.issue-6/20210618/asbcd6.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-25/ancham.2021.93.issue-25/20210629/ancham.2021.93.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-25/bichaw.2021.60.issue-25/20210629/bichaw.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-6/bcches.2021.32.issue-6/20210616/bcches.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-6/bomaf6.2021.22.issue-6/20210614/bomaf6.2021.22.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-24/cgeabj.2021.99.issue-24/20210628-01/cgeabj.2021.99.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-6/crtoec.2021.34.issue-6/20210621/crtoec.2021.34.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-12/chreay.2021.121.issue-12/20210623/chreay.2021.121.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-12/cmatex.2021.33.issue-12/20210622/cmatex.2021.33.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-6/cgdefu.2021.21.issue-6/20210602/cgdefu.2021.21.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-12/enfuem.2021.35.issue-12/20210617/enfuem.2021.35.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-12/esthag.2021.55.issue-12/20210615/esthag.2021.55.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-6/estlcu.2021.8.issue-6/20210608/estlcu.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-25/iecred.2021.60.issue-25/20210630/iecred.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-12/inocaj.2021.60.issue-12/20210621/inocaj.2021.60.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-6/jaaucr.2021.1.issue-6/20210628/jaaucr.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-25/jafcau.2021.69.issue-25/20210630/jafcau.2021.69.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-6/jceaax.2021.66.issue-6/20210610/jceaax.2021.66.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-6/jceda8.2021.98.issue-6/20210608/jceda8.2021.98.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-6/jcisd8.2021.61.issue-6/20210628/jcisd8.2021.61.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-6/jctcce.2021.17.issue-6/20210608/jctcce.2021.17.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/jmcmar.2021.64.issue-12/20210624/jmcmar.2021.64.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-6/jnprdf.2021.84.issue-6/20210625/jnprdf.2021.84.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-12/joceah.2021.86.issue-12/20210618/joceah.2021.86.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-24/jpcafh.2021.125.issue-24/20210624/jpcafh.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-24/jpcbfk.2021.125.issue-24/20210624/jpcbfk.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-24/jpccck.2021.125.issue-24/20210624/jpccck.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-24/jpclcd.2021.12.issue-24/20210624/jpclcd.2021.12.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-6/jprobs.2021.20.issue-6/20210604/jprobs.2021.20.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-25/jacsat.2021.143.issue-25/20210630/jacsat.2021.143.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-6/jamsef.2021.32.issue-6/20210602/jamsef.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-25/langd5.2021.37.issue-25/20210629/langd5.2021.37.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-12/mamobx.2021.54.issue-12/20210622/mamobx.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-6/mpohbp.2021.18.issue-6/20210607/mpohbp.2021.18.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-12/nalefd.2021.21.issue-12/20210623/nalefd.2021.21.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-12/orlef7.2021.23.issue-12/20210618/orlef7.2021.23.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-6/oprdfk.2021.25.issue-6/20210618/oprdfk.2021.25.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-12/orgnd7.2021.40.issue-12/20210628/orgnd7.2021.40.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c00242&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c00242&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c00242&amp;href=/doi/10.1021/acs.jmedchem.0c00242" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 20</span><span class="cit-fg-pageRange">, 11420-11435</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/20" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c00524" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.0c00629" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Fragment Linking Strategies for Structure-Based Drug Design</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Alexandre Bancet</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Alexandre Bancet</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">EA 4446 Bioactive Molecules and Medicinal Chemistry, Faculté de Pharmacie, ISPB, SFR Santé Lyon-Est CNRS UMS3453, INSERM US7, Université de Lyon, Université Claude Bernard Lyon 1, 69373 Lyon Cedex 8, France</div><div class="loa-info-affiliations-info">Centre de RMN à Très Hauts Champs, Université de Lyon, CNRS, Université Claude Bernard Lyon 1, ENS, 5 Rue de la Doua, F-69100 Villeurbanne, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Alexandre++Bancet">Alexandre Bancet</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath1">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4467-8684" title="Orcid link">http://orcid.org/0000-0003-4467-8684</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Claire Raingeval</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Claire Raingeval</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centre de RMN à Très Hauts Champs, Université de Lyon, CNRS, Université Claude Bernard Lyon 1, ENS, 5 Rue de la Doua, F-69100 Villeurbanne, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Claire++Raingeval">Claire Raingeval</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath2">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1161-429X" title="Orcid link">http://orcid.org/0000-0002-1161-429X</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Thierry Lomberget</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Thierry Lomberget</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">EA 4446 Bioactive Molecules and Medicinal Chemistry, Faculté de Pharmacie, ISPB, SFR Santé Lyon-Est CNRS UMS3453, INSERM US7, Université de Lyon, Université Claude Bernard Lyon 1, 69373 Lyon Cedex 8, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Thierry++Lomberget">Thierry Lomberget</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath3">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4071-0002" title="Orcid link">http://orcid.org/0000-0002-4071-0002</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Marc Le Borgne</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Marc Le Borgne</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">EA 4446 Bioactive Molecules and Medicinal Chemistry, Faculté de Pharmacie, ISPB, SFR Santé Lyon-Est CNRS UMS3453, INSERM US7, Université de Lyon, Université Claude Bernard Lyon 1, 69373 Lyon Cedex 8, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Marc++Le+Borgne">Marc Le Borgne</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath4">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1398-075X" title="Orcid link">http://orcid.org/0000-0003-1398-075X</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jean-François Guichou</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jean-François Guichou</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">CBS, Université de Montpellier, CNRS, INSERM, 34095 Montpellier, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jean-Fran%C3%A7ois++Guichou">Jean-François Guichou</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath5">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7699-3235" title="Orcid link">http://orcid.org/0000-0002-7699-3235</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Isabelle Krimm</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Isabelle Krimm</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centre de RMN à Très Hauts Champs, Université de Lyon, CNRS, Université Claude Bernard Lyon 1, ENS, 5 Rue de la Doua, F-69100 Villeurbanne, France</div><div class="loa-info-affiliations-info">Centre de Recherche en Cancérologie de Lyon, Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, 69008 Lyon, France</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#4b22382a292e27272e6520392226260b3e25223d66273224257a652d39"><span class="__cf_email__" data-cfemail="c0a9b3a1a2a5acaca5eeabb2a9adad80b5aea9b6edacb9afaef1eea6b2">[email protected]</span></a>. Phone: +33 4 37 42 35 44.</span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Isabelle++Krimm">Isabelle Krimm</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath6">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5981-109X" title="Orcid link">http://orcid.org/0000-0002-5981-109X</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00242&amp;href=/doi/10.1021%2Facs.jmedchem.0c00242" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 20</span><span class="cit-pageRange">, 11420–11435</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 15, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>9 April 2020</li><li><span class="item_label"><b>Published</b> online</span>15 June 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 22 October 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c00242" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00242</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D11420%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAlexandre%2BBancet%252C%2BClaire%2BRaingeval%252C%2BThierry%2BLomberget%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D20%26contentID%3Dacs.jmedchem.0c00242%26title%3DFragment%2BLinking%2BStrategies%2Bfor%2BStructure-Based%2BDrug%2BDesign%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D11435%26publicationDate%3DOctober%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c00242"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">5911</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">10</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c00242" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Fragment Linking Strategies for Structure-Based Drug Design&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Alexandre&quot;,&quot;last_name&quot;:&quot;Bancet&quot;},{&quot;first_name&quot;:&quot;Claire&quot;,&quot;last_name&quot;:&quot;Raingeval&quot;},{&quot;first_name&quot;:&quot;Thierry&quot;,&quot;last_name&quot;:&quot;Lomberget&quot;},{&quot;first_name&quot;:&quot;Marc&quot;,&quot;last_name&quot;:&quot;Le Borgne&quot;},{&quot;first_name&quot;:&quot;Jean-François&quot;,&quot;last_name&quot;:&quot;Guichou&quot;},{&quot;first_name&quot;:&quot;Isabelle&quot;,&quot;last_name&quot;:&quot;Krimm&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;15&quot;,&quot;issue&quot;:&quot;20&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;11420-11435&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c00242&quot;},&quot;abstract&quot;:&quot;Fragment-based drug discovery is a strategy widely used in both academia and pharmaceutical companies to generate small-molecule protein inhibitors and drug candidates. Among the approaches reported in the literature (growing, linking, and merging), the linking approach theoretically offers the opportunity to rapidly gain in binding energy. Nevertheless, this approach is poorly represented when considering the compounds currently in clinical trials. Here, we report an exhaustive view of the cases published so far in the literature, together with the methods used to identify the two initial fragments either simultaneously or successively. We review the different types of linkers published and discuss how these linkers are designed to obtain the lead compound. Mixing merging and linking methods, where the linker is duplicated from a known inhibitor, appears as an interesting strategy. To reach superadditivity, we propose to grow one of the fragments in order to minimize the distance between the two binders and &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00242&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00242" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00242&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00242" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00242&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00242" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00242&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00242&amp;href=/doi/10.1021/acs.jmedchem.0c00242" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c00242" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c00242" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (6 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c00242%26sid%3Dliteratum%253Aachs%26pmid%3D32539387%26genre%3Darticle%26aulast%3DBancet%26date%3D2020%26atitle%3DFragment%2BLinking%2BStrategies%2Bfor%2BStructure-Based%2BDrug%2BDesign%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D20%26spage%3D11420%26epage%3D11435%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292289" title="Protein identification">Protein identification</a>,</li><li><a href="/action/doSearch?ConceptID=292366" title="Ligands">Ligands</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292382" title="X ray crystallography">X ray crystallography</a>,</li><li><a href="/action/doSearch?ConceptID=291352" title="Screening assays">Screening assays</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/20" title="Go to Volume 63, Issue 20"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/jmcmar.2020.63.issue-20/20201022/jmcmar.2020.63.issue-20.largecover.jpg" alt="Go to Volume 63, Issue 20"/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c00242/20201019/images/medium/jm0c00242_0008.gif" alt="" id="_i2" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c00242/20201019/images/large/jm0c00242_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00242&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Fragment-based drug discovery is a strategy widely used in both academia and pharmaceutical companies to generate small-molecule protein inhibitors and drug candidates. Among the approaches reported in the literature (growing, linking, and merging), the linking approach theoretically offers the opportunity to rapidly gain in binding energy. Nevertheless, this approach is poorly represented when considering the compounds currently in clinical trials. Here, we report an exhaustive view of the cases published so far in the literature, together with the methods used to identify the two initial fragments either simultaneously or successively. We review the different types of linkers published and discuss how these linkers are designed to obtain the lead compound. Mixing merging and linking methods, where the linker is duplicated from a known inhibitor, appears as an interesting strategy. To reach superadditivity, we propose to grow one of the fragments in order to minimize the distance between the two binders and then link the resulting compounds using flexible alkyl-derived linkers.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">1.  Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70600" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70600" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Fragment-based drug discovery (FBDD) has been acknowledged in the past two decades as a powerful tool for rational design of drug leads.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4 ref5 ref6">(1−6)</a> The first step of the FBDD process consists of the identification of fragments that weakly bind the target protein, typically in the micromolar to millimolar affinity range. Fragments are defined as low molecular weight (<300 g/mol) and highly soluble organic molecules. Jhoti and co-workers<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> proposed a rule of three to describe the physicochemical properties of the fragments, by analogy to Lipinski’s rule of five. Due to the weak affinity of the fragments for their targets, biophysical techniques sensitive toward micromolar to millimolar affinities are required to identify hits; among them nuclear magnetic resonance (NMR), X-ray crystallography, and surface plasmon resonance (SPR) are the most widely used.<a onclick="showRef(event, 'ref1 ref2 ref3 ref5'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref5">(1−3,5)</a> In a second, iterative and time-consuming step, the fragments that form high quality interactions are optimized into lead compounds exhibiting higher affinity and selectivity, through the so-called fragment growing, fragment merging, or fragment linking strategies. As we will see in the examples discussed below, fragment linking may include growing or merging steps and distinguishing between the three strategies may be ambiguous. Vemurafenib,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> the first drug originating from a fragment screen, was approved in 2011 by the Food and Drug Administration (FDA), and two other drugs venetoclax<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> and erdafitinib<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> were approved in 2016 and 2019, respectively. Vemurafenib and erdafitinib exemplify the growing approach, while venetoclax illustrates the linking method. To have an overview of the fragment-based development of therapeutic compounds, we report in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> the 43 small molecules currently in clinical trials (phases 1, 2, and 3) and the three FDA-approved compounds. We indicate the therapeutic target and the fragment-based strategy used. As reported in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, most of the compounds in the clinic were obtained using the growing approach, where chemical groups are progressively added to the fragment hit to maximize the favorable interactions with the binding site residues. In some cases, fragment hits can be merged, as reported for the induced myeloid leukemia cell differentiation protein (MCL1) (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Here, we focus on the fragment linking approach, where two fragments that bind at distinct protein pockets are linked together to obtain a new compound. While this approach theoretically represents a very attractive methodology to rapidly gain in binding affinity from the initial fragments, it faces two major challenges. First, the observation of two fragments binding simultaneously at two distinct binding pockets of a protein is not systematic. This is related to the nonequivalence of the corresponding hot-spots in the binding pockets. As reported in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, a second screening to identify fragments capable of binding in the second pocket may be necessary. In addition, the fragments do not necessarily bind to the protein in suitable positions for linking. The second challenge remains the design of a linker that will maintain the protein–fragment interactions. Fesik and co-workers<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11,12)</a> first successfully used the fragment linking methodology through their structure–activity relationships (SARs) by NMR approach (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), with the generation of nanomolar compounds for the FK506-binding protein (FKBP), a prolyl isomerase belonging to the immunophilin family. Due to its binding properties to the immunosuppressant molecule FK506, FKBP is a target for neurodegenerative disorders.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c00242/20201019/images/medium/jm0c00242_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c00242/20201019/images/large/jm0c00242_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Fragment linking approach with venetoclax. The initial fragments discovered through “SAR by NMR” were linked with an alkene moiety. Navitoclax, exhibiting high affinity for both BCL-X<sub>L</sub> and BCL-2, was generated, and finally, medicinal chemistry led to venetoclax, a selective BCL-2 inhibitor. The drug was first approved for use in patients with chronic lymphocytic leukemia and 17p deletion.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c00242/20201019/images/large/jm0c00242_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00242&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Fragment-Based Compounds in Clinical Trials or Approved (from Clinicaltrials.gov, January 2020)</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"><b>drug</b><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" rowspan="2" align="center">company</th><th class="colsep0 rowsep0" rowspan="2" align="center">status</th><th class="colsep0 rowsep0" rowspan="2" align="center">initial fragment strategy</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">biological target</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Erdafitinib</b></td><td class="colsep0 rowsep0" align="left">Johnson & Johnson/Astex</td><td class="colsep0 rowsep0" align="left">Approved</td><td class="colsep0 rowsep0" align="left">Growing</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FGFR</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Vemurafenib</b></td><td class="colsep0 rowsep0" align="left">Plexxikon</td><td class="colsep0 rowsep0" align="left">Approved</td><td class="colsep0 rowsep0" align="left">Growing</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BRAF-V600E</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Venetoclax</b></td><td class="colsep0 rowsep0" align="left">AbbVie/Genentech, Inc.</td><td class="colsep0 rowsep0" align="left">Approved</td><td class="colsep0 rowsep0" align="left">Linking</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BCL-2</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Asciminib</b></td><td class="colsep0 rowsep0" align="left">Novartis</td><td class="colsep0 rowsep0" align="left">Phase 3</td><td class="colsep0 rowsep0" align="left">Growing</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BCR-ABL</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>PLX3397</b></td><td class="colsep0 rowsep0" align="left">Plexxikon</td><td class="colsep0 rowsep0" align="left">Phase 3</td><td class="colsep0 rowsep0" align="left">Growing</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CSF1R, KIT, FLT3</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Verubecestat</b></td><td class="colsep0 rowsep0" align="left">Merck</td><td class="colsep0 rowsep0" align="left">Phase 3</td><td class="colsep0 rowsep0" align="left">Growing</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BACE1</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>AZD3293</b></td><td class="colsep0 rowsep0" align="left">Astex/AstraZeneca/Lilly</td><td class="colsep0 rowsep0" align="left">Phase 2/3</td><td class="colsep0 rowsep0" align="left">Growing</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BACE1</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>ABT-737</b></td><td class="colsep0 rowsep0" align="left">AbbVie</td><td class="colsep0 rowsep0" align="left">Phase 2</td><td class="colsep0 rowsep0" align="left">Linking</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BCL-2 and BCL-X<sub>L</sub></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>AT7519</b></td><td class="colsep0 rowsep0" align="left">Astex</td><td class="colsep0 rowsep0" align="left">Phase 2</td><td class="colsep0 rowsep0" align="left">Growing</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CDK1, CDK2, CDK4, CDK5, CDK9</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>AT9283</b></td><td class="colsep0 rowsep0" align="left">Astex</td><td class="colsep0 rowsep0" align="left">Phase 2</td><td class="colsep0 rowsep0" align="left">Growing</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Aurora and JAK2</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>AUY922</b></td><td class="colsep0 rowsep0" align="left">Novartis/Vernalis</td><td class="colsep0 rowsep0" align="left">Phase 2</td><td class="colsep0 rowsep0" align="left">Growing</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HSP90</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>AZD5363</b></td><td class="colsep0 rowsep0" align="left">AstraZeneca/Astex</td><td class="colsep0 rowsep0" align="left">Phase 2</td><td class="colsep0 rowsep0" align="left">Growing</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AKT</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>CPI-0610</b></td><td class="colsep0 rowsep0" align="left">Constellation</td><td class="colsep0 rowsep0" align="left">Phase 2</td><td class="colsep0 rowsep0" align="left">Growing</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BET</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>eFT508</b></td><td class="colsep0 rowsep0" align="left">eFFECTOR</td><td class="colsep0 rowsep0" align="left">Phase 2</td><td class="colsep0 rowsep0" align="left">Growing</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MNK1 and MNK2</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Indeglitazar</b></td><td class="colsep0 rowsep0" align="left">Plexxikon</td><td class="colsep0 rowsep0" align="left">Phase 2</td><td class="colsep0 rowsep0" align="left">Growing</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PPAR agonist</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>LY3202626</b></td><td class="colsep0 rowsep0" align="left">Lilly</td><td class="colsep0 rowsep0" align="left">Phase 2</td><td class="colsep0 rowsep0" align="left">Growing</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BACE1</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>LY517717</b></td><td class="colsep0 rowsep0" align="left">Lilly/Protherics</td><td class="colsep0 rowsep0" align="left">Phase 2</td><td class="colsep0 rowsep0" align="left">Growing</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FXa</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Navitoclax</b></td><td class="colsep0 rowsep0" align="left">AbbVie</td><td class="colsep0 rowsep0" align="left">Phase 2</td><td class="colsep0 rowsep0" align="left">Linking</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BCL-2 and BCL-X<sub>L</sub></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Onalespib</b></td><td class="colsep0 rowsep0" align="left">Astex</td><td class="colsep0 rowsep0" align="left">Phase 2</td><td class="colsep0 rowsep0" align="left">Growing</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HSP90</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>PF-06650833</b></td><td class="colsep0 rowsep0" align="left">Pfizer</td><td class="colsep0 rowsep0" align="left">Phase 2</td><td class="colsep0 rowsep0" align="left">Growing</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IRAK4</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>PF-06835919</b></td><td class="colsep0 rowsep0" align="left">Pfizer</td><td class="colsep0 rowsep0" align="left">Phase 2</td><td class="colsep0 rowsep0" align="left">Growing</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">KHK</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>AMG 510</b></td><td class="colsep0 rowsep0" align="left">Amgen</td><td class="colsep0 rowsep0" align="left">Phase 1/2</td><td class="colsep0 rowsep0" align="left">Growing</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">KRAS</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>ASTX029</b></td><td class="colsep0 rowsep0" align="left">Astex</td><td class="colsep0 rowsep0" align="left">Phase 1/2</td><td class="colsep0 rowsep0" align="left">Growing</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ERK1 and ERK2</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>ASTX660</b></td><td class="colsep0 rowsep0" align="left">Astex</td><td class="colsep0 rowsep0" align="left">Phase 1/2</td><td class="colsep0 rowsep0" align="left">Growing</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">XIAP and cIAP1</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>LY2886721</b></td><td class="colsep0 rowsep0" align="left">Lilly</td><td class="colsep0 rowsep0" align="left">Phase 1/2</td><td class="colsep0 rowsep0" align="left">Growing</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BACE1</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>MAK683</b></td><td class="colsep0 rowsep0" align="left">Novartis</td><td class="colsep0 rowsep0" align="left">Phase 1/2</td><td class="colsep0 rowsep0" align="left">Growing</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PRC2</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>ABBV-075</b></td><td class="colsep0 rowsep0" align="left">AbbVie</td><td class="colsep0 rowsep0" align="left">Phase 1</td><td class="colsep0 rowsep0" align="left">Growing</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BRD2</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>ABT-518</b></td><td class="colsep0 rowsep0" align="left">AbbVie</td><td class="colsep0 rowsep0" align="left">Phase 1</td><td class="colsep0 rowsep0" align="left">Linking</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MMP2 and MMP9</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>AT13148</b></td><td class="colsep0 rowsep0" align="left">Astex</td><td class="colsep0 rowsep0" align="left">Phase 1</td><td class="colsep0 rowsep0" align="left">Growing</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AKT, S6K1, and ROCK</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>AZD3839</b></td><td class="colsep0 rowsep0" align="left">AstraZeneca/Astex</td><td class="colsep0 rowsep0" align="left">Phase 1</td><td class="colsep0 rowsep0" align="left">Growing</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BACE1</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>AZD5099</b></td><td class="colsep0 rowsep0" align="left">AstraZeneca</td><td class="colsep0 rowsep0" align="left">Phase 1</td><td class="colsep0 rowsep0" align="left">Growing</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Bacterial topoisomerase II</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>AZD5991</b></td><td class="colsep0 rowsep0" align="left">AstraZeneca</td><td class="colsep0 rowsep0" align="left">Phase 1</td><td class="colsep0 rowsep0" align="left">Merging</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MCL1</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>BCL201</b></td><td class="colsep0 rowsep0" align="left">Vernalis/Servier/Novartis</td><td class="colsep0 rowsep0" align="left">Phase 1</td><td class="colsep0 rowsep0" align="left">Growing</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BCL-2</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>BI691751</b></td><td class="colsep0 rowsep0" align="left">Boehringer Ingelheim</td><td class="colsep0 rowsep0" align="left">Phase 1</td><td class="colsep0 rowsep0" align="left">Growing</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LTA4H</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>ETC-1907206</b></td><td class="colsep0 rowsep0" align="left">EDDC/A*STAR Research Entities</td><td class="colsep0 rowsep0" align="left">Phase 1</td><td class="colsep0 rowsep0" align="left">Growing</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MNK1 and MNK2</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>GDC-0919</b></td><td class="colsep0 rowsep0" align="left">Genentech, Inc.</td><td class="colsep0 rowsep0" align="left">Phase 1</td><td class="colsep0 rowsep0" align="left">Growing</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IDO1</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>GDC-0994</b></td><td class="colsep0 rowsep0" align="left">Genentech, Inc.</td><td class="colsep0 rowsep0" align="left">Phase 1</td><td class="colsep0 rowsep0" align="left">Growing</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ERK2</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>HTL0014242</b></td><td class="colsep0 rowsep0" align="left">Sosei Heptares</td><td class="colsep0 rowsep0" align="left">Phase 1</td><td class="colsep0 rowsep0" align="left">Growing</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mGlu5</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>IC-776</b></td><td class="colsep0 rowsep0" align="left">Lilly/ICOS</td><td class="colsep0 rowsep0" align="left">Phase 1</td><td class="colsep0 rowsep0" align="left">Growing</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LFA1</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>LP-261</b></td><td class="colsep0 rowsep0" align="left">Locus Pharmaceuticals</td><td class="colsep0 rowsep0" align="left">Phase 1</td><td class="colsep0 rowsep0" align="left">Growing</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Tubulin</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>LY2811376</b></td><td class="colsep0 rowsep0" align="left">Lilly</td><td class="colsep0 rowsep0" align="left">Phase 1</td><td class="colsep0 rowsep0" align="left">Growing</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BACE1</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>PLX5568</b></td><td class="colsep0 rowsep0" align="left">Plexxikon</td><td class="colsep0 rowsep0" align="left">Phase 1</td><td class="colsep0 rowsep0" align="left">Growing</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">RAF</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>SGX-393</b></td><td class="colsep0 rowsep0" align="left">SGX Pharmaceuticals</td><td class="colsep0 rowsep0" align="left">Phase 1</td><td class="colsep0 rowsep0" align="left">Growing</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BCR-ABL</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>SGX-523</b></td><td class="colsep0 rowsep0" align="left">SGX Pharmaceuticals</td><td class="colsep0 rowsep0" align="left">Phase 1</td><td class="colsep0 rowsep0" align="left">Growing</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MET</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>SNS-314</b></td><td class="colsep0 rowsep0" align="left">Sunesis Pharmaceuticals</td><td class="colsep0 rowsep0" align="left">Phase 1</td><td class="colsep0 rowsep0" align="left">Growing</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Aurora</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>S64315</b></td><td class="colsep0 rowsep0" align="left">Servier/Novartis/Vernalis</td><td class="colsep0 rowsep0" align="left">Phase 1</td><td class="colsep0 rowsep0" align="left">Growing</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MCL1</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Drugs are listed alphabetically within each phase.</p></div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Fragment Linking by Second-Site Screen</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c00242/20201019/images/medium/jm0c00242_0004.gif" alt="" id="GRAPHIC-d7e1085-autogenerated" /></img><div></div></div><div class="NLM_p">In 2011, Whittaker and colleagues<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> reviewed examples where the fragment linking approach was used and focused their discussion on the superadditivity concept. The concept of superadditivity (also called positive cooperativity) was defined by Jencks.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> It stipulates that the affinity of the linked compound should be greater than the affinity resulting from the addition of the binding energies of the two fragments. The superadditivity energetic term includes changes in translational and rotational entropy, loss of binding energy due to the linker, and change in binding orientation of the two fragments. When the orientation of the fragments is not disturbed, changes in translational and rotational entropy dominate. Whittaker and colleagues<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> proposed that one key criterion to achieve superadditivity is to maintain the binding modes of the initial fragments. To be successful, linking should therefore involve one fragment that interacts with the protein through polar interactions and a second fragment that interacts via van der Waals interactions, as the latter will be more tolerant to changes in binding mode. This statement will be further discussed later in the Perspective.</div><div class="NLM_p">Here we have reviewed, to the best of our knowledge, all cases where the fragment linking approach has been used, through 2018. To our point of view, the first step that consists of the identification of two fragment hits is not straightforward. As we report below, two fragments bound in two distinct protein pockets were directly identified in 22 cases out of 39, while 17 cases required the conduction of two successive screens. Once two fragments have been identified, the main challenge is the design of the linker, in particular when the distance between the two fragments is large (>3 Å). One possibility consists of reducing the distance between the two fragments. To do so, one of the two fragments is selected and a growing approach is applied until the distance is close to 3 Å. Regarding the chemical structure of the linker, simple linkers such as alkyl of different lengths are widely used. More sophisticated linkers include functional groups, which may be utilized to fit particular geometries such as 90° bends required to conserve the positions and orientations of the fragments. Such functionalized linkers also enable the addition of interactions between the designed compound and the protein.</div><div class="NLM_p last">The article is organized as follows. First, we summarize the methods used for the identification of the two fragments that will be further linked. This includes successive identification as well as simultaneous identification of the two fragment hits. We also review the particular case of fragment dimerization. Then we discuss the second challenge of the linking process and analyze different types of linkers that have been designed to generate the new linked compounds.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">2.  Second-Site Screening for Identification of a Second Fragment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64315" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64315" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">As widely reported in the literature, it can be necessary to perform a second screening to identify a fragment bound in another binding site (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). To do so, it may be worth occupying the first site to block its entry. This is partly due to the fact that the fragments typically bind a preferred hot-spot on the protein surface. Moreover, the detection of second-site ligands is generally more difficult because these fragments tend to have a weaker affinity for the target than the first-site ligands. We present below six different strategies that have been used in the literature to identify second-site fragments. The strategies are illustrated in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c00242/20201019/images/medium/jm0c00242_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c00242/20201019/images/large/jm0c00242_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Schematic representation of methods for second-site screening for identification of a second fragment hit. (A) Screening using protein-observed NMR or “SAR by NMR”. A first hit (pink) is identified through chemical shift perturbations on a 2D <sup>15</sup>N or <sup>13</sup>C labeled protein spectrum. Chemical shifts perturbations observed in a second site of the protein (gray) indicate the binding of a second fragment. (B) Screening using ligand-observed <sup>1</sup>H NMR: the ILOE method. A first fragment hit is used as a spy to discover a second fragment hit that binds in the vicinity of the first binder (distances (∼5 Å), through NOESY correlations observed between the two adjacent ligands. (C) Screening using ligand-observed <sup>1</sup>H NMR: the PRE method. A first fragment hit is used as a spy labeled with paramagnetic tag using a 2,2,6,6-tetramethylpiperidin-1-oxyl (TEMPO) moiety. The second fragment hit displays reduced NMR signal intensities due its proximity to the TEMPO moiety. (D) Screening using ligand-observed <sup>19</sup>F NMR. A spy molecule is labeled with a fluorine tag to identify fragments that competitively bind with the spy molecule. (E) Second-site ligand resulting from elaboration of a first-site ligand. Fragment growing generates a new ligand that bind in a distinct pocket. (F) Second-site ligand following tethering-based first-site ligand. A first fragment is covalently bound to the protein through a cysteine residue. A second cysteine residue is used to form a disulfide bond with disulfide containing fragments. Tethered compounds are identified by mass spectrometry. (G) Second-site ligand screening with focused libraries. When the nature of a second pocket is known, a focused library can be used to identify a second-site binder.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c00242/20201019/images/large/jm0c00242_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00242&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7">2.1.  Screening Using Protein-Observed NMR or “SAR by NMR”</h3><div class="NLM_p last">NMR is an established technique for fragment screening and is particularly attractive for linking strategies. In protein-detected experiments, the protein is typically <sup>15</sup>N or <sup>13</sup>C labeled and two-dimensional heteronuclear NMR experiments are used to observe the protein NMR peak modifications upon ligand addition. Most of the published cases deal with small to medium-sized proteins, such as protein domains, for which the NMR assignment is not a difficult task. Fesik and collaborators<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11,12)</a> at Abbott established the “SAR by NMR” approach to design a potent inhibitor of the FKBP binding domain. Two fragments bound in two pockets were identified from the NMR experiments, and a linker was elaborated using structural data from <sup>15</sup>N–<sup>13</sup>C-filtered protein–ligand nuclear Overhauser effect (NOE) (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, entry 1). With the same approach, a linked compound was designed for the stromelysin protein (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, entry 2).<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Navitoclax, the orally active anticancer drug,<a onclick="showRef(event, 'ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref18">(16−18)</a> which led to venetoclax,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> was discovered using the SAR by NMR strategy (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). In another study, the group of Hadjuk<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> designed a highly potent B-cell lymphoma 2 (BCL-2) inhibitor using a library of 17 000 compounds for a first screen and a small library of 70 compounds for a second screen (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, entry 3). Another specific inhibitor of B-cell lymphoma-extra-large (BCL-X<sub>L</sub>) was designed by Souers and colleagues.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> In this case, the first site was blocked using a compound derived from high-throughput screening (HTS) and medicinal chemistry. 875 fragments were screened to identify a second-site ligand that could be linked to the first-site compound (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, entry 4). The fragment linking approach was also successfully applied to the heat shock protein 90 (HSP90) (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, entry 5)<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> and to the protein tyrosine phosphatase-1B (PTP1B) (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, entries 6 and 7).<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22,23)</a></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8">2.2.  Screening Using Ligand-Observed <sup>1</sup>H NMR</h3><div class="NLM_p">Ligand-observed NMR offers different opportunities for identifying second-site ligands that bind at the vicinity of a first-site ligand. By contrast to the “SAR by NMR” approach, ligand-observed experiments are performed for medium-size to very large proteins. One strategy is to use 2D nuclear Overhauser effect spectroscopy (NOESY) experiments that allow the identification of compounds that bind near (∼5 Å) a first-site ligand through the observation of interligand NOEs (ILOEs).<a onclick="showRef(event, 'ref24 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref24 ref25 ref26">(24−26)</a> It is possible to modify the first-site ligand through the addition of methyl group(s), allowing the generation of a suitable NOESY probe for the observation of strong NOESY cross peaks in a spectral region with little overlap. Such experiments, referred as “SAR by ILOE”, have been used for the design of protein–protein interaction inhibitors for the targets BCL-X<sub>L</sub> and MCL1 (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, entry 8).<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27,28)</a> In addition to the identification of second-site ligands, the ILOE experiment can be used to assess the orientation of the second-site ligand relative to the first-site ligand, as shown by the group of Abell for the <i>Mycobacterium turberculosis</i> pantothenate synthetase (PS) (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, entry 9),<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> and confirm previously results obtained by X-ray crystallography.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div><div class="NLM_p last">Another strategy is to use paramagnetic labeling,<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31,32)</a> taking advantage of the paramagnetic enhancement (PRE) obtained as a result of the paramagnetic labeling of a first-site ligand. Typically, a 2,2,6,6-tetramethylpiperidin-1-oxyl (TEMPO) moiety is used. The transverse relaxation rate of the protons located within a radius of ∼10 Å of the first-site ligand is drastically enhanced, which significantly reduces the NMR signal intensities.<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33,34)</a> This approach has been successfully applied for the development of nanomolar E-selectin antagonists by Ernst and co-workers<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, entry 10).</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9">2.3.  Screening Using Ligand-Observed <sup>19</sup>F NMR</h3><div class="NLM_p"><sup>19</sup>F NMR spectroscopy is another tool for fragment screening, with the possibility of screening large mixtures of more than 20 fragments, taking advantage of the chemical shift dispersion of the <sup>19</sup>F nucleus. <sup>19</sup>F NMR is also used to search for second-site ligands, as exemplified for inhibitors of the Alzheimer target β-secretase 1 (BACE1) (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, entry 11).<a onclick="showRef(event, 'ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref36 ref37">(36,37)</a></div><div class="NLM_p last">FAXS-NMR screening (fluorine chemical shift anisotropy and exchange for screening) was used to identify a novel class of HSP90 inhibitors. The principle is to use a fluorinated molecule as a spy to recognize fragments that competitively bind with the spy molecule. A fragment hit selected from a 1200 fragments library was further characterized by X-ray crystallography and linked to the known HSP90 ligand resorcinol, leading to a low nanomolar compound (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, entry 12).<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10">2.4.  Second-Site Ligand Resulting from Elaboration of a First-Site Ligand</h3><div class="NLM_p last">Fragment growing may also generate a new ligand that binds in a pocket that differs from the one of the initial fragment hit. This is exemplified by the group of Dalgarno<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> who screened 735 fragments against the lactate deshydrogenase A (LDHA) using saturation transfer difference (STD) NMR. A fragment bound in the substrate pocket and part of the cofactor site was identified by X-ray crystallography. Fragment growing led to a new compound that does not bind in the cofactor binding site. Therefore, the initial fragment and the optimized compound were linked to generate the final structure (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, entry 13).</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11">2.5.  Second-Site Ligand Following Tethering-Based First-Site Ligand</h3><div class="NLM_p last">Wells and colleagues<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> have developed an alternative strategy to identify fragments that bind to proteins, using a cysteine residue that can form a disulfide bond with disulfide containing fragments. The disulfide bonds of the fragments that display affinity for the protein are entropically stabilized while the other disulfide bonds can be easily reduced. Tethered compounds were then recognized by mass spectrometry (MS). The approach was used to generate a novel nonpeptidic inhibitor of caspase 3 (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, entry 14).<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> The methodology was also used by Raimundo and co-workers.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> They developed a potent small-molecule inhibitor of interleukin 2 (IL2) starting from a library of 7000 disulfide-containing fragments (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, entry 15).</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12">2.6.  Second-Site Ligand Screening with Focused Libraries</h3><div class="NLM_p last">To identify second-site ligands, another strategy is to screen a fragment library that is chemically oriented to bind a particular protein-binding pocket. For example, the group of Hudson<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> screened a focused library of 450 fragments containing acids to find hits able to bind to the negatively charged region of the LDHA protein. The hit fragment was then linked to another fragment bound in the adenine region of the cofactor nicotinamide adenine dinucleotide (NADH) (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, entry 16). Another example was published by Gaul and co-workers<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> regarding disruptor of telomeric silencing 1-like (DOT1L), a potential therapeutic target involved in leukemias. The first site was blocked with a DOT1L inhibitor to search for fragments that bind in the cofactor <i>S</i>-adenosylmethionine (SAM) pocket using NMR (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, entry 17). In parallel, a focused virtual screening followed by a biochemical screen was performed for the cofactor pocket. The NMR and biochemical hits were further studied by X-ray crystallography. Modeling studies suggested to link a fragment and a second-site binder, which led to a new structure with low nanomolar affinity.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">3.  Direct Identification of Fragments Bound to Two Distinct Binding Sites</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72616" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72616" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">When techniques such as X-ray crystallography, NMR, or virtual screening are used, the identification of two fragments that bind in two distinct sites can be a direct outcome of the screening process. As discussed below, additional methods have also been used to identify two fragments that simultaneously bind the protein. The different strategies are summarized in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c00242/20201019/images/medium/jm0c00242_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c00242/20201019/images/large/jm0c00242_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Schematic representation of methods for direct identification of fragment bound to two distinct binding sites. (A) Screening using X-ray crystallography. When fragments are screened in cocktails, fragments bound to distinct sites can be observed. (B) Screening using protein-observed NMR. Two fragments that bind simultaneously two distinct protein pockets can be identified on 2D NMR protein spectra. (C) Screening using MS. Fragment hits identified by MS are modified, and competition experiments are performed to derive structural restraints. (D) Screening using biochemical assays. The example shows the use of the oxime function together with a small library of dihydroxylamine linkers. (E) Fragment self-assembly in the presence of a target protein: dynamic combinatorial chemistry (DCC). The example is illustrated with aldehyde and amine moieties that <i>in situ</i> form imines. (F) Inhibitor deconstruction and reconstruction. A known ligand can be improved by replacing a moiety by a fragment hit identified in the presence of the deconstructed fragment. (G) Cooperative binding. A first ligand induces a new pocket for a second fragment hit.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c00242/20201019/images/large/jm0c00242_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00242&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14">3.1.  Screening Using X-ray Crystallography</h3><div class="NLM_p">X-ray crystallography is a particularly attractive technique in FBDD as it directly gives the 3D structure of the protein–fragment complex. Using a focused library of 80 fragments on the protein thrombin,<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Astex Therapeutics observed fragments bound to the S1 pocket of the enzyme and one compound that bound to the S2–S4 region. The X-ray structures then helped the design of a linked compound (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, entry 18). The group of Yarnold<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> identified, using biochemical screening followed by X-ray crystallography, fragments that bound to separate subsites within the ATPase pocket of HSP90 (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, entry 19). In another example, Guichou and colleagues<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> used computational screening of 34 409 fragments to identify fragments of the cyclophilin D (CYPD) active site as well as the gatekeeper pocket. Fourteen X-ray structures were obtained, showing four fragments bound to the catalytic site of the protein while five fragments were observed in the gatekeeper pocket (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, entry 20). Using a thermal shift assay followed by X-ray crystallography, Barral and co-workers<a onclick="showRef(event, 'ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref48 ref49">(48,49)</a> identified three compounds that bind near the <i>S</i>-adenosylmethionine (AdoMet) binding pocket of the NS5 AdoMet-dependent mRNA methyltransferase (MTase) domain, highlighting a new targetable site (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, entry 21). More recently, Spring et al.<a onclick="showRef(event, 'ref50 ref51 ref52'); return false;" href="javascript:void(0);" class="ref ref50 ref51 ref52">(50−52)</a> found a fragment bound at multiple sites on the protein casein kinase 2 (CK2), including a previously unreported site adjacent to the adenosine triphosphate (ATP) site. The fragment was modified to generate a compound that specifically binds the newly identified pocket and linked with ATP-site ligands (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, entry 22).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Fragment Linking by Direct Identification of Two Fragments</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c00242/20201019/images/medium/jm0c00242_0005.gif" alt="" id="gr4" /></img><div></div></div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16">3.2.  Screening Using Protein-Observed NMR</h3><div class="NLM_p last">Protein-observed NMR experiments can also be used to identify two different fragments that bind simultaneously two distinct protein pockets. The group of Fesik<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> examined 14 976 fragments of replication protein A (RPA) by NMR and found compounds that bind to two distinct sites in the basic cleft of RPA70N. X-ray structures revealed the binding modes of the fragments, suggesting a strategy for fragment optimization and linking (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, entry 23).</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17">3.3.  Screening Using MS</h3><div class="NLM_p last">Similar to the “SAR by NMR”, a “SAR by MS” approach has been proposed. Ibis Therapeutics<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> used MS to screen fragments against the 1061 region of bacterial 23S ribosomal ribonucleic acid (rRNA). This process includes a first step where compounds are screened against the RNA by MS. SAR is obtained by chemical modification of the hits and MS experiments. Data obtained for structurally modified hits, for which competition or absence of competition in the MS experiments was observed, led to distant restraints between initial fragments that were then linked (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, entry 24).</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18">3.4.  Screening Using Biochemical Assays</h3><div class="NLM_p last">Biochemical assays constitute straightforward screening methods that require knowledge of the biochemical protein functions. A proof of concept of the linking strategy was reported by Green<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> with biotin analogues binding avidin, illustrating the superadditivity that can be achieved with the fragment linking approach (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, entry 25). Another report<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> showed that the knowledge of the 3D structure of the target was not crucial. Ellman and co-workers screened at high concentration a library of oximes and a small library of dihydroxylamine linkers against the tyrosine kinase c-SRC. They could demonstrate the utility of the method with the identification of a potent and subtype-selective inhibitor (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, entry 26).</div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19">3.5.  Fragment Self-Assembly</h3><div class="NLM_p last">We have also considered fragment self-assembly as examples of fragment linking, even if no linker is designed to obtain the linked compound. The process called dynamic combinatorial chemistry (DCC) is observed <i>in situ</i> in the presence of a target protein. As a first example, Huc and Lehn<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> reported the generation of carbonic anhydrase (CA) inhibitors by combination of aldehyde and amine moieties to <i>in situ</i> form imines (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, entry 27). Other applications were published for a neuraminidase (NA) inhibitor (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, entry 28)<a onclick="showRef(event, 'ref58 ref59'); return false;" href="javascript:void(0);" class="ref ref58 ref59">(58,59)</a> and an aspartic protease endothiapepsin (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, entry 29).<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> Dynamic combinatorial X-ray crystallography, when DCC takes place inside protein crystals, was demonstrated for the cyclin-dependent kinase 2 (CDK2), using a mixture of hydrazines and isatins (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, entry 30).<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> Another methodology called dynamic ligation screening (DLS) was reported by Rademann and co-workers<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> for the protease caspase 3 (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, entry 31). By use of a fluorescent probe attached to a fragment, competitors or fragments that bind cooperatively to the fluorescent probe are detected with the fluorescence polarization assay. The authors also extended the approach to form amide bonds (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, entry 32).<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> Protein-templated click chemistry (PTCC) that relies on the 1,3-dipolar cycloaddition of azides and alkynes to generate a triazole moiety was also reported by the team of Sharpless<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> with the generation of a femtomolar inhibitor of acetylcholinesterase (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, entry 33). Additional examples concern inhibitors developed for histone deacetylases (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, entry 34),<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> chitinase B (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, entry 35),<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> and the aspartic protease endothiapepsin (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, entry 36).<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> The approach can also lead to protein–protein interaction inhibitors, as demonstrated for BCL-X<sub>L</sub> (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, entry 37).<a onclick="showRef(event, 'ref68 ref69'); return false;" href="javascript:void(0);" class="ref ref68 ref69">(68,69)</a></div></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20">3.6.  Inhibitor Deconstruction and Reconstruction</h3><div class="NLM_p">Deconstruction of known ligands can provide a useful strategy for the reconstruction of a new compound.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> By use of HTS, two compounds were identified to bind the human <i>N</i>-myristoyltransferase 1 (NMT1) protein, and X-ray crystallography indicated that the molecules bind in two different pockets.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> To preclude a steric clash upon compound linking, one of the hits was deconstructed to remove the quinoline moiety (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, entry 38).</div><div class="NLM_p last">The linking approach can be particularly useful to replace a part of a compound that is not suitable. For example, fragments were searched to substitute a chymase inhibitor benzothiophene moiety that produced reactive metabolites.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> Takahashi and co-workers screened 1000 fragments and identified a fragment that binds in the same pocket as the benzothiophene core. The deconstruction and reconstruction of the initial inhibitor led to a compound with improved metabolic properties (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, entry 39).</div></div><div id="sec3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21">3.7.  Cooperative Binding</h3><div class="NLM_p last">In some cases, the second binding pocket is only observed in the presence of a first ligand bound to a distinct pocket. For example, Varani and colleagues<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> identified six fragments capable of binding the human immunodeficiency virus 1 (HIV-1) transactivation response RNA only in the presence of the first hit, an arginine mimetic.</div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">4.  Dimerization of a Fragment Hit</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86560" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86560" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A special application of fragment linking is dimerization. This approach allows one to link together two copies of the same fragment binding either to adjacent sites or in the same pocket of a protein.</div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23">4.1.  The Fragment Binds Twice in the Protein Binding Pocket</h3><div class="NLM_p">The first example was reported by Brimijoin and co-workers<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> for the acetylcholine esterase. The observation that two copies of an acridine analogue could be modeled in the active site led to the design of dimeric compounds with different linker lengths. An inhibitor that was 1000-fold more potent than the original molecule was synthesized (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>, entry 40). Another case was reported by Blundell and co-workers<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> for the transcription factor from <i>Mycobacterium tuberculosis</i> (EthR), involved in antibiotic resistance. Thermal shift assay followed by crystallography identified two copies of a fragment hit in the allosteric pocket of the protein, starting from 1250 fragments (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>, entry 41). Similarly, biochemical assay (enzyme inhibition by monitoring NADH absorbance) followed by crystallography identified two copies of a fragment hit in the active site of the protein inosine 5′-monophosphate dehydrogenase (IMPDH) (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>, entry 42).<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> They synthesized an inhibitor that was 2500-fold more potent than the original molecule.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Fragment Linking by Fragment Dimerization</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c00242/20201019/images/medium/jm0c00242_0006.gif" alt="" id="gr6" /></img><div></div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25">4.2.  The Fragment Binds in the Same Pocket in Two Protein Subunits</h3><div class="NLM_p last">Human mast cell tryptase, a trypsin-like serine protease, exists as a tetramer. The ligand benzamidine was modified to contain two benzamidine moieties with a flexible linker region spanning the space between two monomers (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>, entry 43).<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> With a similar approach, an anticancer pyruvate kinase M2 (PKM2) activator was designed (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>, entry 44)<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> as well as an inhibitor of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>, entry 45).<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a></div></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26">5.  Linkers</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52565" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52565" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Once two fragments have been identified, a linker is designed, which can be done using various strategies. From a chemical point of view, we have considered two types of linkers, the alkyl-derived linkers, and the functionalized linkers. We also report two promising approaches, a first one that we have called “linkers inspired by known ligands” and the other one “growing before linking”.</div><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27">5.1.  Alkyl Linkers and Derivatives</h3><div class="NLM_p">Alkyl linkers of variable lengths are largely used in the literature to link two fragments bound in two pockets (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). In some studies, the linkers also include more rigid structures such as phenyl core, alkyne function (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>, entry 11), and cyclohexane (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>, entry 26). Typically, the likely binding mode and structural constraints for the lengths are obtained from NMR experiments (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>, entries 1, 2, and 3), crystal structures of fragments (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>, entries 4, 6, 18, 38, and 39), or a combination of crystallography and molecular modeling (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>, entries 7, 12, 16, 17, 19, 40, 44, and 45). One publication showed that mass spectroscopy competition experiments can also generate distance restraints (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>, entry 24). Linking strategy with an alkyl chain has also successfully generated compounds in the absence of structural information, using biochemical data (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>, entries 25 and 43).</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Linker Chemical Structures and Structural Methods<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c00242/20201019/images/medium/jm0c00242_0007.gif" alt="" id="gr7" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">Footnotes: *Ranking by calculating the internal-strain energies. **Molecular dynamics simulation.</p></div></div><div></div></div><div class="NLM_p last">In a majority of cases, a small set of compounds with varying linker lengths and attachment points are synthesized to explore the hypotheses. In addition, the linking can start from an ether or an amine moiety, making chemical synthesis more straightforward.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29">5.2.  Linkers with Functional Groups</h3><div class="NLM_p">Alkyl functions are more problematic when the linking of the two molecules requires a nonlinear geometry. For example, the team of Barral used a urea function as suggested by <i>in silico</i> studies (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>, entry 21). Hadjuk and co-workers reported a case where a sulfonamide was chosen as it could bend by 180°. In the same study, in order to position correctly a furanone moiety included in the fragment with a 90° twist, an acetylene linker was used (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a> entry 5). Sulfonamide and acyl sulfonamide were also used by the Abell group to replace ester and amide moieties in the case of the pantothenate synthase (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>, entry 9).</div><div class="NLM_p last">In some cases, the linker has been carefully optimized in order to add molecular interactions between the atoms of the linker and the protein residues. For example, Fesik’s team chose to add rigidity and to introduce interactions between the linker and the protein by introducing a thioamide linker for a BCL-2 inhibitor (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>, entry 23). In the Dalgarno group, the initial ether-based linker was modified with the addition of functional groups including ester, amide, amine, and hydroxyl functions. The eight-atom linker containing four hydroxyl groups interacting with protein atoms provided the most active compound (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>, entry 13). A further strategy reported in the literature consisted of selecting the linkers by <i>in silico</i> studies. For example, for the design of a BCL-X<sub>L</sub> inhibitor (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a> entry 8), several types of linkers were proposed and led to more active compounds.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30">5.3.  Structural Data for the Linker Design</h3><div class="NLM_p last">As illustrated in <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>, in the large majority of the cases (26 out of 31 publications), structural information is used to design the linker. X-ray crystallography appears as the method of choice, alone or in combination with modeling, while NMR is much rarely utilized. Structural data can also result from the merging strategy, where a known ligand offers an opportunity to design the linker (see below, <a class="ref internalNav" href="#sec5_4" aria-label="section 5.4">section 5.4</a>). Also, the growing strategy may be necessary to first reduce the distance between the fragments before linking, which necessitates structural characterization of the protein–fragment complexes (see <a class="ref internalNav" href="#sec5_5" aria-label="section 5.5">section 5.5</a>).</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31">5.4.  Linkers Inspired by Known Ligands (Mixing Merging and Linking Strategies)</h3><div class="NLM_p last">Another strategy for the linker design is to take advantage of the knowledge of natural substrates or other known inhibitors. For example, Guichou et al. chose to use a urea moiety, after superimposition of fragments with the known structures of sangliferin A and cyclosporine A, two cyclophilin inhibitors. Two molecules with two different linkers were obtained, and one of them directly showed micromolar activity (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a> entry 20). The Abell group similarly merged a previously known inhibitor with two copies of a fragment hit (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>, entry 42), which has led to a successful linker.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32">5.5.  Growing before Linking</h3><div class="NLM_p last">We want to particularly emphasize one strategy that consists of growing one of the fragments before linking, when the distance between the two fragments is particularly large. This strategy has been used with both alkyl and functionalized linkers. In the report by AstraZeneca (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>, entry 16) on the LDHA protein, growing of one of the fragments was performed until the distance between the two fragments was reduced to 3 Å. Then, a molecular study was used to select suitable linkers. In the case of the protein kinase CK2, due to the long distance between the initial fragments, Spring and colleagues chose to modify one of the fragments by addition of chemical groups with different lengths. The synthesized molecules were then evaluated, and X-ray data were solved to measure the resulting distance between the two fragments (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>, entry 22) before linking.</div></div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i33">6.  Future Perspectives and Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72613" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72613" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">FBDD is a powerful method for the generation of new drug candidates, which so far has led to three FDA-approved drugs and to clinical trials for nearly 50 molecules. While strategies for developing an active molecule from a fragment are typically growing, linking, and merging approaches, some examples reported here show that these strategies may be used one after another to increase the chances of success. Nevertheless, the literature clearly shows that the growing strategy is by far the most widely used strategy, even if the linking strategy raised great expectations due to theoretical considerations.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Are there some experimental, technical difficulties that might explain the moderate success of the linking strategy? The first step in this process is the identification of two fragments that bind the protein in two distinct subsites. Screening a fragment library with a structural method offers a clear advantage in this context. While both NMR and X-ray crystallography techniques theoretically offer the opportunity to directly identify two compounds that simultaneously bind the protein target at two different sites, published examples highlight X-ray crystallography as the most successful (or used) method. By contrast, NMR is a method of choice for the iterative identification of a second-site binder.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> However, when NMR is used as a screening technique, two screens are generally essential. Second-site screening also offers the opportunity to identify new binding pockets, which may open the route for the design of highly selective compound such as allosteric molecules. The optimization of the second-site ligands might be necessary to increase the affinity of those ligands that are typically weaker binders than the first-site ligands. Once the screening has been performed, the most appropriate method to guide the linking process will depend on the distance between the two identified binders. NMR can be an interesting approach for short distances, typically when the two fragments bind in adjacent pockets, using ILOE 2D experiments that do not require protein labeling. We believe this strategy is particularly suitable for catalytic sites of enzymes (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, entries 8 and 9). For larger distances, which might be observed for protein–protein interaction inhibitors or for bivalent compounds targeting two sites (for example, active site and allosteric site), modeling and X-ray crystallography are more efficient techniques than NMR, as the linker design will necessitate the resolution of the complex 3D structure. NMR would require labeled protein samples.</div><div class="NLM_p last">For the majority of the fragment-linking published examples, superadditivity is not observed. This might explain why the growing approach remains the preferred strategy. Out of the 45 examples reported here, 9 only fulfill the superadditivity criterion (entries 2, 4, 18, 20, 25, 30, 32, 33, and 43), including the well-known avidin case, one dimerization case, and three self-assembly examples. This shows that achieving superadditivity is challenging. In particular for noncatalytic sites such as protein–protein interaction sites, protein conformational rearrangement upon compound binding might induce changes in the fragment binding modes. Translational and rotational entropy changes due to the linker also need to be counteracted. It is not straightforward to understand what criteria (regarding the fragment or the linker) lead to superadditivity. Previously, Whittaker and colleagues<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> suggested that successful linking could be achieved by carefully selecting the pair of fragments to be linked, with one forming polar interactions with the protein while the second fragment should interact through van der Waals interactions. The idea is that the binding mode of the fragment that does bind through nonpolar interactions can be changed without penalty upon linking. There are examples in the literature that contradict this assumption, and successful cases here showed polar interactions for both fragments. To our point of view, the linking strategy in FBDD essentially depends on the optimization of the two initial fragments, the geometry required to link the fragments, and the length of the linker. As observed for the compounds for which the superadditivity was reached, the linkers are rather short and flexible, mainly alkyl-derived linkers. Therefore, these findings tend to suggest that mixing the growing and linking approaches could be a promising method to achieve the superadditivity. Growing one fragment helps reduce the length of the linker required. Also, optimization of the fragments before linking may help adapt the linker in the case of protein conformational changes. Another promising approach consists of mixing merging and linking strategies, where the linker is designed because of the imitation of chemical groups observed in known ligands.</div></div><div class="NLM_back"><div class="NLM_notes" id="notes1"><p class="first last">The authors declare no competing financial interest.</p></div><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c00242" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82812" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82812" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Isabelle Krimm</span> - <span class="hlFld-Affiliation affiliation">Centre
de RMN à Très Hauts Champs, Université de Lyon, CNRS, Université Claude Bernard
Lyon 1, ENS, 5 Rue de
la Doua, F-69100 Villeurbanne, France</span>; 
    <span class="hlFld-Affiliation affiliation">Centre
de Recherche en Cancérologie de Lyon, Université de Lyon, Université Claude Bernard Lyon
1, INSERM 1052, CNRS 5286, Centre Léon Bérard, 69008 Lyon, France</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5981-109X" title="Orcid link">http://orcid.org/0000-0002-5981-109X</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#c1a8b2a0a3a4adada4efaab3a8acac81b4afa8b7ecadb8aeaff0efa7b3"><span class="__cf_email__" data-cfemail="2e475d4f4c4b42424b00455c4743436e5b40475803425741401f00485c">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alexandre Bancet</span> - <span class="hlFld-Affiliation affiliation">EA
4446 Bioactive Molecules and Medicinal Chemistry, Faculté de
Pharmacie, ISPB, SFR Santé Lyon-Est
CNRS UMS3453, INSERM US7, Université de Lyon, Université
Claude Bernard Lyon 1, 69373 Lyon Cedex 8, France</span>; 
    <span class="hlFld-Affiliation affiliation">Centre
de RMN à Très Hauts Champs, Université de Lyon, CNRS, Université Claude Bernard
Lyon 1, ENS, 5 Rue de
la Doua, F-69100 Villeurbanne, France</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4467-8684" title="Orcid link">http://orcid.org/0000-0003-4467-8684</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Claire Raingeval</span> - <span class="hlFld-Affiliation affiliation">Centre
de RMN à Très Hauts Champs, Université de Lyon, CNRS, Université Claude Bernard
Lyon 1, ENS, 5 Rue de
la Doua, F-69100 Villeurbanne, France</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1161-429X" title="Orcid link">http://orcid.org/0000-0002-1161-429X</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thierry Lomberget</span> - <span class="hlFld-Affiliation affiliation">EA
4446 Bioactive Molecules and Medicinal Chemistry, Faculté de
Pharmacie, ISPB, SFR Santé Lyon-Est
CNRS UMS3453, INSERM US7, Université de Lyon, Université
Claude Bernard Lyon 1, 69373 Lyon Cedex 8, France</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4071-0002" title="Orcid link">http://orcid.org/0000-0002-4071-0002</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marc Le Borgne</span> - <span class="hlFld-Affiliation affiliation">EA
4446 Bioactive Molecules and Medicinal Chemistry, Faculté de
Pharmacie, ISPB, SFR Santé Lyon-Est
CNRS UMS3453, INSERM US7, Université de Lyon, Université
Claude Bernard Lyon 1, 69373 Lyon Cedex 8, France</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1398-075X" title="Orcid link">http://orcid.org/0000-0003-1398-075X</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jean-François Guichou</span> - <span class="hlFld-Affiliation affiliation">CBS, Université
de Montpellier, CNRS, INSERM, 34095 Montpellier, France</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7699-3235" title="Orcid link">http://orcid.org/0000-0002-7699-3235</a></span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><p>The authors declare no competing financial interest.<br /></br></p></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02850" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02850" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Alexandre Bancet</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00242&amp;id=BIO-d7e1852-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Alexandre Bancet</b> received his Master’s degree in Chemistry in 2017 from the University of Lyon, France. He is currently pursuing his Doctoral degree in Medicinal Chemistry under the supervision of Prof. Thierry Lomberget and Dr. Isabelle Krimm. He is developing a non-ATP-competitive inhibitor of the CK2 kinase using fragment-based approaches and the NMR technique, at the Institut of Pharmacological Sciences, University of Lyon, and at The Very High field NMR Center in Lyon.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Claire Raingeval</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00242&amp;id=BIO-d7e1857-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Claire Raingeval</b> received her Ph.D. from the Chemistry Department at the University of Lyon, France, in 2019, under the supervision of Dr. Isabelle Krimm at the The Very High Field NMR Center in Lyon. Her research was focused on fragment screening against the G-protein-coupled receptors.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Thierry Lomberget</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00242&amp;id=BIO-d7e1862-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Thierry Lomberget</b> obtained his Ph.D. in Organometallic Chemistry from University of Lyon in 2002 under the supervision of Dr. Geneviève Balme. After a two years’ postdoctoral stay at the University of Geneva in the research group of Prof. E. Peter Kündig, he came back to Lyon as a temporary teacher/researcher and then was appointed as a lecturer at ISPB, Faculty of Pharmacy of Lyon in 2005. He was promoted tp Full Professor of Medicinal Chemistry in 2016 at the same institute. His actual main research interests are the design and optimization of anticancer agents, such as microtubule-targeting agents and kinases inhibitors, multidrug resistance modulators, and anti-infective compounds.</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Marc Le Borgne</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00242&amp;id=BIO-d7e1867-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Marc Le Borgne</b> has his Ph.D. in Medicinal Chemistry under the supervision of Prof. Guillaume Le Baut at the University of Nantes (France) in 1997. He began his research and academic career in the School of Pharmacy at the University of Nantes. In 2008, he moved to the University of Lyon as a Full Professor of Medicinal Chemistry. He is currently the head of the research team Bioactive Molecules and Medicinal Chemistry (B2MC). His research interests focus on the design and synthesis of bioactive small molecules as anti-infective compounds or kinase-targeted anticancer therapeutic agents.</p></figure></div><div class="bio" rid="ath5"><figure id="ath5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Jean-François Guichou</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00242&amp;id=BIO-d7e1872-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Jean-François Guichou</b> received his Master’s degree in Chemistry in 1996 from Montpellier University, France. He received the Diploma of ENSCM (Ecole Nationale Suppérieure de Chimie de Montpellier) in 1997 from Montpellier, France. He received his Doctoral degree in Organic Chemistry in 2002 under the supervision of Prof. Manfred Mutter at the Lausanne University, Switzerland. He was Assistant Professor from 2005 to 2016 at Montpellier University. In 2009, he won a “Chercheur d’Avenir” grant for 2 years, France. From 2016 to date, he is Full Professor at Montpellier University. He has been working on various therapeutic targets, using SBDD or FBDD approaches.</p></figure></div><div class="bio" rid="ath6"><figure id="ath6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Isabelle Krimm</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00242&amp;id=BIO-d7e1877-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Isabelle Krimm</b> received her Ph.D. from the Chemistry Department in 2000 in the University of Lyon, France. She served as a postdoctoral fellow at the CEA in Paris for 2 years in order to resolve the 3D structure of the N-terminal part of the lamin protein, using NMR. She then joined the Chemistry Laboratory at University of Lyon and started a new group dedicated to fragment-based approaches for drug design in 2013. In 2019, she joined as Principal Investigator both the The Very High Field NMR Center in Lyon and the Center for Research in Cancer in Lyon.</p></figure></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i40">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65886" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65886" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank the CNRS, the Ligue contre le Cancer and ANR (Convergence PLAScan) for financial support.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">AMPA</td><td class="NLM_def"><p class="first last">α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid</p></td></tr><tr><td class="NLM_term">ACHE</td><td class="NLM_def"><p class="first last">acetylcholinesterase</p></td></tr><tr><td class="NLM_term">AdoMet</td><td class="NLM_def"><p class="first last">adenosylmethionine</p></td></tr><tr><td class="NLM_term">AKT</td><td class="NLM_def"><p class="first last">protein kinase B</p></td></tr><tr><td class="NLM_term">ATP</td><td class="NLM_def"><p class="first last">adenosine triphosphate</p></td></tr><tr><td class="NLM_term">BACE1</td><td class="NLM_def"><p class="first last">β-secretase 1</p></td></tr><tr><td class="NLM_term">BCL-2</td><td class="NLM_def"><p class="first last">B-cell lymphoma 2</p></td></tr><tr><td class="NLM_term">BCL-X<sub>L</sub></td><td class="NLM_def"><p class="first last">B-cell lymphoma-extra-large</p></td></tr><tr><td class="NLM_term">BET</td><td class="NLM_def"><p class="first last">bromo- and extra-terminal domain family</p></td></tr><tr><td class="NLM_term">BRAF</td><td class="NLM_def"><p class="first last">v-raf murine sarcoma viral oncogene homolog B</p></td></tr><tr><td class="NLM_term">BRD2</td><td class="NLM_def"><p class="first last">bromodomain-containing protein 2</p></td></tr><tr><td class="NLM_term">c-SRC</td><td class="NLM_def"><p class="first last">proto-oncogene tyrosine-protein kinase SRC</p></td></tr><tr><td class="NLM_term">CA</td><td class="NLM_def"><p class="first last">carbonic anhydrase</p></td></tr><tr><td class="NLM_term">CASP3</td><td class="NLM_def"><p class="first last">caspase 3</p></td></tr><tr><td class="NLM_term">CDK1/2/4/5/9</td><td class="NLM_def"><p class="first last">cyclin-dependent kinases 1/2/4/5/9</p></td></tr><tr><td class="NLM_term">cIAP1</td><td class="NLM_def"><p class="first last">cellular inhibitor of apoptosis protein 1</p></td></tr><tr><td class="NLM_term">CK2</td><td class="NLM_def"><p class="first last">casein kinase 2</p></td></tr><tr><td class="NLM_term">CSF1R</td><td class="NLM_def"><p class="first last">colony stimulating factor 1 receptor</p></td></tr><tr><td class="NLM_term">CYPD</td><td class="NLM_def"><p class="first last">cyclophilin D</p></td></tr><tr><td class="NLM_term">DCC</td><td class="NLM_def"><p class="first last">dynamic combinatorial chemistry</p></td></tr><tr><td class="NLM_term">DENV</td><td class="NLM_def"><p class="first last">dengue virus</p></td></tr><tr><td class="NLM_term">DLS</td><td class="NLM_def"><p class="first last">dynamic ligation screening</p></td></tr><tr><td class="NLM_term">DOT1L</td><td class="NLM_def"><p class="first last">disruptor of telomeric silencing 1-like</p></td></tr><tr><td class="NLM_term">ERK1/2</td><td class="NLM_def"><p class="first last">mitogen-activated protein kinase 3/1</p></td></tr><tr><td class="NLM_term">EthR</td><td class="NLM_def"><p class="first last"><i>Mycobacterium tuberculosis</i> transcriptional repressor</p></td></tr><tr><td class="NLM_term">FAXS</td><td class="NLM_def"><p class="first last">fluorine chemical shift anisotropy and exchange for screening</p></td></tr><tr><td class="NLM_term">FBDD</td><td class="NLM_def"><p class="first last">fragment-based drug discovery</p></td></tr><tr><td class="NLM_term">FDA</td><td class="NLM_def"><p class="first last">Food and Drug Administration</p></td></tr><tr><td class="NLM_term">FGFR</td><td class="NLM_def"><p class="first last">fibroblast growth factor receptor</p></td></tr><tr><td class="NLM_term">FKBP</td><td class="NLM_def"><p class="first last">FK506-binding protein</p></td></tr><tr><td class="NLM_term">FLT3</td><td class="NLM_def"><p class="first last">fms-like tyrosine kinase 3</p></td></tr><tr><td class="NLM_term">FXa</td><td class="NLM_def"><p class="first last">factor X</p></td></tr><tr><td class="NLM_term">HDAC</td><td class="NLM_def"><p class="first last">histone deacetylases</p></td></tr><tr><td class="NLM_term">HIV-1</td><td class="NLM_def"><p class="first last">human immunodeficiency virus 1</p></td></tr><tr><td class="NLM_term">HSP90</td><td class="NLM_def"><p class="first last">heat shock protein 90</p></td></tr><tr><td class="NLM_term">HTS</td><td class="NLM_def"><p class="first last">high-throughput screening</p></td></tr><tr><td class="NLM_term">IDO1</td><td class="NLM_def"><p class="first last">indoleamine-pyrrole 2,3-dioxygenase</p></td></tr><tr><td class="NLM_term">IL-2</td><td class="NLM_def"><p class="first last">interleukin 2</p></td></tr><tr><td class="NLM_term">ILOE</td><td class="NLM_def"><p class="first last">interligand NOE</p></td></tr><tr><td class="NLM_term">IMPDH</td><td class="NLM_def"><p class="first last">inosine 5′-monophosphate dehydrogenase</p></td></tr><tr><td class="NLM_term">IRAK4</td><td class="NLM_def"><p class="first last">interleukin-1 receptor-associated kinase 4</p></td></tr><tr><td class="NLM_term">JAK2</td><td class="NLM_def"><p class="first last">Janus kinase 2</p></td></tr><tr><td class="NLM_term">KHK</td><td class="NLM_def"><p class="first last">ketohexokinase</p></td></tr><tr><td class="NLM_term">KIT</td><td class="NLM_def"><p class="first last">tyrosine-protein kinase KIT</p></td></tr><tr><td class="NLM_term">KRAS</td><td class="NLM_def"><p class="first last">Kirsten rat sarcoma viral oncogene</p></td></tr><tr><td class="NLM_term">LDHA</td><td class="NLM_def"><p class="first last">lactate deshydrogenase A</p></td></tr><tr><td class="NLM_term">LFA1</td><td class="NLM_def"><p class="first last">lymphocyte function-associated antigen 1</p></td></tr><tr><td class="NLM_term">LTA4H</td><td class="NLM_def"><p class="first last">leukotriene A4 hydrolase</p></td></tr><tr><td class="NLM_term">MCL1</td><td class="NLM_def"><p class="first last">induced myeloid leukemia cell differentiation protein</p></td></tr><tr><td class="NLM_term">MET</td><td class="NLM_def"><p class="first last">tyrosine-protein kinase MET</p></td></tr><tr><td class="NLM_term">mGlu5</td><td class="NLM_def"><p class="first last">metabotropic glutamate receptor 5</p></td></tr><tr><td class="NLM_term">MNK1/2</td><td class="NLM_def"><p class="first last">MAP kinase-interacting serine/threonine-protein kinase 1/2</p></td></tr><tr><td class="NLM_term">MMP2/9</td><td class="NLM_def"><p class="first last">matrix metalloproteinase 2/9</p></td></tr><tr><td class="NLM_term">mRNA</td><td class="NLM_def"><p class="first last">messenger ribonucleic acid</p></td></tr><tr><td class="NLM_term">MS</td><td class="NLM_def"><p class="first last">mass spectrometry</p></td></tr><tr><td class="NLM_term">MTase</td><td class="NLM_def"><p class="first last">methyltransferase</p></td></tr><tr><td class="NLM_term">NA</td><td class="NLM_def"><p class="first last">neuraminidase</p></td></tr><tr><td class="NLM_term">NADH</td><td class="NLM_def"><p class="first last">nicotinamide adenine dinucleotide</p></td></tr><tr><td class="NLM_term">NMR</td><td class="NLM_def"><p class="first last">nuclear magnetic resonance</p></td></tr><tr><td class="NLM_term">NMT1</td><td class="NLM_def"><p class="first last"><i>N</i>-myristoyltransferase 1</p></td></tr><tr><td class="NLM_term">NOE</td><td class="NLM_def"><p class="first last">nuclear Overhauser effect</p></td></tr><tr><td class="NLM_term">NOESY</td><td class="NLM_def"><p class="first last">nuclear Overhauser effect spectroscopy</p></td></tr><tr><td class="NLM_term">PKM2</td><td class="NLM_def"><p class="first last">pyruvate kinase M2</p></td></tr><tr><td class="NLM_term">PPAR</td><td class="NLM_def"><p class="first last">peroxisome proliferator-activated receptor</p></td></tr><tr><td class="NLM_term">PRC2</td><td class="NLM_def"><p class="first last">polycomb repressive complex 2</p></td></tr><tr><td class="NLM_term">PRE</td><td class="NLM_def"><p class="first last">paramagnetic enhancement</p></td></tr><tr><td class="NLM_term">PS</td><td class="NLM_def"><p class="first last">pantothenate synthetase</p></td></tr><tr><td class="NLM_term">PTCC</td><td class="NLM_def"><p class="first last">protein-templated click chemistry</p></td></tr><tr><td class="NLM_term">PTP1B</td><td class="NLM_def"><p class="first last">protein tyrosine phosphatase-1B</p></td></tr><tr><td class="NLM_term">RAF</td><td class="NLM_def"><p class="first last">rapidly accelerated fibrosarcoma</p></td></tr><tr><td class="NLM_term">ROCK</td><td class="NLM_def"><p class="first last">rho-associated protein kinase</p></td></tr><tr><td class="NLM_term">RPA</td><td class="NLM_def"><p class="first last">replication protein A</p></td></tr><tr><td class="NLM_term">rRNA</td><td class="NLM_def"><p class="first last">ribosomal ribonucleic acid</p></td></tr><tr><td class="NLM_term">S6K1</td><td class="NLM_def"><p class="first last">ribosomal protein S6 kinase β1</p></td></tr><tr><td class="NLM_term">SAM</td><td class="NLM_def"><p class="first last"><i>S</i>-adenosylmethionine</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">SmChiB</td><td class="NLM_def"><p class="first last"><i>Serratia marcescens</i> chitinase B</p></td></tr><tr><td class="NLM_term">SPR</td><td class="NLM_def"><p class="first last">surface plasmon resonance</p></td></tr><tr><td class="NLM_term">STD</td><td class="NLM_def"><p class="first last">saturation transfer difference</p></td></tr><tr><td class="NLM_term">TEMPO</td><td class="NLM_def"><p class="first last">2,2,6,6-tetramethylpiperidin-1-oxyl</p></td></tr><tr><td class="NLM_term">VRE</td><td class="NLM_def"><p class="first last">vancomycin-resistant <i>enterococci</i></p></td></tr><tr><td class="NLM_term">XIAP</td><td class="NLM_def"><p class="first last">x-linked inhibitor of apoptosis protein</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i42">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11322" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11322" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 80 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rees, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Congreve, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, C.</span></span> <span> </span><span class="NLM_article-title">Fragment-based lead discovery</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">660</span>– <span class="NLM_lpage">672</span>, <span class="refDoi"> DOI: 10.1038/nrd1467</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1038%2Fnrd1467" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=15286733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtVOht7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=660-672&author=D.+C.+Reesauthor=M.+Congreveauthor=C.+W.+Murrayauthor=C.+Carr&title=Fragment-based+lead+discovery&doi=10.1038%2Fnrd1467"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-based lead discovery</span></div><div class="casAuthors">Rees, David C.; Congreve, Miles; Murray, Christopher W.; Carr, Robin</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">660-672</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Fragment-based lead discovery is gaining momentum in both large pharmaceutical companies and biotechnol. labs. as a complementary approach to traditional screening.  This is because fragment-based approaches require significantly fewer compds. to be screened and synthesized, and are showing a high success rate in generating chem. series with lead-like properties.  Compared with traditional screening hits, the starting fragments have considerably lower mol. mass, and although the binding interactions of these fragments with a target protein are weak, they are structurally understood through x-ray crystallog. or NMR, and they exhibit high 'ligand efficiency'.  Here, the authors use examples from 25 different protein targets to describe chem. strategies that exploit this structural knowledge to rapidly develop fragments into high-affinity leads.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbKeUzFFIlhbVg90H21EOLACvtfcHk0lin75uKRUmRKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtVOht7Y%253D&md5=8d49ac7f698c9b9d573ee3c3485eced8</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrd1467&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1467%26sid%3Dliteratum%253Aachs%26aulast%3DRees%26aufirst%3DD.%2BC.%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DCarr%26aufirst%3DC.%26atitle%3DFragment-based%2520lead%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D660%26epage%3D672%26doi%3D10.1038%2Fnrd1467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hajduk, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greer, J.</span></span> <span> </span><span class="NLM_article-title">A decade of fragment-based drug design: strategic advances and lessons learned</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">211</span>– <span class="NLM_lpage">219</span>, <span class="refDoi"> DOI: 10.1038/nrd2220</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1038%2Fnrd2220" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=17290284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BD2sXit12rtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=211-219&author=P.+J.+Hajdukauthor=J.+Greer&title=A+decade+of+fragment-based+drug+design%3A+strategic+advances+and+lessons+learned&doi=10.1038%2Fnrd2220"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">A decade of fragment-based drug design: strategic advances and lessons learned</span></div><div class="casAuthors">Hajduk, Philip J.; Greer, Jonathan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">211-219</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Since the early 1990s, several technol. and scientific advances - such as combinatorial chem., high-throughput screening and the sequencing of the human genome - have been heralded as remedies to the problems facing the pharmaceutical industry.  The use of these technologies in some form is now well established at most pharmaceutical companies; however, the return on investment in terms of marketed products has not met expectations.  Fragment-based drug design is another tool for drug discovery that has emerged in the past decade.  Here, we describe the development and evolution of fragment-based drug design, analyze the role that this approach can have in combination with other discovery technologies and highlight the impact that fragment-based methods have made in progressing new medicines into the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOB8K3AESqTbVg90H21EOLACvtfcHk0lin75uKRUmRKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXit12rtr4%253D&md5=bae574da3671475d8488615c3bfa9849</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrd2220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2220%26sid%3Dliteratum%253Aachs%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26aulast%3DGreer%26aufirst%3DJ.%26atitle%3DA%2520decade%2520of%2520fragment-based%2520drug%2520design%253A%2520strategic%2520advances%2520and%2520lessons%2520learned%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D211%26epage%3D219%26doi%3D10.1038%2Fnrd2220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chessari, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodhead, A. J.</span></span> <span> </span><span class="NLM_article-title">From fragment to clinical candidate - a historical perspective</span>. <i>Drug Discov. Today</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">668</span>– <span class="NLM_lpage">675</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2009.04.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1016%2Fj.drudis.2009.04.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=19427404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BD1MXotFyktLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=668-675&author=G.+Chessariauthor=A.+J.+Woodhead&title=From+fragment+to+clinical+candidate+-+a+historical+perspective&doi=10.1016%2Fj.drudis.2009.04.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">From fragment to clinical candidate-a historical perspective</span></div><div class="casAuthors">Chessari, Gianni; Woodhead, Andrew J.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">13/14</span>),
    <span class="NLM_cas:pages">668-675</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  As recently as ten years ago few scientists had heard of fragment screening, let alone considered low mol. wt. fragments (MW <300) with weak binding affinities to be attractive start points for drug discovery programs.  Today, however, there is widespread acceptance that these fragments can be progressed into lead series and on to become clin. candidates.  Consequently, over the past three to four years, fragment-based drug discovery has become firmly established within the biotechnol. and pharmaceutical industries as a complimentary strategy to high-throughput screening.  In this review, we give a historical perspective of how rapidly fragment-based drug discovery has developed and describe a no. of clin. compds. discovered using this approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIfibakR1lWLVg90H21EOLACvtfcHk0lin75uKRUmRKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXotFyktLo%253D&md5=1bd47b7787b1b22681466ad220eb7cd1</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2009.04.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2009.04.007%26sid%3Dliteratum%253Aachs%26aulast%3DChessari%26aufirst%3DG.%26aulast%3DWoodhead%26aufirst%3DA.%2BJ.%26atitle%3DFrom%2520fragment%2520to%2520clinical%2520candidate%2520-%2520a%2520historical%2520perspective%26jtitle%3DDrug%2520Discov.%2520Today%26date%3D2009%26volume%3D14%26spage%3D668%26epage%3D675%26doi%3D10.1016%2Fj.drudis.2009.04.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murray, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blundell, T. L.</span></span> <span> </span><span class="NLM_article-title">Structural biology in fragment-based drug design</span>. <i>Curr. Opin. Struct. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">497</span>– <span class="NLM_lpage">507</span>, <span class="refDoi"> DOI: 10.1016/j.sbi.2010.04.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1016%2Fj.sbi.2010.04.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=20471246" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVKhtLvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=497-507&author=C.+W.+Murrayauthor=T.+L.+Blundell&title=Structural+biology+in+fragment-based+drug+design&doi=10.1016%2Fj.sbi.2010.04.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Structural biology in fragment-based drug design</span></div><div class="casAuthors">Murray, Christopher W.; Blundell, Tom L.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Structural Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">497-507</span>CODEN:
                <span class="NLM_cas:coden">COSBEF</span>;
        ISSN:<span class="NLM_cas:issn">0959-440X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Fragment-based ligand screening is now established as an emerging paradigm for drug discovery.  Here we examine the recent literature looking at how structural biol. has been used in a variety of successful fragment-screening applications.  We argue that the detn. of exptl. binding modes has proved to be one of the mainstays of successful fragment-based approaches and that this reflects the difficulty in optimizing a fragment to a lead mol. in the absence of structural information.  We focus on antimicrobial research where fragment-based drug discovery allows control of the phys. properties of the emerging lead mol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1S2lx8J-FX7Vg90H21EOLACvtfcHk0liW6H4CZqiJNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVKhtLvF&md5=ae8cfc0f8be47a316bd92073e95e0c8a</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.sbi.2010.04.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.sbi.2010.04.003%26sid%3Dliteratum%253Aachs%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DBlundell%26aufirst%3DT.%2BL.%26atitle%3DStructural%2520biology%2520in%2520fragment-based%2520drug%2520design%26jtitle%3DCurr.%2520Opin.%2520Struct.%2520Biol.%26date%3D2010%26volume%3D20%26spage%3D497%26epage%3D507%26doi%3D10.1016%2Fj.sbi.2010.04.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Erlanson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubbard, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahnke, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jhoti, H.</span></span> <span> </span><span class="NLM_article-title">Twenty years on: the impact of fragments on drug discovery</span>. <i>Nat. Rev. Drug Discov.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">605</span>– <span class="NLM_lpage">619</span>, <span class="refDoi"> DOI: 10.1038/nrd.2016.109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1038%2Fnrd.2016.109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=27417849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Gisb%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=605-619&author=D.+A.+Erlansonauthor=S.+W.+Fesikauthor=R.+E.+Hubbardauthor=W.+Jahnkeauthor=H.+Jhoti&title=Twenty+years+on%3A+the+impact+of+fragments+on+drug+discovery&doi=10.1038%2Fnrd.2016.109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Twenty years on: the impact of fragments on drug discovery</span></div><div class="casAuthors">Erlanson, Daniel A.; Fesik, Stephen W.; Hubbard, Roderick E.; Jahnke, Wolfgang; Jhoti, Harren</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">605-619</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">After 20 years of sometimes quiet growth, fragment-based drug discovery (FBDD) has become mainstream.  More than 30 drug candidates derived from fragments have entered the clinic, with two approved and several more in advanced trials.  FBDD has been widely applied in both academia and industry, as evidenced by the large no. of papers from universities, non-profit research institutions, biotechnol. companies and pharmaceutical companies.  Moreover, FBDD draws on a diverse range of disciplines, from biochem. and biophysics to computational and medicinal chem.  As the promise of FBDD strategies becomes increasingly realized, now is an opportune time to draw lessons and point the way to the future.  This Review briefly discusses how to design fragment libraries, how to select screening techniques and how to make the most of information gleaned from them.  It also shows how concepts from FBDD have permeated and enhanced drug discovery efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrXQhFttydkrVg90H21EOLACvtfcHk0liW6H4CZqiJNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Gisb%252FE&md5=fc2bcf0da6b7b1083a5ff263057cfa80</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.109%26sid%3Dliteratum%253Aachs%26aulast%3DErlanson%26aufirst%3DD.%2BA.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26aulast%3DJahnke%26aufirst%3DW.%26aulast%3DJhoti%26aufirst%3DH.%26atitle%3DTwenty%2520years%2520on%253A%2520the%2520impact%2520of%2520fragments%2520on%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discov.%26date%3D2016%26volume%3D15%26spage%3D605%26epage%3D619%26doi%3D10.1038%2Fnrd.2016.109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mortenson, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erlanson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Esch, I. J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahnke, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, C. N.</span></span> <span> </span><span class="NLM_article-title">Fragment-to-lead medicinal chemistry publications in 2017</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">3857</span>– <span class="NLM_lpage">3872</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01472</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01472" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1CqsrbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=3857-3872&author=P.+N.+Mortensonauthor=D.+A.+Erlansonauthor=I.+J.+P.+de+Eschauthor=W.+Jahnkeauthor=C.+N.+Johnson&title=Fragment-to-lead+medicinal+chemistry+publications+in+2017&doi=10.1021%2Facs.jmedchem.8b01472"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-to-Lead Medicinal Chemistry Publications in 2017</span></div><div class="casAuthors">Mortenson, Paul N.; Erlanson, Daniel A.; de Esch, Iwan J. P.; Jahnke, Wolfgang; Johnson, Christopher N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3857-3872</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  This Miniperspective is the third in a series reviewing fragment-to-lead publications from a given year.  Following our reviews for 2015 and 2016, this Miniperspective provides tabulated summaries of relevant articles published in 2017 along with some general observations.  In addn., we discuss insights obtained from anal. of the combined data set of 85 examples from all three years of publications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoakuhiet0qZLVg90H21EOLACvtfcHk0liW6H4CZqiJNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1CqsrbK&md5=f755c4768cd2d8f7efaaefa987a16079</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01472%26sid%3Dliteratum%253Aachs%26aulast%3DMortenson%26aufirst%3DP.%2BN.%26aulast%3DErlanson%26aufirst%3DD.%2BA.%26aulast%3Dde%2BEsch%26aufirst%3DI.%2BJ.%2BP.%26aulast%3DJahnke%26aufirst%3DW.%26aulast%3DJohnson%26aufirst%3DC.%2BN.%26atitle%3DFragment-to-lead%2520medicinal%2520chemistry%2520publications%2520in%25202017%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D3857%26epage%3D3872%26doi%3D10.1021%2Facs.jmedchem.8b01472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Congreve, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jhoti, H.</span></span> <span> </span><span class="NLM_article-title">A “Rule of three” for fragment-based lead discovery</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">876</span>– <span class="NLM_lpage">877</span>, <span class="refDoi"> DOI: 10.1016/S1359-6446(03)02831-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1016%2FS1359-6446%2803%2902831-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=14554012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A280%3ADC%252BD3svns1Cnsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2003&pages=876-877&author=M.+Congreveauthor=R.+Carrauthor=C.+Murrayauthor=H.+Jhoti&title=A+%E2%80%9CRule+of+three%E2%80%9D+for+fragment-based+lead+discovery&doi=10.1016%2FS1359-6446%2803%2902831-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">A 'rule of three' for fragment-based lead discovery?</span></div><div class="casAuthors">Congreve Miles; Carr Robin; Murray Chris; Jhoti Harren</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">876-7</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRfFswFSn5vb43yKPtYViAGfW6udTcc2eZzb57ubT7GL7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3svns1Cnsw%253D%253D&md5=137886dbb2062f7a3ad39277dd888df3</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2803%2902831-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252803%252902831-9%26sid%3Dliteratum%253Aachs%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DCarr%26aufirst%3DR.%26aulast%3DMurray%26aufirst%3DC.%26aulast%3DJhoti%26aufirst%3DH.%26atitle%3DA%2520%25E2%2580%259CRule%2520of%2520three%25E2%2580%259D%2520for%2520fragment-based%2520lead%2520discovery%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2003%26volume%3D8%26spage%3D876%26epage%3D877%26doi%3D10.1016%2FS1359-6446%2803%2902831-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bollag, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibrahim, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spevak, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habets, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shellooe, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marimuthu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Artis, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlessinger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higgins, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Andrea, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koehler, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stumm, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grippo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puzanov, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ribas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McArthur, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sosman, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flaherty, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nathanson, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolop, K.</span></span> <span> </span><span class="NLM_article-title">Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>467</i></span>,  <span class="NLM_fpage">596</span>– <span class="NLM_lpage">599</span>, <span class="refDoi"> DOI: 10.1038/nature09454</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1038%2Fnature09454" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=20823850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1ajtbfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=467&publication_year=2010&pages=596-599&author=G.+Bollagauthor=P.+Hirthauthor=J.+Tsaiauthor=J.+Zhangauthor=P.+N.+Ibrahimauthor=H.+Choauthor=W.+Spevakauthor=C.+Zhangauthor=Y.+Zhangauthor=G.+Habetsauthor=E.+A.+Burtonauthor=B.+Wongauthor=G.+Tsangauthor=B.+L.+Westauthor=B.+Powellauthor=R.+Shellooeauthor=A.+Marimuthuauthor=H.+Nguyenauthor=K.+Y.+Zhangauthor=D.+R.+Artisauthor=J.+Schlessingerauthor=F.+Suauthor=B.+Higginsauthor=R.+Iyerauthor=K.+D%E2%80%99Andreaauthor=A.+Koehlerauthor=M.+Stummauthor=P.+S.+Linauthor=R.+J.+Leeauthor=J.+Grippoauthor=I.+Puzanovauthor=K.+B.+Kimauthor=A.+Ribasauthor=G.+A.+McArthurauthor=J.+A.+Sosmanauthor=P.+B.+Chapmanauthor=K.+T.+Flahertyauthor=X.+Xuauthor=K.+L.+Nathansonauthor=K.+Nolop&title=Clinical+efficacy+of+a+RAF+inhibitor+needs+broad+target+blockade+in+BRAF-mutant+melanoma&doi=10.1038%2Fnature09454"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma</span></div><div class="casAuthors">Bollag, Gideon; Hirth, Peter; Tsai, James; Zhang, Jiazhong; Ibrahim, Prabha N.; Cho, Hanna; Spevak, Wayne; Zhang, Chao; Zhang, Ying; Habets, Gaston; Burton, Elizabeth A.; Wong, Bernice; Tsang, Garson; West, Brian L.; Powell, Ben; Shellooe, Rafe; Marimuthu, Adhirai; Nguyen, Hoa; Zhang, Kam Y. J.; Artis, Dean R.; Schlessinger, Joseph; Su, Fei; Higgins, Brian; Iyer, Raman; D'Andrea, Kurt; Koehler, Astrid; Stumm, Michael; Lin, Paul S.; Lee, Richard J.; Grippo, Joseph; Puzanov, Igor; Kim, Kevin B.; Ribas, Antoni; McArthur, Grant A.; Sosman, Jeffrey A.; Chapman, Paul B.; Flaherty, Keith T.; Xu, Xiaowei; Nathanson, Katherine L.; Nolop, Keith</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">467</span>
        (<span class="NLM_cas:issue">7315</span>),
    <span class="NLM_cas:pages">596-599</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">B-RAF is the most frequently mutated protein kinase in human cancers.  The finding that oncogenic mutations in BRAF are common in melanoma, followed by the demonstration that these tumors are dependent on the RAF/MEK/ERK pathway, offered hope that inhibition of B-RAF kinase activity could benefit melanoma patients.  Herein, we describe the structure-guided discovery of PLX4032 (RG7204), a potent inhibitor of oncogenic B-RAF kinase activity.  Preclin. expts. demonstrated that PLX4032 selectively blocked the RAF/MEK/ERK pathway in BRAF mutant cells and caused regression of BRAF mutant xenografts.  Toxicol. studies confirmed a wide safety margin consistent with the high degree of selectivity, enabling Phase 1 clin. trials using a cryst. formulation of PLX4032 (ref. 5).  In a subset of melanoma patients, pathway inhibition was monitored in paired biopsy specimens collected before treatment initiation and following 2 wk of treatment.  This anal. revealed substantial inhibition of ERK phosphorylation, yet clin. evaluation did not show tumor regressions.  At higher drug exposures afforded by a new amorphous drug formulation, greater than 80% inhibition of ERK phosphorylation in the tumors of patients correlated with clin. response.  Indeed, the Phase 1 clin. data revealed a remarkably high 81% response rate in metastatic melanoma patients treated at an oral dose of 960 mg twice daily.  These data demonstrate that BRAF-mutant melanomas are highly dependent on B-RAF kinase activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpYwlns1EfcLVg90H21EOLACvtfcHk0liilSjccOkAOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1ajtbfK&md5=8a26d0ab41970f39a109ddafff2f17b4</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnature09454&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09454%26sid%3Dliteratum%253Aachs%26aulast%3DBollag%26aufirst%3DG.%26aulast%3DHirth%26aufirst%3DP.%26aulast%3DTsai%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DIbrahim%26aufirst%3DP.%2BN.%26aulast%3DCho%26aufirst%3DH.%26aulast%3DSpevak%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DHabets%26aufirst%3DG.%26aulast%3DBurton%26aufirst%3DE.%2BA.%26aulast%3DWong%26aufirst%3DB.%26aulast%3DTsang%26aufirst%3DG.%26aulast%3DWest%26aufirst%3DB.%2BL.%26aulast%3DPowell%26aufirst%3DB.%26aulast%3DShellooe%26aufirst%3DR.%26aulast%3DMarimuthu%26aufirst%3DA.%26aulast%3DNguyen%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DK.%2BY.%26aulast%3DArtis%26aufirst%3DD.%2BR.%26aulast%3DSchlessinger%26aufirst%3DJ.%26aulast%3DSu%26aufirst%3DF.%26aulast%3DHiggins%26aufirst%3DB.%26aulast%3DIyer%26aufirst%3DR.%26aulast%3DD%25E2%2580%2599Andrea%26aufirst%3DK.%26aulast%3DKoehler%26aufirst%3DA.%26aulast%3DStumm%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DP.%2BS.%26aulast%3DLee%26aufirst%3DR.%2BJ.%26aulast%3DGrippo%26aufirst%3DJ.%26aulast%3DPuzanov%26aufirst%3DI.%26aulast%3DKim%26aufirst%3DK.%2BB.%26aulast%3DRibas%26aufirst%3DA.%26aulast%3DMcArthur%26aufirst%3DG.%2BA.%26aulast%3DSosman%26aufirst%3DJ.%2BA.%26aulast%3DChapman%26aufirst%3DP.%2BB.%26aulast%3DFlaherty%26aufirst%3DK.%2BT.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DNathanson%26aufirst%3DK.%2BL.%26aulast%3DNolop%26aufirst%3DK.%26atitle%3DClinical%2520efficacy%2520of%2520a%2520RAF%2520inhibitor%2520needs%2520broad%2520target%2520blockade%2520in%2520BRAF-mutant%2520melanoma%26jtitle%3DNature%26date%3D2010%26volume%3D467%26spage%3D596%26epage%3D599%26doi%3D10.1038%2Fnature09454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Souers, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leverson, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boghaert, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ackler, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catron, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dayton, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enschede, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairbrother, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D. C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hymowitz, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khaw, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovar, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maecker, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsh, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitten, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nimmer, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oleksijew, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sampath, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seymour, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahir, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tse, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wendt, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humerickhouse, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmore, S. W.</span></span> <span> </span><span class="NLM_article-title">ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">202</span>– <span class="NLM_lpage">208</span>, <span class="refDoi"> DOI: 10.1038/nm.3048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1038%2Fnm.3048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=23291630" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjslagtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=202-208&author=A.+J.+Souersauthor=J.+D.+Leversonauthor=E.+R.+Boghaertauthor=S.+L.+Acklerauthor=N.+D.+Catronauthor=J.+Chenauthor=B.+D.+Daytonauthor=H.+Dingauthor=S.+H.+Enschedeauthor=W.+J.+Fairbrotherauthor=D.+C.+S.+Huangauthor=S.+G.+Hymowitzauthor=S.+Jinauthor=S.+L.+Khawauthor=P.+J.+Kovarauthor=L.+T.+Lamauthor=J.+Leeauthor=H.+L.+Maeckerauthor=K.+C.+Marshauthor=K.+D.+Masonauthor=M.+J.+Mittenauthor=P.+M.+Nimmerauthor=A.+Oleksijewauthor=C.+H.+Parkauthor=C.+Parkauthor=D.+C.+Phillipsauthor=A.+W.+Robertsauthor=D.+Sampathauthor=J.+F.+Seymourauthor=M.+L.+Smithauthor=G.+M.+Sullivanauthor=S.+K.+Tahirauthor=C.+Tseauthor=M.+D.+Wendtauthor=Y.+Xiaoauthor=J.+C.+Xueauthor=H.+Zhangauthor=R.+A.+Humerickhouseauthor=S.+H.+Rosenbergauthor=S.+W.+Elmore&title=ABT-199%2C+a+potent+and+selective+BCL-2+inhibitor%2C+achieves+antitumor+activity+while+sparing+platelets&doi=10.1038%2Fnm.3048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets</span></div><div class="casAuthors">Souers, Andrew J.; Leverson, Joel D.; Boghaert, Erwin R.; Ackler, Scott L.; Catron, Nathaniel D.; Chen, Jun; Dayton, Brian D.; Ding, Hong; Enschede, Sari H.; Fairbrother, Wayne J.; Huang, David C. S.; Hymowitz, Sarah G.; Jin, Sha; Khaw, Seong Lin; Kovar, Peter J.; Lam, Lloyd T.; Lee, Jackie; Maecker, Heather L.; Marsh, Kennan C.; Mason, Kylie D.; Mitten, Michael J.; Nimmer, Paul M.; Oleksijew, Anatol; Park, Chang H.; Park, Cheol-Min; Phillips, Darren C.; Roberts, Andrew W.; Sampath, Deepak; Seymour, John F.; Smith, Morey L.; Sullivan, Gerard M.; Tahir, Stephen K.; Tse, Chris; Wendt, Michael D.; Xiao, Yu; Xue, John C.; Zhang, Haichao; Humerickhouse, Rod A.; Rosenberg, Saul H.; Elmore, Steven W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">202-208</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Proteins in the B cell CLL/lymphoma 2 (BCL-2) family are key regulators of the apoptotic process.  This family comprises proapoptotic and prosurvival proteins, and shifting the balance toward the latter is an established mechanism whereby cancer cells evade apoptosis.  The therapeutic potential of directly inhibiting prosurvival proteins was unveiled with the development of navitoclax, a selective inhibitor of both BCL-2 and BCL-2-like 1 (BCL-XL), which has shown clin. efficacy in some BCL-2-dependent hematol. cancers.  However, concomitant on-target thrombocytopenia caused by BCL-XL inhibition limits the efficacy achievable with this agent.  Here we report the re-engineering of navitoclax to create a highly potent, orally bioavailable and BCL-2-selective inhibitor, ABT-199.  This compd. inhibits the growth of BCL-2-dependent tumors in vivo and spares human platelets.  A single dose of ABT-199 in three patients with refractory chronic lymphocytic leukemia resulted in tumor lysis within 24 h.  These data indicate that selective pharmacol. inhibition of BCL-2 shows promise for the treatment of BCL-2-dependent hematol. cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqi7P7koWwJHLVg90H21EOLACvtfcHk0lgQCnVuMV8BKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjslagtQ%253D%253D&md5=6a24b72303eb2062da653f1f61ac74fb</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnm.3048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3048%26sid%3Dliteratum%253Aachs%26aulast%3DSouers%26aufirst%3DA.%2BJ.%26aulast%3DLeverson%26aufirst%3DJ.%2BD.%26aulast%3DBoghaert%26aufirst%3DE.%2BR.%26aulast%3DAckler%26aufirst%3DS.%2BL.%26aulast%3DCatron%26aufirst%3DN.%2BD.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DDayton%26aufirst%3DB.%2BD.%26aulast%3DDing%26aufirst%3DH.%26aulast%3DEnschede%26aufirst%3DS.%2BH.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26aulast%3DHuang%26aufirst%3DD.%2BC.%2BS.%26aulast%3DHymowitz%26aufirst%3DS.%2BG.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DKhaw%26aufirst%3DS.%2BL.%26aulast%3DKovar%26aufirst%3DP.%2BJ.%26aulast%3DLam%26aufirst%3DL.%2BT.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DMaecker%26aufirst%3DH.%2BL.%26aulast%3DMarsh%26aufirst%3DK.%2BC.%26aulast%3DMason%26aufirst%3DK.%2BD.%26aulast%3DMitten%26aufirst%3DM.%2BJ.%26aulast%3DNimmer%26aufirst%3DP.%2BM.%26aulast%3DOleksijew%26aufirst%3DA.%26aulast%3DPark%26aufirst%3DC.%2BH.%26aulast%3DPark%26aufirst%3DC.%26aulast%3DPhillips%26aufirst%3DD.%2BC.%26aulast%3DRoberts%26aufirst%3DA.%2BW.%26aulast%3DSampath%26aufirst%3DD.%26aulast%3DSeymour%26aufirst%3DJ.%2BF.%26aulast%3DSmith%26aufirst%3DM.%2BL.%26aulast%3DSullivan%26aufirst%3DG.%2BM.%26aulast%3DTahir%26aufirst%3DS.%2BK.%26aulast%3DTse%26aufirst%3DC.%26aulast%3DWendt%26aufirst%3DM.%2BD.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DXue%26aufirst%3DJ.%2BC.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DHumerickhouse%26aufirst%3DR.%2BA.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26atitle%3DABT-199%252C%2520a%2520potent%2520and%2520selective%2520BCL-2%2520inhibitor%252C%2520achieves%2520antitumor%2520activity%2520while%2520sparing%2520platelets%26jtitle%3DNat.%2520Med.%26date%3D2013%26volume%3D19%26spage%3D202%26epage%3D208%26doi%3D10.1038%2Fnm.3048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murray, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newell, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angibaud, P.</span></span> <span> </span><span class="NLM_article-title">A successful collaboration between academia, biotech and pharma led to discovery of erdafitinib, a selective FGFR inhibitor recently approved by the FDA</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1509</span>– <span class="NLM_lpage">1511</span>, <span class="refDoi"> DOI: 10.1039/C9MD90044F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1039%2FC9MD90044F" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhs1Oms73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=1509-1511&author=C.+W.+Murrayauthor=D.+R.+Newellauthor=P.+Angibaud&title=A+successful+collaboration+between+academia%2C+biotech+and+pharma+led+to+discovery+of+erdafitinib%2C+a+selective+FGFR+inhibitor+recently+approved+by+the+FDA&doi=10.1039%2FC9MD90044F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">A successful collaboration between academia, biotech and pharma led to discovery of erdafitinib, a selective FGFR inhibitor recently approved by the FDA</span></div><div class="casAuthors">Murray, Christopher W.; Newell, David R.; Angibaud, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1509-1511</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPXodFayPaObVg90H21EOLACvtfcHk0lgQCnVuMV8BKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhs1Oms73P&md5=dab27c44172ffb251ad03a53ffa2176b</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1039%2FC9MD90044F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC9MD90044F%26sid%3Dliteratum%253Aachs%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DNewell%26aufirst%3DD.%2BR.%26aulast%3DAngibaud%26aufirst%3DP.%26atitle%3DA%2520successful%2520collaboration%2520between%2520academia%252C%2520biotech%2520and%2520pharma%2520led%2520to%2520discovery%2520of%2520erdafitinib%252C%2520a%2520selective%2520FGFR%2520inhibitor%2520recently%2520approved%2520by%2520the%2520FDA%26jtitle%3DMedChemComm%26date%3D2019%26volume%3D10%26spage%3D1509%26epage%3D1511%26doi%3D10.1039%2FC9MD90044F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shuker, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajduk, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meadows, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span> <span> </span><span class="NLM_article-title">Discovering high-affinity ligands for proteins: SAR by NMR</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>274</i></span>,  <span class="NLM_fpage">1531</span>– <span class="NLM_lpage">1534</span>, <span class="refDoi"> DOI: 10.1126/science.274.5292.1531</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1126%2Fscience.274.5292.1531" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=8929414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADyaK28Xnt1ansLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1996&pages=1531-1534&author=S.+B.+Shukerauthor=P.+J.+Hajdukauthor=R.+P.+Meadowsauthor=S.+W.+Fesik&title=Discovering+high-affinity+ligands+for+proteins%3A+SAR+by+NMR&doi=10.1126%2Fscience.274.5292.1531"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Discovering high-affinity ligands for proteins: SAR by NMR</span></div><div class="casAuthors">Shuker, Suzanne B.; Hajduk, Philip J.; Meadows, Robert P.; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">274</span>
        (<span class="NLM_cas:issue">5292</span>),
    <span class="NLM_cas:pages">1531-1534</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A NMR-based method is described in which small org. mols. that bind to proximal subsites of a protein are identified, optimized, and linked together to produce high-affinity ligands.  The approach is called "SAR by NMR" because structure-activity relationships (SAR) are obtained from NMR.  With this technique, compds. with nanomolar affinities for the FK506 binding protein were rapidly discovered by tethering two ligands with micromolar affinities.  The method reduces the amt. of chem. synthesis and time required for the discovery of high-affinity ligands and appears particularly useful in target-directed drug research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwkuE4EVU_yrVg90H21EOLACvtfcHk0ljqy4bXxFCAtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xnt1ansLs%253D&md5=1b9a5a5e4f2d6ee4b1c249e3e1faf2ec</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1126%2Fscience.274.5292.1531&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.274.5292.1531%26sid%3Dliteratum%253Aachs%26aulast%3DShuker%26aufirst%3DS.%2BB.%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26aulast%3DMeadows%26aufirst%3DR.%2BP.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DDiscovering%2520high-affinity%2520ligands%2520for%2520proteins%253A%2520SAR%2520by%2520NMR%26jtitle%3DScience%26date%3D1996%26volume%3D274%26spage%3D1531%26epage%3D1534%26doi%3D10.1126%2Fscience.274.5292.1531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hajduk, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meadows, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span> <span> </span><span class="NLM_article-title">Discovering high-affinity ligands for proteins</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">497</span>– <span class="NLM_lpage">499</span>, <span class="refDoi"> DOI: 10.1126/science.278.5337.497</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1126%2Fscience.278.5337.497" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=9381145" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADyaK2sXmslKgtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=1997&pages=497-499&author=P.+J.+Hajdukauthor=R.+P.+Meadowsauthor=S.+W.+Fesik&title=Discovering+high-affinity+ligands+for+proteins&doi=10.1126%2Fscience.278.5337.497"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Discovering high-affinity ligands for proteins</span></div><div class="casAuthors">Hajduk, Philip J.; Meadows, Robert P.; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">5337</span>),
    <span class="NLM_cas:pages">497-499</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review, with 8 refs.  The authors discuss here high-affinity ligands for proteins with new drugs discovery goal in mind.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAhKIa7HM0NLVg90H21EOLACvtfcHk0ljqy4bXxFCAtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmslKgtbc%253D&md5=3999f55faefa13bacdaa75738ec7e513</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1126%2Fscience.278.5337.497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.278.5337.497%26sid%3Dliteratum%253Aachs%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26aulast%3DMeadows%26aufirst%3DR.%2BP.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DDiscovering%2520high-affinity%2520ligands%2520for%2520proteins%26jtitle%3DScience%26date%3D1997%26volume%3D278%26spage%3D497%26epage%3D499%26doi%3D10.1126%2Fscience.278.5337.497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ichihara, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Law, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittaker, M.</span></span> <span> </span><span class="NLM_article-title">Compound design by fragment-linking</span>. <i>Mol. Inf.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">298</span>– <span class="NLM_lpage">306</span>, <span class="refDoi"> DOI: 10.1002/minf.201000174</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1002%2Fminf.201000174" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=27466947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkvVCrt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2011&pages=298-306&author=O.+Ichiharaauthor=J.+Barkerauthor=R.+J.+Lawauthor=M.+Whittaker&title=Compound+design+by+fragment-linking&doi=10.1002%2Fminf.201000174"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Compound Design by Fragment-Linking</span></div><div class="casAuthors">Ichihara, Osamu; Barker, John; Law, Richard J.; Whittaker, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Informatics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">298-306</span>CODEN:
                <span class="NLM_cas:coden">MIONBS</span>;
        ISSN:<span class="NLM_cas:issn">1868-1743</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The linking together of two fragment compds. that bind to distinct protein sub-sites can lead to a superadditivity of binding affinities, in which the binding free energy of the linked fragments exceeds the simple sum of the binding energies of individual fragments (linking coeff. E<1).  However, a review of the literature shows that such events are relatively rare and, in the majority of the cases, linking coeffs. are far from optimal being much greater than 1.  It is crit. to design a linker that does not disturb the original binding poses of each fragment in order to achieve successful linking.  However, such an ideal linker is often difficult to design and even more difficult to actually synthesize.  We suggest that the chance of achieving successful fragment linking can be significantly improved by choosing a fragment pair that consists of one fragment that binds by strong H-bonds (or non-classical equiv.) and a second fragment that is more tolerant of changes in binding mode (hydrophobic or vdW binders).  We also propose that the fragment MO (FMO) calcns. can be used to analyze the nature of the binding interactions of the fragment hits for the selection of fragments for evolution, merging and linking in order to optimize the chance of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTdXDFIpDN_LVg90H21EOLACvtfcHk0ljqy4bXxFCAtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkvVCrt7Y%253D&md5=38457d321df8d9fb487113c57166c987</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1002%2Fminf.201000174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fminf.201000174%26sid%3Dliteratum%253Aachs%26aulast%3DIchihara%26aufirst%3DO.%26aulast%3DBarker%26aufirst%3DJ.%26aulast%3DLaw%26aufirst%3DR.%2BJ.%26aulast%3DWhittaker%26aufirst%3DM.%26atitle%3DCompound%2520design%2520by%2520fragment-linking%26jtitle%3DMol.%2520Inf.%26date%3D2011%26volume%3D30%26spage%3D298%26epage%3D306%26doi%3D10.1002%2Fminf.201000174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jencks, W.</span></span> <span> </span><span class="NLM_article-title">On the attribution and additivity of binding energies</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1981</span>,  <span class="NLM_volume"><i>78</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">4046</span>– <span class="NLM_lpage">4050</span>, <span class="refDoi"> DOI: 10.1073/pnas.78.7.4046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1073%2Fpnas.78.7.4046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=16593049" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADyaL3MXlvVamtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=1981&pages=4046-4050&issue=7&author=W.+Jencks&title=On+the+attribution+and+additivity+of+binding+energies&doi=10.1073%2Fpnas.78.7.4046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">On the attribution and additivity of binding energies</span></div><div class="casAuthors">Jencks, William P.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">4046-50</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">It can be useful to describe the Gibbs free energy changes for the binding to a protein of a mol., A-B, and of its component parts, A and B, in terms of the intrinsic binding energies of A and B, ΔGiA and ΔGiB, and a connection Gibbs energy, ΔGs, that is derived largely from changes in translational and rotational entropy.  The relation between ΔGsand ΔGiA and ΔGiB is discussed.  This empirical approach avoids the difficult of interpreting obsd. ΔH and TΔS values for aq. solns.  The ΔGi and ΔGsterms can be large for binding to enzymes and other proteins.  The use and interpretation of these binding energies are discussed, esp. with respect to ATP interaction with myosin ATPase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2X3Thp5VESLVg90H21EOLACvtfcHk0ljqy4bXxFCAtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXlvVamtbo%253D&md5=1cdbbb8b6e3f9d3ff0ba2c662c772375</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1073%2Fpnas.78.7.4046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.78.7.4046%26sid%3Dliteratum%253Aachs%26aulast%3DJencks%26aufirst%3DW.%26atitle%3DOn%2520the%2520attribution%2520and%2520additivity%2520of%2520binding%2520energies%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1981%26volume%3D78%26issue%3D7%26spage%3D4046%26epage%3D4050%26doi%3D10.1073%2Fpnas.78.7.4046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hajduk, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheppard, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nettesheim, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olejniczak, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuker, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meadows, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinman, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrera, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcotte, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Severin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walter, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gubbins, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holzman, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidsen, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summers, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent nonpeptide inhibitors of stromelysin using SAR by NMR</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">5818</span>– <span class="NLM_lpage">5827</span>, <span class="refDoi"> DOI: 10.1021/ja9702778</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja9702778" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADyaK2sXktVehsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=1997&pages=5818-5827&author=P.+J.+Hajdukauthor=G.+Sheppardauthor=D.+G.+Nettesheimauthor=E.+T.+Olejniczakauthor=S.+B.+Shukerauthor=R.+P.+Meadowsauthor=D.+H.+Steinmanauthor=G.+M.+Carreraauthor=P.+A.+Marcotteauthor=J.+Severinauthor=K.+Walterauthor=H.+Smithauthor=E.+Gubbinsauthor=R.+Simmerauthor=T.+F.+Holzmanauthor=D.+W.+Morganauthor=S.+K.+Davidsenauthor=J.+B.+Summersauthor=S.+W.+Fesik&title=Discovery+of+potent+nonpeptide+inhibitors+of+stromelysin+using+SAR+by+NMR&doi=10.1021%2Fja9702778"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent Nonpeptide Inhibitors of Stromelysin using SAR by NMR</span></div><div class="casAuthors">Hajduk, P. J.; Sheppard, G.; Nettesheim, D. G.; Olejniczak, E. T.; Shuker, S. B.; Meadows, R. P.; Steinman, D. H.; Carrera, G. M., Jr.; Marcotte, P. A.; Severin, J.; Walter, K.; Smith, H.; Gubbins, E.; Simmer, R.; Holzman, T. F.; Morgan, D. W.; Davidsen, S. K.; Summers, J. B.; Fesik, S. W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">5818-5827</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">With the use of an NMR-based method, potent (IC50 < 25 nM) nonpeptide inhibitors of the matrix metalloproteinase stromelysin (MMP-3) were discovered.  The method, called SAR by NMR (for structure-activity relationships by NMR), involves the identification, optimization, and linking of compds. that bind to proximal sites on a protein.  Using this technique, two ligands that bind weakly to stromelysin (acetohydroxamic acid, KD = 17 mM; 3-(cyanomethyl)-4'-hydroxybiphenyl, KD = 0.02 mM) were identified.  On the basis of NMR-derived structural information, the two fragments were connected to produce a 15 nM inhibitor of this enzyme.  This compd. was rapidly discovered (less than 6 mo) and required only a minimal amt. of chem. synthesis.  These studies indicate that the SAR by NMR method can be effectively applied to enzymes to yield potent lead inhibitors-an important part of the drug discovery process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3BJ2Mq-F67rVg90H21EOLACvtfcHk0lh9bUphnxTj-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXktVehsLw%253D&md5=b67d6c7a4c975c63f2c784944567d67b</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fja9702778&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja9702778%26sid%3Dliteratum%253Aachs%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26aulast%3DSheppard%26aufirst%3DG.%26aulast%3DNettesheim%26aufirst%3DD.%2BG.%26aulast%3DOlejniczak%26aufirst%3DE.%2BT.%26aulast%3DShuker%26aufirst%3DS.%2BB.%26aulast%3DMeadows%26aufirst%3DR.%2BP.%26aulast%3DSteinman%26aufirst%3DD.%2BH.%26aulast%3DCarrera%26aufirst%3DG.%2BM.%26aulast%3DMarcotte%26aufirst%3DP.%2BA.%26aulast%3DSeverin%26aufirst%3DJ.%26aulast%3DWalter%26aufirst%3DK.%26aulast%3DSmith%26aufirst%3DH.%26aulast%3DGubbins%26aufirst%3DE.%26aulast%3DSimmer%26aufirst%3DR.%26aulast%3DHolzman%26aufirst%3DT.%2BF.%26aulast%3DMorgan%26aufirst%3DD.%2BW.%26aulast%3DDavidsen%26aufirst%3DS.%2BK.%26aulast%3DSummers%26aufirst%3DJ.%2BB.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DDiscovery%2520of%2520potent%2520nonpeptide%2520inhibitors%2520of%2520stromelysin%2520using%2520SAR%2520by%2520NMR%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1997%26volume%3D119%26spage%3D5818%26epage%3D5827%26doi%3D10.1021%2Fja9702778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oltersdorf, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmore, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoemaker, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armstrong, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Augeri, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belli, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruncko, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deckwerth, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinges, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajduk, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joseph, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korsmeyer, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunzer, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Letai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitten, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nettesheim, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nimmer, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oleksijew, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petros, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahir, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomaselli, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wendt, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, S. H.</span></span> <span> </span><span class="NLM_article-title">An inhibitor of BCL-2 family proteins induces regression of solid tumours</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>435</i></span>,  <span class="NLM_fpage">677</span>– <span class="NLM_lpage">681</span>, <span class="refDoi"> DOI: 10.1038/nature03579</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1038%2Fnature03579" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=15902208" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BD2MXks1Ogtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=435&publication_year=2005&pages=677-681&author=T.+Oltersdorfauthor=S.+W.+Elmoreauthor=A.+R.+Shoemakerauthor=R.+C.+Armstrongauthor=D.+J.+Augeriauthor=B.+A.+Belliauthor=M.+Brunckoauthor=T.+L.+Deckwerthauthor=J.+Dingesauthor=P.+J.+Hajdukauthor=M.+K.+Josephauthor=S.+Kitadaauthor=S.+J.+Korsmeyerauthor=A.+R.+Kunzerauthor=A.+Letaiauthor=C.+Liauthor=M.+J.+Mittenauthor=D.+G.+Nettesheimauthor=S.+Ngauthor=P.+M.+Nimmerauthor=J.+M.+O%E2%80%99Connorauthor=A.+Oleksijewauthor=A.+M.+Petrosauthor=J.+C.+Reedauthor=W.+Shenauthor=S.+K.+Tahirauthor=C.+B.+Thompsonauthor=K.+J.+Tomaselliauthor=B.+Wangauthor=M.+D.+Wendtauthor=H.+Zhangauthor=S.+W.+Fesikauthor=S.+H.+Rosenberg&title=An+inhibitor+of+BCL-2+family+proteins+induces+regression+of+solid+tumours&doi=10.1038%2Fnature03579"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">An inhibitor of Bcl-2 family proteins induces regression of solid tumours</span></div><div class="casAuthors">Oltersdorf, Tilman; Elmore, Steven W.; Shoemaker, Alexander R.; Armstrong, Robert C.; Augeri, David J.; Belli, Barbara A.; Bruncko, Milan; Deckwerth, Thomas L.; Dinges, Jurgen; Hajduk, Philip J.; Joseph, Mary K.; Kitada, Shinichi; Korsmeyer, Stanley J.; Kunzer, Aaron R.; Letai, Anthony; Li, Chi; Mitten, Michael J.; Nettesheim, David G.; Ng, Shi Chung; Nimmer, Paul M.; O'Connor, Jacqueline M.; Oleksijew, Anatol; Petros, Andrew M.; Reed, John C.; Shen, Wang; Tahir, Stephen K.; Thompson, Craig B.; Tomaselli, Kevin J.; Wang, Baole; Wendt, Michael D.; Zhang, Haichao; Fesik, Stephen W.; Rosenberg, Saul H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">435</span>
        (<span class="NLM_cas:issue">7042</span>),
    <span class="NLM_cas:pages">677-681</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Proteins in the Bcl-2 family are central regulators of programmed cell death, and members that inhibit apoptosis, such as Bcl-XL and Bcl-2, are overexpressed in many cancers and contribute to tumor initiation, progression and resistance to therapy.  Bcl-XL expression correlates with chemo-resistance of tumor cell lines, and redns. in Bcl-2 increase sensitivity to anticancer drugs and enhance in vivo survival.  The development of inhibitors of these proteins as potential anticancer therapeutics has been previously explored, but obtaining potent small-mol. inhibitors has proved difficult owing to the necessity of targeting a protein-protein interaction.  Here, using NMR-based screening, parallel synthesis and structure-based design, the authors have discovered ABT-737, a small-mol. inhibitor of the antiapoptotic proteins Bcl-2, Bcl-XL and Bcl-w, with an affinity two to three orders of magnitude more potent than previously reported compds.  Mechanistic studies reveal that ABT-737 does not directly initiate the apoptotic process, but enhances the effects of death signals, displaying synergistic cytotoxicity with chemotherapeutics and radiation.  ABT-737 exhibits single-agent-mechanism-based killing of cells from lymphoma and small-cell lung carcinoma lines, as well as primary patient-derived cells, and in animal models, ABT-737 improves survival, causes regression of established tumors, and produces cures in a high percentage of the mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBt7_zVt8HrbVg90H21EOLACvtfcHk0lh9bUphnxTj-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXks1Ogtb0%253D&md5=4940d06838506f181b6310d3458a595f</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fnature03579&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature03579%26sid%3Dliteratum%253Aachs%26aulast%3DOltersdorf%26aufirst%3DT.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26aulast%3DShoemaker%26aufirst%3DA.%2BR.%26aulast%3DArmstrong%26aufirst%3DR.%2BC.%26aulast%3DAugeri%26aufirst%3DD.%2BJ.%26aulast%3DBelli%26aufirst%3DB.%2BA.%26aulast%3DBruncko%26aufirst%3DM.%26aulast%3DDeckwerth%26aufirst%3DT.%2BL.%26aulast%3DDinges%26aufirst%3DJ.%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26aulast%3DJoseph%26aufirst%3DM.%2BK.%26aulast%3DKitada%26aufirst%3DS.%26aulast%3DKorsmeyer%26aufirst%3DS.%2BJ.%26aulast%3DKunzer%26aufirst%3DA.%2BR.%26aulast%3DLetai%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DMitten%26aufirst%3DM.%2BJ.%26aulast%3DNettesheim%26aufirst%3DD.%2BG.%26aulast%3DNg%26aufirst%3DS.%26aulast%3DNimmer%26aufirst%3DP.%2BM.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DJ.%2BM.%26aulast%3DOleksijew%26aufirst%3DA.%26aulast%3DPetros%26aufirst%3DA.%2BM.%26aulast%3DReed%26aufirst%3DJ.%2BC.%26aulast%3DShen%26aufirst%3DW.%26aulast%3DTahir%26aufirst%3DS.%2BK.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26aulast%3DTomaselli%26aufirst%3DK.%2BJ.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DWendt%26aufirst%3DM.%2BD.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26atitle%3DAn%2520inhibitor%2520of%2520BCL-2%2520family%2520proteins%2520induces%2520regression%2520of%2520solid%2520tumours%26jtitle%3DNature%26date%3D2005%26volume%3D435%26spage%3D677%26epage%3D681%26doi%3D10.1038%2Fnature03579" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Petros, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinges, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Augeri, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumeister, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betebenner, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bures, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmore, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajduk, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joseph, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landis, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nettesheim, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zanze, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of a potent inhibitor of the antiapoptotic protein Bcl-X<sub>L</sub> from NMR and parallel synthesis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">656</span>– <span class="NLM_lpage">663</span>, <span class="refDoi"> DOI: 10.1021/jm0507532</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0507532" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlant73J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=656-663&author=A.+M.+Petrosauthor=J.+Dingesauthor=D.+J.+Augeriauthor=S.+A.+Baumeisterauthor=D.+A.+Betebennerauthor=M.+G.+Buresauthor=S.+W.+Elmoreauthor=P.+J.+Hajdukauthor=M.+K.+Josephauthor=S.+K.+Landisauthor=D.+G.+Nettesheimauthor=S.+H.+Rosenbergauthor=W.+Shenauthor=S.+Thomasauthor=X.+Wangauthor=I.+Zanzeauthor=H.+Zhangauthor=S.+W.+Fesik&title=Discovery+of+a+potent+inhibitor+of+the+antiapoptotic+protein+Bcl-XL+from+NMR+and+parallel+synthesis&doi=10.1021%2Fjm0507532"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent Inhibitor of the Antiapoptotic Protein Bcl-xL from NMR and Parallel Synthesis</span></div><div class="casAuthors">Petros, Andrew M.; Dinges, Jurgen; Augeri, David J.; Baumeister, Steven A.; Betebenner, David A.; Bures, Mark G.; Elmore, Steven W.; Hajduk, Philip J.; Joseph, Mary K.; Landis, Shelley K.; Nettesheim, David G.; Rosenberg, Saul H.; Shen, Wang; Thomas, Sheela; Wang, Xilu; Zanze, Irini; Zhang, Haichao; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">656-663</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The antiapoptotic proteins Bcl-xL and Bcl-2 play key roles in the maintenance of normal cellular homeostasis.  However, their overexpression can lead to oncogenic transformation and is responsible for drug resistance in certain types of cancer.  This makes Bcl-xL and Bcl-2 attractive targets for the development of potential anticancer agents.  Here we describe the structure-based discovery of a potent Bcl-xL inhibitor directed at a hydrophobic groove on the surface of the protein.  This groove represents the binding site for BH3 peptides from proapoptotic Bcl-2 family members such as Bak and Bad.  Application of NMR-based screening yielded an initial biaryl acid with an affinity (Kd) of ∼300 μM for the protein.  Following the classical "SAR by NMR" approach, a second-site ligand was identified that bound proximal to the first-site ligand in the hydrophobic groove.  From NMR-based structural studies and parallel synthesis, a potent ligand was obtained, which binds to Bcl-xL with an inhibition const. (Ki) of 36 ± 2 nM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYP_kg1BoLW7Vg90H21EOLACvtfcHk0lhTmIcDHXQOvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlant73J&md5=ef6d8989682f6eaadeda9d7b6eae09e4</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm0507532&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0507532%26sid%3Dliteratum%253Aachs%26aulast%3DPetros%26aufirst%3DA.%2BM.%26aulast%3DDinges%26aufirst%3DJ.%26aulast%3DAugeri%26aufirst%3DD.%2BJ.%26aulast%3DBaumeister%26aufirst%3DS.%2BA.%26aulast%3DBetebenner%26aufirst%3DD.%2BA.%26aulast%3DBures%26aufirst%3DM.%2BG.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26aulast%3DJoseph%26aufirst%3DM.%2BK.%26aulast%3DLandis%26aufirst%3DS.%2BK.%26aulast%3DNettesheim%26aufirst%3DD.%2BG.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DShen%26aufirst%3DW.%26aulast%3DThomas%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DZanze%26aufirst%3DI.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520inhibitor%2520of%2520the%2520antiapoptotic%2520protein%2520Bcl-XL%2520from%2520NMR%2520and%2520parallel%2520synthesis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D656%26epage%3D663%26doi%3D10.1021%2Fjm0507532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tse, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoemaker, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adickes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsh, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitten, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nimmer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahir, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmore, S. W.</span></span> <span> </span><span class="NLM_article-title">ABT-263: A potent and orally bioavailable Bcl-2 family inhibitor</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">3421</span>– <span class="NLM_lpage">3428</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-07-5836</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1158%2F0008-5472.CAN-07-5836" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=18451170" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BD1cXltlSltrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=3421-3428&author=C.+Tseauthor=A.+R.+Shoemakerauthor=J.+Adickesauthor=M.+G.+Andersonauthor=J.+Chenauthor=S.+Jinauthor=E.+F.+Johnsonauthor=K.+C.+Marshauthor=M.+J.+Mittenauthor=P.+Nimmerauthor=L.+Robertsauthor=S.+K.+Tahirauthor=Y.+Xiaoauthor=X.+Yangauthor=H.+Zhangauthor=S.+Fesikauthor=S.+H.+Rosenbergauthor=S.+W.+Elmore&title=ABT-263%3A+A+potent+and+orally+bioavailable+Bcl-2+family+inhibitor&doi=10.1158%2F0008-5472.CAN-07-5836"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor</span></div><div class="casAuthors">Tse, Christin; Shoemaker, Alexander R.; Adickes, Jessica; Anderson, Mark G.; Chen, Jun; Jin, Sha; Johnson, Eric F.; Marsh, Kennan C.; Mitten, Michael J.; Nimmer, Paul; Roberts, Lisa; Tahir, Stephen K.; Xiao, Yu; Yang, Xiufen; Zhang, Haichao; Fesik, Stephen; Rosenberg, Saul H.; Elmore, Steven W.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3421-3428</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Overexpression of the prosurvival Bcl-2 family members (Bcl-2, Bcl-xL, and Mcl-1) is commonly assocd. with tumor maintenance, progression, and chemoresistance.  We previously reported the discovery of ABT-737, a potent, small-mol. Bcl-2 family protein inhibitor.  A major limitation of ABT-737 is that it is not orally bioavailable, which would limit chronic single agent therapy and flexibility to dose in combination regimens.  Here we report the biol. properties of ABT-263, a potent, orally bioavailable Bad-like BH3 mimetic (Ki's of <1 nmol/L for Bcl-2, Bcl-xL, and Bcl-w).  The oral bioavailability of ABT-263 in preclin. animal models is 20% to 50%, depending on formulation.  ABT-263 disrupts Bcl-2/Bcl-xL interactions with pro-death proteins (e.g., Bim), leading to the initiation of apoptosis within 2 h posttreatment.  In human tumor cells, ABT-263 induces Bax translocation, cytochrome c release, and subsequent apoptosis.  Oral administration of ABT-263 alone induces complete tumor regressions in xenograft models of small-cell lung cancer and acute lymphoblastic leukemia.  In xenograft models of aggressive B-cell lymphoma and multiple myeloma where ABT-263 exhibits modest or no single agent activity, it significantly enhances the efficacy of clin. relevant therapeutic regimens.  These data provide the rationale for clin. trials evaluating ABT-263 in small-cell lung cancer and B-cell malignancies.  The oral efficacy of ABT-263 should provide dosing flexibility to maximize clin. utility both as a single agent and in combination regimens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojLK8zIgyDWbVg90H21EOLACvtfcHk0lhTmIcDHXQOvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXltlSltrs%253D&md5=a43029cc218d25d4e1fb6dd1186475c4</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-07-5836&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-07-5836%26sid%3Dliteratum%253Aachs%26aulast%3DTse%26aufirst%3DC.%26aulast%3DShoemaker%26aufirst%3DA.%2BR.%26aulast%3DAdickes%26aufirst%3DJ.%26aulast%3DAnderson%26aufirst%3DM.%2BG.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26aulast%3DMarsh%26aufirst%3DK.%2BC.%26aulast%3DMitten%26aufirst%3DM.%2BJ.%26aulast%3DNimmer%26aufirst%3DP.%26aulast%3DRoberts%26aufirst%3DL.%26aulast%3DTahir%26aufirst%3DS.%2BK.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DFesik%26aufirst%3DS.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26atitle%3DABT-263%253A%2520A%2520potent%2520and%2520orally%2520bioavailable%2520Bcl-2%2520family%2520inhibitor%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D3421%26epage%3D3428%26doi%3D10.1158%2F0008-5472.CAN-07-5836" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Petros, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huth, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oost, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nimmer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendoza, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mack, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walter, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorwin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gramling, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ladror, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmore, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajduk, P. J.</span></span> <span> </span><span class="NLM_article-title">Discovery of a potent and selective Bcl-2 inhibitor using SAR by NMR</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">6587</span>– <span class="NLM_lpage">6591</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.09.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1016%2Fj.bmcl.2010.09.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=20870405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlSmsL7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=6587-6591&author=A.+M.+Petrosauthor=J.+R.+Huthauthor=T.+Oostauthor=C.+M.+Parkauthor=H.+Dingauthor=X.+Wangauthor=H.+Zhangauthor=P.+Nimmerauthor=R.+Mendozaauthor=C.+Sunauthor=J.+Mackauthor=K.+Walterauthor=S.+Dorwinauthor=E.+Gramlingauthor=U.+Ladrorauthor=S.+H.+Rosenbergauthor=S.+W.+Elmoreauthor=S.+W.+Fesikauthor=P.+J.+Hajduk&title=Discovery+of+a+potent+and+selective+Bcl-2+inhibitor+using+SAR+by+NMR&doi=10.1016%2Fj.bmcl.2010.09.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a potent and selective Bcl-2 inhibitor using SAR by NMR</span></div><div class="casAuthors">Petros, Andrew M.; Huth, Jeffrey R.; Oost, Thorsten; Park, Cheol-Min; Ding, Hong; Wang, Xilu; Zhang, Haichao; Nimmer, Paul; Mendoza, Renaldo; Sun, Chaohong; Mack, Jamey; Walter, Karl; Dorwin, Sarah; Gramling, Emily; Ladror, Uri; Rosenberg, Saul H.; Elmore, Steven W.; Fesik, Stephen W.; Hajduk, Philip J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6587-6591</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The Bcl-2 family of proteins plays a major role in the regulation of apoptosis, or programmed cell death.  Overexpression of the anti-apoptotic members of this family (Bcl-2, Bcl-xL, and Mcl-1) can render cancer cells resistant to chemotherapeutic agents and therefore these proteins are important targets for the development of new anti-cancer agents.  Here we describe the discovery of a potent, highly selective, Bcl-2 inhibitor using SAR by NMR and structure-based drug design which could serve as a starting point for the development of a Bcl-2 selective anti-cancer agent.  Such an agent would potentially overcome the Bcl-xL mediated thrombocytopenia obsd. with ABT-263.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfxdyEr4OJdLVg90H21EOLACvtfcHk0lgr7HmoajZGjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlSmsL7O&md5=936bd4f8f32dc597e4d335c37bad5e9c</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.09.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.09.033%26sid%3Dliteratum%253Aachs%26aulast%3DPetros%26aufirst%3DA.%2BM.%26aulast%3DHuth%26aufirst%3DJ.%2BR.%26aulast%3DOost%26aufirst%3DT.%26aulast%3DPark%26aufirst%3DC.%2BM.%26aulast%3DDing%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DNimmer%26aufirst%3DP.%26aulast%3DMendoza%26aufirst%3DR.%26aulast%3DSun%26aufirst%3DC.%26aulast%3DMack%26aufirst%3DJ.%26aulast%3DWalter%26aufirst%3DK.%26aulast%3DDorwin%26aufirst%3DS.%26aulast%3DGramling%26aufirst%3DE.%26aulast%3DLadror%26aufirst%3DU.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520and%2520selective%2520Bcl-2%2520inhibitor%2520using%2520SAR%2520by%2520NMR%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D6587%26epage%3D6591%26doi%3D10.1016%2Fj.bmcl.2010.09.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tao, Z. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasvold, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petros, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boghaert, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catron, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colman, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czabotar, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshayes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairbrother, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flygare, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hymowitz, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Judge, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koehler, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovar, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lessene, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitten, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ndubaku, C. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nimmer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Purkey, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oleksijew, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sleebs, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahir, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zobel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tse, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leverson, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmore, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Souers, A. J.</span></span> <span> </span><span class="NLM_article-title">Discovery of a potent and selective Bcl-X<sub>L</sub> inhibitor with in vivo activity</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1088</span>– <span class="NLM_lpage">1093</span>, <span class="refDoi"> DOI: 10.1021/ml5001867</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml5001867" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVWrtbnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=1088-1093&author=Z.+F.+Taoauthor=L.+Hasvoldauthor=L.+Wangauthor=X.+Wangauthor=A.+M.+Petrosauthor=C.+H.+Parkauthor=E.+R.+Boghaertauthor=N.+D.+Catronauthor=J.+Chenauthor=P.+M.+Colmanauthor=P.+E.+Czabotarauthor=K.+Deshayesauthor=W.+J.+Fairbrotherauthor=J.+A.+Flygareauthor=S.+G.+Hymowitzauthor=S.+Jinauthor=R.+A.+Judgeauthor=M.+F.+Koehlerauthor=P.+J.+Kovarauthor=G.+Lesseneauthor=M.+J.+Mittenauthor=C.+O.+Ndubakuauthor=P.+Nimmerauthor=H.+E.+Purkeyauthor=A.+Oleksijewauthor=D.+C.+Phillipsauthor=B.+E.+Sleebsauthor=B.+J.+Smithauthor=M.+L.+Smithauthor=S.+K.+Tahirauthor=K.+G.+Watsonauthor=Y.+Xiaoauthor=J.+Xueauthor=H.+Zhangauthor=K.+Zobelauthor=S.+H.+Rosenbergauthor=C.+Tseauthor=J.+D.+Leversonauthor=S.+W.+Elmoreauthor=A.+J.+Souers&title=Discovery+of+a+potent+and+selective+Bcl-XL+inhibitor+with+in+vivo+activity&doi=10.1021%2Fml5001867"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent and Selective BCL-XL Inhibitor with in Vivo Activity</span></div><div class="casAuthors">Tao, Zhi-Fu; Hasvold, Lisa; Wang, Le; Wang, Xilu; Petros, Andrew M.; Park, Chang H.; Boghaert, Erwin R.; Catron, Nathaniel D.; Chen, Jun; Colman, Peter M.; Czabotar, Peter E.; Deshayes, Kurt; Fairbrother, Wayne J.; Flygare, John A.; Hymowitz, Sarah G.; Jin, Sha; Judge, Russell A.; Koehler, Michael F. T.; Kovar, Peter J.; Lessene, Guillaume; Mitten, Michael J.; Ndubaku, Chudi O.; Nimmer, Paul; Purkey, Hans E.; Oleksijew, Anatol; Phillips, Darren C.; Sleebs, Brad E.; Smith, Brian J.; Smith, Morey L.; Tahir, Stephen K.; Watson, Keith G.; Xiao, Yu; Xue, John; Zhang, Haichao; Zobel, Kerry; Rosenberg, Saul H.; Tse, Chris; Leverson, Joel D.; Elmore, Steven W.; Souers, Andrew J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1088-1093</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A-1155463 I, a highly potent and selective BCL-XL inhibitor, was discovered through NMR fragment screening and structure-based design.  This compd. is substantially more potent against BCL-XL-dependent cell lines relative to the recently reported inhibitor, WEHI-539, while possessing none of its inherent pharmaceutical liabilities.  A-1155463 caused a mechanism-based and reversible thrombocytopenia in mice and inhibited H146 small cell lung cancer xenograft tumor growth in vivo following multiple doses.  A-1155463 thus represents an excellent tool mol. for studying BCL-XL biol. as well as a productive lead structure for further optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozGRbIa-4nxbVg90H21EOLACvtfcHk0lgr7HmoajZGjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVWrtbnN&md5=5d2fffa59286214efac3f320a701215a</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fml5001867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml5001867%26sid%3Dliteratum%253Aachs%26aulast%3DTao%26aufirst%3DZ.%2BF.%26aulast%3DHasvold%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DPetros%26aufirst%3DA.%2BM.%26aulast%3DPark%26aufirst%3DC.%2BH.%26aulast%3DBoghaert%26aufirst%3DE.%2BR.%26aulast%3DCatron%26aufirst%3DN.%2BD.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DColman%26aufirst%3DP.%2BM.%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3DDeshayes%26aufirst%3DK.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26aulast%3DFlygare%26aufirst%3DJ.%2BA.%26aulast%3DHymowitz%26aufirst%3DS.%2BG.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DJudge%26aufirst%3DR.%2BA.%26aulast%3DKoehler%26aufirst%3DM.%2BF.%26aulast%3DKovar%26aufirst%3DP.%2BJ.%26aulast%3DLessene%26aufirst%3DG.%26aulast%3DMitten%26aufirst%3DM.%2BJ.%26aulast%3DNdubaku%26aufirst%3DC.%2BO.%26aulast%3DNimmer%26aufirst%3DP.%26aulast%3DPurkey%26aufirst%3DH.%2BE.%26aulast%3DOleksijew%26aufirst%3DA.%26aulast%3DPhillips%26aufirst%3DD.%2BC.%26aulast%3DSleebs%26aufirst%3DB.%2BE.%26aulast%3DSmith%26aufirst%3DB.%2BJ.%26aulast%3DSmith%26aufirst%3DM.%2BL.%26aulast%3DTahir%26aufirst%3DS.%2BK.%26aulast%3DWatson%26aufirst%3DK.%2BG.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DXue%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZobel%26aufirst%3DK.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DTse%26aufirst%3DC.%26aulast%3DLeverson%26aufirst%3DJ.%2BD.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26aulast%3DSouers%26aufirst%3DA.%2BJ.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520and%2520selective%2520Bcl-XL%2520inhibitor%2520with%2520in%2520vivo%2520activity%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D1088%26epage%3D1093%26doi%3D10.1021%2Fml5001867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huth, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petros, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunzer, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wendt, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mack, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swift, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Judge, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahir, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matayoshi, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorwin, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ladror, U. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Severin, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walter, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartley, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmore, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajduk, P. J.</span></span> <span> </span><span class="NLM_article-title">Discovery and Design of Novel HSP90 inhibitors using multiple fragment-based design strategies</span>. <i>Chem. Biol. Drug Des.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">12</span>, <span class="refDoi"> DOI: 10.1111/j.1747-0285.2007.00535.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1111%2Fj.1747-0285.2007.00535.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=17630989" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BD2sXovFCktrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2007&pages=1-12&author=J.+R.+Huthauthor=C.+Parkauthor=A.+M.+Petrosauthor=A.+R.+Kunzerauthor=M.+D.+Wendtauthor=X.+Wangauthor=C.+L.+Lynchauthor=J.+C.+Mackauthor=K.+M.+Swiftauthor=R.+A.+Judgeauthor=J.+Chenauthor=P.+L.+Richardsonauthor=S.+Jinauthor=S.+K.+Tahirauthor=E.+D.+Matayoshiauthor=S.+A.+Dorwinauthor=U.+S.+Ladrorauthor=J.+M.+Severinauthor=K.+A.+Walterauthor=D.+M.+Bartleyauthor=S.+W.+Fesikauthor=S.+W.+Elmoreauthor=P.+J.+Hajduk&title=Discovery+and+Design+of+Novel+HSP90+inhibitors+using+multiple+fragment-based+design+strategies&doi=10.1111%2Fj.1747-0285.2007.00535.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and design of novel HSP90 inhibitors using multiple fragment-based design strategies</span></div><div class="casAuthors">Huth, Jeffrey R.; Park, Chang; Petros, Andrew M.; Kunzer, Aaron R.; Wendt, Michael D.; Wang, Xilu; Lynch, Christopher L.; Mack, Jamey C.; Swift, Kerry M.; Judge, Russell A.; Chen, Jun; Richardson, Paul L.; Jin, Sha; Tahir, Stephen K.; Matayoshi, Edward D.; Dorwin, Sarah A.; Ladror, Uri S.; Severin, Jean M.; Walter, Karl A.; Bartley, Diane M.; Fesik, Stephen W.; Elmore, Steven W.; Hajduk, Philip J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-12</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The mol. chaperone HSP90 has been shown to facilitate cancer cell survival by stabilizing key proteins responsible for a malignant phenotype.  The authors report here the results of parallel fragment-based drug design approaches in the design of novel HSP9O inhibitors.  Initial aminopyrimidine leads were elaborated using high-throughput org. synthesis to yield nanomolar inhibitors of the enzyme.  Second site leads were also identified which bound to HSP90 in two distinct conformations, an 'open' and 'closed' form.  Intriguingly, linked fragment approaches targeting both of these conformations were successful in producing novel, micromolar inhibitors.  Overall, this study shows that, with only a few fragment hits, multiple lead series can be generated for HSP90 due to the inherent flexibility of the active site.  Thus, ample opportunities exist to use these lead series in the development of clin. useful HSP90 inhibitors for the treatment of cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXkkVC5aQLFbVg90H21EOLACvtfcHk0ljVeTTAZoCvjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXovFCktrY%253D&md5=ae1aa497320e997ae5c0971f7c9ab341</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2007.00535.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2007.00535.x%26sid%3Dliteratum%253Aachs%26aulast%3DHuth%26aufirst%3DJ.%2BR.%26aulast%3DPark%26aufirst%3DC.%26aulast%3DPetros%26aufirst%3DA.%2BM.%26aulast%3DKunzer%26aufirst%3DA.%2BR.%26aulast%3DWendt%26aufirst%3DM.%2BD.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLynch%26aufirst%3DC.%2BL.%26aulast%3DMack%26aufirst%3DJ.%2BC.%26aulast%3DSwift%26aufirst%3DK.%2BM.%26aulast%3DJudge%26aufirst%3DR.%2BA.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DRichardson%26aufirst%3DP.%2BL.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DTahir%26aufirst%3DS.%2BK.%26aulast%3DMatayoshi%26aufirst%3DE.%2BD.%26aulast%3DDorwin%26aufirst%3DS.%2BA.%26aulast%3DLadror%26aufirst%3DU.%2BS.%26aulast%3DSeverin%26aufirst%3DJ.%2BM.%26aulast%3DWalter%26aufirst%3DK.%2BA.%26aulast%3DBartley%26aufirst%3DD.%2BM.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26atitle%3DDiscovery%2520and%2520Design%2520of%2520Novel%2520HSP90%2520inhibitors%2520using%2520multiple%2520fragment-based%2520design%2520strategies%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2007%26volume%3D70%26spage%3D1%26epage%3D12%26doi%3D10.1111%2Fj.1747-0285.2007.00535.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Szczepankiewicz, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajduk, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abad-Zapatero, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pei, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lubben, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trevillyan, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stashko, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballaron, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutchins, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jirousek, M. R.</span></span> <span> </span><span class="NLM_article-title">Discovery of a potent, selective protein tyrosine phosphatase 1B inhibitor using a linked-fragment strategy</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>125</i></span>,  <span class="NLM_fpage">4087</span>– <span class="NLM_lpage">4096</span>, <span class="refDoi"> DOI: 10.1021/ja0296733</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja0296733" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhvFeks7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2003&pages=4087-4096&author=B.+G.+Szczepankiewiczauthor=G.+Liuauthor=P.+J.+Hajdukauthor=C.+Abad-Zapateroauthor=Z.+Peiauthor=Z.+Xinauthor=T.+H.+Lubbenauthor=J.+M.+Trevillyanauthor=M.+A.+Stashkoauthor=S.+J.+Ballaronauthor=H.+Liangauthor=F.+Huangauthor=C.+W.+Hutchinsauthor=S.+W.+Fesikauthor=M.+R.+Jirousek&title=Discovery+of+a+potent%2C+selective+protein+tyrosine+phosphatase+1B+inhibitor+using+a+linked-fragment+strategy&doi=10.1021%2Fja0296733"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent, Selective Protein Tyrosine Phosphatase 1B Inhibitor Using a Linked-Fragment Strategy</span></div><div class="casAuthors">Szczepankiewicz, Bruce G.; Liu, Gang; Hajduk, Philip J.; Abad-Zapatero, Cele; Pei, Zhonghua; Xin, Zhili; Lubben, Thomas H.; Trevillyan, James M.; Stashko, Michael A.; Ballaron, Stephen J.; Liang, Heng; Huang, Flora; Hutchins, Charles W.; Fesik, Stephen W.; Jirousek, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4087-4096</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Protein tyrosine phosphatase 1B (PTP1B) is an enzyme that downregulates the insulin receptor.  Inhibition of PTP1B is expected to improve insulin action, and the design of small mol. PTP1B inhibitors to treat type II diabetes has received considerable attention.  In this work, NMR-based screening identified a nonselective competitive inhibitor of PTP1B.  A second site ligand was also identified by NMR-based screening and then linked to the catalytic site ligand by rational design. X-ray data confirmed that the inhibitor bound with the catalytic site in the native, "open" conformation.  The final compd. displayed excellent potency and good selectivity over many other phosphatases.  The modular approach to drug design described in this work should be applicable for the design of potent and selective inhibitors of other therapeutically relevant protein tyrosine phosphatases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAUdjzxyGdkrVg90H21EOLACvtfcHk0ljVeTTAZoCvjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhvFeks7o%253D&md5=ff294c94485d4aa4c7a890b018218c84</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fja0296733&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0296733%26sid%3Dliteratum%253Aachs%26aulast%3DSzczepankiewicz%26aufirst%3DB.%2BG.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26aulast%3DAbad-Zapatero%26aufirst%3DC.%26aulast%3DPei%26aufirst%3DZ.%26aulast%3DXin%26aufirst%3DZ.%26aulast%3DLubben%26aufirst%3DT.%2BH.%26aulast%3DTrevillyan%26aufirst%3DJ.%2BM.%26aulast%3DStashko%26aufirst%3DM.%2BA.%26aulast%3DBallaron%26aufirst%3DS.%2BJ.%26aulast%3DLiang%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DF.%26aulast%3DHutchins%26aufirst%3DC.%2BW.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26aulast%3DJirousek%26aufirst%3DM.%2BR.%26atitle%3DDiscovery%2520of%2520a%2520potent%252C%2520selective%2520protein%2520tyrosine%2520phosphatase%25201B%2520inhibitor%2520using%2520a%2520linked-fragment%2520strategy%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2003%26volume%3D125%26spage%3D4087%26epage%3D4096%26doi%3D10.1021%2Fja0296733" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pei, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajduk, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abad-Zapatero, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutchins, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lubben, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballaron, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haasch, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaszubska, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rondinone, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trevillyan, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jirousek, M. R.</span></span> <span> </span><span class="NLM_article-title">Fragment screening and assembly: a highly efficient approach to a selective and cell active protein tyrosine phosphatase 1B inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">4232</span>– <span class="NLM_lpage">4235</span>, <span class="refDoi"> DOI: 10.1021/jm034122o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm034122o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmvVGhu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=4232-4235&author=G.+Liuauthor=Z.+Xinauthor=Z.+Peiauthor=P.+J.+Hajdukauthor=C.+Abad-Zapateroauthor=C.+W.+Hutchinsauthor=H.+Zhaoauthor=T.+H.+Lubbenauthor=S.+J.+Ballaronauthor=D.+L.+Haaschauthor=W.+Kaszubskaauthor=C.+M.+Rondinoneauthor=J.+M.+Trevillyanauthor=M.+R.+Jirousek&title=Fragment+screening+and+assembly%3A+a+highly+efficient+approach+to+a+selective+and+cell+active+protein+tyrosine+phosphatase+1B+inhibitor&doi=10.1021%2Fjm034122o"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment Screening and Assembly: A Highly Efficient Approach to a Selective and Cell Active Protein Tyrosine Phosphatase 1B Inhibitor</span></div><div class="casAuthors">Liu, Gang; Xin, Zhili; Pei, Zhonghua; Hajduk, Philip J.; Abad-Zapatero, Cele; Hutchins, Charles W.; Zhao, Hongyu; Lubben, Thomas H.; Ballaron, Stephen J.; Haasch, Deanna L.; Kaszubska, Wiweka; Rondinone, Cristina M.; Trevillyan, James M.; Jirousek, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">4232-4235</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Using an NMR-based fragment screening and x-ray crystal structure-based assembly, starting with millimolar ligands for both the catalytic site and the second phosphotyrosine binding site, we have identified a small-mol. inhibitor of protein tyrosine phosphatase 1B with low micromolar inhibition const., high selectivity (30-fold) over the highly homologous T-cell protein tyrosine phosphatase, and good cellular activity in COS-7 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrm-Fe5w65X9rVg90H21EOLACvtfcHk0lioy7yVmHsKbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmvVGhu7k%253D&md5=316055742ee4aa6f6b28963b4576c427</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm034122o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm034122o%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DXin%26aufirst%3DZ.%26aulast%3DPei%26aufirst%3DZ.%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26aulast%3DAbad-Zapatero%26aufirst%3DC.%26aulast%3DHutchins%26aufirst%3DC.%2BW.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DLubben%26aufirst%3DT.%2BH.%26aulast%3DBallaron%26aufirst%3DS.%2BJ.%26aulast%3DHaasch%26aufirst%3DD.%2BL.%26aulast%3DKaszubska%26aufirst%3DW.%26aulast%3DRondinone%26aufirst%3DC.%2BM.%26aulast%3DTrevillyan%26aufirst%3DJ.%2BM.%26aulast%3DJirousek%26aufirst%3DM.%2BR.%26atitle%3DFragment%2520screening%2520and%2520assembly%253A%2520a%2520highly%2520efficient%2520approach%2520to%2520a%2520selective%2520and%2520cell%2520active%2520protein%2520tyrosine%2520phosphatase%25201B%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D4232%26epage%3D4235%26doi%3D10.1021%2Fjm034122o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krimm, I.</span></span> <span> </span><span class="NLM_article-title">INPHARMA-based identification of ligand binding site in fragment-based drug design</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">605</span>– <span class="NLM_lpage">610</span>, <span class="refDoi"> DOI: 10.1039/c2md20035j</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1039%2Fc2md20035j" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsFart70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=605-610&author=I.+Krimm&title=INPHARMA-based+identification+of+ligand+binding+site+in+fragment-based+drug+design&doi=10.1039%2Fc2md20035j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">INPHARMA-based identification of ligand binding site in fragment-based drug design</span></div><div class="casAuthors">Krimm, Isabelle</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">605-610</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">In the fragment-based drug design approach, methods for rapid identification of the ligand-binding site are essential.  The INPHARMA expt., a ligand-obsd. NMR expt. based on the nuclear Overhauser effect, is tested here with fragment-like mols. and the glycogen phosphorylase enzyme that contain multiple binding sites.  The results illustrate the potential of the method for the FBDD process and demonstrate that the INPHARMA expt. is particularly useful to study the binding specificity of the fragments and to assess the ligand binding mode in the presence of a ref. ligand.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUt_LlZxODa7Vg90H21EOLACvtfcHk0lioy7yVmHsKbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsFart70%253D&md5=c07d7c2bfc387d0f3d4e41192db10adb</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1039%2Fc2md20035j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2md20035j%26sid%3Dliteratum%253Aachs%26aulast%3DKrimm%26aufirst%3DI.%26atitle%3DINPHARMA-based%2520identification%2520of%2520ligand%2520binding%2520site%2520in%2520fragment-based%2520drug%2520design%26jtitle%3DMedChemComm%26date%3D2012%26volume%3D3%26spage%3D605%26epage%3D610%26doi%3D10.1039%2Fc2md20035j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeRose, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">London, R. E.</span></span> <span> </span><span class="NLM_article-title">The inter-ligand Overhauser effect: a powerful new NMR approach for mapping structural relationships of macromolecular ligands</span>. <i>J. Biomol. NMR</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">71</span>– <span class="NLM_lpage">76</span>, <span class="refDoi"> DOI: 10.1023/A:1008360208627</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1023%2FA%3A1008360208627" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10549135" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADyaK1MXntFSgtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1999&pages=71-76&author=D.+Liauthor=E.+F.+DeRoseauthor=R.+E.+London&title=The+inter-ligand+Overhauser+effect%3A+a+powerful+new+NMR+approach+for+mapping+structural+relationships+of+macromolecular+ligands&doi=10.1023%2FA%3A1008360208627"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The inter-ligand Overhauser effect: a powerful new NMR approach for mapping structural relationships of macromolecular ligands</span></div><div class="casAuthors">Li, Dawei; DeRose, Eugene F.; London, Robert E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular NMR</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">71-76</span>CODEN:
                <span class="NLM_cas:coden">JBNME9</span>;
        ISSN:<span class="NLM_cas:issn">0925-2738</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">NMR expts. that transfer conformational information from the bound to the uncomplexed state via exchange have been utilized for many years.  It is demonstrated here that inter-ligand NOEs ("ILOEs"), which exist in ternary complexes with enzymes or other macromol. receptors, can be transferred via exchange to pairs of uncomplexed ligands.  This approach is illustrated by studies of glycolate + NAD+ in the presence of porcine heart lactate dehydrogenase, and by glucose-6-phosphate + NADPH in the presence of L. mesenteroides glucose-6-phosphate dehydrogenase.  This strategy opens up a general methodol. for exploring the active sites of enzymes and for the development of artificial ligands which can function as inhibitors, or more generally as modifiers of protein function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprcPANaPftSLVg90H21EOLACvtfcHk0lioy7yVmHsKbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntFSgtr8%253D&md5=ff105603708ffb0e2a4e1501639707e8</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1023%2FA%3A1008360208627&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1008360208627%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DD.%26aulast%3DDeRose%26aufirst%3DE.%2BF.%26aulast%3DLondon%26aufirst%3DR.%2BE.%26atitle%3DThe%2520inter-ligand%2520Overhauser%2520effect%253A%2520a%2520powerful%2520new%2520NMR%2520approach%2520for%2520mapping%2520structural%2520relationships%2520of%2520macromolecular%2520ligands%26jtitle%3DJ.%2520Biomol.%2520NMR%26date%3D1999%26volume%3D15%26spage%3D71%26epage%3D76%26doi%3D10.1023%2FA%3A1008360208627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leone, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freeze, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellechia, M.</span></span> <span> </span><span class="NLM_article-title">The nuclear Overhauser effect in the lead identification process</span>. <i>Curr. Drug Discov. Technol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">91</span>– <span class="NLM_lpage">100</span>, <span class="refDoi"> DOI: 10.2174/157016306778108884</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.2174%2F157016306778108884" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=16925517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVSjsrzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=91-100&author=M.+Leoneauthor=H.+H.+Freezeauthor=C.+S.+Chanauthor=M.+Pellechia&title=The+nuclear+Overhauser+effect+in+the+lead+identification+process&doi=10.2174%2F157016306778108884"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">The nuclear overhauser effect in the lead identification process</span></div><div class="casAuthors">Leone, Marilisa; Freeze, Hudson H.; Chan, Chui Sien; Pellecchia, Maurizio</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Discovery Technologies</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">91-100</span>CODEN:
                <span class="NLM_cas:coden">CDDTAF</span>;
        ISSN:<span class="NLM_cas:issn">1570-1638</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  In the past several years NMR spectroscopy has emerged as a valuable tool in the drug discovery field.  In such context, several NMR-based techniques have been developed aimed at the identification and subsequent optimization of novel binders for a given protein target.  Among the different NMR approaches, those relying on the transferred Nuclear Overhauser Effect (tr-NOE) appear to be particularly useful as in some instances, in addn. to binding, tr-NOE may provide also structural information on the binding mode of a ligand.  In the current work we will reiterate the basic principles and applications that are related to measurements of tr-NOEs.  The tr-NOE can be applied as a screening tool to recognize ligands for a given target protein in a mixt. of compds. or to identify pair of mols. that bind to a protein simultaneously on adjacent sites (interligand NOEs).  Moreover, in the case of peptide-ligands, tr-NOEs furnish intra-mol. distance constraints that can be used to det. their bioactive conformation.  Starting from the conformation thus obtained, a pharmacophoric model can be derived and later used to search within a 3D database of small mols. to find new potentially active non-peptide compds. that fit the pharmacophore.  We will report examples of each of the above mentioned strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeZMslo8YAHLVg90H21EOLACvtfcHk0licxuruOLaGdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVSjsrzO&md5=97ac2642c12206bc235c59c54dbff304</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.2174%2F157016306778108884&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157016306778108884%26sid%3Dliteratum%253Aachs%26aulast%3DLeone%26aufirst%3DM.%26aulast%3DFreeze%26aufirst%3DH.%2BH.%26aulast%3DChan%26aufirst%3DC.%2BS.%26aulast%3DPellechia%26aufirst%3DM.%26atitle%3DThe%2520nuclear%2520Overhauser%2520effect%2520in%2520the%2520lead%2520identification%2520process%26jtitle%3DCurr.%2520Drug%2520Discov.%2520Technol.%26date%3D2006%26volume%3D3%26spage%3D91%26epage%3D100%26doi%3D10.2174%2F157016306778108884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Becattini, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Culmsee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leone, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhai, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crowell, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rega, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landshamer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plesnila, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellecchia, M.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationships by interligand NOE-based design and synthesis of antiapoptotic compounds targeting Bid</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">12602</span>– <span class="NLM_lpage">12606</span>, <span class="refDoi"> DOI: 10.1073/pnas.0603460103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1073%2Fpnas.0603460103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=16891420" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BD28Xos1Ojt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=12602-12606&author=B.+Becattiniauthor=C.+Culmseeauthor=M.+Leoneauthor=D.+Zhaiauthor=X.+Zhangauthor=K.+J.+Crowellauthor=M.+F.+Regaauthor=S.+Landshamerauthor=J.+C.+Reedauthor=N.+Plesnilaauthor=M.+Pellecchia&title=Structure-activity+relationships+by+interligand+NOE-based+design+and+synthesis+of+antiapoptotic+compounds+targeting+Bid&doi=10.1073%2Fpnas.0603460103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationships by interligand NOE-based design and synthesis of antiapoptotic compounds targeting Bid</span></div><div class="casAuthors">Becattini, Barbara; Culmsee, Carsten; Leone, Marilisa; Zhai, Dayong; Zhang, Xiyun; Crowell, Kevin J.; Rega, Michele F.; Landshamer, Stefan; Reed, John C.; Plesnila, Nikolaus; Pellecchia, Maurizio</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">12602-12606</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Bcl-2 family proteins play a crucial role in tissue homeostasis and apoptosis (programmed cell death).  Bid is a proapoptotic member of the Bcl-2 family, promoting cell death when activated by caspase-8.  Following an NMR-based approach (structure-activity relationships by interligand NOE) we were able to identify two chem. fragments that bind on the surface of Bid.  Covalent linkage of the two fragments led to high-affinity bidentate derivs.  In vitro and in-cell assays demonstrate that the compds. prevent tBid translocation to the mitochondrial membrane and the subsequent release of proapoptotic stimuli and inhibit neuronal apoptosis in the low micromolar range.  Therefore, by using a rational chem.-biol. approach, we derived antiapoptotic compds. that may have a therapeutic potential for disorders assocd. with Bid activation, e.g., neurodegenerative diseases, cerebral ischemia, or brain trauma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9bKURSfekX7Vg90H21EOLACvtfcHk0licxuruOLaGdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xos1Ojt78%253D&md5=d3aa703c0a392e10e084f4a7261146e6</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0603460103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0603460103%26sid%3Dliteratum%253Aachs%26aulast%3DBecattini%26aufirst%3DB.%26aulast%3DCulmsee%26aufirst%3DC.%26aulast%3DLeone%26aufirst%3DM.%26aulast%3DZhai%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DCrowell%26aufirst%3DK.%2BJ.%26aulast%3DRega%26aufirst%3DM.%2BF.%26aulast%3DLandshamer%26aufirst%3DS.%26aulast%3DReed%26aufirst%3DJ.%2BC.%26aulast%3DPlesnila%26aufirst%3DN.%26aulast%3DPellecchia%26aufirst%3DM.%26atitle%3DStructure-activity%2520relationships%2520by%2520interligand%2520NOE-based%2520design%2520and%2520synthesis%2520of%2520antiapoptotic%2520compounds%2520targeting%2520Bid%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2006%26volume%3D103%26spage%3D12602%26epage%3D12606%26doi%3D10.1073%2Fpnas.0603460103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rega, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cellitti, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellecchia, M.</span></span> <span> </span><span class="NLM_article-title">SAR by interligand nuclear overhauser effects (ILOEs) based discovery of acylsulfonamide compounds active against Bcl-X<sub>L</sub> and Mcl-1</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">6000</span>– <span class="NLM_lpage">6013</span>, <span class="refDoi"> DOI: 10.1021/jm200826s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200826s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpvVWksrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6000-6013&author=M.+F.+Regaauthor=B.+Wuauthor=J.+Weiauthor=Z.+Zhangauthor=J.+F.+Cellittiauthor=M.+Pellecchia&title=SAR+by+interligand+nuclear+overhauser+effects+%28ILOEs%29+based+discovery+of+acylsulfonamide+compounds+active+against+Bcl-XL+and+Mcl-1&doi=10.1021%2Fjm200826s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">SAR by Interligand Nuclear Overhauser Effects (ILOEs) Based Discovery of Acylsulfonamide Compounds Active against Bcl-xL and Mcl-1</span></div><div class="casAuthors">Rega, Michele F.; Wu, Bainan; Wei, Jun; Zhang, Ziming; Cellitti, Jason F.; Pellecchia, Maurizio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6000-6013</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Overexpression of antiapoptotic members of the Bcl-2 family proteins, such as Bcl-xL and Mfl-1, has been shown to be involved in resistance to chemotherapeutic drugs in many forms of cancers.  Recent efforts from the Abbott Labs. resulted in the development of the acylsulfonamide compd. and clin. candidate that targets selectively Bcl-2, Bcl-xL, and Bcl-w while it is not active against Mcl-1 and Bfl-1.  However, early clin. and preclin. studies suggest that pan-Bcl-2 antagonists, targeting simultaneously Mcl-1, Bcl-xL, and possibly all other four antiapoptotic Bcl-2 proteins, may result in more efficacious drugs.  Here, following an NMR fragment-based approach, SAR by ILOEs, we report on compds. that exhibit nanomolar affinities for both Bcl-xL and Mcl-1 in vitro.  We believe that these mols. can be used as useful starting point for the development of novel Bcl-2 antagonists, in particular targeting Mcl-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwDNlz7vWmFLVg90H21EOLACvtfcHk0licxuruOLaGdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpvVWksrc%253D&md5=e2b1f2a0ffa1ec32c3154f8ef7b0aa22</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm200826s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200826s%26sid%3Dliteratum%253Aachs%26aulast%3DRega%26aufirst%3DM.%2BF.%26aulast%3DWu%26aufirst%3DB.%26aulast%3DWei%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DCellitti%26aufirst%3DJ.%2BF.%26aulast%3DPellecchia%26aufirst%3DM.%26atitle%3DSAR%2520by%2520interligand%2520nuclear%2520overhauser%2520effects%2520%2528ILOEs%2529%2520based%2520discovery%2520of%2520acylsulfonamide%2520compounds%2520active%2520against%2520Bcl-XL%2520and%2520Mcl-1%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D6000%26epage%3D6013%26doi%3D10.1021%2Fjm200826s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sledz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silvestre, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciulli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blundell, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abell, C.</span></span> <span> </span><span class="NLM_article-title">Optimization of the interligand Overhauser effect for fragment linking: application to inhibitor discovery against Mycobacterium tuberculosis pantothenate synthetase</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>132</i></span>,  <span class="NLM_fpage">4544</span>– <span class="NLM_lpage">4545</span>, <span class="refDoi"> DOI: 10.1021/ja100595u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja100595u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtlaisL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2010&pages=4544-4545&author=P.+Sledzauthor=H.+L.+Silvestreauthor=A.+W.+Hungauthor=A.+Ciulliauthor=T.+L.+Blundellauthor=C.+Abell&title=Optimization+of+the+interligand+Overhauser+effect+for+fragment+linking%3A+application+to+inhibitor+discovery+against+Mycobacterium+tuberculosis+pantothenate+synthetase&doi=10.1021%2Fja100595u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of the Interligand Overhauser Effect for Fragment Linking: Application to Inhibitor Discovery against Mycobacterium tuberculosis Pantothenate Synthetase</span></div><div class="casAuthors">Sledz, Pawel; Silvestre, H. Leonardo; Hung, Alvin W.; Ciulli, Alessio; Blundell, Tom L.; Abell, Chris</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4544-4545</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fragment-based methods are a new and emerging approach for the discovery of protein binders that are potential new therapeutic agents.  Several ways of utilizing structural information to guide the inhibitor assembly have been explored to date.  One of the approaches, application of interligand Overhauser effect (ILOE) observations, is of particular interest, as it does not require the availability of a three-dimensional protein structure and is an NMR-based method that can be applied to targets that cannot be obsd. directly because of their size.  Fragments, as small and often hydrophobic mols., suffer from problems including compd. aggregation in an aq. environment and nonspecific binding contributions, esp. when screened at higher concns. suitable for ILOE observations.  Here we report how this problem can be overcome by applying a step-by-step iterative procedure that includes the application of optimized probe mols. with known binding modes to elucidate the unknown binding modes of fragments.  An enzyme substrate with well-characterized binding was used as a starting point, and the relative binding modes of modified fragments derived from ILOE observations were used to guide the fragment linking, leading to a potent inhibitor of our model system, Mycobacterium tuberculosis pantothenate synthetase, a potential drug target.  We have supported our NMR data with crystal structures, thus establishing the guidelines for optimizing the ILOE observations.  This model study should expand the application of the technique in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_1G4hptSAYrVg90H21EOLACvtfcHk0ljV-Zy6eJ1ZRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtlaisL0%253D&md5=70cfadfd68f9711b421b5c3073e6300e</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fja100595u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja100595u%26sid%3Dliteratum%253Aachs%26aulast%3DSledz%26aufirst%3DP.%26aulast%3DSilvestre%26aufirst%3DH.%2BL.%26aulast%3DHung%26aufirst%3DA.%2BW.%26aulast%3DCiulli%26aufirst%3DA.%26aulast%3DBlundell%26aufirst%3DT.%2BL.%26aulast%3DAbell%26aufirst%3DC.%26atitle%3DOptimization%2520of%2520the%2520interligand%2520Overhauser%2520effect%2520for%2520fragment%2520linking%253A%2520application%2520to%2520inhibitor%2520discovery%2520against%2520Mycobacterium%2520tuberculosis%2520pantothenate%2520synthetase%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2010%26volume%3D132%26spage%3D4544%26epage%3D4545%26doi%3D10.1021%2Fja100595u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hung, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silvestre, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciulli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blundell, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abell, C.</span></span> <span> </span><span class="NLM_article-title">Application of fragment growing and fragment linking to the discovery of inhibitors of Mycobacterium tuberculosis pantothenate synthetase</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">8452</span>– <span class="NLM_lpage">8456</span>, <span class="refDoi"> DOI: 10.1002/anie.200903821</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1002%2Fanie.200903821" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlWmur%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=8452-8456&author=A.+W.+Hungauthor=H.+L.+Silvestreauthor=S.+Wenauthor=A.+Ciulliauthor=T.+L.+Blundellauthor=C.+Abell&title=Application+of+fragment+growing+and+fragment+linking+to+the+discovery+of+inhibitors+of+Mycobacterium+tuberculosis+pantothenate+synthetase&doi=10.1002%2Fanie.200903821"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Application of Fragment Growing and Fragment Linking to the Discovery of Inhibitors of Mycobacterium tuberculosis Pantothenate Synthetase</span></div><div class="casAuthors">Hung, Alvin W.; Silvestre, H. Leonardo; Wen, Shijun; Ciulli, Alessio; Blundell, Tom L.; Abell, Chris</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">8452-8456, S8452/1-S8452/26</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Despite the fact that nearly 2 million people a year are killed by Mycobacterium tuberculosis (TB), we still lack a robust pipeline of potential therapies to combat this burden.  Fragment-based approaches have provided a new paradigm in the development of high-quality chem. ligands and have great potential to contribute as starting points in the development of drugs against TB.  To date, studies on pantothenate synthetase (PS) inhibition have focused on the synthesis of analogs of the pantoyl adenylate reaction intermediate or the identification of hits from high-throughput screening.  We describe a combination of fragment-growing and fragment-linking approaches that led to the discovery of a new series of inhibitors of M. tuberculosis PS for the further validation of PS as a potential drug target for TB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjhska_U-KXbVg90H21EOLACvtfcHk0ljV-Zy6eJ1ZRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlWmur%252FK&md5=821f86e9e1d7cbd848741962e3ac47dd</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1002%2Fanie.200903821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200903821%26sid%3Dliteratum%253Aachs%26aulast%3DHung%26aufirst%3DA.%2BW.%26aulast%3DSilvestre%26aufirst%3DH.%2BL.%26aulast%3DWen%26aufirst%3DS.%26aulast%3DCiulli%26aufirst%3DA.%26aulast%3DBlundell%26aufirst%3DT.%2BL.%26aulast%3DAbell%26aufirst%3DC.%26atitle%3DApplication%2520of%2520fragment%2520growing%2520and%2520fragment%2520linking%2520to%2520the%2520discovery%2520of%2520inhibitors%2520of%2520Mycobacterium%2520tuberculosis%2520pantothenate%2520synthetase%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2009%26volume%3D48%26spage%3D8452%26epage%3D8456%26doi%3D10.1002%2Fanie.200903821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jahnke, W.</span></span> <span> </span><span class="NLM_article-title">Spin labels as a tool to identify and characterize protein-ligand interactions by NMR spectroscopy</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">167</span>– <span class="NLM_lpage">173</span>, <span class="refDoi"> DOI: 10.1002/1439-7633(20020301)3:2/3<167::AID-CBIC167>3.0.CO;2-S</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1002%2F1439-7633%2820020301%293%3A2%2F3%3C167%3A%3AAID-CBIC167%3E3.0.CO%3B2-S" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=11921394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BD38Xis1Kit7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2002&pages=167-173&author=W.+Jahnke&title=Spin+labels+as+a+tool+to+identify+and+characterize+protein-ligand+interactions+by+NMR+spectroscopy&doi=10.1002%2F1439-7633%2820020301%293%3A2%2F3%3C167%3A%3AAID-CBIC167%3E3.0.CO%3B2-S"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Spin labels as a tool to identify and characterize protein - ligand interactions by NMR spectroscopy</span></div><div class="casAuthors">Jahnke, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">167-173</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH</span>)
        </div><div class="casAbstract">NMR spectroscopy based discovery and optimization of lead compds. for a given mol. target requires the development of methods with max. sensitivity and robustness.  It is shown here that org. nitroxide radicals ("spin labels") can be used to boost the sensitivity of NMR spectroscopic screening in drug discovery research.  The concept of utilizing spin labels in NMR spectroscopy is summarized, examples for successful first-site and second-site NMR spectroscopic screens are given, and guidelines for linker design are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGIWYbfxkWmrVg90H21EOLACvtfcHk0ljV-Zy6eJ1ZRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xis1Kit7w%253D&md5=e29645610e295da1196d5b2f4c380443</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2F1439-7633%2820020301%293%3A2%2F3%3C167%3A%3AAID-CBIC167%3E3.0.CO%3B2-S&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1439-7633%252820020301%25293%253A2%252F3%253C167%253A%253AAID-CBIC167%253E3.0.CO%253B2-S%26sid%3Dliteratum%253Aachs%26aulast%3DJahnke%26aufirst%3DW.%26atitle%3DSpin%2520labels%2520as%2520a%2520tool%2520to%2520identify%2520and%2520characterize%2520protein-ligand%2520interactions%2520by%2520NMR%2520spectroscopy%26jtitle%3DChemBioChem%26date%3D2002%26volume%3D3%26spage%3D167%26epage%3D173%26doi%3D10.1002%2F1439-7633%2820020301%293%3A2%2F3%3C167%3A%3AAID-CBIC167%3E3.0.CO%3B2-S" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jahnke, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Florsheimer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blommers, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paris, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nalin, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, L. B.</span></span> <span> </span><span class="NLM_article-title">Second-site NMR screening and linker design</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">69</span>– <span class="NLM_lpage">80</span>, <span class="refDoi"> DOI: 10.2174/1568026033392778</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.2174%2F1568026033392778" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=12570778" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BD3sXis1Khtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=69-80&author=W.+Jahnkeauthor=A.+Florsheimerauthor=M.+J.+Blommersauthor=C.+G.+Parisauthor=J.+Heimauthor=C.+M.+Nalinauthor=L.+B.+Perez&title=Second-site+NMR+screening+and+linker+design&doi=10.2174%2F1568026033392778"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Second-site NMR screening and linker design</span></div><div class="casAuthors">Jahnke, Wolfgang; Florsheimer, Andreas; Blommers, Marcel J. J.; Paris, C. Gregory; Heim, Jutta; Nalin, Carlo M.; Perez, Lawrence B.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Hilversum, Netherlands)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">69-80</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  One of the prime merits of NMR as a tool for lead finding in drug discovery research is its sensitivity and robustness to detect weak protein-ligand interactions.  This sensitivity allows to build up ligands for a given target in a modular way, by a fragment-based approach.  In this approach, two ligands are sep. identified which bind to the target protein generally weakly, but at adjacent binding sites.  In a next step, they are chem. linked to produce a high-affinity ligand.  This review discusses methods to detect "second-site" ligands that bind to a protein in the presence of a "first-site" ligand, and methods to elucidate structural details on the spatial orientation of both ligands, so that chem. linkage is based on a large piece of exptl. information.  Published examples from second-site screening and linker design are summarized, and are complemented by previously unpublished inhouse examples.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqk1216TKRkJLVg90H21EOLACvtfcHk0ljyrpJjV9FmtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXis1Khtw%253D%253D&md5=f863a8c10482337eb138a576beb69720</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.2174%2F1568026033392778&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026033392778%26sid%3Dliteratum%253Aachs%26aulast%3DJahnke%26aufirst%3DW.%26aulast%3DFlorsheimer%26aufirst%3DA.%26aulast%3DBlommers%26aufirst%3DM.%2BJ.%26aulast%3DParis%26aufirst%3DC.%2BG.%26aulast%3DHeim%26aufirst%3DJ.%26aulast%3DNalin%26aufirst%3DC.%2BM.%26aulast%3DPerez%26aufirst%3DL.%2BB.%26atitle%3DSecond-site%2520NMR%2520screening%2520and%2520linker%2520design%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2003%26volume%3D3%26spage%3D69%26epage%3D80%26doi%3D10.2174%2F1568026033392778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vazquez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tautz, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vuori, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mustelin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellecchia, M.</span></span> <span> </span><span class="NLM_article-title">Development of molecular probes for second-site screening and design of protein tyrosine phosphatase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">2137</span>– <span class="NLM_lpage">2143</span>, <span class="refDoi"> DOI: 10.1021/jm061481l</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm061481l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjs1Sktr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2137-2143&author=J.+Vazquezauthor=L.+Tautzauthor=J.+J.+Ryanauthor=K.+Vuoriauthor=T.+Mustelinauthor=M.+Pellecchia&title=Development+of+molecular+probes+for+second-site+screening+and+design+of+protein+tyrosine+phosphatase+inhibitors&doi=10.1021%2Fjm061481l"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Molecular Probes for Second-Site Screening and Design of Protein Tyrosine Phosphatase Inhibitors</span></div><div class="casAuthors">Vazquez, Jesus; Tautz, Lutz; Ryan, Jennifer J.; Vuori, Kristiina; Mustelin, Tomas; Pellecchia, Maurizio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2137-2143</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report on the design, synthesis, and evaluation of a series of furanyl-salicyl-nitroxide derivs. as effective chem. probes for second-site screening against phosphotyrosine phosphatases (PTPs) using NMR-based techniques.  The compds. have been tested against a panel of PTPs to assess their ability to inhibit a broad spectrum of these phosphatases.  The utility of the derived compds. is illustrated with the phosphatase YopH, a bacterial toxin from Yersinia pestis.  Novel chem. fragments were identified during an NMR-based screen for compds. that are capable of binding on the surface of YopH in regions adjacent the catalytic site in the presence of the spin-labeled compds.  Our data demonstrate the value of the derived chem. probes for NMR-based second-site screening in PTPs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDvLzBHaggfLVg90H21EOLACvtfcHk0ljyrpJjV9FmtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjs1Sktr8%253D&md5=636f860184d23189ad1d82cf18c66c5a</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm061481l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061481l%26sid%3Dliteratum%253Aachs%26aulast%3DVazquez%26aufirst%3DJ.%26aulast%3DTautz%26aufirst%3DL.%26aulast%3DRyan%26aufirst%3DJ.%2BJ.%26aulast%3DVuori%26aufirst%3DK.%26aulast%3DMustelin%26aufirst%3DT.%26aulast%3DPellecchia%26aufirst%3DM.%26atitle%3DDevelopment%2520of%2520molecular%2520probes%2520for%2520second-site%2520screening%2520and%2520design%2520of%2520protein%2520tyrosine%2520phosphatase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2137%26epage%3D2143%26doi%3D10.1021%2Fjm061481l" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vazquez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riel-Mehan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emdadi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cellitti, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stebbins, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rega, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellecchia, M.</span></span> <span> </span><span class="NLM_article-title">Development of paramagnetic probes for molecular recognition studies in protein kinases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">3460</span>– <span class="NLM_lpage">3465</span>, <span class="refDoi"> DOI: 10.1021/jm800068w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800068w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmtF2rsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=3460-3465&author=J.+Vazquezauthor=S.+K.+Deauthor=L.+H.+Chenauthor=M.+Riel-Mehanauthor=A.+Emdadiauthor=J.+Cellittiauthor=J.+L.+Stebbinsauthor=M.+F.+Regaauthor=M.+Pellecchia&title=Development+of+paramagnetic+probes+for+molecular+recognition+studies+in+protein+kinases&doi=10.1021%2Fjm800068w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Paramagnetic Probes for Molecular Recognition Studies in Protein Kinases</span></div><div class="casAuthors">Vazquez, Jesus; De, Surya K.; Chen, Li-Hsing; Riel-Mehan, Megan; Emdadi, Aras; Cellitti, Jason; Stebbins, John L.; Rega, Michele F.; Pellecchia, Maurizio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3460-3465</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report on the synthesis and evaluation of an indazole-spin-labeled compd. that was designed as an effective chem. probe for second site screening against the protein kinase JNK using NMR-based techniques.  We demonstrate the utility of the derived compd. in detecting and characterizing binding events at the protein kinase docking site.  In addn., we report on the NMR-based design and synthesis of a bidentate compd. spanning both the ATP site and the docking site.  We show that the resulting compd. has nanomolar affinity for JNK despite the relatively weak affinities of the individual fragments that constitute it.  The approach demonstrates that targeting the docking site of protein kinases represents a valuable yet unexplored avenue to obtain potent kinase inhibitors with increased selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2LGC2s51u8rVg90H21EOLACvtfcHk0lgurLWteTocfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmtF2rsb0%253D&md5=62388bd06221e0fd834c97df06fe2640</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm800068w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800068w%26sid%3Dliteratum%253Aachs%26aulast%3DVazquez%26aufirst%3DJ.%26aulast%3DDe%26aufirst%3DS.%2BK.%26aulast%3DChen%26aufirst%3DL.%2BH.%26aulast%3DRiel-Mehan%26aufirst%3DM.%26aulast%3DEmdadi%26aufirst%3DA.%26aulast%3DCellitti%26aufirst%3DJ.%26aulast%3DStebbins%26aufirst%3DJ.%2BL.%26aulast%3DRega%26aufirst%3DM.%2BF.%26aulast%3DPellecchia%26aufirst%3DM.%26atitle%3DDevelopment%2520of%2520paramagnetic%2520probes%2520for%2520molecular%2520recognition%2520studies%2520in%2520protein%2520kinases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D3460%26epage%3D3465%26doi%3D10.1021%2Fjm800068w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Egger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weckerle, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cutting, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwardt, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabbani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemme, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ernst, B.</span></span> <span> </span><span class="NLM_article-title">Nanomolar E-selectin antagonists with prolonged half-lives by a fragment-based approach</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>135</i></span>,  <span class="NLM_fpage">9820</span>– <span class="NLM_lpage">9828</span>, <span class="refDoi"> DOI: 10.1021/ja4029582</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja4029582" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptVSqurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2013&pages=9820-9828&author=J.+Eggerauthor=C.+Weckerleauthor=B.+Cuttingauthor=O.+Schwardtauthor=S.+Rabbaniauthor=K.+Lemmeauthor=B.+Ernst&title=Nanomolar+E-selectin+antagonists+with+prolonged+half-lives+by+a+fragment-based+approach&doi=10.1021%2Fja4029582"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Nano-molar E-Selectin Antagonists with Prolonged Half-Lives by a Fragment-Based Approach</span></div><div class="casAuthors">Egger, Jonas; Weckerle, Celine; Cutting, Brian; Schwardt, Oliver; Rabbani, Said; Lemme, Katrin; Ernst, Beat</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">9820-9828</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Selectins, a family of C-type lectins, play a key role in inflammatory diseases (e.g., asthma and arthritis).  However, the only millimolar affinity of sialyl Lewisx (sLex), which is the common tetrasaccharide epitope of all physiol. selectin ligands, has been a major obstacle to the development of selectin antagonists for therapeutic applications.  In a fragment-based approach guided by NMR, ligands binding to a second site in close proximity to a sLex mimic were identified.  A library of antagonists obtained by connecting the sLex mimic to the best second-site ligand via triazole linkers of different lengths was evaluated by surface plasmon resonance.  Detailed anal. of the five most promising candidates revealed antagonists with KD values ranging from 30 to 89 nM.  In contrast to carbohydrate-lectin complexes with typical half-lives (t1/2) in the range of one second or even less, these fragment-based selectin antagonists show t1/2 of several minutes.  They exhibit a promising starting point for the development of novel anti-inflammatory drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGputib8-AvT-rVg90H21EOLACvtfcHk0lgurLWteTocfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptVSqurw%253D&md5=cefd0f4561991cf087729f6d13a24e2a</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fja4029582&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja4029582%26sid%3Dliteratum%253Aachs%26aulast%3DEgger%26aufirst%3DJ.%26aulast%3DWeckerle%26aufirst%3DC.%26aulast%3DCutting%26aufirst%3DB.%26aulast%3DSchwardt%26aufirst%3DO.%26aulast%3DRabbani%26aufirst%3DS.%26aulast%3DLemme%26aufirst%3DK.%26aulast%3DErnst%26aufirst%3DB.%26atitle%3DNanomolar%2520E-selectin%2520antagonists%2520with%2520prolonged%2520half-lives%2520by%2520a%2520fragment-based%2520approach%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2013%26volume%3D135%26spage%3D9820%26epage%3D9828%26doi%3D10.1021%2Fja4029582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Judd, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartberger, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fremeau, R. T.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hitchcock, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Louie, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michelsen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nixey, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rattan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sickmier, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">St. Jean, D. J.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahl, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, S.</span></span> <span> </span><span class="NLM_article-title">From fragment screening to in vivo efficacy: optimization of a series of 2-aminoquinolines as potent inhibitors of beta-site amyloid precursor protein cleaving enzyme 1 (BACE1)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">5836</span>– <span class="NLM_lpage">5857</span>, <span class="refDoi"> DOI: 10.1021/jm200544q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200544q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpsFSksrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=5836-5857&author=Y.+Chengauthor=T.+C.+Juddauthor=M.+D.+Bartbergerauthor=J.+Brownauthor=K.+Chenauthor=R.+T.+Fremeauauthor=D.+Hickmanauthor=S.+A.+Hitchcockauthor=B.+Jordanauthor=V.+Liauthor=P.+Lopezauthor=S.+W.+Louieauthor=Y.+Luoauthor=K.+Michelsenauthor=T.+Nixeyauthor=T.+S.+Powersauthor=C.+Rattanauthor=E.+A.+Sickmierauthor=D.+J.+St.+Jeanauthor=R.+C.+Wahlauthor=P.+H.+Wenauthor=S.+Wood&title=From+fragment+screening+to+in+vivo+efficacy%3A+optimization+of+a+series+of+2-aminoquinolines+as+potent+inhibitors+of+beta-site+amyloid+precursor+protein+cleaving+enzyme+1+%28BACE1%29&doi=10.1021%2Fjm200544q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">From Fragment Screening to In Vivo Efficacy: Optimization of a Series of 2-Aminoquinolines as Potent Inhibitors of Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1)</span></div><div class="casAuthors">Cheng, Yuan; Judd, Ted C.; Bartberger, Michael D.; Brown, James; Chen, Kui; Fremeau, Robert T.; Hickman, Dean; Hitchcock, Stephen A.; Jordan, Brad; Li, Vivian; Lopez, Patricia; Louie, Steven W.; Luo, Yi; Michelsen, Klaus; Nixey, Thomas; Powers, Timothy S.; Rattan, Claire; Sickmier, E. Allen; St. Jean, David J.; Wahl, Robert C.; Wen, Paul H.; Wood, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5836-5857</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Using fragment-based screening of a focused fragment library, 2-aminoquinoline 1 was identified as an initial hit for BACE1.  Further SAR development was supported by X-ray structures of BACE1 cocrystd. with various ligands and mol. modeling studies to expedite the discovery of potent compds.  These strategies enabled us to integrate the C-3 side chain on 2-aminoquinoline 1 extending deep into the P2' binding pocket of BACE1 and enhancing the ligand's potency.  We were able to improve the BACE1 potency to subnanomolar range, over 106-fold more potent than the initial hit (900 μM).  Further elaboration of the phys. properties of the lead compds. to those more consistent with good blood-brain barrier permeability led to inhibitors with greatly improved cellular activity and permeability.  Compd. 59 showed an IC50 value of 11 nM on BACE1 and cellular activity of 80 nM.  This compd. was advanced into rat pharmacokinetic and pharmacodynamic studies and demonstrated significant redn. of Aβ levels in cerebrospinal fluid (CSF).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLRGyUyxO1fLVg90H21EOLACvtfcHk0lgurLWteTocfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpsFSksrk%253D&md5=fa0f2b9b7524a1c3b75e162801f54d90</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm200544q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200544q%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DJudd%26aufirst%3DT.%2BC.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DJordan%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DV.%26aulast%3DLopez%26aufirst%3DP.%26aulast%3DLouie%26aufirst%3DS.%2BW.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DMichelsen%26aufirst%3DK.%26aulast%3DNixey%26aufirst%3DT.%26aulast%3DPowers%26aufirst%3DT.%2BS.%26aulast%3DRattan%26aufirst%3DC.%26aulast%3DSickmier%26aufirst%3DE.%2BA.%26aulast%3DSt.%2BJean%26aufirst%3DD.%2BJ.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWood%26aufirst%3DS.%26atitle%3DFrom%2520fragment%2520screening%2520to%2520in%2520vivo%2520efficacy%253A%2520optimization%2520of%2520a%2520series%2520of%25202-aminoquinolines%2520as%2520potent%2520inhibitors%2520of%2520beta-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520%2528BACE1%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D5836%26epage%3D5857%26doi%3D10.1021%2Fjm200544q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittington, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartberger, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sickmier, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Judd, T.</span></span> <span> </span><span class="NLM_article-title">A fragment-linking approach using 19F NMR spectroscopy to obtain highly potent and selective inhibitors of β-secretase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">3732</span>– <span class="NLM_lpage">3749</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01917</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01917" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC28XktFeitr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=3732-3749&author=J.+B.+Jordanauthor=D.+A.+Whittingtonauthor=M.+D.+Bartbergerauthor=E.+A.+Sickmierauthor=K.+Chenauthor=Y.+Chengauthor=T.+Judd&title=A+fragment-linking+approach+using+19F+NMR+spectroscopy+to+obtain+highly+potent+and+selective+inhibitors+of+%CE%B2-secretase&doi=10.1021%2Facs.jmedchem.5b01917"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Linking Approach Using 19F NMR Spectroscopy To Obtain Highly Potent and Selective Inhibitors of β-Secretase</span></div><div class="casAuthors">Jordan, John B.; Whittington, Douglas A.; Bartberger, Michael D.; Sickmier, E. Allen; Chen, Kui; Cheng, Yuan; Judd, Ted</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3732-3749</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fragment-based drug discovery (FBDD) has become a widely used tool in small-mol. drug discovery efforts.  One of the most commonly used biophys. methods in detecting weak binding of fragments is NMR (NMR) spectroscopy.  In particular, FBDD performed with 19F NMR-based methods has been shown to provide several advantages over 1H NMR using traditional magnetization-transfer and/or two-dimensional methods.  Here, we demonstrate the utility and power of 19F-based fragment screening by detailing the identification of a second-site fragment through 19F NMR screening that binds to a specific pocket of the aspartic acid protease, β-secretase (BACE-1).  The identification of this second-site fragment allowed the undertaking of a fragment-linking approach, which ultimately yielded a mol. exhibiting a more than 360-fold increase in potency while maintaining reasonable ligand efficiency and gaining much improved selectivity over cathepsin-D (CatD).  X-ray crystallog. studies of the mols. demonstrated that the linked fragments exhibited binding modes consistent with those predicted from the targeted screening approach, through-space NMR data, and mol. modeling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq95M4k5aaQurVg90H21EOLACvtfcHk0lg-7jzdScfvFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktFeitr8%253D&md5=6bd6021938c555d8c7083549e4b49a2e</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01917&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01917%26sid%3Dliteratum%253Aachs%26aulast%3DJordan%26aufirst%3DJ.%2BB.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DSickmier%26aufirst%3DE.%2BA.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DJudd%26aufirst%3DT.%26atitle%3DA%2520fragment-linking%2520approach%2520using%252019F%2520NMR%2520spectroscopy%2520to%2520obtain%2520highly%2520potent%2520and%2520selective%2520inhibitors%2520of%2520%25CE%25B2-secretase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D3732%26epage%3D3749%26doi%3D10.1021%2Facs.jmedchem.5b01917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Casale, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amboldi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brasca, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caronni, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colombo, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalvit, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felder, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fogliatto, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galvani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isacchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polucci, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riceputi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sola, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Visco, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuccotto, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casuscelli, F.</span></span> <span> </span><span class="NLM_article-title">Fragment-based hit discovery and structure-based optimization of aminotriazoloquinazolines as novel HSP90 inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">4135</span>– <span class="NLM_lpage">4150</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2014.05.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1016%2Fj.bmc.2014.05.056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=24980703" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVKhtbfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=4135-4150&author=E.+Casaleauthor=N.+Amboldiauthor=M.+G.+Brascaauthor=D.+Caronniauthor=N.+Colomboauthor=C.+Dalvitauthor=E.+R.+Felderauthor=G.+Fogliattoauthor=A.+Galvaniauthor=A.+Isacchiauthor=P.+Polucciauthor=L.+Riceputiauthor=F.+Solaauthor=C.+Viscoauthor=F.+Zuccottoauthor=F.+Casuscelli&title=Fragment-based+hit+discovery+and+structure-based+optimization+of+aminotriazoloquinazolines+as+novel+HSP90+inhibitors&doi=10.1016%2Fj.bmc.2014.05.056"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-based hit discovery and structure-based optimization of aminotriazoloquinazolines as novel Hsp90 inhibitors</span></div><div class="casAuthors">Casale, Elena; Amboldi, Nadia; Brasca, Maria Gabriella; Caronni, Dannica; Colombo, Nicoletta; Dalvit, Claudio; Felder, Eduard R.; Fogliatto, Gianpaolo; Galvani, Arturo; Isacchi, Antonella; Polucci, Paolo; Riceputi, Laura; Sola, Francesco; Visco, Carlo; Zuccotto, Fabio; Casuscelli, Francesco</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4135-4150</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In the last decade the heat shock protein 90 (Hsp90) has emerged as a major therapeutic target and many efforts have been dedicated to the discovery of Hsp90 inhibitors as new potent anticancer agents.  Here the authors report the identification of a novel class of Hsp90 inhibitors by means of a biophys. FAXS-NMR based screening of a library of fragments.  The use of x-ray structure information combined with modeling studies enabled the fragment evolution of the initial triazoloquinazoline hit to a class of compds. with nanomolar potency and drug-like properties suited for further lead optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8pZK-hye807Vg90H21EOLACvtfcHk0lg-7jzdScfvFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVKhtbfK&md5=7d3d910e96249f6d5550cecc2363af9c</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.05.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.05.056%26sid%3Dliteratum%253Aachs%26aulast%3DCasale%26aufirst%3DE.%26aulast%3DAmboldi%26aufirst%3DN.%26aulast%3DBrasca%26aufirst%3DM.%2BG.%26aulast%3DCaronni%26aufirst%3DD.%26aulast%3DColombo%26aufirst%3DN.%26aulast%3DDalvit%26aufirst%3DC.%26aulast%3DFelder%26aufirst%3DE.%2BR.%26aulast%3DFogliatto%26aufirst%3DG.%26aulast%3DGalvani%26aufirst%3DA.%26aulast%3DIsacchi%26aufirst%3DA.%26aulast%3DPolucci%26aufirst%3DP.%26aulast%3DRiceputi%26aufirst%3DL.%26aulast%3DSola%26aufirst%3DF.%26aulast%3DVisco%26aufirst%3DC.%26aulast%3DZuccotto%26aufirst%3DF.%26aulast%3DCasuscelli%26aufirst%3DF.%26atitle%3DFragment-based%2520hit%2520discovery%2520and%2520structure-based%2520optimization%2520of%2520aminotriazoloquinazolines%2520as%2520novel%2520HSP90%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D4135%26epage%3D4150%26doi%3D10.1016%2Fj.bmc.2014.05.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kohlmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zech, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Squillace, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Commodore, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenfield, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodd, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miret, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clackson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shakespeare, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalgarno, D. C.</span></span> <span> </span><span class="NLM_article-title">Fragment growing and linking lead to novel nanomolar lactate dehydrogenase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">1023</span>– <span class="NLM_lpage">1040</span>, <span class="refDoi"> DOI: 10.1021/jm3014844</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3014844" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC3sXms1OlsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=1023-1040&author=A.+Kohlmannauthor=S.+G.+Zechauthor=F.+Liauthor=T.+Zhouauthor=R.+M.+Squillaceauthor=L.+Commodoreauthor=M.+T.+Greenfieldauthor=X.+Luauthor=D.+P.+Millerauthor=W.+S.+Huangauthor=J.+Qiauthor=R.+M.+Thomasauthor=Y.+Wangauthor=S.+Zhangauthor=R.+Doddauthor=S.+Liuauthor=R.+Xuauthor=Y.+Xuauthor=J.+J.+Miretauthor=V.+Riveraauthor=T.+Clacksonauthor=W.+C.+Shakespeareauthor=X.+Zhuauthor=D.+C.+Dalgarno&title=Fragment+growing+and+linking+lead+to+novel+nanomolar+lactate+dehydrogenase+inhibitors&doi=10.1021%2Fjm3014844"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment Growing and Linking Lead to Novel Nanomolar Lactate Dehydrogenase Inhibitors</span></div><div class="casAuthors">Kohlmann, Anna; Zech, Stephan G.; Li, Feng; Zhou, Tianjun; Squillace, Rachel M.; Commodore, Lois; Greenfield, Matthew T.; Lu, Xiaohui; Miller, David P.; Huang, Wei-Sheng; Qi, Jiwei; Thomas, R. Mathew; Wang, Yihan; Zhang, Sen; Dodd, Rory; Liu, Shuangying; Xu, Rongsong; Xu, Yongjin; Miret, Juan J.; Rivera, Victor; Clackson, Tim; Shakespeare, William C.; Zhu, Xiaotian; Dalgarno, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1023-1040</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Lactate dehydrogenase A (LDH-A) catalyzes the interconversion of lactate and pyruvate in the glycolysis pathway.  Cancer cells rely heavily on glycolysis instead of oxidative phosphorylation to generate ATP, a phenomenon known as the Warburg effect.  The inhibition of LDH-A by small mols. is therefore of interest for potential cancer treatments.  We describe the identification and optimization of LDH-A inhibitors by fragment-based drug discovery.  We applied ligand based NMR screening to identify low affinity fragments binding to LDH-A.  The dissocn. consts. (Kd) and enzyme inhibition (IC50) of fragment hits were measured by surface plasmon resonance (SPR) and enzyme assays, resp.  The binding modes of selected fragments were investigated by X-ray crystallog.  Fragment growing and linking, followed by chem. optimization, resulted in nanomolar LDH-A inhibitors that demonstrated stoichiometric binding to LDH-A.  Selected mols. inhibited lactate prodn. in cells, suggesting target-specific inhibition in cancer cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_pFkSoe2_ALVg90H21EOLACvtfcHk0lgiY2zFs5-oMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXms1OlsA%253D%253D&md5=3a6b0b46318ae2d6c2a7c34e1575ada6</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm3014844&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3014844%26sid%3Dliteratum%253Aachs%26aulast%3DKohlmann%26aufirst%3DA.%26aulast%3DZech%26aufirst%3DS.%2BG.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DSquillace%26aufirst%3DR.%2BM.%26aulast%3DCommodore%26aufirst%3DL.%26aulast%3DGreenfield%26aufirst%3DM.%2BT.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DMiller%26aufirst%3DD.%2BP.%26aulast%3DHuang%26aufirst%3DW.%2BS.%26aulast%3DQi%26aufirst%3DJ.%26aulast%3DThomas%26aufirst%3DR.%2BM.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DDodd%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DR.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DMiret%26aufirst%3DJ.%2BJ.%26aulast%3DRivera%26aufirst%3DV.%26aulast%3DClackson%26aufirst%3DT.%26aulast%3DShakespeare%26aufirst%3DW.%2BC.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DDalgarno%26aufirst%3DD.%2BC.%26atitle%3DFragment%2520growing%2520and%2520linking%2520lead%2520to%2520novel%2520nanomolar%2520lactate%2520dehydrogenase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D1023%26epage%3D1040%26doi%3D10.1021%2Fjm3014844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Erlanson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braisted, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raphael, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stroud, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, J. A.</span></span> <span> </span><span class="NLM_article-title">Site-directed ligand discovery</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">9367</span>– <span class="NLM_lpage">9372</span>, <span class="refDoi"> DOI: 10.1073/pnas.97.17.9367</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1073%2Fpnas.97.17.9367" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10944209" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmtVensr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=9367-9372&author=D.+A.+Erlansonauthor=A.+C.+Braistedauthor=D.+R.+Raphaelauthor=M.+Randalauthor=R.+M.+Stroudauthor=E.+M.+Gordonauthor=J.+A.+Wells&title=Site-directed+ligand+discovery&doi=10.1073%2Fpnas.97.17.9367"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Site-directed ligand discovery</span></div><div class="casAuthors">Erlanson, Daniel A.; Braisted, Andrew C.; Raphael, Darren R.; Randal, Mike; Stroud, Robert M.; Gordon, Eric M.; Wells, James A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">9367-9372</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">We report a strategy (called "tethering") to discover low mol. wt. ligands (≈250 Da) that bind weakly to targeted sites on proteins through an intermediary disulfide tether.  A native or engineered cysteine in a protein is allowed to react reversibly with a small library of disulfide-contg. mols. (≈1,200 compds.) at concns. typically used in drug screening (10 to 200 μM).  The cysteine-captured ligands, which are readily identified by MS, are among the most stable complexes, even though in the absence of the covalent tether the ligands may bind very weakly.  This method was applied to generate a potent inhibitor for thymidylate synthase, an essential enzyme in pyrimidine metab. with therapeutic applications in cancer and infectious diseases.  The affinity of the untethered ligand (Ki≈1 mM) was improved 3,000-fold by synthesis of a small set of analogs with the aid of crystallog. structures of the tethered complex.  Such site-directed ligand discovery allows one to nucleate drug design from a spatially targeted lead fragment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4pxPEoDE3FrVg90H21EOLACvtfcHk0lgiY2zFs5-oMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmtVensr8%253D&md5=fef57a0d21af9bc7f6f1f4bf8c023ae5</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1073%2Fpnas.97.17.9367&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.97.17.9367%26sid%3Dliteratum%253Aachs%26aulast%3DErlanson%26aufirst%3DD.%2BA.%26aulast%3DBraisted%26aufirst%3DA.%2BC.%26aulast%3DRaphael%26aufirst%3DD.%2BR.%26aulast%3DRandal%26aufirst%3DM.%26aulast%3DStroud%26aufirst%3DR.%2BM.%26aulast%3DGordon%26aufirst%3DE.%2BM.%26aulast%3DWells%26aufirst%3DJ.%2BA.%26atitle%3DSite-directed%2520ligand%2520discovery%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2000%26volume%3D97%26spage%3D9367%26epage%3D9372%26doi%3D10.1073%2Fpnas.97.17.9367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Erlanson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiesmann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luong, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmons, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeLano, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choong, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burdett, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flanagan, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, T.</span></span> <span> </span><span class="NLM_article-title">In situ assembly of enzyme inhibitors using extended tethering</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">308</span>– <span class="NLM_lpage">314</span>, <span class="refDoi"> DOI: 10.1038/nbt786</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1038%2Fnbt786" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=12563278" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhsFajs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2003&pages=308-314&author=D.+A.+Erlansonauthor=J.+W.+Lamauthor=C.+Wiesmannauthor=T.+N.+Luongauthor=R.+L.+Simmonsauthor=W.+L.+DeLanoauthor=I.+C.+Choongauthor=M.+T.+Burdettauthor=W.+M.+Flanaganauthor=D.+Leeauthor=E.+M.+Gordonauthor=T.+O%E2%80%99Brien&title=In+situ+assembly+of+enzyme+inhibitors+using+extended+tethering&doi=10.1038%2Fnbt786"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">In situ assembly of enzyme inhibitors using extended tethering</span></div><div class="casAuthors">Erlanson, Daniel A.; Lam, Joni W.; Wiesmann, Christian; Luong, Tinh N.; Simmons, Robert L.; DeLano, Warren L.; Choong, Ingrid C.; Burdett, Matthew T.; Flanagan, W. Michael; Lee, Dennis; Gordon, Eric M.; O'Brien, Tom</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">308-314</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Cysteine aspartyl protease-3 (caspase-3) is a mediator of apoptosis and a therapeutic target for a wide range of diseases.  Using a dynamic combinatorial technol., 'extended tethering', we identified unique nonpeptidic inhibitors for this enzyme.  Extended tethering allowed the identification of ligands that bind to discrete regions of caspase-3 and also helped direct the assembly of these ligands into small-mol. inhibitors.  We first designed a small-mol. 'extender' that irreversibly alkylates the cysteine residue of caspase-3 and also contains a thiol group.  The modified protein was then screened against a library of disulfide-contg. small-mol. fragments.  Mass-spectrometry was used to identify ligands that bind noncovalently to the protein and that also form a disulfide linkage with the extender.  Linking the selected fragments with binding elements from the extenders generates reversible, tight-binding mols. that are drug-like and distinct from known inhibitors.  One mol. derived from this approach inhibited apoptosis in cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIZnkpIfPw2bVg90H21EOLACvtfcHk0lgiY2zFs5-oMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhsFajs78%253D&md5=6b50abe4f31172a09172810beffb5b94</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2Fnbt786&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt786%26sid%3Dliteratum%253Aachs%26aulast%3DErlanson%26aufirst%3DD.%2BA.%26aulast%3DLam%26aufirst%3DJ.%2BW.%26aulast%3DWiesmann%26aufirst%3DC.%26aulast%3DLuong%26aufirst%3DT.%2BN.%26aulast%3DSimmons%26aufirst%3DR.%2BL.%26aulast%3DDeLano%26aufirst%3DW.%2BL.%26aulast%3DChoong%26aufirst%3DI.%2BC.%26aulast%3DBurdett%26aufirst%3DM.%2BT.%26aulast%3DFlanagan%26aufirst%3DW.%2BM.%26aulast%3DLee%26aufirst%3DD.%26aulast%3DGordon%26aufirst%3DE.%2BM.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DT.%26atitle%3DIn%2520situ%2520assembly%2520of%2520enzyme%2520inhibitors%2520using%2520extended%2520tethering%26jtitle%3DNat.%2520Biotechnol.%26date%3D2003%26volume%3D21%26spage%3D308%26epage%3D314%26doi%3D10.1038%2Fnbt786" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Braisted, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oslob, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delano, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyde, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDowell, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waal, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arkin, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raimundo, B. C.</span></span> <span> </span><span class="NLM_article-title">Discovery of a potent small molecule IL-2 inhibitor through fragment assembly</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>125</i></span>,  <span class="NLM_fpage">3714</span>– <span class="NLM_lpage">3715</span>, <span class="refDoi"> DOI: 10.1021/ja034247i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja034247i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhslynurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2003&pages=3714-3715&author=A.+C.+Braistedauthor=J.+D.+Oslobauthor=W.+L.+Delanoauthor=J.+Hydeauthor=R.+S.+McDowellauthor=N.+Waalauthor=C.+Yuauthor=M.+R.+Arkinauthor=B.+C.+Raimundo&title=Discovery+of+a+potent+small+molecule+IL-2+inhibitor+through+fragment+assembly&doi=10.1021%2Fja034247i"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent Small Molecule IL-2 Inhibitor through Fragment Assembly</span></div><div class="casAuthors">Braisted, Andrew C.; Oslob, Johan D.; Delano, Warren L.; Hyde, Jennifer; McDowell, Robert S.; Waal, Nathan; Yu, Chul; Arkin, Michelle R.; Raimundo, Brian C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3714-3715</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Using a site-directed fragment discovery method called tethering, we have identified a 60 nM small mol. antagonist of a cytokine/receptor interaction (IL-2/IL2Rα) with cell-based activity.  Starting with a low micromolar hit, we employed a combination of tethering, structural biol., and computational anal. to design a focused set of 20 compds.  Eight of these compds. were at least 5-fold more active than the original hit.  One of these compds. showed a 50-fold enhancement and represents the highest affinity inhibitor reported against this protein-protein target class.  This method of coupling selected fragments with a low micromolar hit shows great potential for generating high-affinity lead compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjoKdCBcSWbrVg90H21EOLACvtfcHk0lhYtTWa00e3eQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhslynurw%253D&md5=451b65f3a7758f207259a44e1a328d21</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fja034247i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja034247i%26sid%3Dliteratum%253Aachs%26aulast%3DBraisted%26aufirst%3DA.%2BC.%26aulast%3DOslob%26aufirst%3DJ.%2BD.%26aulast%3DDelano%26aufirst%3DW.%2BL.%26aulast%3DHyde%26aufirst%3DJ.%26aulast%3DMcDowell%26aufirst%3DR.%2BS.%26aulast%3DWaal%26aufirst%3DN.%26aulast%3DYu%26aufirst%3DC.%26aulast%3DArkin%26aufirst%3DM.%2BR.%26aulast%3DRaimundo%26aufirst%3DB.%2BC.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520small%2520molecule%2520IL-2%2520inhibitor%2520through%2520fragment%2520assembly%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2003%26volume%3D125%26spage%3D3714%26epage%3D3715%26doi%3D10.1021%2Fja034247i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ward, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brassington, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breeze, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caputo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Critchlow, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodwin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassall, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenwood, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holdgate, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mrosek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norman, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tart, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tucker, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogtherr, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittaker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wingfield, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winter, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudson, K.</span></span> <span> </span><span class="NLM_article-title">Design and Synthesis of novel lactate dehydrogenase A inhibitors by fragment-based lead generation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">3285</span>– <span class="NLM_lpage">3306</span>, <span class="refDoi"> DOI: 10.1021/jm201734r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201734r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC38XjvVSgtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=3285-3306&author=R.+A.+Wardauthor=C.+Brassingtonauthor=A.+L.+Breezeauthor=A.+Caputoauthor=S.+Critchlowauthor=G.+Daviesauthor=L.+Goodwinauthor=G.+Hassallauthor=R.+Greenwoodauthor=G.+A.+Holdgateauthor=M.+Mrosekauthor=R.+A.+Normanauthor=S.+Pearsonauthor=J.+Tartauthor=J.+A.+Tuckerauthor=M.+Vogtherrauthor=D.+Whittakerauthor=J.+Wingfieldauthor=J.+Winterauthor=K.+Hudson&title=Design+and+Synthesis+of+novel+lactate+dehydrogenase+A+inhibitors+by+fragment-based+lead+generation&doi=10.1021%2Fjm201734r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Novel Lactate Dehydrogenase A Inhibitors by Fragment-Based Lead Generation</span></div><div class="casAuthors">Ward, Richard A.; Brassington, Claire; Breeze, Alexander L.; Caputo, Alessandro; Critchlow, Susan; Davies, Gareth; Goodwin, Louise; Hassall, Giles; Greenwood, Ryan; Holdgate, Geoffrey A.; Mrosek, Michael; Norman, Richard A.; Pearson, Stuart; Tart, Jonathan; Tucker, Julie A.; Vogtherr, Martin; Whittaker, David; Wingfield, Jonathan; Winter, Jon; Hudson, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3285-3306</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Lactate dehydrogenase A (LDHA) catalyzes the conversion of pyruvate to lactate, utilizing NADH as a cofactor.  It has been identified as a potential therapeutic target in the area of cancer metab.  In this manuscript we report our progress using fragment-based lead generation (FBLG), assisted by x-ray crystallog. to develop small mol. LDHA inhibitors.  Fragment hits were identified through NMR and SPR screening and optimized into lead compds. with nanomolar binding affinities via fragment linking.  Also reported is their modification into cellular active compds. suitable for target validation work.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrH8QbdIUXNvbVg90H21EOLACvtfcHk0lhYtTWa00e3eQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjvVSgtLs%253D&md5=d638e7a0db361c212ee084d5c05ee70c</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm201734r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201734r%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DR.%2BA.%26aulast%3DBrassington%26aufirst%3DC.%26aulast%3DBreeze%26aufirst%3DA.%2BL.%26aulast%3DCaputo%26aufirst%3DA.%26aulast%3DCritchlow%26aufirst%3DS.%26aulast%3DDavies%26aufirst%3DG.%26aulast%3DGoodwin%26aufirst%3DL.%26aulast%3DHassall%26aufirst%3DG.%26aulast%3DGreenwood%26aufirst%3DR.%26aulast%3DHoldgate%26aufirst%3DG.%2BA.%26aulast%3DMrosek%26aufirst%3DM.%26aulast%3DNorman%26aufirst%3DR.%2BA.%26aulast%3DPearson%26aufirst%3DS.%26aulast%3DTart%26aufirst%3DJ.%26aulast%3DTucker%26aufirst%3DJ.%2BA.%26aulast%3DVogtherr%26aufirst%3DM.%26aulast%3DWhittaker%26aufirst%3DD.%26aulast%3DWingfield%26aufirst%3DJ.%26aulast%3DWinter%26aufirst%3DJ.%26aulast%3DHudson%26aufirst%3DK.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520novel%2520lactate%2520dehydrogenase%2520A%2520inhibitors%2520by%2520fragment-based%2520lead%2520generation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D3285%26epage%3D3306%26doi%3D10.1021%2Fjm201734r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Möbitz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machauer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holzer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaupel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stauffer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ragot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caravatti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheufler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hommel, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiedt, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beyer, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaul, C.</span></span> <span> </span><span class="NLM_article-title">The discovery of potent, selective and structurally novel DOT1L inhibitors by a fragment linking approach</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">338</span>– <span class="NLM_lpage">343</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00519</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00519" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC2sXisFyltr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=338-343&author=H.+M%C3%B6bitzauthor=R.+Machauerauthor=P.+Holzerauthor=A.+Vaupelauthor=F.+Staufferauthor=C.+Ragotauthor=G.+Caravattiauthor=C.+Scheuflerauthor=C.+Fernandezauthor=U.+Hommelauthor=R.+Tiedtauthor=K.+S.+Beyerauthor=C.+Chenauthor=H.+Zhuauthor=C.+Gaul&title=The+discovery+of+potent%2C+selective+and+structurally+novel+DOT1L+inhibitors+by+a+fragment+linking+approach&doi=10.1021%2Facsmedchemlett.6b00519"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent, Selective, and Structurally Novel Dot1L Inhibitors by a Fragment Linking Approach</span></div><div class="casAuthors">Mobitz, Henrik; Machauer, Rainer; Holzer, Philipp; Vaupel, Andrea; Stauffer, Frederic; Ragot, Christian; Caravatti, Giorgio; Scheufler, Clemens; Fernandez, Cesar; Hommel, Ulrich; Tiedt, Ralph; Beyer, Kim S.; Chen, Chao; Zhu, Hugh; Gaul, Christoph</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">338-343</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Misdirected catalytic activity of histone methyltransferase Dot1L is believed to be causative for a subset of highly aggressive acute leukemias.  Targeting the catalytic domain of Dot1L represents a potential therapeutic approach for these leukemias.  In the context of a comprehensive Dot1L hit finding strategy, a knowledge-based virtual screen of the Dot1L SAM binding pocket led to the discovery of a nonnucleoside fragment mimicking key interactions of SAM bound to Dot1L.  Linking of the fragment with an induced back pocket binder identified in earlier studies, followed by careful ligand optimization led to the identification of I, a highly potent, selective and structurally novel Dot1L inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLL327TKiV67Vg90H21EOLACvtfcHk0ljQeM5J9VWrsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXisFyltr0%253D&md5=45d354a4668901ce360cc3914aaa81e4</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00519%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25B6bitz%26aufirst%3DH.%26aulast%3DMachauer%26aufirst%3DR.%26aulast%3DHolzer%26aufirst%3DP.%26aulast%3DVaupel%26aufirst%3DA.%26aulast%3DStauffer%26aufirst%3DF.%26aulast%3DRagot%26aufirst%3DC.%26aulast%3DCaravatti%26aufirst%3DG.%26aulast%3DScheufler%26aufirst%3DC.%26aulast%3DFernandez%26aufirst%3DC.%26aulast%3DHommel%26aufirst%3DU.%26aulast%3DTiedt%26aufirst%3DR.%26aulast%3DBeyer%26aufirst%3DK.%2BS.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DGaul%26aufirst%3DC.%26atitle%3DThe%2520discovery%2520of%2520potent%252C%2520selective%2520and%2520structurally%2520novel%2520DOT1L%2520inhibitors%2520by%2520a%2520fragment%2520linking%2520approach%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26spage%3D338%26epage%3D343%26doi%3D10.1021%2Facsmedchemlett.6b00519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Howard, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blakemore, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chessari, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Congreve, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jhoti, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seavers, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Montfort, R. L.</span></span> <span> </span><span class="NLM_article-title">Application of fragment screening and fragment linking to the discovery of novel thrombin inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">1346</span>– <span class="NLM_lpage">1355</span>, <span class="refDoi"> DOI: 10.1021/jm050850v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050850v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BD28Xlt1OmtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=1346-1355&author=N.+Howardauthor=C.+Abellauthor=W.+Blakemoreauthor=G.+Chessariauthor=M.+Congreveauthor=S.+Howardauthor=H.+Jhotiauthor=C.+W.+Murrayauthor=L.+C.+Seaversauthor=R.+L.+van+Montfort&title=Application+of+fragment+screening+and+fragment+linking+to+the+discovery+of+novel+thrombin+inhibitors&doi=10.1021%2Fjm050850v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Application of Fragment Screening and Fragment Linking to the Discovery of Novel Thrombin Inhibitors</span></div><div class="casAuthors">Howard, Nigel; Abell, Chris; Blakemore, Wendy; Chessari, Gianni; Congreve, Miles; Howard, Steven; Jhoti, Harren; Murray, Christopher W.; Seavers, Lisa C. A.; Van Montfort, Rob L. M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1346-1355</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The screening of fragments is an alternative approach to high-throughput screening for the identification of leads for therapeutic targets.  Fragment hits have been discovered using x-ray crystallog. screening of protein crystals of the serine protease enzyme thrombin.  The fragment library was designed to avoid any well-precedented, strongly basic functionality.  Screening hits included a novel ligand (I), which binds exclusively to the S2-S4 pocket, in addn. to smaller fragments which bind to the S1 pocket.  The structure of these protein-ligand complexes are presented.  A chem. strategy to link two such fragments together and to synthesize larger drug-sized compds. resulted in the efficient identification of hybrid inhibitors with nanomolar potency (e.g., II, IC50 = 3.7 nM).  These potent ligands occupy the same area of the active site as previously described peptidic inhibitors, while having very different chem. architecture.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2hprBaZvhJbVg90H21EOLACvtfcHk0ljQeM5J9VWrsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xlt1OmtQ%253D%253D&md5=d47173e5f17a02658b0c6866198d0718</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm050850v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050850v%26sid%3Dliteratum%253Aachs%26aulast%3DHoward%26aufirst%3DN.%26aulast%3DAbell%26aufirst%3DC.%26aulast%3DBlakemore%26aufirst%3DW.%26aulast%3DChessari%26aufirst%3DG.%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DHoward%26aufirst%3DS.%26aulast%3DJhoti%26aufirst%3DH.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DSeavers%26aufirst%3DL.%2BC.%26aulast%3Dvan%2BMontfort%26aufirst%3DR.%2BL.%26atitle%3DApplication%2520of%2520fragment%2520screening%2520and%2520fragment%2520linking%2520to%2520the%2520discovery%2520of%2520novel%2520thrombin%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D1346%26epage%3D1355%26doi%3D10.1021%2Fjm050850v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barker, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barker, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Courtney, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardiner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hesterkamp, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichihara, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mather, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montalbetti, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varasi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittaker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarnold, C. J.</span></span> <span> </span><span class="NLM_article-title">Discovery of a novel HSP90 inhibitor by fragment linking</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1697</span>– <span class="NLM_lpage">1700</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201000219</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1002%2Fcmdc.201000219" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=20665758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlCkurzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=1697-1700&author=J.+J.+Barkerauthor=O.+Barkerauthor=S.+M.+Courtneyauthor=M.+Gardinerauthor=T.+Hesterkampauthor=O.+Ichiharaauthor=O.+Matherauthor=C.+A.+Montalbettiauthor=A.+M%C3%BCllerauthor=M.+Varasiauthor=M.+Whittakerauthor=C.+J.+Yarnold&title=Discovery+of+a+novel+HSP90+inhibitor+by+fragment+linking&doi=10.1002%2Fcmdc.201000219"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a novel Hsp90 inhibitor by fragment linking</span></div><div class="casAuthors">Barker, John J.; Barker, Oliver; Courtney, Stephen M.; Gardiner, Mihaly; Hesterkamp, Thomas; Ichihara, Osamu; Mather, Owen; Montalbetti, Christian A. G. N.; Muller, Annett; Varasi, Mario; Whittaker, Mark; Yarnold, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1697-1700</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Following a high-throughput biochem. fragment screen, we have identified novel fragment inhibitors of Hsp90.  Two fragment hits were combined to give a dual-fragment Hsp90 complex.  The compd., I, with the lowest strain energy was synthesized, and a 1000-fold improvement in activity was achieved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq05FWLIYmt6bVg90H21EOLACvtfcHk0ljQeM5J9VWrsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlCkurzI&md5=5ae93af1444d6819d8cc4bf2854bff4f</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201000219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201000219%26sid%3Dliteratum%253Aachs%26aulast%3DBarker%26aufirst%3DJ.%2BJ.%26aulast%3DBarker%26aufirst%3DO.%26aulast%3DCourtney%26aufirst%3DS.%2BM.%26aulast%3DGardiner%26aufirst%3DM.%26aulast%3DHesterkamp%26aufirst%3DT.%26aulast%3DIchihara%26aufirst%3DO.%26aulast%3DMather%26aufirst%3DO.%26aulast%3DMontalbetti%26aufirst%3DC.%2BA.%26aulast%3DM%25C3%25BCller%26aufirst%3DA.%26aulast%3DVarasi%26aufirst%3DM.%26aulast%3DWhittaker%26aufirst%3DM.%26aulast%3DYarnold%26aufirst%3DC.%2BJ.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520HSP90%2520inhibitor%2520by%2520fragment%2520linking%26jtitle%3DChemMedChem%26date%3D2010%26volume%3D5%26spage%3D1697%26epage%3D1700%26doi%3D10.1002%2Fcmdc.201000219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed-Belkacem, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colliandre, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahnou, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nevers, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bessin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brillet, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cala, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Douguet, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourguet, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krimm, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pawlotsky, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guichou, J. F.</span></span> <span> </span><span class="NLM_article-title">Fragment-based discovery of a new family of non-peptidic small-molecule cyclophilin inhibitors with potent antiviral activities</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">12777</span>, <span class="refDoi"> DOI: 10.1038/ncomms12777</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1038%2Fncomms12777" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=27652979" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFKmt7vO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=12777&author=A.+Ahmed-Belkacemauthor=L.+Colliandreauthor=N.+Ahnouauthor=Q.+Neversauthor=M.+Gelinauthor=Y.+Bessinauthor=R.+Brilletauthor=O.+Calaauthor=D.+Douguetauthor=W.+Bourguetauthor=I.+Krimmauthor=J.+M.+Pawlotskyauthor=J.+F.+Guichou&title=Fragment-based+discovery+of+a+new+family+of+non-peptidic+small-molecule+cyclophilin+inhibitors+with+potent+antiviral+activities&doi=10.1038%2Fncomms12777"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-based discovery of a new family of non-peptidic small-molecule cyclophilin inhibitors with potent antiviral activities</span></div><div class="casAuthors">Ahmed-Belkacem, Abdelhakim; Colliandre, Lionel; Ahnou, Nazim; Nevers, Quentin; Gelin, Muriel; Bessin, Yannick; Brillet, Rozenn; Cala, Olivier; Douguet, Dominique; Bourguet, William; Krimm, Isabelle; Pawlotsky, Jean-Michel; Guichou, Jean- Francois</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">12777</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Cyclophilins are peptidyl-prolyl cis/trans isomerases (PPIase) that catalyze the interconversion of the peptide bond at proline residues.  Several cyclophilins play a pivotal role in the life cycle of a no. of viruses.  The existing cyclophilin inhibitors, all derived from cyclosporine A or sanglifehrin A, have disadvantages, including their size, potential for side effects unrelated to cyclophilin inhibition and drug-drug interactions, unclear antiviral spectrum and manufg. issues.  Here we use a fragment-based drug discovery approach using nucleic magnetic resonance, X-ray crystallog. and structure-based compd. optimization to generate a new family of non-peptidic, small-mol. cyclophilin inhibitors with potent in vitro PPIase inhibitory activity and antiviral activity against hepatitis C virus, human immunodeficiency virus and coronaviruses.  This family of compds. has the potential for broad-spectrum, high-barrier-to-resistance treatment of viral infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyow1ByjcKUbVg90H21EOLACvtfcHk0ljE4L7JDzKJBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFKmt7vO&md5=f984a686b75eea86431cd048f82f11c5</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1038%2Fncomms12777&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms12777%26sid%3Dliteratum%253Aachs%26aulast%3DAhmed-Belkacem%26aufirst%3DA.%26aulast%3DColliandre%26aufirst%3DL.%26aulast%3DAhnou%26aufirst%3DN.%26aulast%3DNevers%26aufirst%3DQ.%26aulast%3DGelin%26aufirst%3DM.%26aulast%3DBessin%26aufirst%3DY.%26aulast%3DBrillet%26aufirst%3DR.%26aulast%3DCala%26aufirst%3DO.%26aulast%3DDouguet%26aufirst%3DD.%26aulast%3DBourguet%26aufirst%3DW.%26aulast%3DKrimm%26aufirst%3DI.%26aulast%3DPawlotsky%26aufirst%3DJ.%2BM.%26aulast%3DGuichou%26aufirst%3DJ.%2BF.%26atitle%3DFragment-based%2520discovery%2520of%2520a%2520new%2520family%2520of%2520non-peptidic%2520small-molecule%2520cyclophilin%2520inhibitors%2520with%2520potent%2520antiviral%2520activities%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D12777%26doi%3D10.1038%2Fncomms12777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benmansour, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trist, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coutard, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decroly, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Querat, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brancale, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barral, K.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel dengue virus NS5 methyltransferase non-nucleoside inhibitors by fragment-based drug design</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>125</i></span>,  <span class="NLM_fpage">865</span>– <span class="NLM_lpage">880</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.10.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1016%2Fj.ejmech.2016.10.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=27750202" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslShsbjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2017&pages=865-880&author=F.+Benmansourauthor=I.+Tristauthor=B.+Coutardauthor=E.+Decrolyauthor=G.+Queratauthor=A.+Brancaleauthor=K.+Barral&title=Discovery+of+novel+dengue+virus+NS5+methyltransferase+non-nucleoside+inhibitors+by+fragment-based+drug+design&doi=10.1016%2Fj.ejmech.2016.10.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of novel dengue virus NS5 methyltransferase non-nucleoside inhibitors by fragment-based drug design</span></div><div class="casAuthors">Benmansour, Fatiha; Trist, Iuni; Coutard, Bruno; Decroly, Etienne; Querat, Gilles; Brancale, Andrea; Barral, Karine</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">865-880</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">With the aim to help drug discovery against dengue virus (DENV), a fragment-based drug design approach was applied to identify ligands targeting a main component of DENV replication complex: the NS5 AdoMet-dependent mRNA methyltransferase (MTase) domain, playing an essential role in the RNA capping process.  Herein, we describe the identification of new inhibitors developed using fragment-based, structure-guided linking and optimization techniques.  Thermal-shift assay followed by a fragment-based X-ray crystallog. screening lead to the identification of three fragment hits binding DENV MTase.  We considered linking two of them, which bind to proximal sites of the AdoMet binding pocket, in order to improve their potency.  X-ray crystallog. structures and computational docking were used to guide the fragment linking, ultimately leading to novel series of non-nucleoside inhibitors of flavivirus MTase, resp. N-phenyl-[(phenylcarbamoyl)amino]benzene-1-sulfonamide and Ph [(phenylcarbamoyl)amino]benzene-1-sulfonate derivs., that show a 10-100-fold stronger inhibition of 2'-O-MTase activity compared to the initial fragments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq24pKhPTHpcbVg90H21EOLACvtfcHk0ljE4L7JDzKJBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslShsbjN&md5=18e8f271288dd63f330c92a380e69299</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DBenmansour%26aufirst%3DF.%26aulast%3DTrist%26aufirst%3DI.%26aulast%3DCoutard%26aufirst%3DB.%26aulast%3DDecroly%26aufirst%3DE.%26aulast%3DQuerat%26aufirst%3DG.%26aulast%3DBrancale%26aufirst%3DA.%26aulast%3DBarral%26aufirst%3DK.%26atitle%3DDiscovery%2520of%2520novel%2520dengue%2520virus%2520NS5%2520methyltransferase%2520non-nucleoside%2520inhibitors%2520by%2520fragment-based%2520drug%2520design%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D125%26spage%3D865%26epage%3D880%26doi%3D10.1016%2Fj.ejmech.2016.10.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coutard, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Querat, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roche, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morelli, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decroly, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barral, K.</span></span> <span> </span><span class="NLM_article-title">Optimization of a fragment linking hit toward Dengue and Zika virus NS5 methyltransferases inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>161</i></span>,  <span class="NLM_fpage">323</span>– <span class="NLM_lpage">333</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.09.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1016%2Fj.ejmech.2018.09.056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=30368131" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVSlsbnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=161&publication_year=2019&pages=323-333&author=J.+Hernandezauthor=L.+Hofferauthor=B.+Coutardauthor=G.+Queratauthor=P.+Rocheauthor=X.+Morelliauthor=E.+Decrolyauthor=K.+Barral&title=Optimization+of+a+fragment+linking+hit+toward+Dengue+and+Zika+virus+NS5+methyltransferases+inhibitors&doi=10.1016%2Fj.ejmech.2018.09.056"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of a fragment linking hit toward Dengue and Zika virus NS5 methyltransferases inhibitors</span></div><div class="casAuthors">Hernandez, Jessica; Hoffer, Laurent; Coutard, Bruno; Querat, Gilles; Roche, Philippe; Morelli, Xavier; Decroly, Etienne; Barral, Karine</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">161</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">323-333</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">No antiviral drugs to treat or prevent life-threatening flavivirus infections such as those caused by mosquito-borne Dengue (DENV) and more recently Zika (ZIKV) viruses are yet available.  We aim to develop, through a structure-based drug design approach, novel inhibitors targeting the NS5 AdoMet-dependent mRNA methyltransferase (MTase), a viral protein involved in the RNA capping process essential for flaviviruses replication.  Herein, we describe the optimization of a hit (5) identified using fragment-based and structure-guided linking techniques, which binds to a proximal site of the AdoMet binding pocket.  X-ray crystallog. structures and computational docking were used to guide our optimization process and lead to compds. 30 and 33 (DENV IC50 = 26 μM and 23 μM; ZIKV IC50 = 28 μM and 19 μM, resp.), two representatives of novel non-nucleoside inhibitors of flavivirus MTases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq78B-8RHnNwbVg90H21EOLACvtfcHk0ljE4L7JDzKJBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVSlsbnL&md5=f015597fd8ec07b2f32500e4718c454a</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.09.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.09.056%26sid%3Dliteratum%253Aachs%26aulast%3DHernandez%26aufirst%3DJ.%26aulast%3DHoffer%26aufirst%3DL.%26aulast%3DCoutard%26aufirst%3DB.%26aulast%3DQuerat%26aufirst%3DG.%26aulast%3DRoche%26aufirst%3DP.%26aulast%3DMorelli%26aufirst%3DX.%26aulast%3DDecroly%26aufirst%3DE.%26aulast%3DBarral%26aufirst%3DK.%26atitle%3DOptimization%2520of%2520a%2520fragment%2520linking%2520hit%2520toward%2520Dengue%2520and%2520Zika%2520virus%2520NS5%2520methyltransferases%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2019%26volume%3D161%26spage%3D323%26epage%3D333%26doi%3D10.1016%2Fj.ejmech.2018.09.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brear, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Fusco, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hadje Georgiou, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francis-Newton, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stubbs, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sore, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkitaraman, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spring, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyvönen, M.</span></span> <span> </span><span class="NLM_article-title">Specific inhibition of CK2α from an anchor outside the active site</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">6839</span>– <span class="NLM_lpage">6845</span>, <span class="refDoi"> DOI: 10.1039/C6SC02335E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1039%2FC6SC02335E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=28451126" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFCrtbbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=6839-6845&author=P.+Brearauthor=C.+De+Fuscoauthor=K.+Hadje+Georgiouauthor=N.+J.+Francis-Newtonauthor=C.+J.+Stubbsauthor=H.+F.+Soreauthor=A.+R.+Venkitaramanauthor=C.+Abellauthor=D.+R.+Springauthor=M.+Hyv%C3%B6nen&title=Specific+inhibition+of+CK2%CE%B1+from+an+anchor+outside+the+active+site&doi=10.1039%2FC6SC02335E"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Specific inhibition of CK2α from an anchor outside the active site</span></div><div class="casAuthors">Brear, Paul; De Fusco, Claudia; Hadje Georgiou, Kathy; Francis-Newton, Nicola J.; Stubbs, Christopher J.; Sore, Hannah F.; Venkitaraman, Ashok R.; Abell, Chris; Spring, David R.; Hyvonen, Marko</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">6839-6845</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The development of selective inhibitors of protein kinases is challenging because of the significant conservation of the ATP binding site.  Here, we describe a new mechanism by which the protein kinase CK2α can be selectively inhibited using features outside the ATP site.  We have identified a new binding site for small mols. on CK2α adjacent to the ATP site and behind the αD loop, termed the αD pocket.  An elaborated fragment anchored in this site has been linked with a low affinity fragment binding in the ATP site, creating a novel and selective inhibitor (CAM4066) that binds CK2α with a Kd of 320 nM and shows significantly improved selectivity compared to other CK2α inhibitors.  CAM4066 shows target engagement in several cell lines and similar potency to clin. trial candidate CX4945.  Our data demonstrate that targeting a poorly conserved, cryptic pocket allows inhibition of CK2α via a novel mechanism, enabling the development of a new generation of selective CK2α inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3FqxiBkU9frVg90H21EOLACvtfcHk0ljwFgWTjIcsXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFCrtbbP&md5=c4652010f4da70a128fb1dab64f811d0</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1039%2FC6SC02335E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6SC02335E%26sid%3Dliteratum%253Aachs%26aulast%3DBrear%26aufirst%3DP.%26aulast%3DDe%2BFusco%26aufirst%3DC.%26aulast%3DHadje%2BGeorgiou%26aufirst%3DK.%26aulast%3DFrancis-Newton%26aufirst%3DN.%2BJ.%26aulast%3DStubbs%26aufirst%3DC.%2BJ.%26aulast%3DSore%26aufirst%3DH.%2BF.%26aulast%3DVenkitaraman%26aufirst%3DA.%2BR.%26aulast%3DAbell%26aufirst%3DC.%26aulast%3DSpring%26aufirst%3DD.%2BR.%26aulast%3DHyv%25C3%25B6nen%26aufirst%3DM.%26atitle%3DSpecific%2520inhibition%2520of%2520CK2%25CE%25B1%2520from%2520an%2520anchor%2520outside%2520the%2520active%2520site%26jtitle%3DChem.%2520Sci.%26date%3D2016%26volume%3D7%26spage%3D6839%26epage%3D6845%26doi%3D10.1039%2FC6SC02335E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Fusco, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brear, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iegre, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgiou, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sore, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyvönen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spring, D. R.</span></span> <span> </span><span class="NLM_article-title">A fragment-based approach leading to the discovery of a novel binding site and the selective CK2 inhibitor CAM4066</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">3471</span>– <span class="NLM_lpage">3482</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2017.04.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1016%2Fj.bmc.2017.04.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=28495381" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC2sXntlWktbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=3471-3482&author=C.+De%0AFuscoauthor=P.+Brearauthor=J.+Iegreauthor=K.+H.+Georgiouauthor=H.+F.+Soreauthor=M.+Hyv%C3%B6nenauthor=D.+R.+Spring&title=A+fragment-based+approach+leading+to+the+discovery+of+a+novel+binding+site+and+the+selective+CK2+inhibitor+CAM4066&doi=10.1016%2Fj.bmc.2017.04.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">A fragment-based approach leading to the discovery of a novel binding site and the selective CK2 inhibitor CAM4066</span></div><div class="casAuthors">De Fusco, Claudia; Brear, Paul; Iegre, Jessica; Georgiou, Kathy Hadje; Sore, Hannah F.; Hyvonen, Marko; Spring, David R.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3471-3482</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Recently the authors reported the discovery of a potent and selective CK2α inhibitor CAM4066.  This compd. inhibits CK2 activity by exploiting a pocket located outside the ATP binding site (αD pocket).  Here the authors describe in detail the journey that led to the discovery of CAM4066 using the challenging fragment linking strategy.  Specifically, the authors aimed to develop inhibitors by linking a high-affinity fragment anchored in the αD site to a weakly binding warhead fragment occupying the ATP site.  Moreover, the authors describe the remarkable impact that mol. modeling had on the development of this novel chem. tool.  The work described herein shows potential for the development of a novel class of CK2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-es_MXrRt5bVg90H21EOLACvtfcHk0ljwFgWTjIcsXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXntlWktbc%253D&md5=2c4bf2e6b0528149dc09d04badfdeab3</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.04.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.04.037%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BFusco%26aufirst%3DC.%26aulast%3DBrear%26aufirst%3DP.%26aulast%3DIegre%26aufirst%3DJ.%26aulast%3DGeorgiou%26aufirst%3DK.%2BH.%26aulast%3DSore%26aufirst%3DH.%2BF.%26aulast%3DHyv%25C3%25B6nen%26aufirst%3DM.%26aulast%3DSpring%26aufirst%3DD.%2BR.%26atitle%3DA%2520fragment-based%2520approach%2520leading%2520to%2520the%2520discovery%2520of%2520a%2520novel%2520binding%2520site%2520and%2520the%2520selective%2520CK2%2520inhibitor%2520CAM4066%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26spage%3D3471%26epage%3D3482%26doi%3D10.1016%2Fj.bmc.2017.04.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Iegre, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brear, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Fusco, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carro, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sore, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyvönen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spring, D. R.</span></span> <span> </span><span class="NLM_article-title">Second-generation CK2α inhibitors targeting the αD pocket</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">3041</span>– <span class="NLM_lpage">3049</span>, <span class="refDoi"> DOI: 10.1039/C7SC05122K</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1039%2FC7SC05122K" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=29732088" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC1cXivFGls7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=3041-3049&author=J.+Iegreauthor=P.+Brearauthor=C.+De+Fuscoauthor=M.+Yoshidaauthor=S.+L.+Mitchellauthor=M.+Rossmannauthor=L.+Carroauthor=H.+F.+Soreauthor=M.+Hyv%C3%B6nenauthor=D.+R.+Spring&title=Second-generation+CK2%CE%B1+inhibitors+targeting+the+%CE%B1D+pocket&doi=10.1039%2FC7SC05122K"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Second-generation CK2α inhibitors targeting the αD pocket</span></div><div class="casAuthors">Iegre, Jessica; Brear, Paul; De Fusco, Claudia; Yoshida, Masao; Mitchell, Sophie L.; Rossmann, Maxim; Carro, Laura; Sore, Hannah F.; Hyvonen, Marko; Spring, David R.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3041-3049</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">CK2 is a crit. cell cycle regulator that also promotes various anti-apoptotic mechanisms.  Development of ATP-non-competitive inhibitors of CK2 is a very attractive strategy considering that the ATP binding site is highly conserved among other kinases.  We have previously utilized a pocket outside the active site to develop a novel CK2 inhibitor, CAM4066.  While CAM4066 bound to this new pocket it was also interacting with the ATP site: herein, we describe an example of a CK2α inhibitor that binds completely outside the active site.  This second generation αD-site binding inhibitor, compd. CAM4712 (IC50 = 7 μM, GI50 = 10.0 ± 3.6 μM), has numerous advantages over the previously reported CAM4066, including a redn. in the no. of rotatable bonds, the absence of amide groups susceptible to the action of proteases and improved cellular permeability.  Unlike with CAM4066, there was no need to facilitate cellular uptake by making a prodrug.  Moreover, CAM4712 displayed no drop off between its ability to inhibit the kinase in vitro (IC50) and the ability to inhibit cell proliferation (GI50).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprPLu-nG6dLLVg90H21EOLACvtfcHk0ljwFgWTjIcsXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXivFGls7w%253D&md5=4d57e89546e1c7bcac4868e3a02ba2f8</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1039%2FC7SC05122K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7SC05122K%26sid%3Dliteratum%253Aachs%26aulast%3DIegre%26aufirst%3DJ.%26aulast%3DBrear%26aufirst%3DP.%26aulast%3DDe%2BFusco%26aufirst%3DC.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DMitchell%26aufirst%3DS.%2BL.%26aulast%3DRossmann%26aufirst%3DM.%26aulast%3DCarro%26aufirst%3DL.%26aulast%3DSore%26aufirst%3DH.%2BF.%26aulast%3DHyv%25C3%25B6nen%26aufirst%3DM.%26aulast%3DSpring%26aufirst%3DD.%2BR.%26atitle%3DSecond-generation%2520CK2%25CE%25B1%2520inhibitors%2520targeting%2520the%2520%25CE%25B1D%2520pocket%26jtitle%3DChem.%2520Sci.%26date%3D2018%26volume%3D9%26spage%3D3041%26epage%3D3049%26doi%3D10.1039%2FC7SC05122K" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frank, A. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldkamp, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterson, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelz, N. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patrone, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vangamudi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camper, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossanese, O. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chazin, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of a potent inhibitor of replication protein A protein-protein interactions using a fragment-linking approach</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">9242</span>– <span class="NLM_lpage">9250</span>, <span class="refDoi"> DOI: 10.1021/jm401333u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401333u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1CktrzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=9242-9250&author=A.+O.+Frankauthor=M.+D.+Feldkampauthor=J.+P.+Kennedyauthor=A.+G.+Watersonauthor=N.+F.+Pelzauthor=J.+D.+Patroneauthor=B.+Vangamudiauthor=D.+V.+Camperauthor=O.+W.+Rossaneseauthor=W.+J.+Chazinauthor=S.+W.+Fesik&title=Discovery+of+a+potent+inhibitor+of+replication+protein+A+protein-protein+interactions+using+a+fragment-linking+approach&doi=10.1021%2Fjm401333u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent Inhibitor of Replication Protein A Protein-Protein Interactions Using a Fragment-Linking Approach</span></div><div class="casAuthors">Frank, Andreas O.; Feldkamp, Michael D.; Kennedy, J. Phillip; Waterson, Alex G.; Pelz, Nicholas F.; Patrone, James D.; Vangamudi, Bhavatarini; Camper, DeMarco V.; Rossanese, Olivia W.; Chazin, Walter J.; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9242-9250</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Replication protein A (RPA), the major eukaryotic single-stranded DNA (ssDNA)-binding protein, is involved in nearly all cellular DNA transactions.  The RPA N-terminal domain (RPA70N) is a recruitment site for proteins involved in DNA-damage response and repair.  Selective inhibition of these protein-protein interactions has the potential to inhibit the DNA-damage response and to sensitize cancer cells to DNA-damaging agents without affecting other functions of RPA.  To discover a potent, selective inhibitor of the RPA70N protein-protein interactions to test this hypothesis, we used NMR spectroscopy to identify fragment hits that bind to two adjacent sites in the basic cleft of RPA70N.  High-resoln. X-ray crystal structures of RPA70N-ligand complexes revealed how these fragments bind to RPA and guided the design of linked compds. that simultaneously occupy both sites.  We have synthesized linked mols. that bind to RPA70N with submicromolar affinity and minimal disruption of RPA's interaction with ssDNA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgZEDSY6TA3rVg90H21EOLACvtfcHk0ljfvcHQSxZmrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1CktrzL&md5=ee3a60f76302dcb30fec7d88a1a386c5</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjm401333u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401333u%26sid%3Dliteratum%253Aachs%26aulast%3DFrank%26aufirst%3DA.%2BO.%26aulast%3DFeldkamp%26aufirst%3DM.%2BD.%26aulast%3DKennedy%26aufirst%3DJ.%2BP.%26aulast%3DWaterson%26aufirst%3DA.%2BG.%26aulast%3DPelz%26aufirst%3DN.%2BF.%26aulast%3DPatrone%26aufirst%3DJ.%2BD.%26aulast%3DVangamudi%26aufirst%3DB.%26aulast%3DCamper%26aufirst%3DD.%2BV.%26aulast%3DRossanese%26aufirst%3DO.%2BW.%26aulast%3DChazin%26aufirst%3DW.%2BJ.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520inhibitor%2520of%2520replication%2520protein%2520A%2520protein-protein%2520interactions%2520using%2520a%2520fragment-linking%2520approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D9242%26epage%3D9250%26doi%3D10.1021%2Fjm401333u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swayze, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jefferson, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sannes-Lowery, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blyn, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Risen, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arakawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osgood, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofstadler, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffey, R. H.</span></span> <span> </span><span class="NLM_article-title">SAR by MS: a ligand based technique for drug lead discovery against structured RNA targets</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">3816</span>– <span class="NLM_lpage">3819</span>, <span class="refDoi"> DOI: 10.1021/jm0255466</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0255466" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BD38XlsFyns78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=3816-3819&author=E.+E.+Swayzeauthor=E.+A.+Jeffersonauthor=K.+A.+Sannes-Loweryauthor=L.+B.+Blynauthor=L.+M.+Risenauthor=S.+Arakawaauthor=S.+A.+Osgoodauthor=S.+A.+Hofstadlerauthor=R.+H.+Griffey&title=SAR+by+MS%3A+a+ligand+based+technique+for+drug+lead+discovery+against+structured+RNA+targets&doi=10.1021%2Fjm0255466"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">SAR by MS: A Ligand Based Technique for Drug Lead Discovery Against Structured RNA Targets</span></div><div class="casAuthors">Swayze, Eric E.; Jefferson, Elizabeth A.; Sannes-Lowery, Kristin A.; Blyn, Lawrence B.; Risen, Lisa M.; Arakawa, Satoshi; Osgood, Stephen A.; Hofstadler, Steven A.; Griffey, Richard H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">3816-3819</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A technique for lead discovery vs. RNA targets utilizing mass spectrometry (MS) screening methods is described.  The structure-activity relationships (SAR) derived from assaying weak binding motifs allows the pharmacophores discovered to be elaborated via "SAR by MS" to higher affinity ligands.  Application of this strategy to a subdomain of the 23S rRNA afforded a new class of compds. with functional activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtzo3bJvTJKLVg90H21EOLACvtfcHk0ljfvcHQSxZmrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlsFyns78%253D&md5=b2cd9789c58b1b39479e0cbecdfd1afe</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fjm0255466&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0255466%26sid%3Dliteratum%253Aachs%26aulast%3DSwayze%26aufirst%3DE.%2BE.%26aulast%3DJefferson%26aufirst%3DE.%2BA.%26aulast%3DSannes-Lowery%26aufirst%3DK.%2BA.%26aulast%3DBlyn%26aufirst%3DL.%2BB.%26aulast%3DRisen%26aufirst%3DL.%2BM.%26aulast%3DArakawa%26aufirst%3DS.%26aulast%3DOsgood%26aufirst%3DS.%2BA.%26aulast%3DHofstadler%26aufirst%3DS.%2BA.%26aulast%3DGriffey%26aufirst%3DR.%2BH.%26atitle%3DSAR%2520by%2520MS%253A%2520a%2520ligand%2520based%2520technique%2520for%2520drug%2520lead%2520discovery%2520against%2520structured%2520RNA%2520targets%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D3816%26epage%3D3819%26doi%3D10.1021%2Fjm0255466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Green, N. M.</span></span> <span> </span><span class="NLM_article-title">Avidin</span>. <i>Adv. Protein Chem.</i> <span class="NLM_year" style="font-weight: bold;">1975</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">85</span>– <span class="NLM_lpage">133</span>, <span class="refDoi"> DOI: 10.1016/S0065-3233(08)60411-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1016%2FS0065-3233%2808%2960411-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=237414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADyaE2MXksleltrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1975&pages=85-133&author=N.+M.+Green&title=Avidin&doi=10.1016%2FS0065-3233%2808%2960411-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Avidin</span></div><div class="casAuthors">Green, N. Michael</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Protein Chemistry</span>
        (<span class="NLM_cas:date">1975</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">85-133</span>CODEN:
                <span class="NLM_cas:coden">APCHA2</span>;
        ISSN:<span class="NLM_cas:issn">0065-3233</span>.
    </div><div class="casAbstract">A review with 127 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeixkEWQrkbrVg90H21EOLACvtfcHk0ljfvcHQSxZmrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2MXksleltrg%253D&md5=3b3e99d46d44ad504a2b20a18c325f31</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2FS0065-3233%2808%2960411-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0065-3233%252808%252960411-8%26sid%3Dliteratum%253Aachs%26aulast%3DGreen%26aufirst%3DN.%2BM.%26atitle%3DAvidin%26jtitle%3DAdv.%2520Protein%2520Chem.%26date%3D1975%26volume%3D29%26spage%3D85%26epage%3D133%26doi%3D10.1016%2FS0065-3233%2808%2960411-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maly, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choong, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellman, J. A.</span></span> <span> </span><span class="NLM_article-title">Combinatorial target-guided ligand assembly: identification of potent subtype-selective c-SRC inhibitors</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">2419</span>– <span class="NLM_lpage">2424</span>, <span class="refDoi"> DOI: 10.1073/pnas.97.6.2419</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1073%2Fpnas.97.6.2419" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10716979" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BD3cXitVaitL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=2419-2424&author=D.+J.+Malyauthor=I.+C.+Choongauthor=J.+A.+Ellman&title=Combinatorial+target-guided+ligand+assembly%3A+identification+of+potent+subtype-selective+c-SRC+inhibitors&doi=10.1073%2Fpnas.97.6.2419"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Combinatorial target-guided ligand assembly: identification of potent subtype-selective c-Src inhibitors</span></div><div class="casAuthors">Maly, Dustin J.; Choong, Ingrid C.; Ellman, Jonathan A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2419-2424</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">A method for the rapid and efficient identification of ligands to biol. targets is reported.  The combinatorial method does not require structural or mechanistic information and is accomplished in four straightforward steps.  (i) A set of potential binding elements is prepd. wherein each mol. incorporates a common chem. linkage group.  (ii) The set of potential binding elements is screened to identify all binding elements that interact even weakly with the biol. target.  (iii) A combinatorial library of linked binding elements is prepd. whereby the binding elements are connected by the common chem. linkage groups through a set of flexible linkers.  (iv) The combinatorial library is screened to identify the tightest-binding ligands.  The utility of the method was demonstrated by the identification of a potent and subtype-selective small mol. inhibitor of the non-receptor tyrosine kinase c-Src (IC50 = 64 nM).  Because the method relies on connecting two distinct binding elements, the relative contributions of the two binding elements to the potency and selectivity of the inhibitor were readily detd.  This information provides valuable insight into the mol. basis of inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd5dUv6_L16bVg90H21EOLACvtfcHk0ljfvcHQSxZmrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXitVaitL0%253D&md5=26efc511950ea54f41780cb10779dfea</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1073%2Fpnas.97.6.2419&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.97.6.2419%26sid%3Dliteratum%253Aachs%26aulast%3DMaly%26aufirst%3DD.%2BJ.%26aulast%3DChoong%26aufirst%3DI.%2BC.%26aulast%3DEllman%26aufirst%3DJ.%2BA.%26atitle%3DCombinatorial%2520target-guided%2520ligand%2520assembly%253A%2520identification%2520of%2520potent%2520subtype-selective%2520c-SRC%2520inhibitors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2000%26volume%3D97%26spage%3D2419%26epage%3D2424%26doi%3D10.1073%2Fpnas.97.6.2419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huc, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehn, J. M.</span></span> <span> </span><span class="NLM_article-title">Virtual combinatorial libraries: Dynamic generation of molecular and supramolecular diversity by self-assembly</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">2106</span>– <span class="NLM_lpage">2110</span>, <span class="refDoi"> DOI: 10.1073/pnas.94.6.2106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1073%2Fpnas.94.6.2106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=9122156" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADyaK2sXhvF2ltrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1997&pages=2106-2110&author=I.+Hucauthor=J.+M.+Lehn&title=Virtual+combinatorial+libraries%3A+Dynamic+generation+of+molecular+and+supramolecular+diversity+by+self-assembly&doi=10.1073%2Fpnas.94.6.2106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Virtual combinatorial libraries: dynamic generation of molecular and supramolecular diversity by self-assembly</span></div><div class="casAuthors">Huc, Ivan; Lehn, Jean-Marie</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2106-2110</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Mol. and supramol. diversity may be generated, resp., by reversible, covalent or noncovalent self-assembly of basic components whose various potential combinations in no. and nature represent a virtual combinatorial library.  This concept is applied to the induction of inhibitors of carbonic anhydrase (CA) by reversible recombination of aldehyde and amine components.  The presence of CA favors the formation of those condensation compds. that may be expected to present the strongest binding to the CA active site.  The virtual combinatorial library approach may represent a powerful methodol. for the discovery of substrates, inhibitors, receptors, catalysts, and carriers for a variety of processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQ2QpGhf5oDLVg90H21EOLACvtfcHk0ljY8oIMtWLdfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhvF2ltrs%253D&md5=158c74081199c7363a16130ad13cc884</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1073%2Fpnas.94.6.2106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.94.6.2106%26sid%3Dliteratum%253Aachs%26aulast%3DHuc%26aufirst%3DI.%26aulast%3DLehn%26aufirst%3DJ.%2BM.%26atitle%3DVirtual%2520combinatorial%2520libraries%253A%2520Dynamic%2520generation%2520of%2520molecular%2520and%2520supramolecular%2520diversity%2520by%2520self-assembly%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1997%26volume%3D94%26spage%3D2106%26epage%3D2110%26doi%3D10.1073%2Fpnas.94.6.2106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hochgürtel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroth, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piecha, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofmann, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicolau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krause, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaaf, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonnenmoser, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eliseev, A. V.</span></span> <span> </span><span class="NLM_article-title">Target-induced formation of neuraminidase inhibitors from in vitro virtual combinatorial libraries</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">3382</span>– <span class="NLM_lpage">3387</span>, <span class="refDoi"> DOI: 10.1073/pnas.052703799</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1073%2Fpnas.052703799" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=11891312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BD38Xis1Kmurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=3382-3387&author=M.+Hochg%C3%BCrtelauthor=H.+Krothauthor=D.+Piechaauthor=M.+W.+Hofmannauthor=C.+Nicolauauthor=S.+Krauseauthor=O.+Schaafauthor=G.+Sonnenmoserauthor=A.+V.+Eliseev&title=Target-induced+formation+of+neuraminidase+inhibitors+from+in+vitro+virtual+combinatorial+libraries&doi=10.1073%2Fpnas.052703799"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Target-induced formation of neuraminidase inhibitors from in vitro virtual combinatorial libraries</span></div><div class="casAuthors">Hochguertel, Matthias; Kroth, Heiko; Piecha, Dorothea; Hofmann, Michael W.; Nicolau, Claude; Krause, Sonja; Schaaf, Otmar; Sonnenmoser, Gabriele; Eliseev, Alexey V.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3382-3387</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Neuraminidase, a key enzyme responsible for influenza virus propagation, has been used as a template for selective synthesis of small subsets of its own inhibitors from theor. highly diverse dynamic combinatorial libraries.  We show that the library building blocks, aldehydes and amines, form significant amts. of the library components resulting from their coupling by reductive amination only in the presence of the enzyme.  The target amplifies the best hits at least 120-fold.  The dynamic libraries synthesized and screened in such an in vitro virtual mode form the components that possess high inhibitory activity, as confirmed by enzyme assays with independently synthesized individual compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJp4OM54ydgLVg90H21EOLACvtfcHk0ljY8oIMtWLdfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xis1Kmurg%253D&md5=38f68ebcb32969193663941ac874d778</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1073%2Fpnas.052703799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.052703799%26sid%3Dliteratum%253Aachs%26aulast%3DHochg%25C3%25BCrtel%26aufirst%3DM.%26aulast%3DKroth%26aufirst%3DH.%26aulast%3DPiecha%26aufirst%3DD.%26aulast%3DHofmann%26aufirst%3DM.%2BW.%26aulast%3DNicolau%26aufirst%3DC.%26aulast%3DKrause%26aufirst%3DS.%26aulast%3DSchaaf%26aufirst%3DO.%26aulast%3DSonnenmoser%26aufirst%3DG.%26aulast%3DEliseev%26aufirst%3DA.%2BV.%26atitle%3DTarget-induced%2520formation%2520of%2520neuraminidase%2520inhibitors%2520from%2520in%2520vitro%2520virtual%2520combinatorial%2520libraries%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2002%26volume%3D99%26spage%3D3382%26epage%3D3387%26doi%3D10.1073%2Fpnas.052703799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hochgürtel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biesinger, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroth, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piecha, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofmann, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krause, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaaf, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicolau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eliseev, A. V.</span></span> <span> </span><span class="NLM_article-title">Ketones as building blocks for dynamic combinatorial libraries: highly active neuraminidase inhibitors generated via selection pressure of the biological target</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">356</span>– <span class="NLM_lpage">358</span>, <span class="refDoi"> DOI: 10.1021/jm025589m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm025589m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BD3sXotlWh" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=356-358&author=M.+Hochg%C3%BCrtelauthor=R.+Biesingerauthor=H.+Krothauthor=D.+Piechaauthor=M.+W.+Hofmannauthor=S.+Krauseauthor=O.+Schaafauthor=C.+Nicolauauthor=A.+V.+Eliseev&title=Ketones+as+building+blocks+for+dynamic+combinatorial+libraries%3A+highly+active+neuraminidase+inhibitors+generated+via+selection+pressure+of+the+biological+target&doi=10.1021%2Fjm025589m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Ketones as Building Blocks for Dynamic Combinatorial Libraries: Highly Active Neuraminidase Inhibitors Generated via Selection Pressure of the Biological Target</span></div><div class="casAuthors">Hochguertel, Matthias; Biesinger, Ralf; Kroth, Heiko; Piecha, Dorothea; Hofmann, Michael W.; Krause, Sonja; Schaaf, Otmar; Nicolau, Claude; Eliseev, Alexey V.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">356-358</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">New and potent inhibitors of neuraminidase, a key enzyme in the influenza virus activity, have been discovered in dynamic combinatorial libraries based on ketones and amines as building blocks.  Selective synthesis of a no. of inhibitors among multiple theor. possible combinations of building blocks is driven by the presence of the target enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhUyA6CfOz_LVg90H21EOLACvtfcHk0ljY8oIMtWLdfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXotlWh&md5=13a0925f444ac4837b288f0233c6a13e</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Fjm025589m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm025589m%26sid%3Dliteratum%253Aachs%26aulast%3DHochg%25C3%25BCrtel%26aufirst%3DM.%26aulast%3DBiesinger%26aufirst%3DR.%26aulast%3DKroth%26aufirst%3DH.%26aulast%3DPiecha%26aufirst%3DD.%26aulast%3DHofmann%26aufirst%3DM.%2BW.%26aulast%3DKrause%26aufirst%3DS.%26aulast%3DSchaaf%26aufirst%3DO.%26aulast%3DNicolau%26aufirst%3DC.%26aulast%3DEliseev%26aufirst%3DA.%2BV.%26atitle%3DKetones%2520as%2520building%2520blocks%2520for%2520dynamic%2520combinatorial%2520libraries%253A%2520highly%2520active%2520neuraminidase%2520inhibitors%2520generated%2520via%2520selection%2520pressure%2520of%2520the%2520biological%2520target%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D356%26epage%3D358%26doi%3D10.1021%2Fjm025589m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mondal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radeva, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Köster, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potamitis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zervou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klebe, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirsch, A. K.</span></span> <span> </span><span class="NLM_article-title">Structure-based design of inhibitors of the aspartic protease endothiapepsin by exploiting dynamic combinatorial chemistry</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">3259</span>– <span class="NLM_lpage">3263</span>, <span class="refDoi"> DOI: 10.1002/anie.201309682</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1002%2Fanie.201309682" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisFOgtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=3259-3263&author=M.+Mondalauthor=N.+Radevaauthor=H.+K%C3%B6sterauthor=A.+Parkauthor=C.+Potamitisauthor=M.+Zervouauthor=G.+Klebeauthor=A.+K.+Hirsch&title=Structure-based+design+of+inhibitors+of+the+aspartic+protease+endothiapepsin+by+exploiting+dynamic+combinatorial+chemistry&doi=10.1002%2Fanie.201309682"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of Inhibitors of the Aspartic Protease Endothiapepsin by Exploiting Dynamic Combinatorial Chemistry</span></div><div class="casAuthors">Mondal, Milon; Radeva, Nedyalka; Koester, Helene; Park, Ahyoung; Potamitis, Constantinos; Zervou, Maria; Klebe, Gerhard; Hirsch, Anna K. H.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3259-3263</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Structure-based design (SBD) can be used for the design and/or optimization of new inhibitors for a biol. target.  Whereas de novo SBD is rarely used, most reports on SBD are dealing with the optimization of an initial hit.  Dynamic combinatorial chem. (DCC) has emerged as a powerful strategy to identify bioactive ligands given that it enables the target to direct the synthesis of its strongest binder.  We have designed a library of potential inhibitors (acylhydrazones) generated from five aldehydes and five hydrazides and used DCC to identify the best binder(s).  After addn. of the aspartic protease endothiapepsin, we characterized the protein-bound library member(s) by satn.-transfer difference NMR spectroscopy.  Cocrystn. expts. validated the predicted binding mode of the two most potent inhibitors, thus demonstrating that the combination of de novo SBD and DCC constitutes an efficient starting point for hit identification and optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0ZicAgqlVQLVg90H21EOLACvtfcHk0lgQAWZSRjubqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisFOgtrg%253D&md5=45587303d496fb3fe39f80da5d8c277e</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1002%2Fanie.201309682&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201309682%26sid%3Dliteratum%253Aachs%26aulast%3DMondal%26aufirst%3DM.%26aulast%3DRadeva%26aufirst%3DN.%26aulast%3DK%25C3%25B6ster%26aufirst%3DH.%26aulast%3DPark%26aufirst%3DA.%26aulast%3DPotamitis%26aufirst%3DC.%26aulast%3DZervou%26aufirst%3DM.%26aulast%3DKlebe%26aufirst%3DG.%26aulast%3DHirsch%26aufirst%3DA.%2BK.%26atitle%3DStructure-based%2520design%2520of%2520inhibitors%2520of%2520the%2520aspartic%2520protease%2520endothiapepsin%2520by%2520exploiting%2520dynamic%2520combinatorial%2520chemistry%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2014%26volume%3D53%26spage%3D3259%26epage%3D3263%26doi%3D10.1002%2Fanie.201309682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Congreve, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devine, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Granata, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Reilly, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyatt, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jhoti, H.</span></span> <span> </span><span class="NLM_article-title">Detection of ligands from a dynamic combinatorial library by X-ray crystallography</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">4479</span>– <span class="NLM_lpage">4482</span>, <span class="refDoi"> DOI: 10.1002/anie.200351951</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1002%2Fanie.200351951" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BD3sXot1Kqu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2003&pages=4479-4482&author=M.+S.+Congreveauthor=D.+J.+Davisauthor=L.+Devineauthor=C.+Granataauthor=M.+O%E2%80%99Reillyauthor=P.+G.+Wyattauthor=H.+Jhoti&title=Detection+of+ligands+from+a+dynamic+combinatorial+library+by+X-ray+crystallography&doi=10.1002%2Fanie.200351951"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Detection of ligands from a dynamic combinatorial library by X-ray crystallography</span></div><div class="casAuthors">Congreve, Miles S.; Davis, Deborah J.; Devine, Lindsay; Granata, Cesare; O'Reilly, Marc; Wyatt, Paul G.; Jhoti, Harren</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">4479-4482</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Dynamic combinatorial chem. (DCC) is an approach to mol. recognition in which specific members of a combinatorial library are selected and amplified with the use of a template.  The principle difference between DCC and traditional combinatorial chem. is that the reaction linking the building blocks together in DCC is reversible and there is an ongoing interchange between the different members of the dynamic combinatorial library (DCL) under thermodn. control.  A DCL. is therefore able to respond to mol. recognition events owing to the presence of a template, such as a protein, which can stabilize a particular member of the library and induce a shift in the equil., favoring the formation of the selected species.  Also, the effect can only be detected by R comparison of identical libraries, generated R N with and without the protein component R3 present, using either mass spectrometric H anal. or HPLC chromatograms as a fingerprint.  We now report a complimentary approach in which ligands are obsd. directly by X-ray crystallog. by interpretation of electron-d. maps from crystals exposed to a dynamic combinatorial library mixt.  We call this technol. dynamic combinatorial X-ray crystallog. or DCX.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqN6ubgxyFWELVg90H21EOLACvtfcHk0lgQAWZSRjubqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXot1Kqu7w%253D&md5=1a084e609f5b3c7b98d97c3594ad9f46</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1002%2Fanie.200351951&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200351951%26sid%3Dliteratum%253Aachs%26aulast%3DCongreve%26aufirst%3DM.%2BS.%26aulast%3DDavis%26aufirst%3DD.%2BJ.%26aulast%3DDevine%26aufirst%3DL.%26aulast%3DGranata%26aufirst%3DC.%26aulast%3DO%25E2%2580%2599Reilly%26aufirst%3DM.%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26aulast%3DJhoti%26aufirst%3DH.%26atitle%3DDetection%2520of%2520ligands%2520from%2520a%2520dynamic%2520combinatorial%2520library%2520by%2520X-ray%2520crystallography%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2003%26volume%3D42%26spage%3D4479%26epage%3D4482%26doi%3D10.1002%2Fanie.200351951" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Dahshan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rademann, J.</span></span> <span> </span><span class="NLM_article-title">Selective identification of cooperatively binding fragments in a high-throughput ligation assay enables development of a picomolar caspase-3 inhibitor</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">6346</span>– <span class="NLM_lpage">6349</span>, <span class="refDoi"> DOI: 10.1002/anie.200901647</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1002%2Fanie.200901647" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpvFyhu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=6346-6349&author=M.+F.+Schmidtauthor=A.+El-Dahshanauthor=S.+Kellerauthor=J.+Rademann&title=Selective+identification+of+cooperatively+binding+fragments+in+a+high-throughput+ligation+assay+enables+development+of+a+picomolar+caspase-3+inhibitor&doi=10.1002%2Fanie.200901647"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Identification of Cooperatively Binding Fragments in a High-Throughput Ligation Assay Enables Development of a Picomolar Caspase-3 Inhibitor</span></div><div class="casAuthors">Schmidt, Marco F.; El-Dahshan, Adeeb; Keller, Sandro; Rademann, Joerg</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">6346-6349, S6346/1-S6346/13</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Fragment-based lead discovery has become popular over the past years, allowing for a more efficient sampling of the chem. space and thus resulting in higher hit rates than that for the screening of non-fragment chem. libraries.  Reported detection methods for protein-binding fragments, however, do not answer the most challenging question in fragment-based ligand discovery: How can a primary ligand as the starting point be extended optimally by a secondary fragment.  While "second-site screening" by NMR spectroscopy or crystallog. delivers fragment hits for different binding sites, it does not provide information regarding the optimal, bioactive combination of fragments.  Evidently, for a thermodynamically optimized extension of a primary ligand (A) by a secondary fragment (B), cooperative binding of both components is required.  Cooperative binding in this context results if the binding of A is amplified by the binding of B.  Cooperative binding therefore is distinct from additive binding (in which A and B bind independently without mutual influence) and competitive binding where the secondary fragment B inhibits the binding of A.  Cooperatively binding fragments result in strongly increased binding affinities if the two components are connected by a suitable covalent linkage.  The authors developed and implemented the differential detection of cooperative and competitive fragments in one FP expt. operable in high-throughput format.  Cooperative fragment binding can be verified and distinguished from merely additive effects.  By employing a model for the ligation equil. we could est. the ligation const. and the Gibbs free energy of the reversible ligation reaction on the protein surface.  A chem. stable combination of the best fragment hits yielded the most potent inhibitor of caspase-3 reported to date.  Thus, the described dynamic method for cooperativity screening can be used to dissect and analyze binding contributions of single fragments in a ligation system.  As it is based on FP detection, the method is broadly applicable to enzyme targets as well as to protein-protein interactions.  The information gained from this assay can be utilized directly for the construction of improved protein ligands by a rational approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopsSF_8gOhA7Vg90H21EOLACvtfcHk0lgQAWZSRjubqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpvFyhu7k%253D&md5=6d2567d3f6ec9837df92f89202ca6a79</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1002%2Fanie.200901647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200901647%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidt%26aufirst%3DM.%2BF.%26aulast%3DEl-Dahshan%26aufirst%3DA.%26aulast%3DKeller%26aufirst%3DS.%26aulast%3DRademann%26aufirst%3DJ.%26atitle%3DSelective%2520identification%2520of%2520cooperatively%2520binding%2520fragments%2520in%2520a%2520high-throughput%2520ligation%2520assay%2520enables%2520development%2520of%2520a%2520picomolar%2520caspase-3%2520inhibitor%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2009%26volume%3D48%26spage%3D6346%26epage%3D6349%26doi%3D10.1002%2Fanie.200901647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jaegle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinmetzer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rademann, J.</span></span> <span> </span><span class="NLM_article-title">Protein-templated formation of an inhibitor of the blood coagulation factor Xa through a background-free amidation reaction</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">3718</span>– <span class="NLM_lpage">3722</span>, <span class="refDoi"> DOI: 10.1002/anie.201611547</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1002%2Fanie.201611547" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC2sXislGgu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2017&pages=3718-3722&author=M.+Jaegleauthor=T.+Steinmetzerauthor=J.+Rademann&title=Protein-templated+formation+of+an+inhibitor+of+the+blood+coagulation+factor+Xa+through+a+background-free+amidation+reaction&doi=10.1002%2Fanie.201611547"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Protein-Templated Formation of an Inhibitor of the Blood Coagulation Factor Xa through a Background-Free Amidation Reaction</span></div><div class="casAuthors">Jaegle, Mike; Steinmetzer, Torsten; Rademann, Joerg</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3718-3722</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Protein-templated reactions enable the target-guided formation of protein ligands from reactive fragments, ideally with no background reaction.  Herein, we investigate the templated formation of amides.  A nucleophilic fragment that binds to the coagulation factor Xa was incubated with the protein and thirteen differentially activated dipeptides.  The protein induced a non-catalytic templated reaction for the Ph and trifluoroethyl esters; the latter was shown to be a completely background-free reaction.  Starting from two fragments with millimolar affinity, a 29 nM superadditive inhibitor of factor Xa was obtained.  The fragment ligation reaction was detected with high sensitivity by an enzyme activity assay and by mass spectrometry.  The reaction progress and autoinhibition of the templated reaction by the formed ligation product were detd., and the structure of the protein-inhibitor complex was elucidated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMW8n0HDtHjrVg90H21EOLACvtfcHk0lh_sCNSxvC2nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXislGgu7g%253D&md5=30bf632a374bb45d67262a812a62988d</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1002%2Fanie.201611547&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201611547%26sid%3Dliteratum%253Aachs%26aulast%3DJaegle%26aufirst%3DM.%26aulast%3DSteinmetzer%26aufirst%3DT.%26aulast%3DRademann%26aufirst%3DJ.%26atitle%3DProtein-templated%2520formation%2520of%2520an%2520inhibitor%2520of%2520the%2520blood%2520coagulation%2520factor%2520Xa%2520through%2520a%2520background-free%2520amidation%2520reaction%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2017%26volume%3D56%26spage%3D3718%26epage%3D3722%26doi%3D10.1002%2Fanie.201611547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grynszpan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radić, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlier, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finn, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharpless, K. B.</span></span> <span> </span><span class="NLM_article-title">Click chemistry in situ: acetylcholinesterase as a reaction vessel for the selective assembly of a femtomolar inhibitor from an array of building blocks</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">1053</span>– <span class="NLM_lpage">1057</span>, <span class="refDoi"> DOI: 10.1002/1521-3773(20020315)41:6<1053::AID-ANIE1053>3.0.CO;2-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1002%2F1521-3773%2820020315%2941%3A6%3C1053%3A%3AAID-ANIE1053%3E3.0.CO%3B2-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BD38XisVeisbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2002&pages=1053-1057&author=W.+G.+Lewisauthor=L.+G.+Greenauthor=F.+Grynszpanauthor=Z.+Radi%C4%87author=P.+R.+Carlierauthor=P.+Taylorauthor=M.+G.+Finnauthor=K.+B.+Sharpless&title=Click+chemistry+in+situ%3A+acetylcholinesterase+as+a+reaction+vessel+for+the+selective+assembly+of+a+femtomolar+inhibitor+from+an+array+of+building+blocks&doi=10.1002%2F1521-3773%2820020315%2941%3A6%3C1053%3A%3AAID-ANIE1053%3E3.0.CO%3B2-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Click chemistry in situ: Acetylcholinesterase as a reaction vessel for the selective assembly of a femtomolar inhibitor from an array of building blocks</span></div><div class="casAuthors">Lewis, Warren G.; Green, Luke G.; Grynszpan, Flavio; Radic, Zoran; Carlier, Paul R.; Taylor, Palmer; Finn, M. G.; Sharpless, K. Barry</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1053-1057</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH</span>)
        </div><div class="casAbstract">Form-fitting chem. in a protein mold is enabled by the use of the 1,3-dipolar cycloaddn. of azides and alkynes.  The enzyme acetylcholinesterase preferentially assembles one pair of these reactants, each of which bears a group that binds to adjacent positions on the protein structure, into a 1,2,3-triazole adduct that is the most potent noncovalent inhibitor of the enzyme yet developed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYVFLD1n2QrbVg90H21EOLACvtfcHk0lh_sCNSxvC2nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XisVeisbo%253D&md5=e1ff6aedcbf7ae1523f4e3082e801c86</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1002%2F1521-3773%2820020315%2941%3A6%3C1053%3A%3AAID-ANIE1053%3E3.0.CO%3B2-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1521-3773%252820020315%252941%253A6%253C1053%253A%253AAID-ANIE1053%253E3.0.CO%253B2-4%26sid%3Dliteratum%253Aachs%26aulast%3DLewis%26aufirst%3DW.%2BG.%26aulast%3DGreen%26aufirst%3DL.%2BG.%26aulast%3DGrynszpan%26aufirst%3DF.%26aulast%3DRadi%25C4%2587%26aufirst%3DZ.%26aulast%3DCarlier%26aufirst%3DP.%2BR.%26aulast%3DTaylor%26aufirst%3DP.%26aulast%3DFinn%26aufirst%3DM.%2BG.%26aulast%3DSharpless%26aufirst%3DK.%2BB.%26atitle%3DClick%2520chemistry%2520in%2520situ%253A%2520acetylcholinesterase%2520as%2520a%2520reaction%2520vessel%2520for%2520the%2520selective%2520assembly%2520of%2520a%2520femtomolar%2520inhibitor%2520from%2520an%2520array%2520of%2520building%2520blocks%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2002%26volume%3D41%26spage%3D1053%26epage%3D1057%26doi%3D10.1002%2F1521-3773%2820020315%2941%3A6%3C1053%3A%3AAID-ANIE1053%3E3.0.CO%3B2-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ota, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasuya, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mutsuga, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsumoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakagawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finn, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyata, N.</span></span> <span> </span><span class="NLM_article-title">An unexpected example of protein-templated click chemistry</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">6817</span>– <span class="NLM_lpage">6820</span>, <span class="refDoi"> DOI: 10.1002/anie.201002205</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1002%2Fanie.201002205" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFGnsbnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=6817-6820&author=T.+Suzukiauthor=Y.+Otaauthor=Y.+Kasuyaauthor=M.+Mutsugaauthor=Y.+Kawamuraauthor=H.+Tsumotoauthor=H.+Nakagawaauthor=M.+G.+Finnauthor=N.+Miyata&title=An+unexpected+example+of+protein-templated+click+chemistry&doi=10.1002%2Fanie.201002205"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">An Unexpected Example of Protein-Templated Click Chemistry</span></div><div class="casAuthors">Suzuki, Takayoshi; Ota, Yosuke; Kasuya, Yuki; Mutsuga, Motoh; Kawamura, Yoko; Tsumoto, Hiroki; Nakagawa, Hidehiko; Finn, M. G.; Miyata, Naoki</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">6817-6820, S6817/1-S6817/10</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The authors have established that a Cu(I) complex of HDAC8 (human recombinant histone deacetylase) accelerates a selective azide-alkyne cycloaddn. (AAC) between an azide and an alkyne, thereby forming a triazole deriv. with greater inhibitory power towards the enzyme than either of the reactants alone.  In this case, the unwavering regioselectivity of the CuAAC process overrides the tendency of the Cu-free in situ click reaction to form the more potent (syn-isomer, 1,5-triazolyl) of the two triazole isomers.  Thus, regiospecific formation of triazole adducts from alkyne I and azide II in presence of HDAC8 gave rise to a significant peak in HPLC corresponding to anti-isomer (1,4-triazolyl) adduct III along with a smaller peak being the syn-isomer (1,5-triazolyl) adduct IV.  To examine whether Cu(I) is required for the cycloaddn., AAC was conducted using I and II in presence of HDAC8 and bathocuproine disulfonic acid [BCDSA; a Cu(I)-specific chelator and inhibitor of the CuAAC reaction].  The results showed that BCDSA inhibited the triazole formation.  In addn., Zn(OAc)2 was added to the mixt. of reactants I and II along with HDAC8 to displace Cu from the protein.  This treatment completely suppressed the formation of anti-isomer III, whereas in soln., Zn(II) had no effect on the CuAAC reaction.  In summary, the authors regard this study as an important precedent in the search for highly active protein catalysts of the CuAAC reaction, as well as an interesting and potentially useful example of in situ inhibitor formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF5wSD48iQp7Vg90H21EOLACvtfcHk0lgoACzF9ZJQvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFGnsbnK&md5=f6e6a2b9aa0a51df9a9828c8a4c1f92c</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1002%2Fanie.201002205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201002205%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DOta%26aufirst%3DY.%26aulast%3DKasuya%26aufirst%3DY.%26aulast%3DMutsuga%26aufirst%3DM.%26aulast%3DKawamura%26aufirst%3DY.%26aulast%3DTsumoto%26aufirst%3DH.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DFinn%26aufirst%3DM.%2BG.%26aulast%3DMiyata%26aufirst%3DN.%26atitle%3DAn%2520unexpected%2520example%2520of%2520protein-templated%2520click%2520chemistry%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2010%26volume%3D49%26spage%3D6817%26epage%3D6820%26doi%3D10.1002%2Fanie.201002205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hirose, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maita, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gouda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koseki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugawara, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakano, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirono, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiomi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taniguchi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharpless, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sunazuka, T.</span></span> <span> </span><span class="NLM_article-title">Observation of the controlled assembly of preclick components in the in situ click chemistry generation of a chitinase inhibitor</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">15892</span>– <span class="NLM_lpage">15897</span>, <span class="refDoi"> DOI: 10.1073/pnas.1315049110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1073%2Fpnas.1315049110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=24043811" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1SqtbrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=15892-15897&author=T.+Hiroseauthor=N.+Maitaauthor=H.+Goudaauthor=J.+Kosekiauthor=T.+Yamamotoauthor=A.+Sugawaraauthor=H.+Nakanoauthor=S.+Hironoauthor=K.+Shiomiauthor=T.+Watanabeauthor=H.+Taniguchiauthor=K.+B.+Sharplessauthor=S.+Omuraauthor=T.+Sunazuka&title=Observation+of+the+controlled+assembly+of+preclick+components+in+the+in+situ+click+chemistry+generation+of+a+chitinase+inhibitor&doi=10.1073%2Fpnas.1315049110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Observation of the controlled assembly of preclick components in the in situ click chemistry generation of a chitinase inhibitor</span></div><div class="casAuthors">Hirose, Tomoyasu; Maita, Nobuo; Gouda, Hiroaki; Koseki, Jun; Yamamoto, Tsuyoshi; Sugawara, Akihiro; Nakano, Hirofumi; Hirono, Shuichi; Shiomi, Kazuro; Watanabe, Takeshi; Taniguchi, Hisaaki; Sharpless, K. Barry; Omura, Satoshi; Sunazuka, Toshiaki</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">15892-15897,S15892/1-S15892/5</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The Huisgen cycloaddn. of azides and alkynes, accelerated by target biomols., termed "in situ click chem.," has been successfully exploited to discover highly potent enzyme inhibitors.  We have previously reported a specific Serratia marcescens chitinase B (SmChiB)-templated syn-triazole inhibitor generated in situ from an azide-bearing inhibitor and an alkyne fragment.  Several in situ click chem. studies have been reported.  Although some mechanistic evidence has been obtained, such as X-ray anal. of [protein]-["click ligand"] complexes, indicating that proteins act as both mold and template between unique pairs of azide and alkyne fragments, to date, observations have been based solely on "postclick" structural information.  Here, we describe crystal structures of SmChiB complexed with an azide ligand and an O-allyl oxime fragment as a mimic of a click partner, revealing a mechanism for accelerating syn-triazole formation, which allows generation of its own distinct inhibitor.  We have also performed d. functional theory calcns. based on the X-ray structure to explore the acceleration of the Huisgen cycloaddn. by SmChiB.  The d. functional theory calcns. reasonably support that SmChiB plays a role by the cage effect during the pre-translation and post-translation states of selective syn-triazole click formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvlga4V4v-ZbVg90H21EOLACvtfcHk0lgoACzF9ZJQvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1SqtbrL&md5=b605dc38fae207c49cd915ac28f2d2f1</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1315049110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1315049110%26sid%3Dliteratum%253Aachs%26aulast%3DHirose%26aufirst%3DT.%26aulast%3DMaita%26aufirst%3DN.%26aulast%3DGouda%26aufirst%3DH.%26aulast%3DKoseki%26aufirst%3DJ.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DSugawara%26aufirst%3DA.%26aulast%3DNakano%26aufirst%3DH.%26aulast%3DHirono%26aufirst%3DS.%26aulast%3DShiomi%26aufirst%3DK.%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DTaniguchi%26aufirst%3DH.%26aulast%3DSharpless%26aufirst%3DK.%2BB.%26aulast%3DOmura%26aufirst%3DS.%26aulast%3DSunazuka%26aufirst%3DT.%26atitle%3DObservation%2520of%2520the%2520controlled%2520assembly%2520of%2520preclick%2520components%2520in%2520the%2520in%2520situ%2520click%2520chemistry%2520generation%2520of%2520a%2520chitinase%2520inhibitor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D15892%26epage%3D15897%26doi%3D10.1073%2Fpnas.1315049110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mondal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unver, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berrier, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirsch, A. K. H.</span></span> <span> </span><span class="NLM_article-title">Fragment-based drug design facilitated by protein-templated click chemistry: fragment linking and optimization of inhibitors of the aspartic protease endothiapepsin</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">14826</span>– <span class="NLM_lpage">14830</span>, <span class="refDoi"> DOI: 10.1002/chem.201603001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1002%2Fchem.201603001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=27604032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVymt7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2016&pages=14826-14830&author=M.+Mondalauthor=M.+Y.+Unverauthor=A.+Palauthor=M.+Bakkerauthor=S.+P.+Berrierauthor=A.+K.+H.+Hirsch&title=Fragment-based+drug+design+facilitated+by+protein-templated+click+chemistry%3A+fragment+linking+and+optimization+of+inhibitors+of+the+aspartic+protease+endothiapepsin&doi=10.1002%2Fchem.201603001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Drug Design Facilitated by Protein-Templated Click Chemistry: Fragment Linking and -Optimization of Inhibitors of the Aspartic Protease Endothiapepsin</span></div><div class="casAuthors">Mondal, Milon; Unver, M. Yagiz; Pal, Asish; Bakker, Matthijs; Berrier, Stephan P.; Hirsch, Anna K. H.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">14826-14830</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">There is an urgent need for the development of efficient methodologies that accelerate drug discovery.  The authors demonstrate that the strategic combination of fragment linking/optimization and protein-templated click chem. is an efficient and powerful method that accelerates the hit-identification process for the aspartic protease endothiapepsin.  The best binder, which inhibits endothiapepsin with an IC50 value of 43 μM, represents the first example of triazole-based inhibitors of endothiapepsin.  The authors' strategy could find application on a whole range of drug targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUHCQeKvPBdbVg90H21EOLACvtfcHk0liOraZLB1zIWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVymt7fN&md5=adbc2c39fd6f750d420e89e6e01d5ebb</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1002%2Fchem.201603001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201603001%26sid%3Dliteratum%253Aachs%26aulast%3DMondal%26aufirst%3DM.%26aulast%3DUnver%26aufirst%3DM.%2BY.%26aulast%3DPal%26aufirst%3DA.%26aulast%3DBakker%26aufirst%3DM.%26aulast%3DBerrier%26aufirst%3DS.%2BP.%26aulast%3DHirsch%26aufirst%3DA.%2BK.%2BH.%26atitle%3DFragment-based%2520drug%2520design%2520facilitated%2520by%2520protein-templated%2520click%2520chemistry%253A%2520fragment%2520linking%2520and%2520optimization%2520of%2520inhibitors%2520of%2520the%2520aspartic%2520protease%2520endothiapepsin%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2016%26volume%3D22%26spage%3D14826%26epage%3D14830%26doi%3D10.1002%2Fchem.201603001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manetsch, R.</span></span> <span> </span><span class="NLM_article-title">Bcl-X<sub>L</sub>-templated assembly of its own protein-protein interaction modulator from fragments decorated with thio acids and sulfonyl azides</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>130</i></span>,  <span class="NLM_fpage">13820</span>– <span class="NLM_lpage">13821</span>, <span class="refDoi"> DOI: 10.1021/ja802683u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja802683u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFGntrjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2008&pages=13820-13821&author=X.+Huauthor=J.+Sunauthor=H.+G.+Wangauthor=R.+Manetsch&title=Bcl-XL-templated+assembly+of+its+own+protein-protein+interaction+modulator+from+fragments+decorated+with+thio+acids+and+sulfonyl+azides&doi=10.1021%2Fja802683u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Bcl-XL-Templated Assembly of Its Own Protein-Protein Interaction Modulator from Fragments Decorated with Thio Acids and Sulfonyl Azides</span></div><div class="casAuthors">Hu, Xiangdong; Sun, Jiazhi; Wang, Hong-Gang; Manetsch, Roman</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">13820-13821</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Protein-protein interactions have key importance in various biol. processes and modulation of particular protein-protein interactions has been shown to have therapeutic effects.  However, disrupting or modulating protein-protein interactions with low-mol.-wt. compds. is extremely difficult due to the lack of deep binding pockets on protein surfaces.  Herein the authors describe the development of an unprecedented lead synthesis and discovery method that generates only biol. active compds. from a library of reactive fragments.  Using the protein Bcl-XL, a central regulator of programmed cell death, the authors demonstrated that an amidation reaction between thio acids and sulfonyl azides is applicable for Bcl-XL-templated assembly of inhibitory compds.  The authors have demonstrated for the first time that kinetic target-guided synthesis can be applied not only on enzymic targets but also for the discovery of small mols. modulating protein-protein interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrALNx42CCC0rVg90H21EOLACvtfcHk0liOraZLB1zIWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFGntrjI&md5=df38484d872f0ab7203c1e69ec8ea1d9</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1021%2Fja802683u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja802683u%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DH.%2BG.%26aulast%3DManetsch%26aufirst%3DR.%26atitle%3DBcl-XL-templated%2520assembly%2520of%2520its%2520own%2520protein-protein%2520interaction%2520modulator%2520from%2520fragments%2520decorated%2520with%2520thio%2520acids%2520and%2520sulfonyl%2520azides%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2008%26volume%3D130%26spage%3D13820%26epage%3D13821%26doi%3D10.1021%2Fja802683u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kulkarni, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manetsch, R.</span></span> <span> </span><span class="NLM_article-title">Screening of protein-protein interaction modulators via sulfo-click kinetic target-guided synthesis</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">724</span>– <span class="NLM_lpage">723</span>, <span class="refDoi"> DOI: 10.1021/cb200085q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb200085q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlsFyqt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=724-723&author=S.+S.+Kulkarniauthor=X.+Huauthor=K.+Doiauthor=H.+G.+Wangauthor=R.+Manetsch&title=Screening+of+protein-protein+interaction+modulators+via+sulfo-click+kinetic+target-guided+synthesis&doi=10.1021%2Fcb200085q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Screening of Protein-Protein Interaction Modulators via Sulfo-Click Kinetic Target-Guided Synthesis</span></div><div class="casAuthors">Kulkarni, Sameer S.; Hu, Xiangdong; Doi, Kenichiro; Wang, Hong-Gang; Manetsch, Roman</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">724-732</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Kinetic target-guided synthesis (TGS) and in situ click chem. are among unconventional discovery strategies having the potential to streamline the development of protein-protein interaction modulators (PPIMs).  In kinetic TGS and in situ click chem., the target is directly involved in the assembly of its own potent, bidentate ligand from a pool of reactive fragments.  Herein, we report the use and validation of kinetic TGS based on the sulfo-click reaction between thio acids and sulfonyl azides as a screening and synthesis platform for the identification of high-quality PPIMs.  Starting from a randomly designed library consisting of 9 thio acids and 9 sulfonyl azides leading to 81 potential acylsulfonamides, the target protein, Bcl-XL, selectively assembled four PPIMs, acylsulfonamides SZ4TA2, SZ7TA2, SZ9TA1, and SZ9TA5, which have been shown to modulate Bcl-XL/BH3 interactions.  To further investigate the Bcl-XL templation effect, control expts. were carried out using two mutants of Bcl-XL.  In one mutant, phenylalanine Phe131 and aspartic acid Asp133, which are crit. for the BH3 domain binding, were substituted by alanines, while arginine Arg139, a residue identified to play a crucial role in the binding of ABT-737, a BH3 mimetic, was replaced by an alanine in the other mutant.  Incubation of these mutants with the reactive fragments and subsequent LC/MS-SIM anal. confirmed that these building block combinations yield the corresponding acylsulfonamides at the BH3 binding site, the actual "hot spot" of Bcl-XL.  These results validate kinetic TGS using the sulfo-click reaction as a valuable tool for the straightforward identification of high-quality PPIMs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonWmMNREV6MrVg90H21EOLACvtfcHk0liOraZLB1zIWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlsFyqt7Y%253D&md5=c57b60a88631ce37bd5dbeaa3b2e2f35</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fcb200085q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb200085q%26sid%3Dliteratum%253Aachs%26aulast%3DKulkarni%26aufirst%3DS.%2BS.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DDoi%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DH.%2BG.%26aulast%3DManetsch%26aufirst%3DR.%26atitle%3DScreening%2520of%2520protein-protein%2520interaction%2520modulators%2520via%2520sulfo-click%2520kinetic%2520target-guided%2520synthesis%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2011%26volume%3D6%26spage%3D724%26epage%3D723%26doi%3D10.1021%2Fcb200085q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span> <span> </span><span class="NLM_article-title">Evolutions in fragment-based drug design: the deconstruction-reconstruction approach</span>. <i>Drug Discov. Today</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">105</span>– <span class="NLM_lpage">113</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2014.09.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1016%2Fj.drudis.2014.09.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=25263697" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1KgtL%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2015&pages=105-113&author=H.+Chenauthor=X.+Zhouauthor=A.+Wangauthor=Y.+Zhengauthor=Y.+Gaoauthor=J.+Zhou&title=Evolutions+in+fragment-based+drug+design%3A+the+deconstruction-reconstruction+approach&doi=10.1016%2Fj.drudis.2014.09.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Evolutions in fragment-based drug design: the deconstruction-reconstruction approach</span></div><div class="casAuthors">Chen, Haijun; Zhou, Xiaobin; Wang, Ailan; Zheng, Yunquan; Gao, Yu; Zhou, Jia</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">105-113</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Recent advances in the understanding of mol. recognition and protein-ligand interactions have facilitated rapid development of potent and selective ligands for therapeutically relevant targets.  Over the past two decades, a variety of useful approaches and emerging techniques have been developed to promote the identification and optimization of leads that have high potential for generating new therapeutic agents.  Intriguingly, the innovation of a fragment-based drug design (FBDD) approach has enabled rapid and efficient progress in drug discovery.  In this crit. review, we focus on the construction of fragment libraries and the advantages and disadvantages of various fragment-based screening (FBS) for constructing such libraries.  We also highlight the deconstruction-reconstruction strategy by utilizing privileged fragments of reported ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVWzbA5c5707Vg90H21EOLACvtfcHk0lhmDCfE5X149A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1KgtL%252FO&md5=13ce52517b336a860136ac3eb4151b16</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2014.09.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2014.09.015%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DJ.%26atitle%3DEvolutions%2520in%2520fragment-based%2520drug%2520design%253A%2520the%2520deconstruction-reconstruction%2520approach%26jtitle%3DDrug%2520Discov.%2520Today%26date%3D2015%26volume%3D20%26spage%3D105%26epage%3D113%26doi%3D10.1016%2Fj.drudis.2014.09.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mousnier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swieboda, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morales-Sanfrutos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-Dorado, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brannigan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritzefeld, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutton, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guedán, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asfor, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins-Navratilova, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnston, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leatherbarrow, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuthill, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solari, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, E. W.</span></span> <span> </span><span class="NLM_article-title">Fragment-derived inhibitors of human N-myristoyltransferase block capsid assembly and replication of the common cold virus</span>. <i>Nat. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">599</span>– <span class="NLM_lpage">606</span>, <span class="refDoi"> DOI: 10.1038/s41557-018-0039-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1038%2Fs41557-018-0039-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=29760414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC1cXps1KktLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&pages=599-606&author=A.+Mousnierauthor=A.+S.+Bellauthor=D.+P.+Swiebodaauthor=J.+Morales-Sanfrutosauthor=I.+P%C3%A9rez-Doradoauthor=J.+A.+Branniganauthor=J.+Newmanauthor=M.+Ritzefeldauthor=J.+A.+Huttonauthor=A.+Gued%C3%A1nauthor=A.+S.+Asforauthor=S.+W.+Robinsonauthor=I.+Hopkins-Navratilovaauthor=A.+J.+Wilkinsonauthor=S.+L.+Johnstonauthor=R.+J.+Leatherbarrowauthor=T.+J.+Tuthillauthor=R.+Solariauthor=E.+W.+Tate&title=Fragment-derived+inhibitors+of+human+N-myristoyltransferase+block+capsid+assembly+and+replication+of+the+common+cold+virus&doi=10.1038%2Fs41557-018-0039-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-derived inhibitors of human N-myristoyltransferase block capsid assembly and replication of the common cold virus</span></div><div class="casAuthors">Mousnier, Aurelie; Bell, Andrew S.; Swieboda, Dawid P.; Morales-Sanfrutos, Julia; Perez-Dorado, Inmaculada; Brannigan, James A.; Newman, Joseph; Ritzefeld, Markus; Hutton, Jennie A.; Guedan, Anabel; Asfor, Amin S.; Robinson, Sean W.; Hopkins-Navratilova, Iva; Wilkinson, Anthony J.; Johnston, Sebastian L.; Leatherbarrow, Robin J.; Tuthill, Tobias J.; Solari, Roberto; Tate, Edward W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">599-606</span>CODEN:
                <span class="NLM_cas:coden">NCAHBB</span>;
        ISSN:<span class="NLM_cas:issn">1755-4330</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Rhinoviruses (RVs) are the pathogens most often responsible for the common cold, and are a frequent cause of exacerbations in asthma, chronic obstructive pulmonary disease and cystic fibrosis.  Here we report the discovery of IMP-1088, a picomolar dual inhibitor of the human N-myristoyltransferases NMT1 and NMT2, and use it to demonstrate that pharmacol. inhibition of host-cell N-myristoylation rapidly and completely prevents rhinoviral replication without inducing cytotoxicity.  The identification of cooperative binding between weak-binding fragments led to rapid inhibitor optimization through fragment reconstruction, structure-guided fragment linking and conformational control over linker geometry.  We show that inhibition of the co-translational myristoylation of a specific virus-encoded protein (VP0) by IMP-1088 potently blocks a key step in viral capsid assembly, to deliver a low nanomolar antiviral activity against multiple RV strains, poliovirus and foot and-mouth disease virus, and protection of cells against virus-induced killing, highlighting the potential of host myristoylation as a drug target in picornaviral infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfyeVtScn0oLVg90H21EOLACvtfcHk0lhmDCfE5X149A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXps1KktLY%253D&md5=4142792d359c5344041c1f28b7cb813f</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1038%2Fs41557-018-0039-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41557-018-0039-2%26sid%3Dliteratum%253Aachs%26aulast%3DMousnier%26aufirst%3DA.%26aulast%3DBell%26aufirst%3DA.%2BS.%26aulast%3DSwieboda%26aufirst%3DD.%2BP.%26aulast%3DMorales-Sanfrutos%26aufirst%3DJ.%26aulast%3DP%25C3%25A9rez-Dorado%26aufirst%3DI.%26aulast%3DBrannigan%26aufirst%3DJ.%2BA.%26aulast%3DNewman%26aufirst%3DJ.%26aulast%3DRitzefeld%26aufirst%3DM.%26aulast%3DHutton%26aufirst%3DJ.%2BA.%26aulast%3DGued%25C3%25A1n%26aufirst%3DA.%26aulast%3DAsfor%26aufirst%3DA.%2BS.%26aulast%3DRobinson%26aufirst%3DS.%2BW.%26aulast%3DHopkins-Navratilova%26aufirst%3DI.%26aulast%3DWilkinson%26aufirst%3DA.%2BJ.%26aulast%3DJohnston%26aufirst%3DS.%2BL.%26aulast%3DLeatherbarrow%26aufirst%3DR.%2BJ.%26aulast%3DTuthill%26aufirst%3DT.%2BJ.%26aulast%3DSolari%26aufirst%3DR.%26aulast%3DTate%26aufirst%3DE.%2BW.%26atitle%3DFragment-derived%2520inhibitors%2520of%2520human%2520N-myristoyltransferase%2520block%2520capsid%2520assembly%2520and%2520replication%2520of%2520the%2520common%2520cold%2520virus%26jtitle%3DNat.%2520Chem.%26date%3D2018%26volume%3D10%26spage%3D599%26epage%3D606%26doi%3D10.1038%2Fs41557-018-0039-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padyana, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abeywardane, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Lombaert, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proudfoot, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farmer, B. S.,  3rd.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albaugh, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill-Drzewi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pullen, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, H.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent, selective chymase inhibitors via fragment linking strategies</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">4465</span>– <span class="NLM_lpage">4481</span>, <span class="refDoi"> DOI: 10.1021/jm400138z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400138z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnsVWjurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4465-4481&author=S.+J.+Taylorauthor=A.+K.+Padyanaauthor=A.+Abeywardaneauthor=S.+Liangauthor=M.+H.+Haoauthor=S.+De+Lombaertauthor=J.+Proudfootauthor=B.+S.+Farmerauthor=X.+Liauthor=B.+Collinsauthor=L.+Martinauthor=D.+R.+Albaughauthor=M.+Hill-Drzewiauthor=S.+S.+Pullenauthor=H.+Takahashi&title=Discovery+of+potent%2C+selective+chymase+inhibitors+via+fragment+linking+strategies&doi=10.1021%2Fjm400138z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent, Selective Chymase Inhibitors via Fragment Linking Strategies</span></div><div class="casAuthors">Taylor, Steven J.; Padyana, Anil K.; Abeywardane, Asitha; Liang, Shuang; Hao, Ming-Hong; De Lombaert, Stephane; Proudfoot, John; Farmer, Bennett S.; Li, Xiang; Collins, Brandon; Martin, Leslie; Albaugh, Daniel R.; Hill-Drzewi, Melissa; Pullen, Steven S.; Takahashi, Hidenori</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4465-4481</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Chymase plays an important and diverse role in the homeostasis of a no. of cardiovascular processes.  Herein, the identification of potent, selective chymase inhibitors I [R = H, Cl, Br; X = CH2CH2, CH(n-Pr)CH2, CH2CH(n-Pr); Y = CH2, S], developed using fragment-based, structure-guided linking and optimization techniques, is described.  High-concn. biophys. screening methods followed by high-throughput crystallog. identified an oxindole fragment bound to the S1 pocket of the protein exhibiting a novel interaction pattern hitherto not obsd. in chymase inhibitors.  X-ray crystallog. structures were used to guide the elaboration/linking of the fragment, ultimately leading to a potent inhibitor I [R = Br; X = CH(n-Pr)CH2; Y = CH2] that was >100-fold selective over cathepsin G and that mitigated a no. of liabilities assocd. with poor physicochem. properties of the series it was derived from.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrf9osg33HdDbVg90H21EOLACvtfcHk0lhNfA1NhEw1Cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnsVWjurY%253D&md5=f0c17458a4c4ba0a5d316ecec937ca63</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1021%2Fjm400138z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400138z%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DS.%2BJ.%26aulast%3DPadyana%26aufirst%3DA.%2BK.%26aulast%3DAbeywardane%26aufirst%3DA.%26aulast%3DLiang%26aufirst%3DS.%26aulast%3DHao%26aufirst%3DM.%2BH.%26aulast%3DDe%2BLombaert%26aufirst%3DS.%26aulast%3DProudfoot%26aufirst%3DJ.%26aulast%3DFarmer%26aufirst%3DB.%2BS.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DCollins%26aufirst%3DB.%26aulast%3DMartin%26aufirst%3DL.%26aulast%3DAlbaugh%26aufirst%3DD.%2BR.%26aulast%3DHill-Drzewi%26aufirst%3DM.%26aulast%3DPullen%26aufirst%3DS.%2BS.%26aulast%3DTakahashi%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520potent%252C%2520selective%2520chymase%2520inhibitors%2520via%2520fragment%2520linking%2520strategies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4465%26epage%3D4481%26doi%3D10.1021%2Fjm400138z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davidson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Begley, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varani, G.</span></span> <span> </span><span class="NLM_article-title">A small molecule probe induces a conformation in HIV TAR RNA capable of binding drug-like fragments</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>410</i></span>,  <span class="NLM_fpage">984</span>– <span class="NLM_lpage">996</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2011.03.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1016%2Fj.jmb.2011.03.039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=21763501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovF2gtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=410&publication_year=2011&pages=984-996&author=A.+Davidsonauthor=D.+W.+Begleyauthor=C.+Lauauthor=G.+Varani&title=A+small+molecule+probe+induces+a+conformation+in+HIV+TAR+RNA+capable+of+binding+drug-like+fragments&doi=10.1016%2Fj.jmb.2011.03.039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">A Small-Molecule Probe Induces a Conformation in HIV TAR RNA Capable of Binding Drug-Like Fragments</span></div><div class="casAuthors">Davidson, Amy; Begley, Darren W.; Lau, Carmen; Varani, Gabriele</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">410</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">984-996</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The HIV-1 transactivation response (TAR) element-Tat interaction is a potentially valuable target for treating HIV infection, but efforts to develop TAR-binding antiviral drugs have not yet yielded a successful candidate for clin. development.  In this work, we describe a novel approach toward screening fragments against RNA that uses a chem. probe to target the Tat-binding region of TAR.  This probe fulfills two crit. roles in the screen: by locking the RNA into a conformation capable of binding other fragments, it simultaneously allows the identification of proximal binding fragments by ligand-based NMR.  Using this approach, we have discovered six novel TAR-binding fragments, three of which were docked relative to the probe-RNA structure using exptl. NMR restraints.  The consistent orientations of functional groups in our data-driven docked structures and common electrostatic properties across all fragment leads reveal a surprising level of selectivity by our fragment-sized screening hits.  These models further suggest linking strategies for the development of higher-affinity lead compds. for the inhibition of the TAR-Tat interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpntywlZpxR_LVg90H21EOLACvtfcHk0lhNfA1NhEw1Cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovF2gtLg%253D&md5=43b63e4aa6c988773c770d9c99dbdb82</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2011.03.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2011.03.039%26sid%3Dliteratum%253Aachs%26aulast%3DDavidson%26aufirst%3DA.%26aulast%3DBegley%26aufirst%3DD.%2BW.%26aulast%3DLau%26aufirst%3DC.%26aulast%3DVarani%26aufirst%3DG.%26atitle%3DA%2520small%2520molecule%2520probe%2520induces%2520a%2520conformation%2520in%2520HIV%2520TAR%2520RNA%2520capable%2520of%2520binding%2520drug-like%2520fragments%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2011%26volume%3D410%26spage%3D984%26epage%3D996%26doi%3D10.1016%2Fj.jmb.2011.03.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pang, Y. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quiram, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jelacic, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brimijoin, S.</span></span> <span> </span><span class="NLM_article-title">Highly potent, selective, and low cost bis-tetrahydroaminacrine inhibitors of acetylcholinesterase. Steps toward novel drugs for treating Alzheimer’s disease</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>271</i></span>,  <span class="NLM_fpage">23646</span>– <span class="NLM_lpage">23649</span>, <span class="refDoi"> DOI: 10.1074/jbc.271.39.23646</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1074%2Fjbc.271.39.23646" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=8798583" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADyaK28XlvFSltL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=23646-23649&author=Y.+P.+Pangauthor=P.+Quiramauthor=T.+Jelacicauthor=F.+Hongauthor=S.+Brimijoin&title=Highly+potent%2C+selective%2C+and+low+cost+bis-tetrahydroaminacrine+inhibitors+of+acetylcholinesterase.+Steps+toward+novel+drugs+for+treating+Alzheimer%E2%80%99s+disease&doi=10.1074%2Fjbc.271.39.23646"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Highly potent, selective, and low cost bis-tetrahydroaminacrine inhibitors of acetylcholinesterase. Steps toward novel drugs for treating Alzheimer's disease</span></div><div class="casAuthors">Pang, Yuan-Ping; Quiram, Polly; Jelacic, Tanya; Hong, Feng; Brimijoin, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">271</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">23646-23649</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">We report highly potent, selective, and low cost bifunctional acetylcholinesterase (AChE) inhibitors developed by our two-step prototype optimization strategy utilizing computer modeling of ligand docking with target proteins: (1) identify low affinity sites normally missed by x-ray crystallog.; and (2) design bifunctional analogs capable of simultaneous binding at the computer-detd. low affinity site and the x-ray-identified high affinity site.  Applying this strategy to 9-amino-1,2,3,4-tetrahydroacridine (THA), a drug for Alzheimer's disease, we obtained alkylene linked bis-THA analogs.  These analogs were up to 10,000-fold more selective and 1,000-fold more potent than THA in inhibiting rat AChE and yet required one simple reaction to synthesize.  Addnl., alkylene linked benzyl-THA analogs were developed to examine the specificity of the docking-derived low affinity THA peripheral site in AChE.  The present work and our previous computational studies strongly suggest that a low affinity THA peripheral site exists in AChE.  This peripheral site provides a structural basis for design of improved cholinesterase ligands for treating Alzheimer's disease and for other health-related purposes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMjTElkdbiv7Vg90H21EOLACvtfcHk0lhNfA1NhEw1Cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XlvFSltL0%253D&md5=d8ff73789f75d61060df44c3d5edc769</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1074%2Fjbc.271.39.23646&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.271.39.23646%26sid%3Dliteratum%253Aachs%26aulast%3DPang%26aufirst%3DY.%2BP.%26aulast%3DQuiram%26aufirst%3DP.%26aulast%3DJelacic%26aufirst%3DT.%26aulast%3DHong%26aufirst%3DF.%26aulast%3DBrimijoin%26aufirst%3DS.%26atitle%3DHighly%2520potent%252C%2520selective%252C%2520and%2520low%2520cost%2520bis-tetrahydroaminacrine%2520inhibitors%2520of%2520acetylcholinesterase.%2520Steps%2520toward%2520novel%2520drugs%2520for%2520treating%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26spage%3D23646%26epage%3D23649%26doi%3D10.1074%2Fjbc.271.39.23646" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Surade, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ty, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hengrung, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lechartier, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blundell, T. L.</span></span> <span> </span><span class="NLM_article-title">A structure-guided fragment-based approach for the discovery of allosteric inhibitors targeting the lipophilic binding site of transcription factor EthR</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>458</i></span>,  <span class="NLM_fpage">387</span>– <span class="NLM_lpage">394</span>, <span class="refDoi"> DOI: 10.1042/BJ20131127</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1042%2FBJ20131127" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=24313835" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisFSisL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=458&publication_year=2014&pages=387-394&author=S.+Suradeauthor=N.+Tyauthor=N.+Hengrungauthor=B.+Lechartierauthor=S.+T.+Coleauthor=C.+Abellauthor=T.+L.+Blundell&title=A+structure-guided+fragment-based+approach+for+the+discovery+of+allosteric+inhibitors+targeting+the+lipophilic+binding+site+of+transcription+factor+EthR&doi=10.1042%2FBJ20131127"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">A structure-guided fragment-based approach for the discovery of allosteric inhibitors targeting the lipophilic binding site of transcription factor EthR</span></div><div class="casAuthors">Surade, Sachin; Ty, Nancy; Hengrung, Narin; Lechartier, Benoit; Cole, Stewart T.; Abell, Chris; Blundell, Tom L.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">458</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">387-394</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A structure-guided fragment-based approach was used to target the lipophilic allosteric binding site of Mycobacterium tuberculosis EthR.  This elongated channel has many hydrophobic residues lining the binding site, with few opportunities for hydrogen bonding.  We demonstrate that a fragment-based approach involving the inclusion of flexible fragments in the library leads to an efficient exploration of chem. space, that fragment binding can lead to an extension of the cavity, and that fragments are able to identify hydrogen-bonding opportunities in this hydrophobic environment that are not exploited in Nature.  In the present paper, we report the identification of a 1 μM affinity ligand obtained by structure-guided fragment linking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDrPgQPCfy17Vg90H21EOLACvtfcHk0lhE8ZJpaNumLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisFSisL0%253D&md5=4ad9610654764f032f8928209b381d81</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1042%2FBJ20131127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20131127%26sid%3Dliteratum%253Aachs%26aulast%3DSurade%26aufirst%3DS.%26aulast%3DTy%26aufirst%3DN.%26aulast%3DHengrung%26aufirst%3DN.%26aulast%3DLechartier%26aufirst%3DB.%26aulast%3DCole%26aufirst%3DS.%2BT.%26aulast%3DAbell%26aufirst%3DC.%26aulast%3DBlundell%26aufirst%3DT.%2BL.%26atitle%3DA%2520structure-guided%2520fragment-based%2520approach%2520for%2520the%2520discovery%2520of%2520allosteric%2520inhibitors%2520targeting%2520the%2520lipophilic%2520binding%2520site%2520of%2520transcription%2520factor%2520EthR%26jtitle%3DBiochem.%2520J.%26date%3D2014%26volume%3D458%26spage%3D387%26epage%3D394%26doi%3D10.1042%2FBJ20131127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trapero, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pacitto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabbah, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coyne, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizrahi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blundell, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ascher, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abell, C.</span></span> <span> </span><span class="NLM_article-title">A fragment-based approach to targeting inosine-5′-monophosphate dehydrogenase (IMPDH) from Mycobacterium tuberculosis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">2806</span>– <span class="NLM_lpage">2822</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01622</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01622" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC1cXltVGksb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=2806-2822&author=A.+Traperoauthor=A.+Pacittoauthor=V.+Singhauthor=M.+Sabbahauthor=A.+G.+Coyneauthor=V.+Mizrahiauthor=T.+L.+Blundellauthor=D.+B.+Ascherauthor=C.+Abell&title=A+fragment-based+approach+to+targeting+inosine-5%E2%80%B2-monophosphate+dehydrogenase+%28IMPDH%29+from+Mycobacterium+tuberculosis&doi=10.1021%2Facs.jmedchem.7b01622"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Approach to Targeting Inosine-5'-monophosphate Dehydrogenase (IMPDH) from Mycobacterium tuberculosis</span></div><div class="casAuthors">Trapero, Ana; Pacitto, Angela; Singh, Vinayak; Sabbah, Mohamad; Coyne, Anthony G.; Mizrahi, Valerie; Blundell, Tom L.; Ascher, David B.; Abell, Chris</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2806-2822</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tuberculosis (TB) remains a major cause of mortality worldwide, and improved treatments are needed to combat emergence of drug resistance.  IMP dehydrogenase (IMPDH), a crucial enzyme required for de novo synthesis of guanine nucleotides, is an attractive TB drug target.  Herein, we describe the identification of potent IMPDH inhibitors using fragment-based screening and structure-based design techniques.  Screening of a fragment library for Mycobacterium thermoresistible (Mth) IMPDH ΔCBS inhibitors identified a low affinity phenylimidazole deriv.  X-ray crystallog. of the Mth IMPDH ΔCBS-IMP-inhibitor complex revealed that two mols. of the fragment were bound in the NAD binding pocket of IMPDH.  Linking the two mols. of the fragment afforded compds. with more than 1000-fold improvement in IMPDH affinity over the initial fragment hit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIloJxzRRl5bVg90H21EOLACvtfcHk0lhE8ZJpaNumLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXltVGksb0%253D&md5=a0decf859d321144e41547dda2b38fbf</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01622&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01622%26sid%3Dliteratum%253Aachs%26aulast%3DTrapero%26aufirst%3DA.%26aulast%3DPacitto%26aufirst%3DA.%26aulast%3DSingh%26aufirst%3DV.%26aulast%3DSabbah%26aufirst%3DM.%26aulast%3DCoyne%26aufirst%3DA.%2BG.%26aulast%3DMizrahi%26aufirst%3DV.%26aulast%3DBlundell%26aufirst%3DT.%2BL.%26aulast%3DAscher%26aufirst%3DD.%2BB.%26aulast%3DAbell%26aufirst%3DC.%26atitle%3DA%2520fragment-based%2520approach%2520to%2520targeting%2520inosine-5%25E2%2580%25B2-monophosphate%2520dehydrogenase%2520%2528IMPDH%2529%2520from%2520Mycobacterium%2520tuberculosis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D2806%26epage%3D2822%26doi%3D10.1021%2Facs.jmedchem.7b01622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burgess, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newhouse, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibrahim, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kashem, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandhuber, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomson, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vigers, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, K.</span></span> <span> </span><span class="NLM_article-title">Potent selective nonpeptidic inhibitors of human lung tryptase</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">8348</span>– <span class="NLM_lpage">8352</span>, <span class="refDoi"> DOI: 10.1073/pnas.96.15.8348</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1073%2Fpnas.96.15.8348" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10411878" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADyaK1MXkslOksrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=8348-8352&author=L.+E.+Burgessauthor=B.+J.+Newhouseauthor=P.+Ibrahimauthor=J.+Rizziauthor=M.+A.+Kashemauthor=A.+Hartmanauthor=B.+J.+Brandhuberauthor=C.+D.+Wrightauthor=D.+S.+Thomsonauthor=G.+P.+Vigersauthor=K.+Koch&title=Potent+selective+nonpeptidic+inhibitors+of+human+lung+tryptase&doi=10.1073%2Fpnas.96.15.8348"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Potent selective nonpeptidic inhibitors of human lung tryptase</span></div><div class="casAuthors">Burgess, Laurence E.; Newhouse, Bradley J.; Ibrahim, Prabha; Rizzi, James; Kashem, Mohammed A.; Hartman, Ann; Brandhuber, Barbara J.; Wright, Clifford D.; Thomson, David S.; Vigers, Guy P. A.; Koch, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">8348-8352</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Human lung tryptase, a homotetrameric serine protease unique to mast cell secretory granules, has been implicated in the pathogenesis of asthma.  A hypothesis that tethered sym. inhibitors might bridge two adjacent active sites was explored via a rationally designed series of bisbenzamidines.  These compds. demonstrated a remarkable distanced-defined structure-activity relation against human tryptase with one series possessing subnanomolar potencies.  Addnl. evidence supporting the concept of active-site bridging is also presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvTdnETNgr1LVg90H21EOLACvtfcHk0lhE8ZJpaNumLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXkslOksrc%253D&md5=e3d86ffa51565acc1b2b3f4671c5923d</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1073%2Fpnas.96.15.8348&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.96.15.8348%26sid%3Dliteratum%253Aachs%26aulast%3DBurgess%26aufirst%3DL.%2BE.%26aulast%3DNewhouse%26aufirst%3DB.%2BJ.%26aulast%3DIbrahim%26aufirst%3DP.%26aulast%3DRizzi%26aufirst%3DJ.%26aulast%3DKashem%26aufirst%3DM.%2BA.%26aulast%3DHartman%26aufirst%3DA.%26aulast%3DBrandhuber%26aufirst%3DB.%2BJ.%26aulast%3DWright%26aufirst%3DC.%2BD.%26aulast%3DThomson%26aufirst%3DD.%2BS.%26aulast%3DVigers%26aufirst%3DG.%2BP.%26aulast%3DKoch%26aufirst%3DK.%26atitle%3DPotent%2520selective%2520nonpeptidic%2520inhibitors%2520of%2520human%2520lung%2520tryptase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1999%26volume%3D96%26spage%3D8348%26epage%3D8352%26doi%3D10.1073%2Fpnas.96.15.8348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matsui, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasumatsu, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asahi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitamura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ubukata, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayasaka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takaishi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanzawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katakura, S.</span></span> <span> </span><span class="NLM_article-title">Discovery and structure-guided fragment-linking of 4-(2,3-dichlorobenzoyl)-1-methyl-pyrrole-2-carboxamide as a pyruvate kinase M2 activator</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">3540</span>– <span class="NLM_lpage">3546</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2017.05.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1016%2Fj.bmc.2017.05.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=28511909" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC2sXnsl2ntL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=3540-3546&author=Y.+Matsuiauthor=I.+Yasumatsuauthor=T.+Asahiauthor=T.+Kitamuraauthor=K.+Kanaiauthor=O.+Ubukataauthor=H.+Hayasakaauthor=S.+Takaishiauthor=H.+Hanzawaauthor=S.+Katakura&title=Discovery+and+structure-guided+fragment-linking+of+4-%282%2C3-dichlorobenzoyl%29-1-methyl-pyrrole-2-carboxamide+as+a+pyruvate+kinase+M2+activator&doi=10.1016%2Fj.bmc.2017.05.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and structure-guided fragment-linking of 4-(2,3-dichlorobenzoyl)-1-methyl-pyrrole-2-carboxamide as a pyruvate kinase M2 activator</span></div><div class="casAuthors">Matsui, Yumi; Yasumatsu, Isao; Asahi, Takashi; Kitamura, Takahiro; Kanai, Kazuo; Ubukata, Osamu; Hayasaka, Hitoshi; Takaishi, Sachiko; Hanzawa, Hiroyuki; Katakura, Shinichi</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3540-3546</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Tumor cells switch glucose metab. to aerobic glycolysis by expressing the pyruvate kinase M2 isoform (PKM2) in a low active form, providing glycolytic intermediates as building blocks for biosynthetic processes, and thereby supporting cell proliferation.  Activation of PKM2 should invert aerobic glycolysis to an oxidative metab. and prevent cancer growth.  Thus, PKM2 has gained attention as a promising cancer therapy target.  To obtain novel PKM2 activators, we conducted a high-throughput screening (HTS).  Among several hit compds., a fragment-like hit compd. with low potency but high ligand efficiency was identified.  Two mols. of the hit compd. bound at one activator binding site, and the mols. were linked based on the crystal structure.  Since this linkage succeeded in maintaining the original position of the hit compd., the obtained compd. exhibited highly improved potency in an in vitro assay.  The linked compd. also showed PKM2 activating activity in a cell based assay, and cellular growth inhibition of the A549 cancer cell line.  Discovery of this novel scaffold and binding mode of the linked compd. provides a valuable platform for the structure-guided design of PKM2 activators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo61HcdZycO27Vg90H21EOLACvtfcHk0lj7OC-YIIKG7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXnsl2ntL4%253D&md5=ffcb6ad85417be83c0d1e0967da78b70</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.05.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.05.004%26sid%3Dliteratum%253Aachs%26aulast%3DMatsui%26aufirst%3DY.%26aulast%3DYasumatsu%26aufirst%3DI.%26aulast%3DAsahi%26aufirst%3DT.%26aulast%3DKitamura%26aufirst%3DT.%26aulast%3DKanai%26aufirst%3DK.%26aulast%3DUbukata%26aufirst%3DO.%26aulast%3DHayasaka%26aufirst%3DH.%26aulast%3DTakaishi%26aufirst%3DS.%26aulast%3DHanzawa%26aufirst%3DH.%26aulast%3DKatakura%26aufirst%3DS.%26atitle%3DDiscovery%2520and%2520structure-guided%2520fragment-linking%2520of%25204-%25282%252C3-dichlorobenzoyl%2529-1-methyl-pyrrole-2-carboxamide%2520as%2520a%2520pyruvate%2520kinase%2520M2%2520activator%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26spage%3D3540%26epage%3D3546%26doi%3D10.1016%2Fj.bmc.2017.05.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Drapier, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geubelle, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouckaert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laulumaa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goffin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dilly, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francotte, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pochet, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kastrup, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pirotte, B.</span></span> <span> </span><span class="NLM_article-title">Enhancing action of positive allosteric modulators through the design of dimeric compounds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">5279</span>– <span class="NLM_lpage">5291</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00250</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00250" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC1cXps12lsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=5279-5291&author=T.+Drapierauthor=P.+Geubelleauthor=C.+Bouckaertauthor=L.+Nielsenauthor=S.+Laulumaaauthor=E.+Goffinauthor=S.+Dillyauthor=P.+Francotteauthor=J.+Hansonauthor=L.+Pochetauthor=J.+Kastrupauthor=B.+Pirotte&title=Enhancing+action+of+positive+allosteric+modulators+through+the+design+of+dimeric+compounds&doi=10.1021%2Facs.jmedchem.8b00250"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Enhancing Action of Positive Allosteric Modulators through the Design of Dimeric Compounds</span></div><div class="casAuthors">Drapier, Thomas; Geubelle, Pierre; Bouckaert, Charlotte; Nielsen, Lise; Laulumaa, Saara; Goffin, Eric; Dilly, Sebastien; Francotte, Pierre; Hanson, Julien; Pochet, Lionel; Kastrup, Jette Sandholm; Pirotte, Bernard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5279-5291</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The present study describes the identification of highly potent dimeric 1,2,4-benzothiadiazine 1,1-dioxide (BTD)-type pos. allosteric modulators of the AMPA receptors (AMPApams) obtained by linking two monomeric BTD scaffolds through their resp. 6-positions.  Using previous X-ray data from monomeric BTDs cocrystd. with the GluA2 ligand-binding domain (LBD), a mol. modeling approach was performed to predict the preferred dimeric combinations.  Two 6,6-ethylene-linked dimeric BTD compds. (16 and 22) were prepd. and evaluated as AMPApams on HEK293 cells expressing GluA2o(Q) (calcium flux expt.).  These compds. were found to be about 10,000 times more potent than their resp. monomers, the most active dimeric compd. being the bis-4-cyclopropyl-substituted compd. 22 [6,6'-(ethane-1,2-diyl)bis(4-cyclopropyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide], with an EC50 value of 1.4 nM.  As a proof of concept, the bis-4-methyl-substituted dimeric compd. 16 (EC50 = 13 nM) was successfully cocrystd. with the GluA2o-LBD and was found to occupy the two BTD binding sites at the LBD dimer interface.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6AJCoOPIir7Vg90H21EOLACvtfcHk0lj7OC-YIIKG7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXps12lsrw%253D&md5=d438a5a16c5ab50e72cda5a71f6c5550</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00250&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00250%26sid%3Dliteratum%253Aachs%26aulast%3DDrapier%26aufirst%3DT.%26aulast%3DGeubelle%26aufirst%3DP.%26aulast%3DBouckaert%26aufirst%3DC.%26aulast%3DNielsen%26aufirst%3DL.%26aulast%3DLaulumaa%26aufirst%3DS.%26aulast%3DGoffin%26aufirst%3DE.%26aulast%3DDilly%26aufirst%3DS.%26aulast%3DFrancotte%26aufirst%3DP.%26aulast%3DHanson%26aufirst%3DJ.%26aulast%3DPochet%26aufirst%3DL.%26aulast%3DKastrup%26aufirst%3DJ.%26aulast%3DPirotte%26aufirst%3DB.%26atitle%3DEnhancing%2520action%2520of%2520positive%2520allosteric%2520modulators%2520through%2520the%2520design%2520of%2520dimeric%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D5279%26epage%3D5291%26doi%3D10.1021%2Facs.jmedchem.8b00250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friberg, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camper, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olejniczak, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span> <span> </span><span class="NLM_article-title">A method for the second-site screening of K-Ras in the presence of a covalently attached first-site ligand</span>. <i>J. Biomol. NMR</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">11</span>– <span class="NLM_lpage">14</span>, <span class="refDoi"> DOI: 10.1007/s10858-014-9849-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1007%2Fs10858-014-9849-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=25087006" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1KltLjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2014&pages=11-14&author=Q.+Sunauthor=J.+Phanauthor=A.+R.+Fribergauthor=D.+V.+Camperauthor=E.+T.+Olejniczakauthor=S.+W.+Fesik&title=A+method+for+the+second-site+screening+of+K-Ras+in+the+presence+of+a+covalently+attached+first-site+ligand&doi=10.1007%2Fs10858-014-9849-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">A method for the second-site screening of K-Ras in the presence of a covalently attached first-site ligand</span></div><div class="casAuthors">Sun, Qi; Phan, Jason; Friberg, Anders R.; Camper, DeMarco V.; Olejniczak, Edward T.; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular NMR</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">11-14</span>CODEN:
                <span class="NLM_cas:coden">JBNME9</span>;
        ISSN:<span class="NLM_cas:issn">0925-2738</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">K-Ras is a well-validated cancer target but is considered to be "undruggable" due to the lack of suitable binding pockets.  We previously discovered small mols. that bind weakly to K-Ras but wanted to improve their binding affinities by identifying ligands that bind near our initial hits that we could link together.  Here we describe an approach for identifying second site ligands that uses a cysteine residue to covalently attach a compd. for tight binding to the first site pocket followed by a fragment screen for binding to a second site.  This approach could be very useful for targeting Ras and other challenging drug targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpe1TZw6wmpAbVg90H21EOLACvtfcHk0lj7OC-YIIKG7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1KltLjM&md5=706c8878b0ee6923c3a956b89ae42d89</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1007%2Fs10858-014-9849-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10858-014-9849-8%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DQ.%26aulast%3DPhan%26aufirst%3DJ.%26aulast%3DFriberg%26aufirst%3DA.%2BR.%26aulast%3DCamper%26aufirst%3DD.%2BV.%26aulast%3DOlejniczak%26aufirst%3DE.%2BT.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DA%2520method%2520for%2520the%2520second-site%2520screening%2520of%2520K-Ras%2520in%2520the%2520presence%2520of%2520a%2520covalently%2520attached%2520first-site%2520ligand%26jtitle%3DJ.%2520Biomol.%2520NMR%26date%3D2014%26volume%3D60%26spage%3D11%26epage%3D14%26doi%3D10.1007%2Fs10858-014-9849-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 10 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Roy González-Alemán, Nicolas Chevrollier, Manuel Simoes, Luis Montero-Cabrera, <span class="NLM_string-name hlFld-ContribAuthor">Fabrice Leclerc</span>. </span><span class="cited-content_cbyCitation_article-title">MCSS-Based Predictions of Binding Mode and Selectivity of Nucleotide Ligands. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Theory and Computation</span><span> <strong>2021,</strong> <em>17 </em>
                                    (4)
                                     , 2599-2618. <a href="https://doi.org/10.1021/acs.jctc.0c01339" title="DOI URL">https://doi.org/10.1021/acs.jctc.0c01339</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jctc.0c01339&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jctc.0c01339%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Theory%2520and%2520Computation%26atitle%3DMCSS-Based%252BPredictions%252Bof%252BBinding%252BMode%252Band%252BSelectivity%252Bof%252BNucleotide%252BLigands%26aulast%3DGonz%25C3%25A1lez-Alem%25C3%25A1n%26aufirst%3DRoy%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D28122020%26date%3D25032021%26volume%3D17%26issue%3D4%26spage%3D2599%26epage%3D2618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hua Li, Meng-Qi Gao, Yan Chen, Yu-Xia Wang, Xiao-Lei Zhu, <span class="NLM_string-name hlFld-ContribAuthor">Guang-Fu Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Pyrazine-Carboxamide-Diphenyl-Ethers as Novel Succinate Dehydrogenase Inhibitors via Fragment Recombination. </span><span class="cited-content_cbyCitation_journal-name">Journal of Agricultural and Food Chemistry</span><span> <strong>2020,</strong> <em>68 </em>
                                    (47)
                                     , 14001-14008. <a href="https://doi.org/10.1021/acs.jafc.0c05646" title="DOI URL">https://doi.org/10.1021/acs.jafc.0c05646</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jafc.0c05646&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jafc.0c05646%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Agricultural%2520and%2520Food%2520Chemistry%26atitle%3DDiscovery%252Bof%252BPyrazine-Carboxamide-Diphenyl-Ethers%252Bas%252BNovel%252BSuccinate%252BDehydrogenase%252BInhibitors%252Bvia%252BFragment%252BRecombination%26aulast%3DLi%26aufirst%3DHua%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D01092020%26date%3D04112020%26date%3D29102020%26date%3D13112020%26volume%3D68%26issue%3D47%26spage%3D14001%26epage%3D14008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhi-Zheng  Wang</span>, <span class="hlFld-ContribAuthor ">Xing-Xing  Shi</span>, <span class="hlFld-ContribAuthor ">Guang-Yi  Huang</span>, <span class="hlFld-ContribAuthor ">Ge-Fei  Hao</span>, <span class="hlFld-ContribAuthor ">Guang-Fu  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment-based drug design facilitates selective kinase inhibitor discovery. </span><span class="cited-content_cbyCitation_journal-name">Trends in Pharmacological Sciences</span><span> <strong>2021,</strong> <em>42 </em>
                                    (7)
                                     , 551-565. <a href="https://doi.org/10.1016/j.tips.2021.04.001" title="DOI URL">https://doi.org/10.1016/j.tips.2021.04.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tips.2021.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tips.2021.04.001%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Pharmacological%2520Sciences%26atitle%3DFragment-based%252Bdrug%252Bdesign%252Bfacilitates%252Bselective%252Bkinase%252Binhibitor%252Bdiscovery%26aulast%3DWang%26aufirst%3DZhi-Zheng%26date%3D2021%26volume%3D42%26issue%3D7%26spage%3D551%26epage%3D565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">José T.  Moreira-Filho</span>, <span class="hlFld-ContribAuthor ">Arthur C.  Silva</span>, <span class="hlFld-ContribAuthor ">Rafael F.  Dantas</span>, <span class="hlFld-ContribAuthor ">Barbara F.  Gomes</span>, <span class="hlFld-ContribAuthor ">Lauro R.  Souza Neto</span>, <span class="hlFld-ContribAuthor ">Jose  Brandao-Neto</span>, <span class="hlFld-ContribAuthor ">Raymond J.  Owens</span>, <span class="hlFld-ContribAuthor ">Nicholas  Furnham</span>, <span class="hlFld-ContribAuthor ">Bruno J.  Neves</span>, <span class="hlFld-ContribAuthor ">Floriano P.  Silva-Junior</span>, <span class="hlFld-ContribAuthor ">Carolina H.  Andrade</span>. </span><span class="cited-content_cbyCitation_article-title">Schistosomiasis Drug Discovery in the Era of Automation and Artificial Intelligence. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Immunology</span><span> <strong>2021,</strong> <em>12 </em><a href="https://doi.org/10.3389/fimmu.2021.642383" title="DOI URL">https://doi.org/10.3389/fimmu.2021.642383</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fimmu.2021.642383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffimmu.2021.642383%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Immunology%26atitle%3DSchistosomiasis%252BDrug%252BDiscovery%252Bin%252Bthe%252BEra%252Bof%252BAutomation%252Band%252BArtificial%252BIntelligence%26aulast%3DMoreira-Filho%26aufirst%3DJos%25C3%25A9%2BT.%26date%3D2021%26date%3D2021%26volume%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew D.  Lloyd</span>, <span class="hlFld-ContribAuthor ">Maksims  Yevglevskis</span>, <span class="hlFld-ContribAuthor ">Amit  Nathubhai</span>, <span class="hlFld-ContribAuthor ">Tony D.  James</span>, <span class="hlFld-ContribAuthor ">Michael D.  Threadgill</span>, <span class="hlFld-ContribAuthor ">Timothy J.  Woodman</span>. </span><span class="cited-content_cbyCitation_article-title">Racemases and epimerases operating through a 1,1-proton transfer mechanism: reactivity, mechanism and inhibition. </span><span class="cited-content_cbyCitation_journal-name">Chemical Society Reviews</span><span> <strong>2021,</strong> <em>50 </em>
                                    (10)
                                     , 5952-5984. <a href="https://doi.org/10.1039/D0CS00540A" title="DOI URL">https://doi.org/10.1039/D0CS00540A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0CS00540A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0CS00540A%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Society%2520Reviews%26atitle%3DRacemases%252Band%252Bepimerases%252Boperating%252Bthrough%252Ba%252B1%25252C1-proton%252Btransfer%252Bmechanism%25253A%252Breactivity%25252C%252Bmechanism%252Band%252Binhibition%26aulast%3DLloyd%26aufirst%3DMatthew%2BD.%26date%3D2021%26date%3D2021%26volume%3D50%26issue%3D10%26spage%3D5952%26epage%3D5984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhenyou  Tan</span>, <span class="hlFld-ContribAuthor ">Jun  Deng</span>, <span class="hlFld-ContribAuthor ">Qiongxian  Ye</span>, <span class="hlFld-ContribAuthor ">Zhenfeng  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Triazole-containing hybrids with anti-
              Mycobacterium tuberculosis
              potential – Part I: 1,2,3-Triazole. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2021,</strong> <em>6 </em><a href="https://doi.org/10.4155/fmc-2020-0301" title="DOI URL">https://doi.org/10.4155/fmc-2020-0301</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2020-0301&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2020-0301%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DTriazole-containing%252Bhybrids%252Bwith%252Banti-%252BMycobacterium%252Btuberculosis%252Bpotential%252B%2525E2%252580%252593%2525C2%2525A0Part%252BI%25253A%252B1%25252C2%25252C3-Triazole%26aulast%3DTan%26aufirst%3DZhenyou%26date%3D2021%26date%3D2021%26volume%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hang  Zhang</span>, <span class="hlFld-ContribAuthor ">Haiwei  Xu</span>, <span class="hlFld-ContribAuthor ">Charles R.  Ashby</span>, <span class="hlFld-ContribAuthor ">Yehuda G.  Assaraf</span>, <span class="hlFld-ContribAuthor ">Zhe‐Sheng  Chen</span>, <span class="hlFld-ContribAuthor ">Hong‐Min  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Chemical molecular‐based approach to overcome multidrug resistance in cancer by targeting P‐glycoprotein (P‐gp). </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2021,</strong> <em>41 </em>
                                    (1)
                                     , 525-555. <a href="https://doi.org/10.1002/med.21739" title="DOI URL">https://doi.org/10.1002/med.21739</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21739&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21739%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DChemical%252Bmolecular%2525E2%252580%252590based%252Bapproach%252Bto%252Bovercome%252Bmultidrug%252Bresistance%252Bin%252Bcancer%252Bby%252Btargeting%252BP%2525E2%252580%252590glycoprotein%252B%252528P%2525E2%252580%252590gp%252529%26aulast%3DZhang%26aufirst%3DHang%26date%3D2021%26date%3D2020%26volume%3D41%26issue%3D1%26spage%3D525%26epage%3D555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Frauke  Antoni</span>, <span class="hlFld-ContribAuthor ">David  Wifling</span>, <span class="hlFld-ContribAuthor ">Günther  Bernhardt</span>. </span><span class="cited-content_cbyCitation_article-title">Water-soluble inhibitors of ABCG2 (BCRP) – A fragment-based and computational approach. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>210 </em>, 112958. <a href="https://doi.org/10.1016/j.ejmech.2020.112958" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112958</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112958&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112958%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DWater-soluble%252Binhibitors%252Bof%252BABCG2%252B%252528BCRP%252529%252B%2525E2%252580%252593%252BA%252Bfragment-based%252Band%252Bcomputational%252Bapproach%26aulast%3DAntoni%26aufirst%3DFrauke%26date%3D2021%26volume%3D210%26spage%3D112958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marie  Hoarau</span>, <span class="hlFld-ContribAuthor ">Jarunee  Vanichtanankul</span>, <span class="hlFld-ContribAuthor ">Nitipol  Srimongkolpithak</span>, <span class="hlFld-ContribAuthor ">Danoo  Vitsupakorn</span>, <span class="hlFld-ContribAuthor ">Yongyuth  Yuthavong</span>, <span class="hlFld-ContribAuthor ">Sumalee  Kamchonwongpaisan</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of new non-pyrimidine scaffolds as
              Plasmodium falciparum
              DHFR inhibitors by fragment-based screening. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2021,</strong> <em>36 </em>
                                    (1)
                                     , 198-206. <a href="https://doi.org/10.1080/14756366.2020.1854244" title="DOI URL">https://doi.org/10.1080/14756366.2020.1854244</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2020.1854244&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2020.1854244%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnew%252Bnon-pyrimidine%252Bscaffolds%252Bas%252BPlasmodium%252Bfalciparum%252BDHFR%252Binhibitors%252Bby%252Bfragment-based%252Bscreening%26aulast%3DHoarau%26aufirst%3DMarie%26date%3D2021%26date%3D2021%26volume%3D36%26issue%3D1%26spage%3D198%26epage%3D206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Abdul-Hamid  Emwas</span>, <span class="hlFld-ContribAuthor ">Kacper  Szczepski</span>, <span class="hlFld-ContribAuthor ">Benjamin Gabriel  Poulson</span>, <span class="hlFld-ContribAuthor ">Kousik  Chandra</span>, <span class="hlFld-ContribAuthor ">Ryan T.  McKay</span>, <span class="hlFld-ContribAuthor ">Manel  Dhahri</span>, <span class="hlFld-ContribAuthor ">Fatimah  Alahmari</span>, <span class="hlFld-ContribAuthor ">Lukasz  Jaremko</span>, <span class="hlFld-ContribAuthor ">Joanna Izabela  Lachowicz</span>, <span class="hlFld-ContribAuthor ">Mariusz  Jaremko</span>. </span><span class="cited-content_cbyCitation_article-title">NMR as a “Gold Standard” Method in Drug Design and Discovery. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (20)
                                     , 4597. <a href="https://doi.org/10.3390/molecules25204597" title="DOI URL">https://doi.org/10.3390/molecules25204597</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25204597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25204597%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DNMR%252Bas%252Ba%252B%2525E2%252580%25259CGold%252BStandard%2525E2%252580%25259D%252BMethod%252Bin%252BDrug%252BDesign%252Band%252BDiscovery%26aulast%3DEmwas%26aufirst%3DAbdul-Hamid%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D20%26spage%3D4597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c00242/20201019/images/medium/jm0c00242_0008.gif" alt="" id="_i2" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c00242/20201019/images/large/jm0c00242_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00242&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c00242/20201019/images/medium/jm0c00242_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c00242/20201019/images/large/jm0c00242_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Fragment linking approach with venetoclax. The initial fragments discovered through “SAR by NMR” were linked with an alkene moiety. Navitoclax, exhibiting high affinity for both BCL-X<sub>L</sub> and BCL-2, was generated, and finally, medicinal chemistry led to venetoclax, a selective BCL-2 inhibitor. The drug was first approved for use in patients with chronic lymphocytic leukemia and 17p deletion.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c00242/20201019/images/large/jm0c00242_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00242&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c00242/20201019/images/medium/jm0c00242_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c00242/20201019/images/large/jm0c00242_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Schematic representation of methods for second-site screening for identification of a second fragment hit. (A) Screening using protein-observed NMR or “SAR by NMR”. A first hit (pink) is identified through chemical shift perturbations on a 2D <sup>15</sup>N or <sup>13</sup>C labeled protein spectrum. Chemical shifts perturbations observed in a second site of the protein (gray) indicate the binding of a second fragment. (B) Screening using ligand-observed <sup>1</sup>H NMR: the ILOE method. A first fragment hit is used as a spy to discover a second fragment hit that binds in the vicinity of the first binder (distances (∼5 Å), through NOESY correlations observed between the two adjacent ligands. (C) Screening using ligand-observed <sup>1</sup>H NMR: the PRE method. A first fragment hit is used as a spy labeled with paramagnetic tag using a 2,2,6,6-tetramethylpiperidin-1-oxyl (TEMPO) moiety. The second fragment hit displays reduced NMR signal intensities due its proximity to the TEMPO moiety. (D) Screening using ligand-observed <sup>19</sup>F NMR. A spy molecule is labeled with a fluorine tag to identify fragments that competitively bind with the spy molecule. (E) Second-site ligand resulting from elaboration of a first-site ligand. Fragment growing generates a new ligand that bind in a distinct pocket. (F) Second-site ligand following tethering-based first-site ligand. A first fragment is covalently bound to the protein through a cysteine residue. A second cysteine residue is used to form a disulfide bond with disulfide containing fragments. Tethered compounds are identified by mass spectrometry. (G) Second-site ligand screening with focused libraries. When the nature of a second pocket is known, a focused library can be used to identify a second-site binder.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c00242/20201019/images/large/jm0c00242_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00242&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c00242/20201019/images/medium/jm0c00242_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c00242/20201019/images/large/jm0c00242_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Schematic representation of methods for direct identification of fragment bound to two distinct binding sites. (A) Screening using X-ray crystallography. When fragments are screened in cocktails, fragments bound to distinct sites can be observed. (B) Screening using protein-observed NMR. Two fragments that bind simultaneously two distinct protein pockets can be identified on 2D NMR protein spectra. (C) Screening using MS. Fragment hits identified by MS are modified, and competition experiments are performed to derive structural restraints. (D) Screening using biochemical assays. The example shows the use of the oxime function together with a small library of dihydroxylamine linkers. (E) Fragment self-assembly in the presence of a target protein: dynamic combinatorial chemistry (DCC). The example is illustrated with aldehyde and amine moieties that <i>in situ</i> form imines. (F) Inhibitor deconstruction and reconstruction. A known ligand can be improved by replacing a moiety by a fragment hit identified in the presence of the deconstructed fragment. (G) Cooperative binding. A first ligand induces a new pocket for a second fragment hit.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c00242/20201019/images/large/jm0c00242_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00242&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i42">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83276" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83276" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 80 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rees, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Congreve, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, C.</span></span> <span> </span><span class="NLM_article-title">Fragment-based lead discovery</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">660</span>– <span class="NLM_lpage">672</span>, <span class="refDoi"> DOI: 10.1038/nrd1467</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1038%2Fnrd1467" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=15286733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtVOht7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=660-672&author=D.+C.+Reesauthor=M.+Congreveauthor=C.+W.+Murrayauthor=C.+Carr&title=Fragment-based+lead+discovery&doi=10.1038%2Fnrd1467"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-based lead discovery</span></div><div class="casAuthors">Rees, David C.; Congreve, Miles; Murray, Christopher W.; Carr, Robin</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">660-672</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Fragment-based lead discovery is gaining momentum in both large pharmaceutical companies and biotechnol. labs. as a complementary approach to traditional screening.  This is because fragment-based approaches require significantly fewer compds. to be screened and synthesized, and are showing a high success rate in generating chem. series with lead-like properties.  Compared with traditional screening hits, the starting fragments have considerably lower mol. mass, and although the binding interactions of these fragments with a target protein are weak, they are structurally understood through x-ray crystallog. or NMR, and they exhibit high 'ligand efficiency'.  Here, the authors use examples from 25 different protein targets to describe chem. strategies that exploit this structural knowledge to rapidly develop fragments into high-affinity leads.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbKeUzFFIlhbVg90H21EOLACvtfcHk0licR_0Ms8s_aQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtVOht7Y%253D&md5=8d49ac7f698c9b9d573ee3c3485eced8</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrd1467&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1467%26sid%3Dliteratum%253Aachs%26aulast%3DRees%26aufirst%3DD.%2BC.%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DCarr%26aufirst%3DC.%26atitle%3DFragment-based%2520lead%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D660%26epage%3D672%26doi%3D10.1038%2Fnrd1467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hajduk, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greer, J.</span></span> <span> </span><span class="NLM_article-title">A decade of fragment-based drug design: strategic advances and lessons learned</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">211</span>– <span class="NLM_lpage">219</span>, <span class="refDoi"> DOI: 10.1038/nrd2220</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1038%2Fnrd2220" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=17290284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BD2sXit12rtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=211-219&author=P.+J.+Hajdukauthor=J.+Greer&title=A+decade+of+fragment-based+drug+design%3A+strategic+advances+and+lessons+learned&doi=10.1038%2Fnrd2220"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">A decade of fragment-based drug design: strategic advances and lessons learned</span></div><div class="casAuthors">Hajduk, Philip J.; Greer, Jonathan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">211-219</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Since the early 1990s, several technol. and scientific advances - such as combinatorial chem., high-throughput screening and the sequencing of the human genome - have been heralded as remedies to the problems facing the pharmaceutical industry.  The use of these technologies in some form is now well established at most pharmaceutical companies; however, the return on investment in terms of marketed products has not met expectations.  Fragment-based drug design is another tool for drug discovery that has emerged in the past decade.  Here, we describe the development and evolution of fragment-based drug design, analyze the role that this approach can have in combination with other discovery technologies and highlight the impact that fragment-based methods have made in progressing new medicines into the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOB8K3AESqTbVg90H21EOLACvtfcHk0licR_0Ms8s_aQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXit12rtr4%253D&md5=bae574da3671475d8488615c3bfa9849</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrd2220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2220%26sid%3Dliteratum%253Aachs%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26aulast%3DGreer%26aufirst%3DJ.%26atitle%3DA%2520decade%2520of%2520fragment-based%2520drug%2520design%253A%2520strategic%2520advances%2520and%2520lessons%2520learned%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D211%26epage%3D219%26doi%3D10.1038%2Fnrd2220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chessari, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodhead, A. J.</span></span> <span> </span><span class="NLM_article-title">From fragment to clinical candidate - a historical perspective</span>. <i>Drug Discov. Today</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">668</span>– <span class="NLM_lpage">675</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2009.04.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1016%2Fj.drudis.2009.04.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=19427404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BD1MXotFyktLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=668-675&author=G.+Chessariauthor=A.+J.+Woodhead&title=From+fragment+to+clinical+candidate+-+a+historical+perspective&doi=10.1016%2Fj.drudis.2009.04.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">From fragment to clinical candidate-a historical perspective</span></div><div class="casAuthors">Chessari, Gianni; Woodhead, Andrew J.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">13/14</span>),
    <span class="NLM_cas:pages">668-675</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  As recently as ten years ago few scientists had heard of fragment screening, let alone considered low mol. wt. fragments (MW <300) with weak binding affinities to be attractive start points for drug discovery programs.  Today, however, there is widespread acceptance that these fragments can be progressed into lead series and on to become clin. candidates.  Consequently, over the past three to four years, fragment-based drug discovery has become firmly established within the biotechnol. and pharmaceutical industries as a complimentary strategy to high-throughput screening.  In this review, we give a historical perspective of how rapidly fragment-based drug discovery has developed and describe a no. of clin. compds. discovered using this approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIfibakR1lWLVg90H21EOLACvtfcHk0lhsft2oR22DHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXotFyktLo%253D&md5=1bd47b7787b1b22681466ad220eb7cd1</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2009.04.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2009.04.007%26sid%3Dliteratum%253Aachs%26aulast%3DChessari%26aufirst%3DG.%26aulast%3DWoodhead%26aufirst%3DA.%2BJ.%26atitle%3DFrom%2520fragment%2520to%2520clinical%2520candidate%2520-%2520a%2520historical%2520perspective%26jtitle%3DDrug%2520Discov.%2520Today%26date%3D2009%26volume%3D14%26spage%3D668%26epage%3D675%26doi%3D10.1016%2Fj.drudis.2009.04.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murray, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blundell, T. L.</span></span> <span> </span><span class="NLM_article-title">Structural biology in fragment-based drug design</span>. <i>Curr. Opin. Struct. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">497</span>– <span class="NLM_lpage">507</span>, <span class="refDoi"> DOI: 10.1016/j.sbi.2010.04.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1016%2Fj.sbi.2010.04.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=20471246" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVKhtLvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=497-507&author=C.+W.+Murrayauthor=T.+L.+Blundell&title=Structural+biology+in+fragment-based+drug+design&doi=10.1016%2Fj.sbi.2010.04.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Structural biology in fragment-based drug design</span></div><div class="casAuthors">Murray, Christopher W.; Blundell, Tom L.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Structural Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">497-507</span>CODEN:
                <span class="NLM_cas:coden">COSBEF</span>;
        ISSN:<span class="NLM_cas:issn">0959-440X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Fragment-based ligand screening is now established as an emerging paradigm for drug discovery.  Here we examine the recent literature looking at how structural biol. has been used in a variety of successful fragment-screening applications.  We argue that the detn. of exptl. binding modes has proved to be one of the mainstays of successful fragment-based approaches and that this reflects the difficulty in optimizing a fragment to a lead mol. in the absence of structural information.  We focus on antimicrobial research where fragment-based drug discovery allows control of the phys. properties of the emerging lead mol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1S2lx8J-FX7Vg90H21EOLACvtfcHk0lhsft2oR22DHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVKhtLvF&md5=ae8cfc0f8be47a316bd92073e95e0c8a</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.sbi.2010.04.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.sbi.2010.04.003%26sid%3Dliteratum%253Aachs%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DBlundell%26aufirst%3DT.%2BL.%26atitle%3DStructural%2520biology%2520in%2520fragment-based%2520drug%2520design%26jtitle%3DCurr.%2520Opin.%2520Struct.%2520Biol.%26date%3D2010%26volume%3D20%26spage%3D497%26epage%3D507%26doi%3D10.1016%2Fj.sbi.2010.04.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Erlanson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubbard, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahnke, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jhoti, H.</span></span> <span> </span><span class="NLM_article-title">Twenty years on: the impact of fragments on drug discovery</span>. <i>Nat. Rev. Drug Discov.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">605</span>– <span class="NLM_lpage">619</span>, <span class="refDoi"> DOI: 10.1038/nrd.2016.109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1038%2Fnrd.2016.109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=27417849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Gisb%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=605-619&author=D.+A.+Erlansonauthor=S.+W.+Fesikauthor=R.+E.+Hubbardauthor=W.+Jahnkeauthor=H.+Jhoti&title=Twenty+years+on%3A+the+impact+of+fragments+on+drug+discovery&doi=10.1038%2Fnrd.2016.109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Twenty years on: the impact of fragments on drug discovery</span></div><div class="casAuthors">Erlanson, Daniel A.; Fesik, Stephen W.; Hubbard, Roderick E.; Jahnke, Wolfgang; Jhoti, Harren</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">605-619</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">After 20 years of sometimes quiet growth, fragment-based drug discovery (FBDD) has become mainstream.  More than 30 drug candidates derived from fragments have entered the clinic, with two approved and several more in advanced trials.  FBDD has been widely applied in both academia and industry, as evidenced by the large no. of papers from universities, non-profit research institutions, biotechnol. companies and pharmaceutical companies.  Moreover, FBDD draws on a diverse range of disciplines, from biochem. and biophysics to computational and medicinal chem.  As the promise of FBDD strategies becomes increasingly realized, now is an opportune time to draw lessons and point the way to the future.  This Review briefly discusses how to design fragment libraries, how to select screening techniques and how to make the most of information gleaned from them.  It also shows how concepts from FBDD have permeated and enhanced drug discovery efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrXQhFttydkrVg90H21EOLACvtfcHk0lhsft2oR22DHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Gisb%252FE&md5=fc2bcf0da6b7b1083a5ff263057cfa80</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.109%26sid%3Dliteratum%253Aachs%26aulast%3DErlanson%26aufirst%3DD.%2BA.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26aulast%3DJahnke%26aufirst%3DW.%26aulast%3DJhoti%26aufirst%3DH.%26atitle%3DTwenty%2520years%2520on%253A%2520the%2520impact%2520of%2520fragments%2520on%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discov.%26date%3D2016%26volume%3D15%26spage%3D605%26epage%3D619%26doi%3D10.1038%2Fnrd.2016.109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mortenson, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erlanson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Esch, I. J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahnke, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, C. N.</span></span> <span> </span><span class="NLM_article-title">Fragment-to-lead medicinal chemistry publications in 2017</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">3857</span>– <span class="NLM_lpage">3872</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01472</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01472" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1CqsrbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=3857-3872&author=P.+N.+Mortensonauthor=D.+A.+Erlansonauthor=I.+J.+P.+de+Eschauthor=W.+Jahnkeauthor=C.+N.+Johnson&title=Fragment-to-lead+medicinal+chemistry+publications+in+2017&doi=10.1021%2Facs.jmedchem.8b01472"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-to-Lead Medicinal Chemistry Publications in 2017</span></div><div class="casAuthors">Mortenson, Paul N.; Erlanson, Daniel A.; de Esch, Iwan J. P.; Jahnke, Wolfgang; Johnson, Christopher N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3857-3872</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  This Miniperspective is the third in a series reviewing fragment-to-lead publications from a given year.  Following our reviews for 2015 and 2016, this Miniperspective provides tabulated summaries of relevant articles published in 2017 along with some general observations.  In addn., we discuss insights obtained from anal. of the combined data set of 85 examples from all three years of publications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoakuhiet0qZLVg90H21EOLACvtfcHk0li_gkxM9yEn7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1CqsrbK&md5=f755c4768cd2d8f7efaaefa987a16079</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01472%26sid%3Dliteratum%253Aachs%26aulast%3DMortenson%26aufirst%3DP.%2BN.%26aulast%3DErlanson%26aufirst%3DD.%2BA.%26aulast%3Dde%2BEsch%26aufirst%3DI.%2BJ.%2BP.%26aulast%3DJahnke%26aufirst%3DW.%26aulast%3DJohnson%26aufirst%3DC.%2BN.%26atitle%3DFragment-to-lead%2520medicinal%2520chemistry%2520publications%2520in%25202017%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D3857%26epage%3D3872%26doi%3D10.1021%2Facs.jmedchem.8b01472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Congreve, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jhoti, H.</span></span> <span> </span><span class="NLM_article-title">A “Rule of three” for fragment-based lead discovery</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">876</span>– <span class="NLM_lpage">877</span>, <span class="refDoi"> DOI: 10.1016/S1359-6446(03)02831-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1016%2FS1359-6446%2803%2902831-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=14554012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A280%3ADC%252BD3svns1Cnsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2003&pages=876-877&author=M.+Congreveauthor=R.+Carrauthor=C.+Murrayauthor=H.+Jhoti&title=A+%E2%80%9CRule+of+three%E2%80%9D+for+fragment-based+lead+discovery&doi=10.1016%2FS1359-6446%2803%2902831-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">A 'rule of three' for fragment-based lead discovery?</span></div><div class="casAuthors">Congreve Miles; Carr Robin; Murray Chris; Jhoti Harren</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">876-7</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRfFswFSn5vb43yKPtYViAGfW6udTcc2eYDbsIbL_f8Pbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3svns1Cnsw%253D%253D&md5=137886dbb2062f7a3ad39277dd888df3</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2803%2902831-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252803%252902831-9%26sid%3Dliteratum%253Aachs%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DCarr%26aufirst%3DR.%26aulast%3DMurray%26aufirst%3DC.%26aulast%3DJhoti%26aufirst%3DH.%26atitle%3DA%2520%25E2%2580%259CRule%2520of%2520three%25E2%2580%259D%2520for%2520fragment-based%2520lead%2520discovery%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2003%26volume%3D8%26spage%3D876%26epage%3D877%26doi%3D10.1016%2FS1359-6446%2803%2902831-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bollag, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibrahim, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spevak, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habets, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shellooe, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marimuthu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Artis, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlessinger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higgins, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Andrea, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koehler, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stumm, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grippo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puzanov, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ribas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McArthur, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sosman, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flaherty, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nathanson, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolop, K.</span></span> <span> </span><span class="NLM_article-title">Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>467</i></span>,  <span class="NLM_fpage">596</span>– <span class="NLM_lpage">599</span>, <span class="refDoi"> DOI: 10.1038/nature09454</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1038%2Fnature09454" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=20823850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1ajtbfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=467&publication_year=2010&pages=596-599&author=G.+Bollagauthor=P.+Hirthauthor=J.+Tsaiauthor=J.+Zhangauthor=P.+N.+Ibrahimauthor=H.+Choauthor=W.+Spevakauthor=C.+Zhangauthor=Y.+Zhangauthor=G.+Habetsauthor=E.+A.+Burtonauthor=B.+Wongauthor=G.+Tsangauthor=B.+L.+Westauthor=B.+Powellauthor=R.+Shellooeauthor=A.+Marimuthuauthor=H.+Nguyenauthor=K.+Y.+Zhangauthor=D.+R.+Artisauthor=J.+Schlessingerauthor=F.+Suauthor=B.+Higginsauthor=R.+Iyerauthor=K.+D%E2%80%99Andreaauthor=A.+Koehlerauthor=M.+Stummauthor=P.+S.+Linauthor=R.+J.+Leeauthor=J.+Grippoauthor=I.+Puzanovauthor=K.+B.+Kimauthor=A.+Ribasauthor=G.+A.+McArthurauthor=J.+A.+Sosmanauthor=P.+B.+Chapmanauthor=K.+T.+Flahertyauthor=X.+Xuauthor=K.+L.+Nathansonauthor=K.+Nolop&title=Clinical+efficacy+of+a+RAF+inhibitor+needs+broad+target+blockade+in+BRAF-mutant+melanoma&doi=10.1038%2Fnature09454"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma</span></div><div class="casAuthors">Bollag, Gideon; Hirth, Peter; Tsai, James; Zhang, Jiazhong; Ibrahim, Prabha N.; Cho, Hanna; Spevak, Wayne; Zhang, Chao; Zhang, Ying; Habets, Gaston; Burton, Elizabeth A.; Wong, Bernice; Tsang, Garson; West, Brian L.; Powell, Ben; Shellooe, Rafe; Marimuthu, Adhirai; Nguyen, Hoa; Zhang, Kam Y. J.; Artis, Dean R.; Schlessinger, Joseph; Su, Fei; Higgins, Brian; Iyer, Raman; D'Andrea, Kurt; Koehler, Astrid; Stumm, Michael; Lin, Paul S.; Lee, Richard J.; Grippo, Joseph; Puzanov, Igor; Kim, Kevin B.; Ribas, Antoni; McArthur, Grant A.; Sosman, Jeffrey A.; Chapman, Paul B.; Flaherty, Keith T.; Xu, Xiaowei; Nathanson, Katherine L.; Nolop, Keith</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">467</span>
        (<span class="NLM_cas:issue">7315</span>),
    <span class="NLM_cas:pages">596-599</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">B-RAF is the most frequently mutated protein kinase in human cancers.  The finding that oncogenic mutations in BRAF are common in melanoma, followed by the demonstration that these tumors are dependent on the RAF/MEK/ERK pathway, offered hope that inhibition of B-RAF kinase activity could benefit melanoma patients.  Herein, we describe the structure-guided discovery of PLX4032 (RG7204), a potent inhibitor of oncogenic B-RAF kinase activity.  Preclin. expts. demonstrated that PLX4032 selectively blocked the RAF/MEK/ERK pathway in BRAF mutant cells and caused regression of BRAF mutant xenografts.  Toxicol. studies confirmed a wide safety margin consistent with the high degree of selectivity, enabling Phase 1 clin. trials using a cryst. formulation of PLX4032 (ref. 5).  In a subset of melanoma patients, pathway inhibition was monitored in paired biopsy specimens collected before treatment initiation and following 2 wk of treatment.  This anal. revealed substantial inhibition of ERK phosphorylation, yet clin. evaluation did not show tumor regressions.  At higher drug exposures afforded by a new amorphous drug formulation, greater than 80% inhibition of ERK phosphorylation in the tumors of patients correlated with clin. response.  Indeed, the Phase 1 clin. data revealed a remarkably high 81% response rate in metastatic melanoma patients treated at an oral dose of 960 mg twice daily.  These data demonstrate that BRAF-mutant melanomas are highly dependent on B-RAF kinase activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpYwlns1EfcLVg90H21EOLACvtfcHk0licdrcI0OGKaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1ajtbfK&md5=8a26d0ab41970f39a109ddafff2f17b4</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnature09454&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09454%26sid%3Dliteratum%253Aachs%26aulast%3DBollag%26aufirst%3DG.%26aulast%3DHirth%26aufirst%3DP.%26aulast%3DTsai%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DIbrahim%26aufirst%3DP.%2BN.%26aulast%3DCho%26aufirst%3DH.%26aulast%3DSpevak%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DHabets%26aufirst%3DG.%26aulast%3DBurton%26aufirst%3DE.%2BA.%26aulast%3DWong%26aufirst%3DB.%26aulast%3DTsang%26aufirst%3DG.%26aulast%3DWest%26aufirst%3DB.%2BL.%26aulast%3DPowell%26aufirst%3DB.%26aulast%3DShellooe%26aufirst%3DR.%26aulast%3DMarimuthu%26aufirst%3DA.%26aulast%3DNguyen%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DK.%2BY.%26aulast%3DArtis%26aufirst%3DD.%2BR.%26aulast%3DSchlessinger%26aufirst%3DJ.%26aulast%3DSu%26aufirst%3DF.%26aulast%3DHiggins%26aufirst%3DB.%26aulast%3DIyer%26aufirst%3DR.%26aulast%3DD%25E2%2580%2599Andrea%26aufirst%3DK.%26aulast%3DKoehler%26aufirst%3DA.%26aulast%3DStumm%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DP.%2BS.%26aulast%3DLee%26aufirst%3DR.%2BJ.%26aulast%3DGrippo%26aufirst%3DJ.%26aulast%3DPuzanov%26aufirst%3DI.%26aulast%3DKim%26aufirst%3DK.%2BB.%26aulast%3DRibas%26aufirst%3DA.%26aulast%3DMcArthur%26aufirst%3DG.%2BA.%26aulast%3DSosman%26aufirst%3DJ.%2BA.%26aulast%3DChapman%26aufirst%3DP.%2BB.%26aulast%3DFlaherty%26aufirst%3DK.%2BT.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DNathanson%26aufirst%3DK.%2BL.%26aulast%3DNolop%26aufirst%3DK.%26atitle%3DClinical%2520efficacy%2520of%2520a%2520RAF%2520inhibitor%2520needs%2520broad%2520target%2520blockade%2520in%2520BRAF-mutant%2520melanoma%26jtitle%3DNature%26date%3D2010%26volume%3D467%26spage%3D596%26epage%3D599%26doi%3D10.1038%2Fnature09454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Souers, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leverson, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boghaert, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ackler, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catron, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dayton, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enschede, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairbrother, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D. C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hymowitz, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khaw, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovar, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maecker, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsh, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitten, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nimmer, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oleksijew, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sampath, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seymour, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahir, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tse, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wendt, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humerickhouse, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmore, S. W.</span></span> <span> </span><span class="NLM_article-title">ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">202</span>– <span class="NLM_lpage">208</span>, <span class="refDoi"> DOI: 10.1038/nm.3048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1038%2Fnm.3048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=23291630" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjslagtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=202-208&author=A.+J.+Souersauthor=J.+D.+Leversonauthor=E.+R.+Boghaertauthor=S.+L.+Acklerauthor=N.+D.+Catronauthor=J.+Chenauthor=B.+D.+Daytonauthor=H.+Dingauthor=S.+H.+Enschedeauthor=W.+J.+Fairbrotherauthor=D.+C.+S.+Huangauthor=S.+G.+Hymowitzauthor=S.+Jinauthor=S.+L.+Khawauthor=P.+J.+Kovarauthor=L.+T.+Lamauthor=J.+Leeauthor=H.+L.+Maeckerauthor=K.+C.+Marshauthor=K.+D.+Masonauthor=M.+J.+Mittenauthor=P.+M.+Nimmerauthor=A.+Oleksijewauthor=C.+H.+Parkauthor=C.+Parkauthor=D.+C.+Phillipsauthor=A.+W.+Robertsauthor=D.+Sampathauthor=J.+F.+Seymourauthor=M.+L.+Smithauthor=G.+M.+Sullivanauthor=S.+K.+Tahirauthor=C.+Tseauthor=M.+D.+Wendtauthor=Y.+Xiaoauthor=J.+C.+Xueauthor=H.+Zhangauthor=R.+A.+Humerickhouseauthor=S.+H.+Rosenbergauthor=S.+W.+Elmore&title=ABT-199%2C+a+potent+and+selective+BCL-2+inhibitor%2C+achieves+antitumor+activity+while+sparing+platelets&doi=10.1038%2Fnm.3048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets</span></div><div class="casAuthors">Souers, Andrew J.; Leverson, Joel D.; Boghaert, Erwin R.; Ackler, Scott L.; Catron, Nathaniel D.; Chen, Jun; Dayton, Brian D.; Ding, Hong; Enschede, Sari H.; Fairbrother, Wayne J.; Huang, David C. S.; Hymowitz, Sarah G.; Jin, Sha; Khaw, Seong Lin; Kovar, Peter J.; Lam, Lloyd T.; Lee, Jackie; Maecker, Heather L.; Marsh, Kennan C.; Mason, Kylie D.; Mitten, Michael J.; Nimmer, Paul M.; Oleksijew, Anatol; Park, Chang H.; Park, Cheol-Min; Phillips, Darren C.; Roberts, Andrew W.; Sampath, Deepak; Seymour, John F.; Smith, Morey L.; Sullivan, Gerard M.; Tahir, Stephen K.; Tse, Chris; Wendt, Michael D.; Xiao, Yu; Xue, John C.; Zhang, Haichao; Humerickhouse, Rod A.; Rosenberg, Saul H.; Elmore, Steven W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">202-208</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Proteins in the B cell CLL/lymphoma 2 (BCL-2) family are key regulators of the apoptotic process.  This family comprises proapoptotic and prosurvival proteins, and shifting the balance toward the latter is an established mechanism whereby cancer cells evade apoptosis.  The therapeutic potential of directly inhibiting prosurvival proteins was unveiled with the development of navitoclax, a selective inhibitor of both BCL-2 and BCL-2-like 1 (BCL-XL), which has shown clin. efficacy in some BCL-2-dependent hematol. cancers.  However, concomitant on-target thrombocytopenia caused by BCL-XL inhibition limits the efficacy achievable with this agent.  Here we report the re-engineering of navitoclax to create a highly potent, orally bioavailable and BCL-2-selective inhibitor, ABT-199.  This compd. inhibits the growth of BCL-2-dependent tumors in vivo and spares human platelets.  A single dose of ABT-199 in three patients with refractory chronic lymphocytic leukemia resulted in tumor lysis within 24 h.  These data indicate that selective pharmacol. inhibition of BCL-2 shows promise for the treatment of BCL-2-dependent hematol. cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqi7P7koWwJHLVg90H21EOLACvtfcHk0licdrcI0OGKaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjslagtQ%253D%253D&md5=6a24b72303eb2062da653f1f61ac74fb</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnm.3048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3048%26sid%3Dliteratum%253Aachs%26aulast%3DSouers%26aufirst%3DA.%2BJ.%26aulast%3DLeverson%26aufirst%3DJ.%2BD.%26aulast%3DBoghaert%26aufirst%3DE.%2BR.%26aulast%3DAckler%26aufirst%3DS.%2BL.%26aulast%3DCatron%26aufirst%3DN.%2BD.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DDayton%26aufirst%3DB.%2BD.%26aulast%3DDing%26aufirst%3DH.%26aulast%3DEnschede%26aufirst%3DS.%2BH.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26aulast%3DHuang%26aufirst%3DD.%2BC.%2BS.%26aulast%3DHymowitz%26aufirst%3DS.%2BG.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DKhaw%26aufirst%3DS.%2BL.%26aulast%3DKovar%26aufirst%3DP.%2BJ.%26aulast%3DLam%26aufirst%3DL.%2BT.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DMaecker%26aufirst%3DH.%2BL.%26aulast%3DMarsh%26aufirst%3DK.%2BC.%26aulast%3DMason%26aufirst%3DK.%2BD.%26aulast%3DMitten%26aufirst%3DM.%2BJ.%26aulast%3DNimmer%26aufirst%3DP.%2BM.%26aulast%3DOleksijew%26aufirst%3DA.%26aulast%3DPark%26aufirst%3DC.%2BH.%26aulast%3DPark%26aufirst%3DC.%26aulast%3DPhillips%26aufirst%3DD.%2BC.%26aulast%3DRoberts%26aufirst%3DA.%2BW.%26aulast%3DSampath%26aufirst%3DD.%26aulast%3DSeymour%26aufirst%3DJ.%2BF.%26aulast%3DSmith%26aufirst%3DM.%2BL.%26aulast%3DSullivan%26aufirst%3DG.%2BM.%26aulast%3DTahir%26aufirst%3DS.%2BK.%26aulast%3DTse%26aufirst%3DC.%26aulast%3DWendt%26aufirst%3DM.%2BD.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DXue%26aufirst%3DJ.%2BC.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DHumerickhouse%26aufirst%3DR.%2BA.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26atitle%3DABT-199%252C%2520a%2520potent%2520and%2520selective%2520BCL-2%2520inhibitor%252C%2520achieves%2520antitumor%2520activity%2520while%2520sparing%2520platelets%26jtitle%3DNat.%2520Med.%26date%3D2013%26volume%3D19%26spage%3D202%26epage%3D208%26doi%3D10.1038%2Fnm.3048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murray, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newell, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angibaud, P.</span></span> <span> </span><span class="NLM_article-title">A successful collaboration between academia, biotech and pharma led to discovery of erdafitinib, a selective FGFR inhibitor recently approved by the FDA</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1509</span>– <span class="NLM_lpage">1511</span>, <span class="refDoi"> DOI: 10.1039/C9MD90044F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1039%2FC9MD90044F" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhs1Oms73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=1509-1511&author=C.+W.+Murrayauthor=D.+R.+Newellauthor=P.+Angibaud&title=A+successful+collaboration+between+academia%2C+biotech+and+pharma+led+to+discovery+of+erdafitinib%2C+a+selective+FGFR+inhibitor+recently+approved+by+the+FDA&doi=10.1039%2FC9MD90044F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">A successful collaboration between academia, biotech and pharma led to discovery of erdafitinib, a selective FGFR inhibitor recently approved by the FDA</span></div><div class="casAuthors">Murray, Christopher W.; Newell, David R.; Angibaud, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1509-1511</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPXodFayPaObVg90H21EOLACvtfcHk0lj8_5hDLMhcuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhs1Oms73P&md5=dab27c44172ffb251ad03a53ffa2176b</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1039%2FC9MD90044F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC9MD90044F%26sid%3Dliteratum%253Aachs%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DNewell%26aufirst%3DD.%2BR.%26aulast%3DAngibaud%26aufirst%3DP.%26atitle%3DA%2520successful%2520collaboration%2520between%2520academia%252C%2520biotech%2520and%2520pharma%2520led%2520to%2520discovery%2520of%2520erdafitinib%252C%2520a%2520selective%2520FGFR%2520inhibitor%2520recently%2520approved%2520by%2520the%2520FDA%26jtitle%3DMedChemComm%26date%3D2019%26volume%3D10%26spage%3D1509%26epage%3D1511%26doi%3D10.1039%2FC9MD90044F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shuker, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajduk, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meadows, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span> <span> </span><span class="NLM_article-title">Discovering high-affinity ligands for proteins: SAR by NMR</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>274</i></span>,  <span class="NLM_fpage">1531</span>– <span class="NLM_lpage">1534</span>, <span class="refDoi"> DOI: 10.1126/science.274.5292.1531</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1126%2Fscience.274.5292.1531" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=8929414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADyaK28Xnt1ansLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1996&pages=1531-1534&author=S.+B.+Shukerauthor=P.+J.+Hajdukauthor=R.+P.+Meadowsauthor=S.+W.+Fesik&title=Discovering+high-affinity+ligands+for+proteins%3A+SAR+by+NMR&doi=10.1126%2Fscience.274.5292.1531"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Discovering high-affinity ligands for proteins: SAR by NMR</span></div><div class="casAuthors">Shuker, Suzanne B.; Hajduk, Philip J.; Meadows, Robert P.; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">274</span>
        (<span class="NLM_cas:issue">5292</span>),
    <span class="NLM_cas:pages">1531-1534</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A NMR-based method is described in which small org. mols. that bind to proximal subsites of a protein are identified, optimized, and linked together to produce high-affinity ligands.  The approach is called "SAR by NMR" because structure-activity relationships (SAR) are obtained from NMR.  With this technique, compds. with nanomolar affinities for the FK506 binding protein were rapidly discovered by tethering two ligands with micromolar affinities.  The method reduces the amt. of chem. synthesis and time required for the discovery of high-affinity ligands and appears particularly useful in target-directed drug research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwkuE4EVU_yrVg90H21EOLACvtfcHk0lj8_5hDLMhcuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xnt1ansLs%253D&md5=1b9a5a5e4f2d6ee4b1c249e3e1faf2ec</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1126%2Fscience.274.5292.1531&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.274.5292.1531%26sid%3Dliteratum%253Aachs%26aulast%3DShuker%26aufirst%3DS.%2BB.%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26aulast%3DMeadows%26aufirst%3DR.%2BP.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DDiscovering%2520high-affinity%2520ligands%2520for%2520proteins%253A%2520SAR%2520by%2520NMR%26jtitle%3DScience%26date%3D1996%26volume%3D274%26spage%3D1531%26epage%3D1534%26doi%3D10.1126%2Fscience.274.5292.1531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hajduk, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meadows, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span> <span> </span><span class="NLM_article-title">Discovering high-affinity ligands for proteins</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">497</span>– <span class="NLM_lpage">499</span>, <span class="refDoi"> DOI: 10.1126/science.278.5337.497</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1126%2Fscience.278.5337.497" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=9381145" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADyaK2sXmslKgtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=1997&pages=497-499&author=P.+J.+Hajdukauthor=R.+P.+Meadowsauthor=S.+W.+Fesik&title=Discovering+high-affinity+ligands+for+proteins&doi=10.1126%2Fscience.278.5337.497"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Discovering high-affinity ligands for proteins</span></div><div class="casAuthors">Hajduk, Philip J.; Meadows, Robert P.; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">5337</span>),
    <span class="NLM_cas:pages">497-499</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review, with 8 refs.  The authors discuss here high-affinity ligands for proteins with new drugs discovery goal in mind.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAhKIa7HM0NLVg90H21EOLACvtfcHk0lj8_5hDLMhcuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmslKgtbc%253D&md5=3999f55faefa13bacdaa75738ec7e513</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1126%2Fscience.278.5337.497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.278.5337.497%26sid%3Dliteratum%253Aachs%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26aulast%3DMeadows%26aufirst%3DR.%2BP.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DDiscovering%2520high-affinity%2520ligands%2520for%2520proteins%26jtitle%3DScience%26date%3D1997%26volume%3D278%26spage%3D497%26epage%3D499%26doi%3D10.1126%2Fscience.278.5337.497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ichihara, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Law, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittaker, M.</span></span> <span> </span><span class="NLM_article-title">Compound design by fragment-linking</span>. <i>Mol. Inf.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">298</span>– <span class="NLM_lpage">306</span>, <span class="refDoi"> DOI: 10.1002/minf.201000174</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1002%2Fminf.201000174" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=27466947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkvVCrt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2011&pages=298-306&author=O.+Ichiharaauthor=J.+Barkerauthor=R.+J.+Lawauthor=M.+Whittaker&title=Compound+design+by+fragment-linking&doi=10.1002%2Fminf.201000174"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Compound Design by Fragment-Linking</span></div><div class="casAuthors">Ichihara, Osamu; Barker, John; Law, Richard J.; Whittaker, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Informatics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">298-306</span>CODEN:
                <span class="NLM_cas:coden">MIONBS</span>;
        ISSN:<span class="NLM_cas:issn">1868-1743</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The linking together of two fragment compds. that bind to distinct protein sub-sites can lead to a superadditivity of binding affinities, in which the binding free energy of the linked fragments exceeds the simple sum of the binding energies of individual fragments (linking coeff. E<1).  However, a review of the literature shows that such events are relatively rare and, in the majority of the cases, linking coeffs. are far from optimal being much greater than 1.  It is crit. to design a linker that does not disturb the original binding poses of each fragment in order to achieve successful linking.  However, such an ideal linker is often difficult to design and even more difficult to actually synthesize.  We suggest that the chance of achieving successful fragment linking can be significantly improved by choosing a fragment pair that consists of one fragment that binds by strong H-bonds (or non-classical equiv.) and a second fragment that is more tolerant of changes in binding mode (hydrophobic or vdW binders).  We also propose that the fragment MO (FMO) calcns. can be used to analyze the nature of the binding interactions of the fragment hits for the selection of fragments for evolution, merging and linking in order to optimize the chance of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTdXDFIpDN_LVg90H21EOLACvtfcHk0lhBswg3O3n5vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkvVCrt7Y%253D&md5=38457d321df8d9fb487113c57166c987</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1002%2Fminf.201000174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fminf.201000174%26sid%3Dliteratum%253Aachs%26aulast%3DIchihara%26aufirst%3DO.%26aulast%3DBarker%26aufirst%3DJ.%26aulast%3DLaw%26aufirst%3DR.%2BJ.%26aulast%3DWhittaker%26aufirst%3DM.%26atitle%3DCompound%2520design%2520by%2520fragment-linking%26jtitle%3DMol.%2520Inf.%26date%3D2011%26volume%3D30%26spage%3D298%26epage%3D306%26doi%3D10.1002%2Fminf.201000174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jencks, W.</span></span> <span> </span><span class="NLM_article-title">On the attribution and additivity of binding energies</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1981</span>,  <span class="NLM_volume"><i>78</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">4046</span>– <span class="NLM_lpage">4050</span>, <span class="refDoi"> DOI: 10.1073/pnas.78.7.4046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1073%2Fpnas.78.7.4046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=16593049" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADyaL3MXlvVamtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=1981&pages=4046-4050&issue=7&author=W.+Jencks&title=On+the+attribution+and+additivity+of+binding+energies&doi=10.1073%2Fpnas.78.7.4046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">On the attribution and additivity of binding energies</span></div><div class="casAuthors">Jencks, William P.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">4046-50</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">It can be useful to describe the Gibbs free energy changes for the binding to a protein of a mol., A-B, and of its component parts, A and B, in terms of the intrinsic binding energies of A and B, ΔGiA and ΔGiB, and a connection Gibbs energy, ΔGs, that is derived largely from changes in translational and rotational entropy.  The relation between ΔGsand ΔGiA and ΔGiB is discussed.  This empirical approach avoids the difficult of interpreting obsd. ΔH and TΔS values for aq. solns.  The ΔGi and ΔGsterms can be large for binding to enzymes and other proteins.  The use and interpretation of these binding energies are discussed, esp. with respect to ATP interaction with myosin ATPase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2X3Thp5VESLVg90H21EOLACvtfcHk0lhBswg3O3n5vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXlvVamtbo%253D&md5=1cdbbb8b6e3f9d3ff0ba2c662c772375</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1073%2Fpnas.78.7.4046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.78.7.4046%26sid%3Dliteratum%253Aachs%26aulast%3DJencks%26aufirst%3DW.%26atitle%3DOn%2520the%2520attribution%2520and%2520additivity%2520of%2520binding%2520energies%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1981%26volume%3D78%26issue%3D7%26spage%3D4046%26epage%3D4050%26doi%3D10.1073%2Fpnas.78.7.4046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hajduk, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheppard, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nettesheim, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olejniczak, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuker, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meadows, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinman, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrera, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcotte, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Severin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walter, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gubbins, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holzman, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidsen, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summers, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent nonpeptide inhibitors of stromelysin using SAR by NMR</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">5818</span>– <span class="NLM_lpage">5827</span>, <span class="refDoi"> DOI: 10.1021/ja9702778</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja9702778" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADyaK2sXktVehsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=1997&pages=5818-5827&author=P.+J.+Hajdukauthor=G.+Sheppardauthor=D.+G.+Nettesheimauthor=E.+T.+Olejniczakauthor=S.+B.+Shukerauthor=R.+P.+Meadowsauthor=D.+H.+Steinmanauthor=G.+M.+Carreraauthor=P.+A.+Marcotteauthor=J.+Severinauthor=K.+Walterauthor=H.+Smithauthor=E.+Gubbinsauthor=R.+Simmerauthor=T.+F.+Holzmanauthor=D.+W.+Morganauthor=S.+K.+Davidsenauthor=J.+B.+Summersauthor=S.+W.+Fesik&title=Discovery+of+potent+nonpeptide+inhibitors+of+stromelysin+using+SAR+by+NMR&doi=10.1021%2Fja9702778"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent Nonpeptide Inhibitors of Stromelysin using SAR by NMR</span></div><div class="casAuthors">Hajduk, P. J.; Sheppard, G.; Nettesheim, D. G.; Olejniczak, E. T.; Shuker, S. B.; Meadows, R. P.; Steinman, D. H.; Carrera, G. M., Jr.; Marcotte, P. A.; Severin, J.; Walter, K.; Smith, H.; Gubbins, E.; Simmer, R.; Holzman, T. F.; Morgan, D. W.; Davidsen, S. K.; Summers, J. B.; Fesik, S. W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">5818-5827</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">With the use of an NMR-based method, potent (IC50 < 25 nM) nonpeptide inhibitors of the matrix metalloproteinase stromelysin (MMP-3) were discovered.  The method, called SAR by NMR (for structure-activity relationships by NMR), involves the identification, optimization, and linking of compds. that bind to proximal sites on a protein.  Using this technique, two ligands that bind weakly to stromelysin (acetohydroxamic acid, KD = 17 mM; 3-(cyanomethyl)-4'-hydroxybiphenyl, KD = 0.02 mM) were identified.  On the basis of NMR-derived structural information, the two fragments were connected to produce a 15 nM inhibitor of this enzyme.  This compd. was rapidly discovered (less than 6 mo) and required only a minimal amt. of chem. synthesis.  These studies indicate that the SAR by NMR method can be effectively applied to enzymes to yield potent lead inhibitors-an important part of the drug discovery process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3BJ2Mq-F67rVg90H21EOLACvtfcHk0lhBswg3O3n5vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXktVehsLw%253D&md5=b67d6c7a4c975c63f2c784944567d67b</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fja9702778&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja9702778%26sid%3Dliteratum%253Aachs%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26aulast%3DSheppard%26aufirst%3DG.%26aulast%3DNettesheim%26aufirst%3DD.%2BG.%26aulast%3DOlejniczak%26aufirst%3DE.%2BT.%26aulast%3DShuker%26aufirst%3DS.%2BB.%26aulast%3DMeadows%26aufirst%3DR.%2BP.%26aulast%3DSteinman%26aufirst%3DD.%2BH.%26aulast%3DCarrera%26aufirst%3DG.%2BM.%26aulast%3DMarcotte%26aufirst%3DP.%2BA.%26aulast%3DSeverin%26aufirst%3DJ.%26aulast%3DWalter%26aufirst%3DK.%26aulast%3DSmith%26aufirst%3DH.%26aulast%3DGubbins%26aufirst%3DE.%26aulast%3DSimmer%26aufirst%3DR.%26aulast%3DHolzman%26aufirst%3DT.%2BF.%26aulast%3DMorgan%26aufirst%3DD.%2BW.%26aulast%3DDavidsen%26aufirst%3DS.%2BK.%26aulast%3DSummers%26aufirst%3DJ.%2BB.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DDiscovery%2520of%2520potent%2520nonpeptide%2520inhibitors%2520of%2520stromelysin%2520using%2520SAR%2520by%2520NMR%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1997%26volume%3D119%26spage%3D5818%26epage%3D5827%26doi%3D10.1021%2Fja9702778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oltersdorf, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmore, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoemaker, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armstrong, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Augeri, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belli, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruncko, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deckwerth, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinges, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajduk, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joseph, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korsmeyer, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunzer, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Letai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitten, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nettesheim, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nimmer, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oleksijew, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petros, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahir, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomaselli, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wendt, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, S. H.</span></span> <span> </span><span class="NLM_article-title">An inhibitor of BCL-2 family proteins induces regression of solid tumours</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>435</i></span>,  <span class="NLM_fpage">677</span>– <span class="NLM_lpage">681</span>, <span class="refDoi"> DOI: 10.1038/nature03579</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1038%2Fnature03579" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=15902208" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BD2MXks1Ogtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=435&publication_year=2005&pages=677-681&author=T.+Oltersdorfauthor=S.+W.+Elmoreauthor=A.+R.+Shoemakerauthor=R.+C.+Armstrongauthor=D.+J.+Augeriauthor=B.+A.+Belliauthor=M.+Brunckoauthor=T.+L.+Deckwerthauthor=J.+Dingesauthor=P.+J.+Hajdukauthor=M.+K.+Josephauthor=S.+Kitadaauthor=S.+J.+Korsmeyerauthor=A.+R.+Kunzerauthor=A.+Letaiauthor=C.+Liauthor=M.+J.+Mittenauthor=D.+G.+Nettesheimauthor=S.+Ngauthor=P.+M.+Nimmerauthor=J.+M.+O%E2%80%99Connorauthor=A.+Oleksijewauthor=A.+M.+Petrosauthor=J.+C.+Reedauthor=W.+Shenauthor=S.+K.+Tahirauthor=C.+B.+Thompsonauthor=K.+J.+Tomaselliauthor=B.+Wangauthor=M.+D.+Wendtauthor=H.+Zhangauthor=S.+W.+Fesikauthor=S.+H.+Rosenberg&title=An+inhibitor+of+BCL-2+family+proteins+induces+regression+of+solid+tumours&doi=10.1038%2Fnature03579"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">An inhibitor of Bcl-2 family proteins induces regression of solid tumours</span></div><div class="casAuthors">Oltersdorf, Tilman; Elmore, Steven W.; Shoemaker, Alexander R.; Armstrong, Robert C.; Augeri, David J.; Belli, Barbara A.; Bruncko, Milan; Deckwerth, Thomas L.; Dinges, Jurgen; Hajduk, Philip J.; Joseph, Mary K.; Kitada, Shinichi; Korsmeyer, Stanley J.; Kunzer, Aaron R.; Letai, Anthony; Li, Chi; Mitten, Michael J.; Nettesheim, David G.; Ng, Shi Chung; Nimmer, Paul M.; O'Connor, Jacqueline M.; Oleksijew, Anatol; Petros, Andrew M.; Reed, John C.; Shen, Wang; Tahir, Stephen K.; Thompson, Craig B.; Tomaselli, Kevin J.; Wang, Baole; Wendt, Michael D.; Zhang, Haichao; Fesik, Stephen W.; Rosenberg, Saul H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">435</span>
        (<span class="NLM_cas:issue">7042</span>),
    <span class="NLM_cas:pages">677-681</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Proteins in the Bcl-2 family are central regulators of programmed cell death, and members that inhibit apoptosis, such as Bcl-XL and Bcl-2, are overexpressed in many cancers and contribute to tumor initiation, progression and resistance to therapy.  Bcl-XL expression correlates with chemo-resistance of tumor cell lines, and redns. in Bcl-2 increase sensitivity to anticancer drugs and enhance in vivo survival.  The development of inhibitors of these proteins as potential anticancer therapeutics has been previously explored, but obtaining potent small-mol. inhibitors has proved difficult owing to the necessity of targeting a protein-protein interaction.  Here, using NMR-based screening, parallel synthesis and structure-based design, the authors have discovered ABT-737, a small-mol. inhibitor of the antiapoptotic proteins Bcl-2, Bcl-XL and Bcl-w, with an affinity two to three orders of magnitude more potent than previously reported compds.  Mechanistic studies reveal that ABT-737 does not directly initiate the apoptotic process, but enhances the effects of death signals, displaying synergistic cytotoxicity with chemotherapeutics and radiation.  ABT-737 exhibits single-agent-mechanism-based killing of cells from lymphoma and small-cell lung carcinoma lines, as well as primary patient-derived cells, and in animal models, ABT-737 improves survival, causes regression of established tumors, and produces cures in a high percentage of the mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBt7_zVt8HrbVg90H21EOLACvtfcHk0ljt5Ua9EXhe7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXks1Ogtb0%253D&md5=4940d06838506f181b6310d3458a595f</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fnature03579&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature03579%26sid%3Dliteratum%253Aachs%26aulast%3DOltersdorf%26aufirst%3DT.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26aulast%3DShoemaker%26aufirst%3DA.%2BR.%26aulast%3DArmstrong%26aufirst%3DR.%2BC.%26aulast%3DAugeri%26aufirst%3DD.%2BJ.%26aulast%3DBelli%26aufirst%3DB.%2BA.%26aulast%3DBruncko%26aufirst%3DM.%26aulast%3DDeckwerth%26aufirst%3DT.%2BL.%26aulast%3DDinges%26aufirst%3DJ.%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26aulast%3DJoseph%26aufirst%3DM.%2BK.%26aulast%3DKitada%26aufirst%3DS.%26aulast%3DKorsmeyer%26aufirst%3DS.%2BJ.%26aulast%3DKunzer%26aufirst%3DA.%2BR.%26aulast%3DLetai%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DMitten%26aufirst%3DM.%2BJ.%26aulast%3DNettesheim%26aufirst%3DD.%2BG.%26aulast%3DNg%26aufirst%3DS.%26aulast%3DNimmer%26aufirst%3DP.%2BM.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DJ.%2BM.%26aulast%3DOleksijew%26aufirst%3DA.%26aulast%3DPetros%26aufirst%3DA.%2BM.%26aulast%3DReed%26aufirst%3DJ.%2BC.%26aulast%3DShen%26aufirst%3DW.%26aulast%3DTahir%26aufirst%3DS.%2BK.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26aulast%3DTomaselli%26aufirst%3DK.%2BJ.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DWendt%26aufirst%3DM.%2BD.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26atitle%3DAn%2520inhibitor%2520of%2520BCL-2%2520family%2520proteins%2520induces%2520regression%2520of%2520solid%2520tumours%26jtitle%3DNature%26date%3D2005%26volume%3D435%26spage%3D677%26epage%3D681%26doi%3D10.1038%2Fnature03579" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Petros, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinges, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Augeri, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumeister, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betebenner, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bures, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmore, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajduk, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joseph, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landis, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nettesheim, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zanze, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of a potent inhibitor of the antiapoptotic protein Bcl-X<sub>L</sub> from NMR and parallel synthesis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">656</span>– <span class="NLM_lpage">663</span>, <span class="refDoi"> DOI: 10.1021/jm0507532</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0507532" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlant73J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=656-663&author=A.+M.+Petrosauthor=J.+Dingesauthor=D.+J.+Augeriauthor=S.+A.+Baumeisterauthor=D.+A.+Betebennerauthor=M.+G.+Buresauthor=S.+W.+Elmoreauthor=P.+J.+Hajdukauthor=M.+K.+Josephauthor=S.+K.+Landisauthor=D.+G.+Nettesheimauthor=S.+H.+Rosenbergauthor=W.+Shenauthor=S.+Thomasauthor=X.+Wangauthor=I.+Zanzeauthor=H.+Zhangauthor=S.+W.+Fesik&title=Discovery+of+a+potent+inhibitor+of+the+antiapoptotic+protein+Bcl-XL+from+NMR+and+parallel+synthesis&doi=10.1021%2Fjm0507532"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent Inhibitor of the Antiapoptotic Protein Bcl-xL from NMR and Parallel Synthesis</span></div><div class="casAuthors">Petros, Andrew M.; Dinges, Jurgen; Augeri, David J.; Baumeister, Steven A.; Betebenner, David A.; Bures, Mark G.; Elmore, Steven W.; Hajduk, Philip J.; Joseph, Mary K.; Landis, Shelley K.; Nettesheim, David G.; Rosenberg, Saul H.; Shen, Wang; Thomas, Sheela; Wang, Xilu; Zanze, Irini; Zhang, Haichao; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">656-663</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The antiapoptotic proteins Bcl-xL and Bcl-2 play key roles in the maintenance of normal cellular homeostasis.  However, their overexpression can lead to oncogenic transformation and is responsible for drug resistance in certain types of cancer.  This makes Bcl-xL and Bcl-2 attractive targets for the development of potential anticancer agents.  Here we describe the structure-based discovery of a potent Bcl-xL inhibitor directed at a hydrophobic groove on the surface of the protein.  This groove represents the binding site for BH3 peptides from proapoptotic Bcl-2 family members such as Bak and Bad.  Application of NMR-based screening yielded an initial biaryl acid with an affinity (Kd) of ∼300 μM for the protein.  Following the classical "SAR by NMR" approach, a second-site ligand was identified that bound proximal to the first-site ligand in the hydrophobic groove.  From NMR-based structural studies and parallel synthesis, a potent ligand was obtained, which binds to Bcl-xL with an inhibition const. (Ki) of 36 ± 2 nM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYP_kg1BoLW7Vg90H21EOLACvtfcHk0ljt5Ua9EXhe7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlant73J&md5=ef6d8989682f6eaadeda9d7b6eae09e4</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm0507532&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0507532%26sid%3Dliteratum%253Aachs%26aulast%3DPetros%26aufirst%3DA.%2BM.%26aulast%3DDinges%26aufirst%3DJ.%26aulast%3DAugeri%26aufirst%3DD.%2BJ.%26aulast%3DBaumeister%26aufirst%3DS.%2BA.%26aulast%3DBetebenner%26aufirst%3DD.%2BA.%26aulast%3DBures%26aufirst%3DM.%2BG.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26aulast%3DJoseph%26aufirst%3DM.%2BK.%26aulast%3DLandis%26aufirst%3DS.%2BK.%26aulast%3DNettesheim%26aufirst%3DD.%2BG.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DShen%26aufirst%3DW.%26aulast%3DThomas%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DZanze%26aufirst%3DI.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520inhibitor%2520of%2520the%2520antiapoptotic%2520protein%2520Bcl-XL%2520from%2520NMR%2520and%2520parallel%2520synthesis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D656%26epage%3D663%26doi%3D10.1021%2Fjm0507532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tse, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoemaker, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adickes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsh, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitten, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nimmer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahir, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmore, S. W.</span></span> <span> </span><span class="NLM_article-title">ABT-263: A potent and orally bioavailable Bcl-2 family inhibitor</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">3421</span>– <span class="NLM_lpage">3428</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-07-5836</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1158%2F0008-5472.CAN-07-5836" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=18451170" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BD1cXltlSltrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=3421-3428&author=C.+Tseauthor=A.+R.+Shoemakerauthor=J.+Adickesauthor=M.+G.+Andersonauthor=J.+Chenauthor=S.+Jinauthor=E.+F.+Johnsonauthor=K.+C.+Marshauthor=M.+J.+Mittenauthor=P.+Nimmerauthor=L.+Robertsauthor=S.+K.+Tahirauthor=Y.+Xiaoauthor=X.+Yangauthor=H.+Zhangauthor=S.+Fesikauthor=S.+H.+Rosenbergauthor=S.+W.+Elmore&title=ABT-263%3A+A+potent+and+orally+bioavailable+Bcl-2+family+inhibitor&doi=10.1158%2F0008-5472.CAN-07-5836"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor</span></div><div class="casAuthors">Tse, Christin; Shoemaker, Alexander R.; Adickes, Jessica; Anderson, Mark G.; Chen, Jun; Jin, Sha; Johnson, Eric F.; Marsh, Kennan C.; Mitten, Michael J.; Nimmer, Paul; Roberts, Lisa; Tahir, Stephen K.; Xiao, Yu; Yang, Xiufen; Zhang, Haichao; Fesik, Stephen; Rosenberg, Saul H.; Elmore, Steven W.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3421-3428</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Overexpression of the prosurvival Bcl-2 family members (Bcl-2, Bcl-xL, and Mcl-1) is commonly assocd. with tumor maintenance, progression, and chemoresistance.  We previously reported the discovery of ABT-737, a potent, small-mol. Bcl-2 family protein inhibitor.  A major limitation of ABT-737 is that it is not orally bioavailable, which would limit chronic single agent therapy and flexibility to dose in combination regimens.  Here we report the biol. properties of ABT-263, a potent, orally bioavailable Bad-like BH3 mimetic (Ki's of <1 nmol/L for Bcl-2, Bcl-xL, and Bcl-w).  The oral bioavailability of ABT-263 in preclin. animal models is 20% to 50%, depending on formulation.  ABT-263 disrupts Bcl-2/Bcl-xL interactions with pro-death proteins (e.g., Bim), leading to the initiation of apoptosis within 2 h posttreatment.  In human tumor cells, ABT-263 induces Bax translocation, cytochrome c release, and subsequent apoptosis.  Oral administration of ABT-263 alone induces complete tumor regressions in xenograft models of small-cell lung cancer and acute lymphoblastic leukemia.  In xenograft models of aggressive B-cell lymphoma and multiple myeloma where ABT-263 exhibits modest or no single agent activity, it significantly enhances the efficacy of clin. relevant therapeutic regimens.  These data provide the rationale for clin. trials evaluating ABT-263 in small-cell lung cancer and B-cell malignancies.  The oral efficacy of ABT-263 should provide dosing flexibility to maximize clin. utility both as a single agent and in combination regimens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojLK8zIgyDWbVg90H21EOLACvtfcHk0lhgbdbG0z1YRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXltlSltrs%253D&md5=a43029cc218d25d4e1fb6dd1186475c4</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-07-5836&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-07-5836%26sid%3Dliteratum%253Aachs%26aulast%3DTse%26aufirst%3DC.%26aulast%3DShoemaker%26aufirst%3DA.%2BR.%26aulast%3DAdickes%26aufirst%3DJ.%26aulast%3DAnderson%26aufirst%3DM.%2BG.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26aulast%3DMarsh%26aufirst%3DK.%2BC.%26aulast%3DMitten%26aufirst%3DM.%2BJ.%26aulast%3DNimmer%26aufirst%3DP.%26aulast%3DRoberts%26aufirst%3DL.%26aulast%3DTahir%26aufirst%3DS.%2BK.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DFesik%26aufirst%3DS.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26atitle%3DABT-263%253A%2520A%2520potent%2520and%2520orally%2520bioavailable%2520Bcl-2%2520family%2520inhibitor%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D3421%26epage%3D3428%26doi%3D10.1158%2F0008-5472.CAN-07-5836" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Petros, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huth, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oost, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nimmer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendoza, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mack, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walter, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorwin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gramling, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ladror, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmore, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajduk, P. J.</span></span> <span> </span><span class="NLM_article-title">Discovery of a potent and selective Bcl-2 inhibitor using SAR by NMR</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">6587</span>– <span class="NLM_lpage">6591</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.09.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1016%2Fj.bmcl.2010.09.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=20870405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlSmsL7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=6587-6591&author=A.+M.+Petrosauthor=J.+R.+Huthauthor=T.+Oostauthor=C.+M.+Parkauthor=H.+Dingauthor=X.+Wangauthor=H.+Zhangauthor=P.+Nimmerauthor=R.+Mendozaauthor=C.+Sunauthor=J.+Mackauthor=K.+Walterauthor=S.+Dorwinauthor=E.+Gramlingauthor=U.+Ladrorauthor=S.+H.+Rosenbergauthor=S.+W.+Elmoreauthor=S.+W.+Fesikauthor=P.+J.+Hajduk&title=Discovery+of+a+potent+and+selective+Bcl-2+inhibitor+using+SAR+by+NMR&doi=10.1016%2Fj.bmcl.2010.09.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a potent and selective Bcl-2 inhibitor using SAR by NMR</span></div><div class="casAuthors">Petros, Andrew M.; Huth, Jeffrey R.; Oost, Thorsten; Park, Cheol-Min; Ding, Hong; Wang, Xilu; Zhang, Haichao; Nimmer, Paul; Mendoza, Renaldo; Sun, Chaohong; Mack, Jamey; Walter, Karl; Dorwin, Sarah; Gramling, Emily; Ladror, Uri; Rosenberg, Saul H.; Elmore, Steven W.; Fesik, Stephen W.; Hajduk, Philip J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6587-6591</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The Bcl-2 family of proteins plays a major role in the regulation of apoptosis, or programmed cell death.  Overexpression of the anti-apoptotic members of this family (Bcl-2, Bcl-xL, and Mcl-1) can render cancer cells resistant to chemotherapeutic agents and therefore these proteins are important targets for the development of new anti-cancer agents.  Here we describe the discovery of a potent, highly selective, Bcl-2 inhibitor using SAR by NMR and structure-based drug design which could serve as a starting point for the development of a Bcl-2 selective anti-cancer agent.  Such an agent would potentially overcome the Bcl-xL mediated thrombocytopenia obsd. with ABT-263.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfxdyEr4OJdLVg90H21EOLACvtfcHk0lhgbdbG0z1YRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlSmsL7O&md5=936bd4f8f32dc597e4d335c37bad5e9c</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.09.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.09.033%26sid%3Dliteratum%253Aachs%26aulast%3DPetros%26aufirst%3DA.%2BM.%26aulast%3DHuth%26aufirst%3DJ.%2BR.%26aulast%3DOost%26aufirst%3DT.%26aulast%3DPark%26aufirst%3DC.%2BM.%26aulast%3DDing%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DNimmer%26aufirst%3DP.%26aulast%3DMendoza%26aufirst%3DR.%26aulast%3DSun%26aufirst%3DC.%26aulast%3DMack%26aufirst%3DJ.%26aulast%3DWalter%26aufirst%3DK.%26aulast%3DDorwin%26aufirst%3DS.%26aulast%3DGramling%26aufirst%3DE.%26aulast%3DLadror%26aufirst%3DU.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520and%2520selective%2520Bcl-2%2520inhibitor%2520using%2520SAR%2520by%2520NMR%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D6587%26epage%3D6591%26doi%3D10.1016%2Fj.bmcl.2010.09.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tao, Z. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasvold, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petros, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boghaert, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catron, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colman, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czabotar, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshayes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairbrother, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flygare, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hymowitz, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Judge, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koehler, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovar, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lessene, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitten, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ndubaku, C. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nimmer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Purkey, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oleksijew, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sleebs, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahir, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zobel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tse, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leverson, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmore, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Souers, A. J.</span></span> <span> </span><span class="NLM_article-title">Discovery of a potent and selective Bcl-X<sub>L</sub> inhibitor with in vivo activity</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1088</span>– <span class="NLM_lpage">1093</span>, <span class="refDoi"> DOI: 10.1021/ml5001867</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml5001867" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVWrtbnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=1088-1093&author=Z.+F.+Taoauthor=L.+Hasvoldauthor=L.+Wangauthor=X.+Wangauthor=A.+M.+Petrosauthor=C.+H.+Parkauthor=E.+R.+Boghaertauthor=N.+D.+Catronauthor=J.+Chenauthor=P.+M.+Colmanauthor=P.+E.+Czabotarauthor=K.+Deshayesauthor=W.+J.+Fairbrotherauthor=J.+A.+Flygareauthor=S.+G.+Hymowitzauthor=S.+Jinauthor=R.+A.+Judgeauthor=M.+F.+Koehlerauthor=P.+J.+Kovarauthor=G.+Lesseneauthor=M.+J.+Mittenauthor=C.+O.+Ndubakuauthor=P.+Nimmerauthor=H.+E.+Purkeyauthor=A.+Oleksijewauthor=D.+C.+Phillipsauthor=B.+E.+Sleebsauthor=B.+J.+Smithauthor=M.+L.+Smithauthor=S.+K.+Tahirauthor=K.+G.+Watsonauthor=Y.+Xiaoauthor=J.+Xueauthor=H.+Zhangauthor=K.+Zobelauthor=S.+H.+Rosenbergauthor=C.+Tseauthor=J.+D.+Leversonauthor=S.+W.+Elmoreauthor=A.+J.+Souers&title=Discovery+of+a+potent+and+selective+Bcl-XL+inhibitor+with+in+vivo+activity&doi=10.1021%2Fml5001867"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent and Selective BCL-XL Inhibitor with in Vivo Activity</span></div><div class="casAuthors">Tao, Zhi-Fu; Hasvold, Lisa; Wang, Le; Wang, Xilu; Petros, Andrew M.; Park, Chang H.; Boghaert, Erwin R.; Catron, Nathaniel D.; Chen, Jun; Colman, Peter M.; Czabotar, Peter E.; Deshayes, Kurt; Fairbrother, Wayne J.; Flygare, John A.; Hymowitz, Sarah G.; Jin, Sha; Judge, Russell A.; Koehler, Michael F. T.; Kovar, Peter J.; Lessene, Guillaume; Mitten, Michael J.; Ndubaku, Chudi O.; Nimmer, Paul; Purkey, Hans E.; Oleksijew, Anatol; Phillips, Darren C.; Sleebs, Brad E.; Smith, Brian J.; Smith, Morey L.; Tahir, Stephen K.; Watson, Keith G.; Xiao, Yu; Xue, John; Zhang, Haichao; Zobel, Kerry; Rosenberg, Saul H.; Tse, Chris; Leverson, Joel D.; Elmore, Steven W.; Souers, Andrew J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1088-1093</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A-1155463 I, a highly potent and selective BCL-XL inhibitor, was discovered through NMR fragment screening and structure-based design.  This compd. is substantially more potent against BCL-XL-dependent cell lines relative to the recently reported inhibitor, WEHI-539, while possessing none of its inherent pharmaceutical liabilities.  A-1155463 caused a mechanism-based and reversible thrombocytopenia in mice and inhibited H146 small cell lung cancer xenograft tumor growth in vivo following multiple doses.  A-1155463 thus represents an excellent tool mol. for studying BCL-XL biol. as well as a productive lead structure for further optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozGRbIa-4nxbVg90H21EOLACvtfcHk0lhgbdbG0z1YRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVWrtbnN&md5=5d2fffa59286214efac3f320a701215a</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fml5001867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml5001867%26sid%3Dliteratum%253Aachs%26aulast%3DTao%26aufirst%3DZ.%2BF.%26aulast%3DHasvold%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DPetros%26aufirst%3DA.%2BM.%26aulast%3DPark%26aufirst%3DC.%2BH.%26aulast%3DBoghaert%26aufirst%3DE.%2BR.%26aulast%3DCatron%26aufirst%3DN.%2BD.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DColman%26aufirst%3DP.%2BM.%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3DDeshayes%26aufirst%3DK.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26aulast%3DFlygare%26aufirst%3DJ.%2BA.%26aulast%3DHymowitz%26aufirst%3DS.%2BG.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DJudge%26aufirst%3DR.%2BA.%26aulast%3DKoehler%26aufirst%3DM.%2BF.%26aulast%3DKovar%26aufirst%3DP.%2BJ.%26aulast%3DLessene%26aufirst%3DG.%26aulast%3DMitten%26aufirst%3DM.%2BJ.%26aulast%3DNdubaku%26aufirst%3DC.%2BO.%26aulast%3DNimmer%26aufirst%3DP.%26aulast%3DPurkey%26aufirst%3DH.%2BE.%26aulast%3DOleksijew%26aufirst%3DA.%26aulast%3DPhillips%26aufirst%3DD.%2BC.%26aulast%3DSleebs%26aufirst%3DB.%2BE.%26aulast%3DSmith%26aufirst%3DB.%2BJ.%26aulast%3DSmith%26aufirst%3DM.%2BL.%26aulast%3DTahir%26aufirst%3DS.%2BK.%26aulast%3DWatson%26aufirst%3DK.%2BG.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DXue%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZobel%26aufirst%3DK.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DTse%26aufirst%3DC.%26aulast%3DLeverson%26aufirst%3DJ.%2BD.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26aulast%3DSouers%26aufirst%3DA.%2BJ.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520and%2520selective%2520Bcl-XL%2520inhibitor%2520with%2520in%2520vivo%2520activity%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D1088%26epage%3D1093%26doi%3D10.1021%2Fml5001867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huth, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petros, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunzer, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wendt, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mack, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swift, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Judge, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahir, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matayoshi, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorwin, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ladror, U. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Severin, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walter, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartley, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmore, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajduk, P. J.</span></span> <span> </span><span class="NLM_article-title">Discovery and Design of Novel HSP90 inhibitors using multiple fragment-based design strategies</span>. <i>Chem. Biol. Drug Des.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">12</span>, <span class="refDoi"> DOI: 10.1111/j.1747-0285.2007.00535.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1111%2Fj.1747-0285.2007.00535.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=17630989" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BD2sXovFCktrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2007&pages=1-12&author=J.+R.+Huthauthor=C.+Parkauthor=A.+M.+Petrosauthor=A.+R.+Kunzerauthor=M.+D.+Wendtauthor=X.+Wangauthor=C.+L.+Lynchauthor=J.+C.+Mackauthor=K.+M.+Swiftauthor=R.+A.+Judgeauthor=J.+Chenauthor=P.+L.+Richardsonauthor=S.+Jinauthor=S.+K.+Tahirauthor=E.+D.+Matayoshiauthor=S.+A.+Dorwinauthor=U.+S.+Ladrorauthor=J.+M.+Severinauthor=K.+A.+Walterauthor=D.+M.+Bartleyauthor=S.+W.+Fesikauthor=S.+W.+Elmoreauthor=P.+J.+Hajduk&title=Discovery+and+Design+of+Novel+HSP90+inhibitors+using+multiple+fragment-based+design+strategies&doi=10.1111%2Fj.1747-0285.2007.00535.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and design of novel HSP90 inhibitors using multiple fragment-based design strategies</span></div><div class="casAuthors">Huth, Jeffrey R.; Park, Chang; Petros, Andrew M.; Kunzer, Aaron R.; Wendt, Michael D.; Wang, Xilu; Lynch, Christopher L.; Mack, Jamey C.; Swift, Kerry M.; Judge, Russell A.; Chen, Jun; Richardson, Paul L.; Jin, Sha; Tahir, Stephen K.; Matayoshi, Edward D.; Dorwin, Sarah A.; Ladror, Uri S.; Severin, Jean M.; Walter, Karl A.; Bartley, Diane M.; Fesik, Stephen W.; Elmore, Steven W.; Hajduk, Philip J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-12</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The mol. chaperone HSP90 has been shown to facilitate cancer cell survival by stabilizing key proteins responsible for a malignant phenotype.  The authors report here the results of parallel fragment-based drug design approaches in the design of novel HSP9O inhibitors.  Initial aminopyrimidine leads were elaborated using high-throughput org. synthesis to yield nanomolar inhibitors of the enzyme.  Second site leads were also identified which bound to HSP90 in two distinct conformations, an 'open' and 'closed' form.  Intriguingly, linked fragment approaches targeting both of these conformations were successful in producing novel, micromolar inhibitors.  Overall, this study shows that, with only a few fragment hits, multiple lead series can be generated for HSP90 due to the inherent flexibility of the active site.  Thus, ample opportunities exist to use these lead series in the development of clin. useful HSP90 inhibitors for the treatment of cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXkkVC5aQLFbVg90H21EOLACvtfcHk0lit_UIdljGFbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXovFCktrY%253D&md5=ae1aa497320e997ae5c0971f7c9ab341</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2007.00535.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2007.00535.x%26sid%3Dliteratum%253Aachs%26aulast%3DHuth%26aufirst%3DJ.%2BR.%26aulast%3DPark%26aufirst%3DC.%26aulast%3DPetros%26aufirst%3DA.%2BM.%26aulast%3DKunzer%26aufirst%3DA.%2BR.%26aulast%3DWendt%26aufirst%3DM.%2BD.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLynch%26aufirst%3DC.%2BL.%26aulast%3DMack%26aufirst%3DJ.%2BC.%26aulast%3DSwift%26aufirst%3DK.%2BM.%26aulast%3DJudge%26aufirst%3DR.%2BA.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DRichardson%26aufirst%3DP.%2BL.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DTahir%26aufirst%3DS.%2BK.%26aulast%3DMatayoshi%26aufirst%3DE.%2BD.%26aulast%3DDorwin%26aufirst%3DS.%2BA.%26aulast%3DLadror%26aufirst%3DU.%2BS.%26aulast%3DSeverin%26aufirst%3DJ.%2BM.%26aulast%3DWalter%26aufirst%3DK.%2BA.%26aulast%3DBartley%26aufirst%3DD.%2BM.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26atitle%3DDiscovery%2520and%2520Design%2520of%2520Novel%2520HSP90%2520inhibitors%2520using%2520multiple%2520fragment-based%2520design%2520strategies%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2007%26volume%3D70%26spage%3D1%26epage%3D12%26doi%3D10.1111%2Fj.1747-0285.2007.00535.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Szczepankiewicz, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajduk, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abad-Zapatero, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pei, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lubben, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trevillyan, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stashko, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballaron, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutchins, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jirousek, M. R.</span></span> <span> </span><span class="NLM_article-title">Discovery of a potent, selective protein tyrosine phosphatase 1B inhibitor using a linked-fragment strategy</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>125</i></span>,  <span class="NLM_fpage">4087</span>– <span class="NLM_lpage">4096</span>, <span class="refDoi"> DOI: 10.1021/ja0296733</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja0296733" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhvFeks7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2003&pages=4087-4096&author=B.+G.+Szczepankiewiczauthor=G.+Liuauthor=P.+J.+Hajdukauthor=C.+Abad-Zapateroauthor=Z.+Peiauthor=Z.+Xinauthor=T.+H.+Lubbenauthor=J.+M.+Trevillyanauthor=M.+A.+Stashkoauthor=S.+J.+Ballaronauthor=H.+Liangauthor=F.+Huangauthor=C.+W.+Hutchinsauthor=S.+W.+Fesikauthor=M.+R.+Jirousek&title=Discovery+of+a+potent%2C+selective+protein+tyrosine+phosphatase+1B+inhibitor+using+a+linked-fragment+strategy&doi=10.1021%2Fja0296733"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent, Selective Protein Tyrosine Phosphatase 1B Inhibitor Using a Linked-Fragment Strategy</span></div><div class="casAuthors">Szczepankiewicz, Bruce G.; Liu, Gang; Hajduk, Philip J.; Abad-Zapatero, Cele; Pei, Zhonghua; Xin, Zhili; Lubben, Thomas H.; Trevillyan, James M.; Stashko, Michael A.; Ballaron, Stephen J.; Liang, Heng; Huang, Flora; Hutchins, Charles W.; Fesik, Stephen W.; Jirousek, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4087-4096</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Protein tyrosine phosphatase 1B (PTP1B) is an enzyme that downregulates the insulin receptor.  Inhibition of PTP1B is expected to improve insulin action, and the design of small mol. PTP1B inhibitors to treat type II diabetes has received considerable attention.  In this work, NMR-based screening identified a nonselective competitive inhibitor of PTP1B.  A second site ligand was also identified by NMR-based screening and then linked to the catalytic site ligand by rational design. X-ray data confirmed that the inhibitor bound with the catalytic site in the native, "open" conformation.  The final compd. displayed excellent potency and good selectivity over many other phosphatases.  The modular approach to drug design described in this work should be applicable for the design of potent and selective inhibitors of other therapeutically relevant protein tyrosine phosphatases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAUdjzxyGdkrVg90H21EOLACvtfcHk0lit_UIdljGFbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhvFeks7o%253D&md5=ff294c94485d4aa4c7a890b018218c84</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fja0296733&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0296733%26sid%3Dliteratum%253Aachs%26aulast%3DSzczepankiewicz%26aufirst%3DB.%2BG.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26aulast%3DAbad-Zapatero%26aufirst%3DC.%26aulast%3DPei%26aufirst%3DZ.%26aulast%3DXin%26aufirst%3DZ.%26aulast%3DLubben%26aufirst%3DT.%2BH.%26aulast%3DTrevillyan%26aufirst%3DJ.%2BM.%26aulast%3DStashko%26aufirst%3DM.%2BA.%26aulast%3DBallaron%26aufirst%3DS.%2BJ.%26aulast%3DLiang%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DF.%26aulast%3DHutchins%26aufirst%3DC.%2BW.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26aulast%3DJirousek%26aufirst%3DM.%2BR.%26atitle%3DDiscovery%2520of%2520a%2520potent%252C%2520selective%2520protein%2520tyrosine%2520phosphatase%25201B%2520inhibitor%2520using%2520a%2520linked-fragment%2520strategy%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2003%26volume%3D125%26spage%3D4087%26epage%3D4096%26doi%3D10.1021%2Fja0296733" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pei, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajduk, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abad-Zapatero, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutchins, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lubben, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballaron, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haasch, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaszubska, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rondinone, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trevillyan, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jirousek, M. R.</span></span> <span> </span><span class="NLM_article-title">Fragment screening and assembly: a highly efficient approach to a selective and cell active protein tyrosine phosphatase 1B inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">4232</span>– <span class="NLM_lpage">4235</span>, <span class="refDoi"> DOI: 10.1021/jm034122o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm034122o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmvVGhu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=4232-4235&author=G.+Liuauthor=Z.+Xinauthor=Z.+Peiauthor=P.+J.+Hajdukauthor=C.+Abad-Zapateroauthor=C.+W.+Hutchinsauthor=H.+Zhaoauthor=T.+H.+Lubbenauthor=S.+J.+Ballaronauthor=D.+L.+Haaschauthor=W.+Kaszubskaauthor=C.+M.+Rondinoneauthor=J.+M.+Trevillyanauthor=M.+R.+Jirousek&title=Fragment+screening+and+assembly%3A+a+highly+efficient+approach+to+a+selective+and+cell+active+protein+tyrosine+phosphatase+1B+inhibitor&doi=10.1021%2Fjm034122o"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment Screening and Assembly: A Highly Efficient Approach to a Selective and Cell Active Protein Tyrosine Phosphatase 1B Inhibitor</span></div><div class="casAuthors">Liu, Gang; Xin, Zhili; Pei, Zhonghua; Hajduk, Philip J.; Abad-Zapatero, Cele; Hutchins, Charles W.; Zhao, Hongyu; Lubben, Thomas H.; Ballaron, Stephen J.; Haasch, Deanna L.; Kaszubska, Wiweka; Rondinone, Cristina M.; Trevillyan, James M.; Jirousek, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">4232-4235</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Using an NMR-based fragment screening and x-ray crystal structure-based assembly, starting with millimolar ligands for both the catalytic site and the second phosphotyrosine binding site, we have identified a small-mol. inhibitor of protein tyrosine phosphatase 1B with low micromolar inhibition const., high selectivity (30-fold) over the highly homologous T-cell protein tyrosine phosphatase, and good cellular activity in COS-7 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrm-Fe5w65X9rVg90H21EOLACvtfcHk0lhl6bnFzSAsMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmvVGhu7k%253D&md5=316055742ee4aa6f6b28963b4576c427</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm034122o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm034122o%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DXin%26aufirst%3DZ.%26aulast%3DPei%26aufirst%3DZ.%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26aulast%3DAbad-Zapatero%26aufirst%3DC.%26aulast%3DHutchins%26aufirst%3DC.%2BW.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DLubben%26aufirst%3DT.%2BH.%26aulast%3DBallaron%26aufirst%3DS.%2BJ.%26aulast%3DHaasch%26aufirst%3DD.%2BL.%26aulast%3DKaszubska%26aufirst%3DW.%26aulast%3DRondinone%26aufirst%3DC.%2BM.%26aulast%3DTrevillyan%26aufirst%3DJ.%2BM.%26aulast%3DJirousek%26aufirst%3DM.%2BR.%26atitle%3DFragment%2520screening%2520and%2520assembly%253A%2520a%2520highly%2520efficient%2520approach%2520to%2520a%2520selective%2520and%2520cell%2520active%2520protein%2520tyrosine%2520phosphatase%25201B%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D4232%26epage%3D4235%26doi%3D10.1021%2Fjm034122o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krimm, I.</span></span> <span> </span><span class="NLM_article-title">INPHARMA-based identification of ligand binding site in fragment-based drug design</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">605</span>– <span class="NLM_lpage">610</span>, <span class="refDoi"> DOI: 10.1039/c2md20035j</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1039%2Fc2md20035j" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsFart70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=605-610&author=I.+Krimm&title=INPHARMA-based+identification+of+ligand+binding+site+in+fragment-based+drug+design&doi=10.1039%2Fc2md20035j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">INPHARMA-based identification of ligand binding site in fragment-based drug design</span></div><div class="casAuthors">Krimm, Isabelle</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">605-610</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">In the fragment-based drug design approach, methods for rapid identification of the ligand-binding site are essential.  The INPHARMA expt., a ligand-obsd. NMR expt. based on the nuclear Overhauser effect, is tested here with fragment-like mols. and the glycogen phosphorylase enzyme that contain multiple binding sites.  The results illustrate the potential of the method for the FBDD process and demonstrate that the INPHARMA expt. is particularly useful to study the binding specificity of the fragments and to assess the ligand binding mode in the presence of a ref. ligand.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUt_LlZxODa7Vg90H21EOLACvtfcHk0lhl6bnFzSAsMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsFart70%253D&md5=c07d7c2bfc387d0f3d4e41192db10adb</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1039%2Fc2md20035j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2md20035j%26sid%3Dliteratum%253Aachs%26aulast%3DKrimm%26aufirst%3DI.%26atitle%3DINPHARMA-based%2520identification%2520of%2520ligand%2520binding%2520site%2520in%2520fragment-based%2520drug%2520design%26jtitle%3DMedChemComm%26date%3D2012%26volume%3D3%26spage%3D605%26epage%3D610%26doi%3D10.1039%2Fc2md20035j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeRose, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">London, R. E.</span></span> <span> </span><span class="NLM_article-title">The inter-ligand Overhauser effect: a powerful new NMR approach for mapping structural relationships of macromolecular ligands</span>. <i>J. Biomol. NMR</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">71</span>– <span class="NLM_lpage">76</span>, <span class="refDoi"> DOI: 10.1023/A:1008360208627</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1023%2FA%3A1008360208627" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10549135" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADyaK1MXntFSgtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1999&pages=71-76&author=D.+Liauthor=E.+F.+DeRoseauthor=R.+E.+London&title=The+inter-ligand+Overhauser+effect%3A+a+powerful+new+NMR+approach+for+mapping+structural+relationships+of+macromolecular+ligands&doi=10.1023%2FA%3A1008360208627"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The inter-ligand Overhauser effect: a powerful new NMR approach for mapping structural relationships of macromolecular ligands</span></div><div class="casAuthors">Li, Dawei; DeRose, Eugene F.; London, Robert E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular NMR</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">71-76</span>CODEN:
                <span class="NLM_cas:coden">JBNME9</span>;
        ISSN:<span class="NLM_cas:issn">0925-2738</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">NMR expts. that transfer conformational information from the bound to the uncomplexed state via exchange have been utilized for many years.  It is demonstrated here that inter-ligand NOEs ("ILOEs"), which exist in ternary complexes with enzymes or other macromol. receptors, can be transferred via exchange to pairs of uncomplexed ligands.  This approach is illustrated by studies of glycolate + NAD+ in the presence of porcine heart lactate dehydrogenase, and by glucose-6-phosphate + NADPH in the presence of L. mesenteroides glucose-6-phosphate dehydrogenase.  This strategy opens up a general methodol. for exploring the active sites of enzymes and for the development of artificial ligands which can function as inhibitors, or more generally as modifiers of protein function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprcPANaPftSLVg90H21EOLACvtfcHk0lhl6bnFzSAsMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntFSgtr8%253D&md5=ff105603708ffb0e2a4e1501639707e8</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1023%2FA%3A1008360208627&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1008360208627%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DD.%26aulast%3DDeRose%26aufirst%3DE.%2BF.%26aulast%3DLondon%26aufirst%3DR.%2BE.%26atitle%3DThe%2520inter-ligand%2520Overhauser%2520effect%253A%2520a%2520powerful%2520new%2520NMR%2520approach%2520for%2520mapping%2520structural%2520relationships%2520of%2520macromolecular%2520ligands%26jtitle%3DJ.%2520Biomol.%2520NMR%26date%3D1999%26volume%3D15%26spage%3D71%26epage%3D76%26doi%3D10.1023%2FA%3A1008360208627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leone, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freeze, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellechia, M.</span></span> <span> </span><span class="NLM_article-title">The nuclear Overhauser effect in the lead identification process</span>. <i>Curr. Drug Discov. Technol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">91</span>– <span class="NLM_lpage">100</span>, <span class="refDoi"> DOI: 10.2174/157016306778108884</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.2174%2F157016306778108884" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=16925517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVSjsrzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=91-100&author=M.+Leoneauthor=H.+H.+Freezeauthor=C.+S.+Chanauthor=M.+Pellechia&title=The+nuclear+Overhauser+effect+in+the+lead+identification+process&doi=10.2174%2F157016306778108884"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">The nuclear overhauser effect in the lead identification process</span></div><div class="casAuthors">Leone, Marilisa; Freeze, Hudson H.; Chan, Chui Sien; Pellecchia, Maurizio</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Discovery Technologies</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">91-100</span>CODEN:
                <span class="NLM_cas:coden">CDDTAF</span>;
        ISSN:<span class="NLM_cas:issn">1570-1638</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  In the past several years NMR spectroscopy has emerged as a valuable tool in the drug discovery field.  In such context, several NMR-based techniques have been developed aimed at the identification and subsequent optimization of novel binders for a given protein target.  Among the different NMR approaches, those relying on the transferred Nuclear Overhauser Effect (tr-NOE) appear to be particularly useful as in some instances, in addn. to binding, tr-NOE may provide also structural information on the binding mode of a ligand.  In the current work we will reiterate the basic principles and applications that are related to measurements of tr-NOEs.  The tr-NOE can be applied as a screening tool to recognize ligands for a given target protein in a mixt. of compds. or to identify pair of mols. that bind to a protein simultaneously on adjacent sites (interligand NOEs).  Moreover, in the case of peptide-ligands, tr-NOEs furnish intra-mol. distance constraints that can be used to det. their bioactive conformation.  Starting from the conformation thus obtained, a pharmacophoric model can be derived and later used to search within a 3D database of small mols. to find new potentially active non-peptide compds. that fit the pharmacophore.  We will report examples of each of the above mentioned strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeZMslo8YAHLVg90H21EOLACvtfcHk0lg1mbmA8c6Ejw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVSjsrzO&md5=97ac2642c12206bc235c59c54dbff304</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.2174%2F157016306778108884&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157016306778108884%26sid%3Dliteratum%253Aachs%26aulast%3DLeone%26aufirst%3DM.%26aulast%3DFreeze%26aufirst%3DH.%2BH.%26aulast%3DChan%26aufirst%3DC.%2BS.%26aulast%3DPellechia%26aufirst%3DM.%26atitle%3DThe%2520nuclear%2520Overhauser%2520effect%2520in%2520the%2520lead%2520identification%2520process%26jtitle%3DCurr.%2520Drug%2520Discov.%2520Technol.%26date%3D2006%26volume%3D3%26spage%3D91%26epage%3D100%26doi%3D10.2174%2F157016306778108884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Becattini, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Culmsee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leone, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhai, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crowell, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rega, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landshamer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plesnila, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellecchia, M.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationships by interligand NOE-based design and synthesis of antiapoptotic compounds targeting Bid</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">12602</span>– <span class="NLM_lpage">12606</span>, <span class="refDoi"> DOI: 10.1073/pnas.0603460103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1073%2Fpnas.0603460103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=16891420" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BD28Xos1Ojt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=12602-12606&author=B.+Becattiniauthor=C.+Culmseeauthor=M.+Leoneauthor=D.+Zhaiauthor=X.+Zhangauthor=K.+J.+Crowellauthor=M.+F.+Regaauthor=S.+Landshamerauthor=J.+C.+Reedauthor=N.+Plesnilaauthor=M.+Pellecchia&title=Structure-activity+relationships+by+interligand+NOE-based+design+and+synthesis+of+antiapoptotic+compounds+targeting+Bid&doi=10.1073%2Fpnas.0603460103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationships by interligand NOE-based design and synthesis of antiapoptotic compounds targeting Bid</span></div><div class="casAuthors">Becattini, Barbara; Culmsee, Carsten; Leone, Marilisa; Zhai, Dayong; Zhang, Xiyun; Crowell, Kevin J.; Rega, Michele F.; Landshamer, Stefan; Reed, John C.; Plesnila, Nikolaus; Pellecchia, Maurizio</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">12602-12606</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Bcl-2 family proteins play a crucial role in tissue homeostasis and apoptosis (programmed cell death).  Bid is a proapoptotic member of the Bcl-2 family, promoting cell death when activated by caspase-8.  Following an NMR-based approach (structure-activity relationships by interligand NOE) we were able to identify two chem. fragments that bind on the surface of Bid.  Covalent linkage of the two fragments led to high-affinity bidentate derivs.  In vitro and in-cell assays demonstrate that the compds. prevent tBid translocation to the mitochondrial membrane and the subsequent release of proapoptotic stimuli and inhibit neuronal apoptosis in the low micromolar range.  Therefore, by using a rational chem.-biol. approach, we derived antiapoptotic compds. that may have a therapeutic potential for disorders assocd. with Bid activation, e.g., neurodegenerative diseases, cerebral ischemia, or brain trauma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9bKURSfekX7Vg90H21EOLACvtfcHk0lg1mbmA8c6Ejw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xos1Ojt78%253D&md5=d3aa703c0a392e10e084f4a7261146e6</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0603460103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0603460103%26sid%3Dliteratum%253Aachs%26aulast%3DBecattini%26aufirst%3DB.%26aulast%3DCulmsee%26aufirst%3DC.%26aulast%3DLeone%26aufirst%3DM.%26aulast%3DZhai%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DCrowell%26aufirst%3DK.%2BJ.%26aulast%3DRega%26aufirst%3DM.%2BF.%26aulast%3DLandshamer%26aufirst%3DS.%26aulast%3DReed%26aufirst%3DJ.%2BC.%26aulast%3DPlesnila%26aufirst%3DN.%26aulast%3DPellecchia%26aufirst%3DM.%26atitle%3DStructure-activity%2520relationships%2520by%2520interligand%2520NOE-based%2520design%2520and%2520synthesis%2520of%2520antiapoptotic%2520compounds%2520targeting%2520Bid%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2006%26volume%3D103%26spage%3D12602%26epage%3D12606%26doi%3D10.1073%2Fpnas.0603460103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rega, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cellitti, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellecchia, M.</span></span> <span> </span><span class="NLM_article-title">SAR by interligand nuclear overhauser effects (ILOEs) based discovery of acylsulfonamide compounds active against Bcl-X<sub>L</sub> and Mcl-1</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">6000</span>– <span class="NLM_lpage">6013</span>, <span class="refDoi"> DOI: 10.1021/jm200826s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200826s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpvVWksrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6000-6013&author=M.+F.+Regaauthor=B.+Wuauthor=J.+Weiauthor=Z.+Zhangauthor=J.+F.+Cellittiauthor=M.+Pellecchia&title=SAR+by+interligand+nuclear+overhauser+effects+%28ILOEs%29+based+discovery+of+acylsulfonamide+compounds+active+against+Bcl-XL+and+Mcl-1&doi=10.1021%2Fjm200826s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">SAR by Interligand Nuclear Overhauser Effects (ILOEs) Based Discovery of Acylsulfonamide Compounds Active against Bcl-xL and Mcl-1</span></div><div class="casAuthors">Rega, Michele F.; Wu, Bainan; Wei, Jun; Zhang, Ziming; Cellitti, Jason F.; Pellecchia, Maurizio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6000-6013</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Overexpression of antiapoptotic members of the Bcl-2 family proteins, such as Bcl-xL and Mfl-1, has been shown to be involved in resistance to chemotherapeutic drugs in many forms of cancers.  Recent efforts from the Abbott Labs. resulted in the development of the acylsulfonamide compd. and clin. candidate that targets selectively Bcl-2, Bcl-xL, and Bcl-w while it is not active against Mcl-1 and Bfl-1.  However, early clin. and preclin. studies suggest that pan-Bcl-2 antagonists, targeting simultaneously Mcl-1, Bcl-xL, and possibly all other four antiapoptotic Bcl-2 proteins, may result in more efficacious drugs.  Here, following an NMR fragment-based approach, SAR by ILOEs, we report on compds. that exhibit nanomolar affinities for both Bcl-xL and Mcl-1 in vitro.  We believe that these mols. can be used as useful starting point for the development of novel Bcl-2 antagonists, in particular targeting Mcl-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwDNlz7vWmFLVg90H21EOLACvtfcHk0lg1mbmA8c6Ejw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpvVWksrc%253D&md5=e2b1f2a0ffa1ec32c3154f8ef7b0aa22</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm200826s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200826s%26sid%3Dliteratum%253Aachs%26aulast%3DRega%26aufirst%3DM.%2BF.%26aulast%3DWu%26aufirst%3DB.%26aulast%3DWei%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DCellitti%26aufirst%3DJ.%2BF.%26aulast%3DPellecchia%26aufirst%3DM.%26atitle%3DSAR%2520by%2520interligand%2520nuclear%2520overhauser%2520effects%2520%2528ILOEs%2529%2520based%2520discovery%2520of%2520acylsulfonamide%2520compounds%2520active%2520against%2520Bcl-XL%2520and%2520Mcl-1%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D6000%26epage%3D6013%26doi%3D10.1021%2Fjm200826s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sledz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silvestre, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciulli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blundell, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abell, C.</span></span> <span> </span><span class="NLM_article-title">Optimization of the interligand Overhauser effect for fragment linking: application to inhibitor discovery against Mycobacterium tuberculosis pantothenate synthetase</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>132</i></span>,  <span class="NLM_fpage">4544</span>– <span class="NLM_lpage">4545</span>, <span class="refDoi"> DOI: 10.1021/ja100595u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja100595u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtlaisL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2010&pages=4544-4545&author=P.+Sledzauthor=H.+L.+Silvestreauthor=A.+W.+Hungauthor=A.+Ciulliauthor=T.+L.+Blundellauthor=C.+Abell&title=Optimization+of+the+interligand+Overhauser+effect+for+fragment+linking%3A+application+to+inhibitor+discovery+against+Mycobacterium+tuberculosis+pantothenate+synthetase&doi=10.1021%2Fja100595u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of the Interligand Overhauser Effect for Fragment Linking: Application to Inhibitor Discovery against Mycobacterium tuberculosis Pantothenate Synthetase</span></div><div class="casAuthors">Sledz, Pawel; Silvestre, H. Leonardo; Hung, Alvin W.; Ciulli, Alessio; Blundell, Tom L.; Abell, Chris</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4544-4545</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fragment-based methods are a new and emerging approach for the discovery of protein binders that are potential new therapeutic agents.  Several ways of utilizing structural information to guide the inhibitor assembly have been explored to date.  One of the approaches, application of interligand Overhauser effect (ILOE) observations, is of particular interest, as it does not require the availability of a three-dimensional protein structure and is an NMR-based method that can be applied to targets that cannot be obsd. directly because of their size.  Fragments, as small and often hydrophobic mols., suffer from problems including compd. aggregation in an aq. environment and nonspecific binding contributions, esp. when screened at higher concns. suitable for ILOE observations.  Here we report how this problem can be overcome by applying a step-by-step iterative procedure that includes the application of optimized probe mols. with known binding modes to elucidate the unknown binding modes of fragments.  An enzyme substrate with well-characterized binding was used as a starting point, and the relative binding modes of modified fragments derived from ILOE observations were used to guide the fragment linking, leading to a potent inhibitor of our model system, Mycobacterium tuberculosis pantothenate synthetase, a potential drug target.  We have supported our NMR data with crystal structures, thus establishing the guidelines for optimizing the ILOE observations.  This model study should expand the application of the technique in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_1G4hptSAYrVg90H21EOLACvtfcHk0lgQjQuE62BD7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtlaisL0%253D&md5=70cfadfd68f9711b421b5c3073e6300e</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fja100595u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja100595u%26sid%3Dliteratum%253Aachs%26aulast%3DSledz%26aufirst%3DP.%26aulast%3DSilvestre%26aufirst%3DH.%2BL.%26aulast%3DHung%26aufirst%3DA.%2BW.%26aulast%3DCiulli%26aufirst%3DA.%26aulast%3DBlundell%26aufirst%3DT.%2BL.%26aulast%3DAbell%26aufirst%3DC.%26atitle%3DOptimization%2520of%2520the%2520interligand%2520Overhauser%2520effect%2520for%2520fragment%2520linking%253A%2520application%2520to%2520inhibitor%2520discovery%2520against%2520Mycobacterium%2520tuberculosis%2520pantothenate%2520synthetase%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2010%26volume%3D132%26spage%3D4544%26epage%3D4545%26doi%3D10.1021%2Fja100595u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hung, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silvestre, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciulli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blundell, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abell, C.</span></span> <span> </span><span class="NLM_article-title">Application of fragment growing and fragment linking to the discovery of inhibitors of Mycobacterium tuberculosis pantothenate synthetase</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">8452</span>– <span class="NLM_lpage">8456</span>, <span class="refDoi"> DOI: 10.1002/anie.200903821</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1002%2Fanie.200903821" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlWmur%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=8452-8456&author=A.+W.+Hungauthor=H.+L.+Silvestreauthor=S.+Wenauthor=A.+Ciulliauthor=T.+L.+Blundellauthor=C.+Abell&title=Application+of+fragment+growing+and+fragment+linking+to+the+discovery+of+inhibitors+of+Mycobacterium+tuberculosis+pantothenate+synthetase&doi=10.1002%2Fanie.200903821"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Application of Fragment Growing and Fragment Linking to the Discovery of Inhibitors of Mycobacterium tuberculosis Pantothenate Synthetase</span></div><div class="casAuthors">Hung, Alvin W.; Silvestre, H. Leonardo; Wen, Shijun; Ciulli, Alessio; Blundell, Tom L.; Abell, Chris</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">8452-8456, S8452/1-S8452/26</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Despite the fact that nearly 2 million people a year are killed by Mycobacterium tuberculosis (TB), we still lack a robust pipeline of potential therapies to combat this burden.  Fragment-based approaches have provided a new paradigm in the development of high-quality chem. ligands and have great potential to contribute as starting points in the development of drugs against TB.  To date, studies on pantothenate synthetase (PS) inhibition have focused on the synthesis of analogs of the pantoyl adenylate reaction intermediate or the identification of hits from high-throughput screening.  We describe a combination of fragment-growing and fragment-linking approaches that led to the discovery of a new series of inhibitors of M. tuberculosis PS for the further validation of PS as a potential drug target for TB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjhska_U-KXbVg90H21EOLACvtfcHk0lgQjQuE62BD7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlWmur%252FK&md5=821f86e9e1d7cbd848741962e3ac47dd</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1002%2Fanie.200903821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200903821%26sid%3Dliteratum%253Aachs%26aulast%3DHung%26aufirst%3DA.%2BW.%26aulast%3DSilvestre%26aufirst%3DH.%2BL.%26aulast%3DWen%26aufirst%3DS.%26aulast%3DCiulli%26aufirst%3DA.%26aulast%3DBlundell%26aufirst%3DT.%2BL.%26aulast%3DAbell%26aufirst%3DC.%26atitle%3DApplication%2520of%2520fragment%2520growing%2520and%2520fragment%2520linking%2520to%2520the%2520discovery%2520of%2520inhibitors%2520of%2520Mycobacterium%2520tuberculosis%2520pantothenate%2520synthetase%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2009%26volume%3D48%26spage%3D8452%26epage%3D8456%26doi%3D10.1002%2Fanie.200903821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jahnke, W.</span></span> <span> </span><span class="NLM_article-title">Spin labels as a tool to identify and characterize protein-ligand interactions by NMR spectroscopy</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">167</span>– <span class="NLM_lpage">173</span>, <span class="refDoi"> DOI: 10.1002/1439-7633(20020301)3:2/3<167::AID-CBIC167>3.0.CO;2-S</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1002%2F1439-7633%2820020301%293%3A2%2F3%3C167%3A%3AAID-CBIC167%3E3.0.CO%3B2-S" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=11921394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BD38Xis1Kit7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2002&pages=167-173&author=W.+Jahnke&title=Spin+labels+as+a+tool+to+identify+and+characterize+protein-ligand+interactions+by+NMR+spectroscopy&doi=10.1002%2F1439-7633%2820020301%293%3A2%2F3%3C167%3A%3AAID-CBIC167%3E3.0.CO%3B2-S"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Spin labels as a tool to identify and characterize protein - ligand interactions by NMR spectroscopy</span></div><div class="casAuthors">Jahnke, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">167-173</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH</span>)
        </div><div class="casAbstract">NMR spectroscopy based discovery and optimization of lead compds. for a given mol. target requires the development of methods with max. sensitivity and robustness.  It is shown here that org. nitroxide radicals ("spin labels") can be used to boost the sensitivity of NMR spectroscopic screening in drug discovery research.  The concept of utilizing spin labels in NMR spectroscopy is summarized, examples for successful first-site and second-site NMR spectroscopic screens are given, and guidelines for linker design are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGIWYbfxkWmrVg90H21EOLACvtfcHk0lgQjQuE62BD7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xis1Kit7w%253D&md5=e29645610e295da1196d5b2f4c380443</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2F1439-7633%2820020301%293%3A2%2F3%3C167%3A%3AAID-CBIC167%3E3.0.CO%3B2-S&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1439-7633%252820020301%25293%253A2%252F3%253C167%253A%253AAID-CBIC167%253E3.0.CO%253B2-S%26sid%3Dliteratum%253Aachs%26aulast%3DJahnke%26aufirst%3DW.%26atitle%3DSpin%2520labels%2520as%2520a%2520tool%2520to%2520identify%2520and%2520characterize%2520protein-ligand%2520interactions%2520by%2520NMR%2520spectroscopy%26jtitle%3DChemBioChem%26date%3D2002%26volume%3D3%26spage%3D167%26epage%3D173%26doi%3D10.1002%2F1439-7633%2820020301%293%3A2%2F3%3C167%3A%3AAID-CBIC167%3E3.0.CO%3B2-S" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jahnke, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Florsheimer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blommers, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paris, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nalin, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, L. B.</span></span> <span> </span><span class="NLM_article-title">Second-site NMR screening and linker design</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">69</span>– <span class="NLM_lpage">80</span>, <span class="refDoi"> DOI: 10.2174/1568026033392778</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.2174%2F1568026033392778" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=12570778" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BD3sXis1Khtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=69-80&author=W.+Jahnkeauthor=A.+Florsheimerauthor=M.+J.+Blommersauthor=C.+G.+Parisauthor=J.+Heimauthor=C.+M.+Nalinauthor=L.+B.+Perez&title=Second-site+NMR+screening+and+linker+design&doi=10.2174%2F1568026033392778"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Second-site NMR screening and linker design</span></div><div class="casAuthors">Jahnke, Wolfgang; Florsheimer, Andreas; Blommers, Marcel J. J.; Paris, C. Gregory; Heim, Jutta; Nalin, Carlo M.; Perez, Lawrence B.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Hilversum, Netherlands)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">69-80</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  One of the prime merits of NMR as a tool for lead finding in drug discovery research is its sensitivity and robustness to detect weak protein-ligand interactions.  This sensitivity allows to build up ligands for a given target in a modular way, by a fragment-based approach.  In this approach, two ligands are sep. identified which bind to the target protein generally weakly, but at adjacent binding sites.  In a next step, they are chem. linked to produce a high-affinity ligand.  This review discusses methods to detect "second-site" ligands that bind to a protein in the presence of a "first-site" ligand, and methods to elucidate structural details on the spatial orientation of both ligands, so that chem. linkage is based on a large piece of exptl. information.  Published examples from second-site screening and linker design are summarized, and are complemented by previously unpublished inhouse examples.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqk1216TKRkJLVg90H21EOLACvtfcHk0ljH1M0kTcpsqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXis1Khtw%253D%253D&md5=f863a8c10482337eb138a576beb69720</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.2174%2F1568026033392778&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026033392778%26sid%3Dliteratum%253Aachs%26aulast%3DJahnke%26aufirst%3DW.%26aulast%3DFlorsheimer%26aufirst%3DA.%26aulast%3DBlommers%26aufirst%3DM.%2BJ.%26aulast%3DParis%26aufirst%3DC.%2BG.%26aulast%3DHeim%26aufirst%3DJ.%26aulast%3DNalin%26aufirst%3DC.%2BM.%26aulast%3DPerez%26aufirst%3DL.%2BB.%26atitle%3DSecond-site%2520NMR%2520screening%2520and%2520linker%2520design%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2003%26volume%3D3%26spage%3D69%26epage%3D80%26doi%3D10.2174%2F1568026033392778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vazquez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tautz, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vuori, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mustelin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellecchia, M.</span></span> <span> </span><span class="NLM_article-title">Development of molecular probes for second-site screening and design of protein tyrosine phosphatase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">2137</span>– <span class="NLM_lpage">2143</span>, <span class="refDoi"> DOI: 10.1021/jm061481l</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm061481l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjs1Sktr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2137-2143&author=J.+Vazquezauthor=L.+Tautzauthor=J.+J.+Ryanauthor=K.+Vuoriauthor=T.+Mustelinauthor=M.+Pellecchia&title=Development+of+molecular+probes+for+second-site+screening+and+design+of+protein+tyrosine+phosphatase+inhibitors&doi=10.1021%2Fjm061481l"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Molecular Probes for Second-Site Screening and Design of Protein Tyrosine Phosphatase Inhibitors</span></div><div class="casAuthors">Vazquez, Jesus; Tautz, Lutz; Ryan, Jennifer J.; Vuori, Kristiina; Mustelin, Tomas; Pellecchia, Maurizio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2137-2143</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report on the design, synthesis, and evaluation of a series of furanyl-salicyl-nitroxide derivs. as effective chem. probes for second-site screening against phosphotyrosine phosphatases (PTPs) using NMR-based techniques.  The compds. have been tested against a panel of PTPs to assess their ability to inhibit a broad spectrum of these phosphatases.  The utility of the derived compds. is illustrated with the phosphatase YopH, a bacterial toxin from Yersinia pestis.  Novel chem. fragments were identified during an NMR-based screen for compds. that are capable of binding on the surface of YopH in regions adjacent the catalytic site in the presence of the spin-labeled compds.  Our data demonstrate the value of the derived chem. probes for NMR-based second-site screening in PTPs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDvLzBHaggfLVg90H21EOLACvtfcHk0ljH1M0kTcpsqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjs1Sktr8%253D&md5=636f860184d23189ad1d82cf18c66c5a</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm061481l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061481l%26sid%3Dliteratum%253Aachs%26aulast%3DVazquez%26aufirst%3DJ.%26aulast%3DTautz%26aufirst%3DL.%26aulast%3DRyan%26aufirst%3DJ.%2BJ.%26aulast%3DVuori%26aufirst%3DK.%26aulast%3DMustelin%26aufirst%3DT.%26aulast%3DPellecchia%26aufirst%3DM.%26atitle%3DDevelopment%2520of%2520molecular%2520probes%2520for%2520second-site%2520screening%2520and%2520design%2520of%2520protein%2520tyrosine%2520phosphatase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2137%26epage%3D2143%26doi%3D10.1021%2Fjm061481l" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vazquez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riel-Mehan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emdadi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cellitti, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stebbins, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rega, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellecchia, M.</span></span> <span> </span><span class="NLM_article-title">Development of paramagnetic probes for molecular recognition studies in protein kinases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">3460</span>– <span class="NLM_lpage">3465</span>, <span class="refDoi"> DOI: 10.1021/jm800068w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800068w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmtF2rsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=3460-3465&author=J.+Vazquezauthor=S.+K.+Deauthor=L.+H.+Chenauthor=M.+Riel-Mehanauthor=A.+Emdadiauthor=J.+Cellittiauthor=J.+L.+Stebbinsauthor=M.+F.+Regaauthor=M.+Pellecchia&title=Development+of+paramagnetic+probes+for+molecular+recognition+studies+in+protein+kinases&doi=10.1021%2Fjm800068w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Paramagnetic Probes for Molecular Recognition Studies in Protein Kinases</span></div><div class="casAuthors">Vazquez, Jesus; De, Surya K.; Chen, Li-Hsing; Riel-Mehan, Megan; Emdadi, Aras; Cellitti, Jason; Stebbins, John L.; Rega, Michele F.; Pellecchia, Maurizio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3460-3465</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report on the synthesis and evaluation of an indazole-spin-labeled compd. that was designed as an effective chem. probe for second site screening against the protein kinase JNK using NMR-based techniques.  We demonstrate the utility of the derived compd. in detecting and characterizing binding events at the protein kinase docking site.  In addn., we report on the NMR-based design and synthesis of a bidentate compd. spanning both the ATP site and the docking site.  We show that the resulting compd. has nanomolar affinity for JNK despite the relatively weak affinities of the individual fragments that constitute it.  The approach demonstrates that targeting the docking site of protein kinases represents a valuable yet unexplored avenue to obtain potent kinase inhibitors with increased selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2LGC2s51u8rVg90H21EOLACvtfcHk0ljH1M0kTcpsqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmtF2rsb0%253D&md5=62388bd06221e0fd834c97df06fe2640</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm800068w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800068w%26sid%3Dliteratum%253Aachs%26aulast%3DVazquez%26aufirst%3DJ.%26aulast%3DDe%26aufirst%3DS.%2BK.%26aulast%3DChen%26aufirst%3DL.%2BH.%26aulast%3DRiel-Mehan%26aufirst%3DM.%26aulast%3DEmdadi%26aufirst%3DA.%26aulast%3DCellitti%26aufirst%3DJ.%26aulast%3DStebbins%26aufirst%3DJ.%2BL.%26aulast%3DRega%26aufirst%3DM.%2BF.%26aulast%3DPellecchia%26aufirst%3DM.%26atitle%3DDevelopment%2520of%2520paramagnetic%2520probes%2520for%2520molecular%2520recognition%2520studies%2520in%2520protein%2520kinases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D3460%26epage%3D3465%26doi%3D10.1021%2Fjm800068w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Egger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weckerle, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cutting, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwardt, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabbani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemme, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ernst, B.</span></span> <span> </span><span class="NLM_article-title">Nanomolar E-selectin antagonists with prolonged half-lives by a fragment-based approach</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>135</i></span>,  <span class="NLM_fpage">9820</span>– <span class="NLM_lpage">9828</span>, <span class="refDoi"> DOI: 10.1021/ja4029582</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja4029582" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptVSqurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2013&pages=9820-9828&author=J.+Eggerauthor=C.+Weckerleauthor=B.+Cuttingauthor=O.+Schwardtauthor=S.+Rabbaniauthor=K.+Lemmeauthor=B.+Ernst&title=Nanomolar+E-selectin+antagonists+with+prolonged+half-lives+by+a+fragment-based+approach&doi=10.1021%2Fja4029582"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Nano-molar E-Selectin Antagonists with Prolonged Half-Lives by a Fragment-Based Approach</span></div><div class="casAuthors">Egger, Jonas; Weckerle, Celine; Cutting, Brian; Schwardt, Oliver; Rabbani, Said; Lemme, Katrin; Ernst, Beat</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">9820-9828</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Selectins, a family of C-type lectins, play a key role in inflammatory diseases (e.g., asthma and arthritis).  However, the only millimolar affinity of sialyl Lewisx (sLex), which is the common tetrasaccharide epitope of all physiol. selectin ligands, has been a major obstacle to the development of selectin antagonists for therapeutic applications.  In a fragment-based approach guided by NMR, ligands binding to a second site in close proximity to a sLex mimic were identified.  A library of antagonists obtained by connecting the sLex mimic to the best second-site ligand via triazole linkers of different lengths was evaluated by surface plasmon resonance.  Detailed anal. of the five most promising candidates revealed antagonists with KD values ranging from 30 to 89 nM.  In contrast to carbohydrate-lectin complexes with typical half-lives (t1/2) in the range of one second or even less, these fragment-based selectin antagonists show t1/2 of several minutes.  They exhibit a promising starting point for the development of novel anti-inflammatory drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGputib8-AvT-rVg90H21EOLACvtfcHk0lhwz671gD2iCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptVSqurw%253D&md5=cefd0f4561991cf087729f6d13a24e2a</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fja4029582&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja4029582%26sid%3Dliteratum%253Aachs%26aulast%3DEgger%26aufirst%3DJ.%26aulast%3DWeckerle%26aufirst%3DC.%26aulast%3DCutting%26aufirst%3DB.%26aulast%3DSchwardt%26aufirst%3DO.%26aulast%3DRabbani%26aufirst%3DS.%26aulast%3DLemme%26aufirst%3DK.%26aulast%3DErnst%26aufirst%3DB.%26atitle%3DNanomolar%2520E-selectin%2520antagonists%2520with%2520prolonged%2520half-lives%2520by%2520a%2520fragment-based%2520approach%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2013%26volume%3D135%26spage%3D9820%26epage%3D9828%26doi%3D10.1021%2Fja4029582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Judd, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartberger, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fremeau, R. T.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hitchcock, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Louie, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michelsen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nixey, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rattan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sickmier, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">St. Jean, D. J.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahl, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, S.</span></span> <span> </span><span class="NLM_article-title">From fragment screening to in vivo efficacy: optimization of a series of 2-aminoquinolines as potent inhibitors of beta-site amyloid precursor protein cleaving enzyme 1 (BACE1)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">5836</span>– <span class="NLM_lpage">5857</span>, <span class="refDoi"> DOI: 10.1021/jm200544q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200544q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpsFSksrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=5836-5857&author=Y.+Chengauthor=T.+C.+Juddauthor=M.+D.+Bartbergerauthor=J.+Brownauthor=K.+Chenauthor=R.+T.+Fremeauauthor=D.+Hickmanauthor=S.+A.+Hitchcockauthor=B.+Jordanauthor=V.+Liauthor=P.+Lopezauthor=S.+W.+Louieauthor=Y.+Luoauthor=K.+Michelsenauthor=T.+Nixeyauthor=T.+S.+Powersauthor=C.+Rattanauthor=E.+A.+Sickmierauthor=D.+J.+St.+Jeanauthor=R.+C.+Wahlauthor=P.+H.+Wenauthor=S.+Wood&title=From+fragment+screening+to+in+vivo+efficacy%3A+optimization+of+a+series+of+2-aminoquinolines+as+potent+inhibitors+of+beta-site+amyloid+precursor+protein+cleaving+enzyme+1+%28BACE1%29&doi=10.1021%2Fjm200544q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">From Fragment Screening to In Vivo Efficacy: Optimization of a Series of 2-Aminoquinolines as Potent Inhibitors of Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1)</span></div><div class="casAuthors">Cheng, Yuan; Judd, Ted C.; Bartberger, Michael D.; Brown, James; Chen, Kui; Fremeau, Robert T.; Hickman, Dean; Hitchcock, Stephen A.; Jordan, Brad; Li, Vivian; Lopez, Patricia; Louie, Steven W.; Luo, Yi; Michelsen, Klaus; Nixey, Thomas; Powers, Timothy S.; Rattan, Claire; Sickmier, E. Allen; St. Jean, David J.; Wahl, Robert C.; Wen, Paul H.; Wood, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5836-5857</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Using fragment-based screening of a focused fragment library, 2-aminoquinoline 1 was identified as an initial hit for BACE1.  Further SAR development was supported by X-ray structures of BACE1 cocrystd. with various ligands and mol. modeling studies to expedite the discovery of potent compds.  These strategies enabled us to integrate the C-3 side chain on 2-aminoquinoline 1 extending deep into the P2' binding pocket of BACE1 and enhancing the ligand's potency.  We were able to improve the BACE1 potency to subnanomolar range, over 106-fold more potent than the initial hit (900 μM).  Further elaboration of the phys. properties of the lead compds. to those more consistent with good blood-brain barrier permeability led to inhibitors with greatly improved cellular activity and permeability.  Compd. 59 showed an IC50 value of 11 nM on BACE1 and cellular activity of 80 nM.  This compd. was advanced into rat pharmacokinetic and pharmacodynamic studies and demonstrated significant redn. of Aβ levels in cerebrospinal fluid (CSF).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLRGyUyxO1fLVg90H21EOLACvtfcHk0lhwz671gD2iCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpsFSksrk%253D&md5=fa0f2b9b7524a1c3b75e162801f54d90</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm200544q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200544q%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DJudd%26aufirst%3DT.%2BC.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DJordan%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DV.%26aulast%3DLopez%26aufirst%3DP.%26aulast%3DLouie%26aufirst%3DS.%2BW.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DMichelsen%26aufirst%3DK.%26aulast%3DNixey%26aufirst%3DT.%26aulast%3DPowers%26aufirst%3DT.%2BS.%26aulast%3DRattan%26aufirst%3DC.%26aulast%3DSickmier%26aufirst%3DE.%2BA.%26aulast%3DSt.%2BJean%26aufirst%3DD.%2BJ.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWood%26aufirst%3DS.%26atitle%3DFrom%2520fragment%2520screening%2520to%2520in%2520vivo%2520efficacy%253A%2520optimization%2520of%2520a%2520series%2520of%25202-aminoquinolines%2520as%2520potent%2520inhibitors%2520of%2520beta-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520%2528BACE1%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D5836%26epage%3D5857%26doi%3D10.1021%2Fjm200544q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittington, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartberger, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sickmier, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Judd, T.</span></span> <span> </span><span class="NLM_article-title">A fragment-linking approach using 19F NMR spectroscopy to obtain highly potent and selective inhibitors of β-secretase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">3732</span>– <span class="NLM_lpage">3749</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01917</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01917" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC28XktFeitr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=3732-3749&author=J.+B.+Jordanauthor=D.+A.+Whittingtonauthor=M.+D.+Bartbergerauthor=E.+A.+Sickmierauthor=K.+Chenauthor=Y.+Chengauthor=T.+Judd&title=A+fragment-linking+approach+using+19F+NMR+spectroscopy+to+obtain+highly+potent+and+selective+inhibitors+of+%CE%B2-secretase&doi=10.1021%2Facs.jmedchem.5b01917"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Linking Approach Using 19F NMR Spectroscopy To Obtain Highly Potent and Selective Inhibitors of β-Secretase</span></div><div class="casAuthors">Jordan, John B.; Whittington, Douglas A.; Bartberger, Michael D.; Sickmier, E. Allen; Chen, Kui; Cheng, Yuan; Judd, Ted</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3732-3749</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fragment-based drug discovery (FBDD) has become a widely used tool in small-mol. drug discovery efforts.  One of the most commonly used biophys. methods in detecting weak binding of fragments is NMR (NMR) spectroscopy.  In particular, FBDD performed with 19F NMR-based methods has been shown to provide several advantages over 1H NMR using traditional magnetization-transfer and/or two-dimensional methods.  Here, we demonstrate the utility and power of 19F-based fragment screening by detailing the identification of a second-site fragment through 19F NMR screening that binds to a specific pocket of the aspartic acid protease, β-secretase (BACE-1).  The identification of this second-site fragment allowed the undertaking of a fragment-linking approach, which ultimately yielded a mol. exhibiting a more than 360-fold increase in potency while maintaining reasonable ligand efficiency and gaining much improved selectivity over cathepsin-D (CatD).  X-ray crystallog. studies of the mols. demonstrated that the linked fragments exhibited binding modes consistent with those predicted from the targeted screening approach, through-space NMR data, and mol. modeling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq95M4k5aaQurVg90H21EOLACvtfcHk0lhwz671gD2iCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktFeitr8%253D&md5=6bd6021938c555d8c7083549e4b49a2e</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01917&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01917%26sid%3Dliteratum%253Aachs%26aulast%3DJordan%26aufirst%3DJ.%2BB.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DSickmier%26aufirst%3DE.%2BA.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DJudd%26aufirst%3DT.%26atitle%3DA%2520fragment-linking%2520approach%2520using%252019F%2520NMR%2520spectroscopy%2520to%2520obtain%2520highly%2520potent%2520and%2520selective%2520inhibitors%2520of%2520%25CE%25B2-secretase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D3732%26epage%3D3749%26doi%3D10.1021%2Facs.jmedchem.5b01917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Casale, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amboldi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brasca, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caronni, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colombo, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalvit, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felder, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fogliatto, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galvani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isacchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polucci, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riceputi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sola, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Visco, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuccotto, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casuscelli, F.</span></span> <span> </span><span class="NLM_article-title">Fragment-based hit discovery and structure-based optimization of aminotriazoloquinazolines as novel HSP90 inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">4135</span>– <span class="NLM_lpage">4150</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2014.05.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1016%2Fj.bmc.2014.05.056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=24980703" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVKhtbfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=4135-4150&author=E.+Casaleauthor=N.+Amboldiauthor=M.+G.+Brascaauthor=D.+Caronniauthor=N.+Colomboauthor=C.+Dalvitauthor=E.+R.+Felderauthor=G.+Fogliattoauthor=A.+Galvaniauthor=A.+Isacchiauthor=P.+Polucciauthor=L.+Riceputiauthor=F.+Solaauthor=C.+Viscoauthor=F.+Zuccottoauthor=F.+Casuscelli&title=Fragment-based+hit+discovery+and+structure-based+optimization+of+aminotriazoloquinazolines+as+novel+HSP90+inhibitors&doi=10.1016%2Fj.bmc.2014.05.056"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-based hit discovery and structure-based optimization of aminotriazoloquinazolines as novel Hsp90 inhibitors</span></div><div class="casAuthors">Casale, Elena; Amboldi, Nadia; Brasca, Maria Gabriella; Caronni, Dannica; Colombo, Nicoletta; Dalvit, Claudio; Felder, Eduard R.; Fogliatto, Gianpaolo; Galvani, Arturo; Isacchi, Antonella; Polucci, Paolo; Riceputi, Laura; Sola, Francesco; Visco, Carlo; Zuccotto, Fabio; Casuscelli, Francesco</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4135-4150</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In the last decade the heat shock protein 90 (Hsp90) has emerged as a major therapeutic target and many efforts have been dedicated to the discovery of Hsp90 inhibitors as new potent anticancer agents.  Here the authors report the identification of a novel class of Hsp90 inhibitors by means of a biophys. FAXS-NMR based screening of a library of fragments.  The use of x-ray structure information combined with modeling studies enabled the fragment evolution of the initial triazoloquinazoline hit to a class of compds. with nanomolar potency and drug-like properties suited for further lead optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8pZK-hye807Vg90H21EOLACvtfcHk0lhqzq1ohJLI1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVKhtbfK&md5=7d3d910e96249f6d5550cecc2363af9c</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.05.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.05.056%26sid%3Dliteratum%253Aachs%26aulast%3DCasale%26aufirst%3DE.%26aulast%3DAmboldi%26aufirst%3DN.%26aulast%3DBrasca%26aufirst%3DM.%2BG.%26aulast%3DCaronni%26aufirst%3DD.%26aulast%3DColombo%26aufirst%3DN.%26aulast%3DDalvit%26aufirst%3DC.%26aulast%3DFelder%26aufirst%3DE.%2BR.%26aulast%3DFogliatto%26aufirst%3DG.%26aulast%3DGalvani%26aufirst%3DA.%26aulast%3DIsacchi%26aufirst%3DA.%26aulast%3DPolucci%26aufirst%3DP.%26aulast%3DRiceputi%26aufirst%3DL.%26aulast%3DSola%26aufirst%3DF.%26aulast%3DVisco%26aufirst%3DC.%26aulast%3DZuccotto%26aufirst%3DF.%26aulast%3DCasuscelli%26aufirst%3DF.%26atitle%3DFragment-based%2520hit%2520discovery%2520and%2520structure-based%2520optimization%2520of%2520aminotriazoloquinazolines%2520as%2520novel%2520HSP90%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D4135%26epage%3D4150%26doi%3D10.1016%2Fj.bmc.2014.05.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kohlmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zech, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Squillace, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Commodore, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenfield, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodd, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miret, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clackson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shakespeare, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalgarno, D. C.</span></span> <span> </span><span class="NLM_article-title">Fragment growing and linking lead to novel nanomolar lactate dehydrogenase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">1023</span>– <span class="NLM_lpage">1040</span>, <span class="refDoi"> DOI: 10.1021/jm3014844</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3014844" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC3sXms1OlsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=1023-1040&author=A.+Kohlmannauthor=S.+G.+Zechauthor=F.+Liauthor=T.+Zhouauthor=R.+M.+Squillaceauthor=L.+Commodoreauthor=M.+T.+Greenfieldauthor=X.+Luauthor=D.+P.+Millerauthor=W.+S.+Huangauthor=J.+Qiauthor=R.+M.+Thomasauthor=Y.+Wangauthor=S.+Zhangauthor=R.+Doddauthor=S.+Liuauthor=R.+Xuauthor=Y.+Xuauthor=J.+J.+Miretauthor=V.+Riveraauthor=T.+Clacksonauthor=W.+C.+Shakespeareauthor=X.+Zhuauthor=D.+C.+Dalgarno&title=Fragment+growing+and+linking+lead+to+novel+nanomolar+lactate+dehydrogenase+inhibitors&doi=10.1021%2Fjm3014844"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment Growing and Linking Lead to Novel Nanomolar Lactate Dehydrogenase Inhibitors</span></div><div class="casAuthors">Kohlmann, Anna; Zech, Stephan G.; Li, Feng; Zhou, Tianjun; Squillace, Rachel M.; Commodore, Lois; Greenfield, Matthew T.; Lu, Xiaohui; Miller, David P.; Huang, Wei-Sheng; Qi, Jiwei; Thomas, R. Mathew; Wang, Yihan; Zhang, Sen; Dodd, Rory; Liu, Shuangying; Xu, Rongsong; Xu, Yongjin; Miret, Juan J.; Rivera, Victor; Clackson, Tim; Shakespeare, William C.; Zhu, Xiaotian; Dalgarno, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1023-1040</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Lactate dehydrogenase A (LDH-A) catalyzes the interconversion of lactate and pyruvate in the glycolysis pathway.  Cancer cells rely heavily on glycolysis instead of oxidative phosphorylation to generate ATP, a phenomenon known as the Warburg effect.  The inhibition of LDH-A by small mols. is therefore of interest for potential cancer treatments.  We describe the identification and optimization of LDH-A inhibitors by fragment-based drug discovery.  We applied ligand based NMR screening to identify low affinity fragments binding to LDH-A.  The dissocn. consts. (Kd) and enzyme inhibition (IC50) of fragment hits were measured by surface plasmon resonance (SPR) and enzyme assays, resp.  The binding modes of selected fragments were investigated by X-ray crystallog.  Fragment growing and linking, followed by chem. optimization, resulted in nanomolar LDH-A inhibitors that demonstrated stoichiometric binding to LDH-A.  Selected mols. inhibited lactate prodn. in cells, suggesting target-specific inhibition in cancer cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_pFkSoe2_ALVg90H21EOLACvtfcHk0lhqzq1ohJLI1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXms1OlsA%253D%253D&md5=3a6b0b46318ae2d6c2a7c34e1575ada6</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm3014844&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3014844%26sid%3Dliteratum%253Aachs%26aulast%3DKohlmann%26aufirst%3DA.%26aulast%3DZech%26aufirst%3DS.%2BG.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DSquillace%26aufirst%3DR.%2BM.%26aulast%3DCommodore%26aufirst%3DL.%26aulast%3DGreenfield%26aufirst%3DM.%2BT.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DMiller%26aufirst%3DD.%2BP.%26aulast%3DHuang%26aufirst%3DW.%2BS.%26aulast%3DQi%26aufirst%3DJ.%26aulast%3DThomas%26aufirst%3DR.%2BM.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DDodd%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DR.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DMiret%26aufirst%3DJ.%2BJ.%26aulast%3DRivera%26aufirst%3DV.%26aulast%3DClackson%26aufirst%3DT.%26aulast%3DShakespeare%26aufirst%3DW.%2BC.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DDalgarno%26aufirst%3DD.%2BC.%26atitle%3DFragment%2520growing%2520and%2520linking%2520lead%2520to%2520novel%2520nanomolar%2520lactate%2520dehydrogenase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D1023%26epage%3D1040%26doi%3D10.1021%2Fjm3014844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Erlanson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braisted, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raphael, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stroud, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, J. A.</span></span> <span> </span><span class="NLM_article-title">Site-directed ligand discovery</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">9367</span>– <span class="NLM_lpage">9372</span>, <span class="refDoi"> DOI: 10.1073/pnas.97.17.9367</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1073%2Fpnas.97.17.9367" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10944209" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmtVensr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=9367-9372&author=D.+A.+Erlansonauthor=A.+C.+Braistedauthor=D.+R.+Raphaelauthor=M.+Randalauthor=R.+M.+Stroudauthor=E.+M.+Gordonauthor=J.+A.+Wells&title=Site-directed+ligand+discovery&doi=10.1073%2Fpnas.97.17.9367"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Site-directed ligand discovery</span></div><div class="casAuthors">Erlanson, Daniel A.; Braisted, Andrew C.; Raphael, Darren R.; Randal, Mike; Stroud, Robert M.; Gordon, Eric M.; Wells, James A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">9367-9372</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">We report a strategy (called "tethering") to discover low mol. wt. ligands (≈250 Da) that bind weakly to targeted sites on proteins through an intermediary disulfide tether.  A native or engineered cysteine in a protein is allowed to react reversibly with a small library of disulfide-contg. mols. (≈1,200 compds.) at concns. typically used in drug screening (10 to 200 μM).  The cysteine-captured ligands, which are readily identified by MS, are among the most stable complexes, even though in the absence of the covalent tether the ligands may bind very weakly.  This method was applied to generate a potent inhibitor for thymidylate synthase, an essential enzyme in pyrimidine metab. with therapeutic applications in cancer and infectious diseases.  The affinity of the untethered ligand (Ki≈1 mM) was improved 3,000-fold by synthesis of a small set of analogs with the aid of crystallog. structures of the tethered complex.  Such site-directed ligand discovery allows one to nucleate drug design from a spatially targeted lead fragment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4pxPEoDE3FrVg90H21EOLACvtfcHk0ljxsx-zcCiaRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmtVensr8%253D&md5=fef57a0d21af9bc7f6f1f4bf8c023ae5</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1073%2Fpnas.97.17.9367&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.97.17.9367%26sid%3Dliteratum%253Aachs%26aulast%3DErlanson%26aufirst%3DD.%2BA.%26aulast%3DBraisted%26aufirst%3DA.%2BC.%26aulast%3DRaphael%26aufirst%3DD.%2BR.%26aulast%3DRandal%26aufirst%3DM.%26aulast%3DStroud%26aufirst%3DR.%2BM.%26aulast%3DGordon%26aufirst%3DE.%2BM.%26aulast%3DWells%26aufirst%3DJ.%2BA.%26atitle%3DSite-directed%2520ligand%2520discovery%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2000%26volume%3D97%26spage%3D9367%26epage%3D9372%26doi%3D10.1073%2Fpnas.97.17.9367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Erlanson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiesmann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luong, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmons, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeLano, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choong, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burdett, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flanagan, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, T.</span></span> <span> </span><span class="NLM_article-title">In situ assembly of enzyme inhibitors using extended tethering</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">308</span>– <span class="NLM_lpage">314</span>, <span class="refDoi"> DOI: 10.1038/nbt786</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1038%2Fnbt786" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=12563278" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhsFajs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2003&pages=308-314&author=D.+A.+Erlansonauthor=J.+W.+Lamauthor=C.+Wiesmannauthor=T.+N.+Luongauthor=R.+L.+Simmonsauthor=W.+L.+DeLanoauthor=I.+C.+Choongauthor=M.+T.+Burdettauthor=W.+M.+Flanaganauthor=D.+Leeauthor=E.+M.+Gordonauthor=T.+O%E2%80%99Brien&title=In+situ+assembly+of+enzyme+inhibitors+using+extended+tethering&doi=10.1038%2Fnbt786"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">In situ assembly of enzyme inhibitors using extended tethering</span></div><div class="casAuthors">Erlanson, Daniel A.; Lam, Joni W.; Wiesmann, Christian; Luong, Tinh N.; Simmons, Robert L.; DeLano, Warren L.; Choong, Ingrid C.; Burdett, Matthew T.; Flanagan, W. Michael; Lee, Dennis; Gordon, Eric M.; O'Brien, Tom</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">308-314</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Cysteine aspartyl protease-3 (caspase-3) is a mediator of apoptosis and a therapeutic target for a wide range of diseases.  Using a dynamic combinatorial technol., 'extended tethering', we identified unique nonpeptidic inhibitors for this enzyme.  Extended tethering allowed the identification of ligands that bind to discrete regions of caspase-3 and also helped direct the assembly of these ligands into small-mol. inhibitors.  We first designed a small-mol. 'extender' that irreversibly alkylates the cysteine residue of caspase-3 and also contains a thiol group.  The modified protein was then screened against a library of disulfide-contg. small-mol. fragments.  Mass-spectrometry was used to identify ligands that bind noncovalently to the protein and that also form a disulfide linkage with the extender.  Linking the selected fragments with binding elements from the extenders generates reversible, tight-binding mols. that are drug-like and distinct from known inhibitors.  One mol. derived from this approach inhibited apoptosis in cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIZnkpIfPw2bVg90H21EOLACvtfcHk0ljxsx-zcCiaRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhsFajs78%253D&md5=6b50abe4f31172a09172810beffb5b94</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2Fnbt786&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt786%26sid%3Dliteratum%253Aachs%26aulast%3DErlanson%26aufirst%3DD.%2BA.%26aulast%3DLam%26aufirst%3DJ.%2BW.%26aulast%3DWiesmann%26aufirst%3DC.%26aulast%3DLuong%26aufirst%3DT.%2BN.%26aulast%3DSimmons%26aufirst%3DR.%2BL.%26aulast%3DDeLano%26aufirst%3DW.%2BL.%26aulast%3DChoong%26aufirst%3DI.%2BC.%26aulast%3DBurdett%26aufirst%3DM.%2BT.%26aulast%3DFlanagan%26aufirst%3DW.%2BM.%26aulast%3DLee%26aufirst%3DD.%26aulast%3DGordon%26aufirst%3DE.%2BM.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DT.%26atitle%3DIn%2520situ%2520assembly%2520of%2520enzyme%2520inhibitors%2520using%2520extended%2520tethering%26jtitle%3DNat.%2520Biotechnol.%26date%3D2003%26volume%3D21%26spage%3D308%26epage%3D314%26doi%3D10.1038%2Fnbt786" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Braisted, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oslob, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delano, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyde, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDowell, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waal, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arkin, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raimundo, B. C.</span></span> <span> </span><span class="NLM_article-title">Discovery of a potent small molecule IL-2 inhibitor through fragment assembly</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>125</i></span>,  <span class="NLM_fpage">3714</span>– <span class="NLM_lpage">3715</span>, <span class="refDoi"> DOI: 10.1021/ja034247i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja034247i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhslynurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2003&pages=3714-3715&author=A.+C.+Braistedauthor=J.+D.+Oslobauthor=W.+L.+Delanoauthor=J.+Hydeauthor=R.+S.+McDowellauthor=N.+Waalauthor=C.+Yuauthor=M.+R.+Arkinauthor=B.+C.+Raimundo&title=Discovery+of+a+potent+small+molecule+IL-2+inhibitor+through+fragment+assembly&doi=10.1021%2Fja034247i"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent Small Molecule IL-2 Inhibitor through Fragment Assembly</span></div><div class="casAuthors">Braisted, Andrew C.; Oslob, Johan D.; Delano, Warren L.; Hyde, Jennifer; McDowell, Robert S.; Waal, Nathan; Yu, Chul; Arkin, Michelle R.; Raimundo, Brian C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3714-3715</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Using a site-directed fragment discovery method called tethering, we have identified a 60 nM small mol. antagonist of a cytokine/receptor interaction (IL-2/IL2Rα) with cell-based activity.  Starting with a low micromolar hit, we employed a combination of tethering, structural biol., and computational anal. to design a focused set of 20 compds.  Eight of these compds. were at least 5-fold more active than the original hit.  One of these compds. showed a 50-fold enhancement and represents the highest affinity inhibitor reported against this protein-protein target class.  This method of coupling selected fragments with a low micromolar hit shows great potential for generating high-affinity lead compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjoKdCBcSWbrVg90H21EOLACvtfcHk0ljSrOz-Bui4Bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhslynurw%253D&md5=451b65f3a7758f207259a44e1a328d21</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fja034247i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja034247i%26sid%3Dliteratum%253Aachs%26aulast%3DBraisted%26aufirst%3DA.%2BC.%26aulast%3DOslob%26aufirst%3DJ.%2BD.%26aulast%3DDelano%26aufirst%3DW.%2BL.%26aulast%3DHyde%26aufirst%3DJ.%26aulast%3DMcDowell%26aufirst%3DR.%2BS.%26aulast%3DWaal%26aufirst%3DN.%26aulast%3DYu%26aufirst%3DC.%26aulast%3DArkin%26aufirst%3DM.%2BR.%26aulast%3DRaimundo%26aufirst%3DB.%2BC.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520small%2520molecule%2520IL-2%2520inhibitor%2520through%2520fragment%2520assembly%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2003%26volume%3D125%26spage%3D3714%26epage%3D3715%26doi%3D10.1021%2Fja034247i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ward, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brassington, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breeze, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caputo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Critchlow, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodwin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassall, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenwood, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holdgate, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mrosek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norman, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tart, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tucker, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogtherr, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittaker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wingfield, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winter, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudson, K.</span></span> <span> </span><span class="NLM_article-title">Design and Synthesis of novel lactate dehydrogenase A inhibitors by fragment-based lead generation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">3285</span>– <span class="NLM_lpage">3306</span>, <span class="refDoi"> DOI: 10.1021/jm201734r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201734r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC38XjvVSgtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=3285-3306&author=R.+A.+Wardauthor=C.+Brassingtonauthor=A.+L.+Breezeauthor=A.+Caputoauthor=S.+Critchlowauthor=G.+Daviesauthor=L.+Goodwinauthor=G.+Hassallauthor=R.+Greenwoodauthor=G.+A.+Holdgateauthor=M.+Mrosekauthor=R.+A.+Normanauthor=S.+Pearsonauthor=J.+Tartauthor=J.+A.+Tuckerauthor=M.+Vogtherrauthor=D.+Whittakerauthor=J.+Wingfieldauthor=J.+Winterauthor=K.+Hudson&title=Design+and+Synthesis+of+novel+lactate+dehydrogenase+A+inhibitors+by+fragment-based+lead+generation&doi=10.1021%2Fjm201734r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Novel Lactate Dehydrogenase A Inhibitors by Fragment-Based Lead Generation</span></div><div class="casAuthors">Ward, Richard A.; Brassington, Claire; Breeze, Alexander L.; Caputo, Alessandro; Critchlow, Susan; Davies, Gareth; Goodwin, Louise; Hassall, Giles; Greenwood, Ryan; Holdgate, Geoffrey A.; Mrosek, Michael; Norman, Richard A.; Pearson, Stuart; Tart, Jonathan; Tucker, Julie A.; Vogtherr, Martin; Whittaker, David; Wingfield, Jonathan; Winter, Jon; Hudson, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3285-3306</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Lactate dehydrogenase A (LDHA) catalyzes the conversion of pyruvate to lactate, utilizing NADH as a cofactor.  It has been identified as a potential therapeutic target in the area of cancer metab.  In this manuscript we report our progress using fragment-based lead generation (FBLG), assisted by x-ray crystallog. to develop small mol. LDHA inhibitors.  Fragment hits were identified through NMR and SPR screening and optimized into lead compds. with nanomolar binding affinities via fragment linking.  Also reported is their modification into cellular active compds. suitable for target validation work.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrH8QbdIUXNvbVg90H21EOLACvtfcHk0ljSrOz-Bui4Bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjvVSgtLs%253D&md5=d638e7a0db361c212ee084d5c05ee70c</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm201734r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201734r%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DR.%2BA.%26aulast%3DBrassington%26aufirst%3DC.%26aulast%3DBreeze%26aufirst%3DA.%2BL.%26aulast%3DCaputo%26aufirst%3DA.%26aulast%3DCritchlow%26aufirst%3DS.%26aulast%3DDavies%26aufirst%3DG.%26aulast%3DGoodwin%26aufirst%3DL.%26aulast%3DHassall%26aufirst%3DG.%26aulast%3DGreenwood%26aufirst%3DR.%26aulast%3DHoldgate%26aufirst%3DG.%2BA.%26aulast%3DMrosek%26aufirst%3DM.%26aulast%3DNorman%26aufirst%3DR.%2BA.%26aulast%3DPearson%26aufirst%3DS.%26aulast%3DTart%26aufirst%3DJ.%26aulast%3DTucker%26aufirst%3DJ.%2BA.%26aulast%3DVogtherr%26aufirst%3DM.%26aulast%3DWhittaker%26aufirst%3DD.%26aulast%3DWingfield%26aufirst%3DJ.%26aulast%3DWinter%26aufirst%3DJ.%26aulast%3DHudson%26aufirst%3DK.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520novel%2520lactate%2520dehydrogenase%2520A%2520inhibitors%2520by%2520fragment-based%2520lead%2520generation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D3285%26epage%3D3306%26doi%3D10.1021%2Fjm201734r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Möbitz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machauer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holzer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaupel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stauffer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ragot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caravatti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheufler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hommel, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiedt, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beyer, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaul, C.</span></span> <span> </span><span class="NLM_article-title">The discovery of potent, selective and structurally novel DOT1L inhibitors by a fragment linking approach</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">338</span>– <span class="NLM_lpage">343</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00519</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00519" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC2sXisFyltr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=338-343&author=H.+M%C3%B6bitzauthor=R.+Machauerauthor=P.+Holzerauthor=A.+Vaupelauthor=F.+Staufferauthor=C.+Ragotauthor=G.+Caravattiauthor=C.+Scheuflerauthor=C.+Fernandezauthor=U.+Hommelauthor=R.+Tiedtauthor=K.+S.+Beyerauthor=C.+Chenauthor=H.+Zhuauthor=C.+Gaul&title=The+discovery+of+potent%2C+selective+and+structurally+novel+DOT1L+inhibitors+by+a+fragment+linking+approach&doi=10.1021%2Facsmedchemlett.6b00519"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent, Selective, and Structurally Novel Dot1L Inhibitors by a Fragment Linking Approach</span></div><div class="casAuthors">Mobitz, Henrik; Machauer, Rainer; Holzer, Philipp; Vaupel, Andrea; Stauffer, Frederic; Ragot, Christian; Caravatti, Giorgio; Scheufler, Clemens; Fernandez, Cesar; Hommel, Ulrich; Tiedt, Ralph; Beyer, Kim S.; Chen, Chao; Zhu, Hugh; Gaul, Christoph</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">338-343</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Misdirected catalytic activity of histone methyltransferase Dot1L is believed to be causative for a subset of highly aggressive acute leukemias.  Targeting the catalytic domain of Dot1L represents a potential therapeutic approach for these leukemias.  In the context of a comprehensive Dot1L hit finding strategy, a knowledge-based virtual screen of the Dot1L SAM binding pocket led to the discovery of a nonnucleoside fragment mimicking key interactions of SAM bound to Dot1L.  Linking of the fragment with an induced back pocket binder identified in earlier studies, followed by careful ligand optimization led to the identification of I, a highly potent, selective and structurally novel Dot1L inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLL327TKiV67Vg90H21EOLACvtfcHk0ljSrOz-Bui4Bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXisFyltr0%253D&md5=45d354a4668901ce360cc3914aaa81e4</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00519%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25B6bitz%26aufirst%3DH.%26aulast%3DMachauer%26aufirst%3DR.%26aulast%3DHolzer%26aufirst%3DP.%26aulast%3DVaupel%26aufirst%3DA.%26aulast%3DStauffer%26aufirst%3DF.%26aulast%3DRagot%26aufirst%3DC.%26aulast%3DCaravatti%26aufirst%3DG.%26aulast%3DScheufler%26aufirst%3DC.%26aulast%3DFernandez%26aufirst%3DC.%26aulast%3DHommel%26aufirst%3DU.%26aulast%3DTiedt%26aufirst%3DR.%26aulast%3DBeyer%26aufirst%3DK.%2BS.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DGaul%26aufirst%3DC.%26atitle%3DThe%2520discovery%2520of%2520potent%252C%2520selective%2520and%2520structurally%2520novel%2520DOT1L%2520inhibitors%2520by%2520a%2520fragment%2520linking%2520approach%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26spage%3D338%26epage%3D343%26doi%3D10.1021%2Facsmedchemlett.6b00519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Howard, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blakemore, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chessari, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Congreve, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jhoti, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seavers, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Montfort, R. L.</span></span> <span> </span><span class="NLM_article-title">Application of fragment screening and fragment linking to the discovery of novel thrombin inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">1346</span>– <span class="NLM_lpage">1355</span>, <span class="refDoi"> DOI: 10.1021/jm050850v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050850v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BD28Xlt1OmtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=1346-1355&author=N.+Howardauthor=C.+Abellauthor=W.+Blakemoreauthor=G.+Chessariauthor=M.+Congreveauthor=S.+Howardauthor=H.+Jhotiauthor=C.+W.+Murrayauthor=L.+C.+Seaversauthor=R.+L.+van+Montfort&title=Application+of+fragment+screening+and+fragment+linking+to+the+discovery+of+novel+thrombin+inhibitors&doi=10.1021%2Fjm050850v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Application of Fragment Screening and Fragment Linking to the Discovery of Novel Thrombin Inhibitors</span></div><div class="casAuthors">Howard, Nigel; Abell, Chris; Blakemore, Wendy; Chessari, Gianni; Congreve, Miles; Howard, Steven; Jhoti, Harren; Murray, Christopher W.; Seavers, Lisa C. A.; Van Montfort, Rob L. M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1346-1355</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The screening of fragments is an alternative approach to high-throughput screening for the identification of leads for therapeutic targets.  Fragment hits have been discovered using x-ray crystallog. screening of protein crystals of the serine protease enzyme thrombin.  The fragment library was designed to avoid any well-precedented, strongly basic functionality.  Screening hits included a novel ligand (I), which binds exclusively to the S2-S4 pocket, in addn. to smaller fragments which bind to the S1 pocket.  The structure of these protein-ligand complexes are presented.  A chem. strategy to link two such fragments together and to synthesize larger drug-sized compds. resulted in the efficient identification of hybrid inhibitors with nanomolar potency (e.g., II, IC50 = 3.7 nM).  These potent ligands occupy the same area of the active site as previously described peptidic inhibitors, while having very different chem. architecture.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2hprBaZvhJbVg90H21EOLACvtfcHk0lix8Yrb8SU9Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xlt1OmtQ%253D%253D&md5=d47173e5f17a02658b0c6866198d0718</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm050850v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050850v%26sid%3Dliteratum%253Aachs%26aulast%3DHoward%26aufirst%3DN.%26aulast%3DAbell%26aufirst%3DC.%26aulast%3DBlakemore%26aufirst%3DW.%26aulast%3DChessari%26aufirst%3DG.%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DHoward%26aufirst%3DS.%26aulast%3DJhoti%26aufirst%3DH.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DSeavers%26aufirst%3DL.%2BC.%26aulast%3Dvan%2BMontfort%26aufirst%3DR.%2BL.%26atitle%3DApplication%2520of%2520fragment%2520screening%2520and%2520fragment%2520linking%2520to%2520the%2520discovery%2520of%2520novel%2520thrombin%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D1346%26epage%3D1355%26doi%3D10.1021%2Fjm050850v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barker, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barker, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Courtney, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardiner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hesterkamp, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichihara, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mather, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montalbetti, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varasi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittaker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarnold, C. J.</span></span> <span> </span><span class="NLM_article-title">Discovery of a novel HSP90 inhibitor by fragment linking</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1697</span>– <span class="NLM_lpage">1700</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201000219</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1002%2Fcmdc.201000219" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=20665758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlCkurzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=1697-1700&author=J.+J.+Barkerauthor=O.+Barkerauthor=S.+M.+Courtneyauthor=M.+Gardinerauthor=T.+Hesterkampauthor=O.+Ichiharaauthor=O.+Matherauthor=C.+A.+Montalbettiauthor=A.+M%C3%BCllerauthor=M.+Varasiauthor=M.+Whittakerauthor=C.+J.+Yarnold&title=Discovery+of+a+novel+HSP90+inhibitor+by+fragment+linking&doi=10.1002%2Fcmdc.201000219"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a novel Hsp90 inhibitor by fragment linking</span></div><div class="casAuthors">Barker, John J.; Barker, Oliver; Courtney, Stephen M.; Gardiner, Mihaly; Hesterkamp, Thomas; Ichihara, Osamu; Mather, Owen; Montalbetti, Christian A. G. N.; Muller, Annett; Varasi, Mario; Whittaker, Mark; Yarnold, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1697-1700</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Following a high-throughput biochem. fragment screen, we have identified novel fragment inhibitors of Hsp90.  Two fragment hits were combined to give a dual-fragment Hsp90 complex.  The compd., I, with the lowest strain energy was synthesized, and a 1000-fold improvement in activity was achieved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq05FWLIYmt6bVg90H21EOLACvtfcHk0lix8Yrb8SU9Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlCkurzI&md5=5ae93af1444d6819d8cc4bf2854bff4f</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201000219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201000219%26sid%3Dliteratum%253Aachs%26aulast%3DBarker%26aufirst%3DJ.%2BJ.%26aulast%3DBarker%26aufirst%3DO.%26aulast%3DCourtney%26aufirst%3DS.%2BM.%26aulast%3DGardiner%26aufirst%3DM.%26aulast%3DHesterkamp%26aufirst%3DT.%26aulast%3DIchihara%26aufirst%3DO.%26aulast%3DMather%26aufirst%3DO.%26aulast%3DMontalbetti%26aufirst%3DC.%2BA.%26aulast%3DM%25C3%25BCller%26aufirst%3DA.%26aulast%3DVarasi%26aufirst%3DM.%26aulast%3DWhittaker%26aufirst%3DM.%26aulast%3DYarnold%26aufirst%3DC.%2BJ.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520HSP90%2520inhibitor%2520by%2520fragment%2520linking%26jtitle%3DChemMedChem%26date%3D2010%26volume%3D5%26spage%3D1697%26epage%3D1700%26doi%3D10.1002%2Fcmdc.201000219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed-Belkacem, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colliandre, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahnou, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nevers, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bessin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brillet, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cala, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Douguet, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourguet, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krimm, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pawlotsky, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guichou, J. F.</span></span> <span> </span><span class="NLM_article-title">Fragment-based discovery of a new family of non-peptidic small-molecule cyclophilin inhibitors with potent antiviral activities</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">12777</span>, <span class="refDoi"> DOI: 10.1038/ncomms12777</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1038%2Fncomms12777" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=27652979" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFKmt7vO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=12777&author=A.+Ahmed-Belkacemauthor=L.+Colliandreauthor=N.+Ahnouauthor=Q.+Neversauthor=M.+Gelinauthor=Y.+Bessinauthor=R.+Brilletauthor=O.+Calaauthor=D.+Douguetauthor=W.+Bourguetauthor=I.+Krimmauthor=J.+M.+Pawlotskyauthor=J.+F.+Guichou&title=Fragment-based+discovery+of+a+new+family+of+non-peptidic+small-molecule+cyclophilin+inhibitors+with+potent+antiviral+activities&doi=10.1038%2Fncomms12777"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-based discovery of a new family of non-peptidic small-molecule cyclophilin inhibitors with potent antiviral activities</span></div><div class="casAuthors">Ahmed-Belkacem, Abdelhakim; Colliandre, Lionel; Ahnou, Nazim; Nevers, Quentin; Gelin, Muriel; Bessin, Yannick; Brillet, Rozenn; Cala, Olivier; Douguet, Dominique; Bourguet, William; Krimm, Isabelle; Pawlotsky, Jean-Michel; Guichou, Jean- Francois</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">12777</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Cyclophilins are peptidyl-prolyl cis/trans isomerases (PPIase) that catalyze the interconversion of the peptide bond at proline residues.  Several cyclophilins play a pivotal role in the life cycle of a no. of viruses.  The existing cyclophilin inhibitors, all derived from cyclosporine A or sanglifehrin A, have disadvantages, including their size, potential for side effects unrelated to cyclophilin inhibition and drug-drug interactions, unclear antiviral spectrum and manufg. issues.  Here we use a fragment-based drug discovery approach using nucleic magnetic resonance, X-ray crystallog. and structure-based compd. optimization to generate a new family of non-peptidic, small-mol. cyclophilin inhibitors with potent in vitro PPIase inhibitory activity and antiviral activity against hepatitis C virus, human immunodeficiency virus and coronaviruses.  This family of compds. has the potential for broad-spectrum, high-barrier-to-resistance treatment of viral infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyow1ByjcKUbVg90H21EOLACvtfcHk0liCQrzd7NFUtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFKmt7vO&md5=f984a686b75eea86431cd048f82f11c5</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1038%2Fncomms12777&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms12777%26sid%3Dliteratum%253Aachs%26aulast%3DAhmed-Belkacem%26aufirst%3DA.%26aulast%3DColliandre%26aufirst%3DL.%26aulast%3DAhnou%26aufirst%3DN.%26aulast%3DNevers%26aufirst%3DQ.%26aulast%3DGelin%26aufirst%3DM.%26aulast%3DBessin%26aufirst%3DY.%26aulast%3DBrillet%26aufirst%3DR.%26aulast%3DCala%26aufirst%3DO.%26aulast%3DDouguet%26aufirst%3DD.%26aulast%3DBourguet%26aufirst%3DW.%26aulast%3DKrimm%26aufirst%3DI.%26aulast%3DPawlotsky%26aufirst%3DJ.%2BM.%26aulast%3DGuichou%26aufirst%3DJ.%2BF.%26atitle%3DFragment-based%2520discovery%2520of%2520a%2520new%2520family%2520of%2520non-peptidic%2520small-molecule%2520cyclophilin%2520inhibitors%2520with%2520potent%2520antiviral%2520activities%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D12777%26doi%3D10.1038%2Fncomms12777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benmansour, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trist, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coutard, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decroly, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Querat, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brancale, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barral, K.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel dengue virus NS5 methyltransferase non-nucleoside inhibitors by fragment-based drug design</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>125</i></span>,  <span class="NLM_fpage">865</span>– <span class="NLM_lpage">880</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.10.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1016%2Fj.ejmech.2016.10.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=27750202" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslShsbjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2017&pages=865-880&author=F.+Benmansourauthor=I.+Tristauthor=B.+Coutardauthor=E.+Decrolyauthor=G.+Queratauthor=A.+Brancaleauthor=K.+Barral&title=Discovery+of+novel+dengue+virus+NS5+methyltransferase+non-nucleoside+inhibitors+by+fragment-based+drug+design&doi=10.1016%2Fj.ejmech.2016.10.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of novel dengue virus NS5 methyltransferase non-nucleoside inhibitors by fragment-based drug design</span></div><div class="casAuthors">Benmansour, Fatiha; Trist, Iuni; Coutard, Bruno; Decroly, Etienne; Querat, Gilles; Brancale, Andrea; Barral, Karine</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">865-880</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">With the aim to help drug discovery against dengue virus (DENV), a fragment-based drug design approach was applied to identify ligands targeting a main component of DENV replication complex: the NS5 AdoMet-dependent mRNA methyltransferase (MTase) domain, playing an essential role in the RNA capping process.  Herein, we describe the identification of new inhibitors developed using fragment-based, structure-guided linking and optimization techniques.  Thermal-shift assay followed by a fragment-based X-ray crystallog. screening lead to the identification of three fragment hits binding DENV MTase.  We considered linking two of them, which bind to proximal sites of the AdoMet binding pocket, in order to improve their potency.  X-ray crystallog. structures and computational docking were used to guide the fragment linking, ultimately leading to novel series of non-nucleoside inhibitors of flavivirus MTase, resp. N-phenyl-[(phenylcarbamoyl)amino]benzene-1-sulfonamide and Ph [(phenylcarbamoyl)amino]benzene-1-sulfonate derivs., that show a 10-100-fold stronger inhibition of 2'-O-MTase activity compared to the initial fragments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq24pKhPTHpcbVg90H21EOLACvtfcHk0liCQrzd7NFUtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslShsbjN&md5=18e8f271288dd63f330c92a380e69299</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DBenmansour%26aufirst%3DF.%26aulast%3DTrist%26aufirst%3DI.%26aulast%3DCoutard%26aufirst%3DB.%26aulast%3DDecroly%26aufirst%3DE.%26aulast%3DQuerat%26aufirst%3DG.%26aulast%3DBrancale%26aufirst%3DA.%26aulast%3DBarral%26aufirst%3DK.%26atitle%3DDiscovery%2520of%2520novel%2520dengue%2520virus%2520NS5%2520methyltransferase%2520non-nucleoside%2520inhibitors%2520by%2520fragment-based%2520drug%2520design%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D125%26spage%3D865%26epage%3D880%26doi%3D10.1016%2Fj.ejmech.2016.10.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coutard, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Querat, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roche, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morelli, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decroly, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barral, K.</span></span> <span> </span><span class="NLM_article-title">Optimization of a fragment linking hit toward Dengue and Zika virus NS5 methyltransferases inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>161</i></span>,  <span class="NLM_fpage">323</span>– <span class="NLM_lpage">333</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.09.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1016%2Fj.ejmech.2018.09.056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=30368131" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVSlsbnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=161&publication_year=2019&pages=323-333&author=J.+Hernandezauthor=L.+Hofferauthor=B.+Coutardauthor=G.+Queratauthor=P.+Rocheauthor=X.+Morelliauthor=E.+Decrolyauthor=K.+Barral&title=Optimization+of+a+fragment+linking+hit+toward+Dengue+and+Zika+virus+NS5+methyltransferases+inhibitors&doi=10.1016%2Fj.ejmech.2018.09.056"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of a fragment linking hit toward Dengue and Zika virus NS5 methyltransferases inhibitors</span></div><div class="casAuthors">Hernandez, Jessica; Hoffer, Laurent; Coutard, Bruno; Querat, Gilles; Roche, Philippe; Morelli, Xavier; Decroly, Etienne; Barral, Karine</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">161</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">323-333</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">No antiviral drugs to treat or prevent life-threatening flavivirus infections such as those caused by mosquito-borne Dengue (DENV) and more recently Zika (ZIKV) viruses are yet available.  We aim to develop, through a structure-based drug design approach, novel inhibitors targeting the NS5 AdoMet-dependent mRNA methyltransferase (MTase), a viral protein involved in the RNA capping process essential for flaviviruses replication.  Herein, we describe the optimization of a hit (5) identified using fragment-based and structure-guided linking techniques, which binds to a proximal site of the AdoMet binding pocket.  X-ray crystallog. structures and computational docking were used to guide our optimization process and lead to compds. 30 and 33 (DENV IC50 = 26 μM and 23 μM; ZIKV IC50 = 28 μM and 19 μM, resp.), two representatives of novel non-nucleoside inhibitors of flavivirus MTases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq78B-8RHnNwbVg90H21EOLACvtfcHk0liCQrzd7NFUtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVSlsbnL&md5=f015597fd8ec07b2f32500e4718c454a</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.09.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.09.056%26sid%3Dliteratum%253Aachs%26aulast%3DHernandez%26aufirst%3DJ.%26aulast%3DHoffer%26aufirst%3DL.%26aulast%3DCoutard%26aufirst%3DB.%26aulast%3DQuerat%26aufirst%3DG.%26aulast%3DRoche%26aufirst%3DP.%26aulast%3DMorelli%26aufirst%3DX.%26aulast%3DDecroly%26aufirst%3DE.%26aulast%3DBarral%26aufirst%3DK.%26atitle%3DOptimization%2520of%2520a%2520fragment%2520linking%2520hit%2520toward%2520Dengue%2520and%2520Zika%2520virus%2520NS5%2520methyltransferases%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2019%26volume%3D161%26spage%3D323%26epage%3D333%26doi%3D10.1016%2Fj.ejmech.2018.09.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brear, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Fusco, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hadje Georgiou, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francis-Newton, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stubbs, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sore, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkitaraman, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spring, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyvönen, M.</span></span> <span> </span><span class="NLM_article-title">Specific inhibition of CK2α from an anchor outside the active site</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">6839</span>– <span class="NLM_lpage">6845</span>, <span class="refDoi"> DOI: 10.1039/C6SC02335E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1039%2FC6SC02335E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=28451126" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFCrtbbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=6839-6845&author=P.+Brearauthor=C.+De+Fuscoauthor=K.+Hadje+Georgiouauthor=N.+J.+Francis-Newtonauthor=C.+J.+Stubbsauthor=H.+F.+Soreauthor=A.+R.+Venkitaramanauthor=C.+Abellauthor=D.+R.+Springauthor=M.+Hyv%C3%B6nen&title=Specific+inhibition+of+CK2%CE%B1+from+an+anchor+outside+the+active+site&doi=10.1039%2FC6SC02335E"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Specific inhibition of CK2α from an anchor outside the active site</span></div><div class="casAuthors">Brear, Paul; De Fusco, Claudia; Hadje Georgiou, Kathy; Francis-Newton, Nicola J.; Stubbs, Christopher J.; Sore, Hannah F.; Venkitaraman, Ashok R.; Abell, Chris; Spring, David R.; Hyvonen, Marko</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">6839-6845</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The development of selective inhibitors of protein kinases is challenging because of the significant conservation of the ATP binding site.  Here, we describe a new mechanism by which the protein kinase CK2α can be selectively inhibited using features outside the ATP site.  We have identified a new binding site for small mols. on CK2α adjacent to the ATP site and behind the αD loop, termed the αD pocket.  An elaborated fragment anchored in this site has been linked with a low affinity fragment binding in the ATP site, creating a novel and selective inhibitor (CAM4066) that binds CK2α with a Kd of 320 nM and shows significantly improved selectivity compared to other CK2α inhibitors.  CAM4066 shows target engagement in several cell lines and similar potency to clin. trial candidate CX4945.  Our data demonstrate that targeting a poorly conserved, cryptic pocket allows inhibition of CK2α via a novel mechanism, enabling the development of a new generation of selective CK2α inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3FqxiBkU9frVg90H21EOLACvtfcHk0ljsqTqoeDuJww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFCrtbbP&md5=c4652010f4da70a128fb1dab64f811d0</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1039%2FC6SC02335E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6SC02335E%26sid%3Dliteratum%253Aachs%26aulast%3DBrear%26aufirst%3DP.%26aulast%3DDe%2BFusco%26aufirst%3DC.%26aulast%3DHadje%2BGeorgiou%26aufirst%3DK.%26aulast%3DFrancis-Newton%26aufirst%3DN.%2BJ.%26aulast%3DStubbs%26aufirst%3DC.%2BJ.%26aulast%3DSore%26aufirst%3DH.%2BF.%26aulast%3DVenkitaraman%26aufirst%3DA.%2BR.%26aulast%3DAbell%26aufirst%3DC.%26aulast%3DSpring%26aufirst%3DD.%2BR.%26aulast%3DHyv%25C3%25B6nen%26aufirst%3DM.%26atitle%3DSpecific%2520inhibition%2520of%2520CK2%25CE%25B1%2520from%2520an%2520anchor%2520outside%2520the%2520active%2520site%26jtitle%3DChem.%2520Sci.%26date%3D2016%26volume%3D7%26spage%3D6839%26epage%3D6845%26doi%3D10.1039%2FC6SC02335E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Fusco, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brear, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iegre, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgiou, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sore, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyvönen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spring, D. R.</span></span> <span> </span><span class="NLM_article-title">A fragment-based approach leading to the discovery of a novel binding site and the selective CK2 inhibitor CAM4066</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">3471</span>– <span class="NLM_lpage">3482</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2017.04.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1016%2Fj.bmc.2017.04.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=28495381" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC2sXntlWktbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=3471-3482&author=C.+De%0AFuscoauthor=P.+Brearauthor=J.+Iegreauthor=K.+H.+Georgiouauthor=H.+F.+Soreauthor=M.+Hyv%C3%B6nenauthor=D.+R.+Spring&title=A+fragment-based+approach+leading+to+the+discovery+of+a+novel+binding+site+and+the+selective+CK2+inhibitor+CAM4066&doi=10.1016%2Fj.bmc.2017.04.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">A fragment-based approach leading to the discovery of a novel binding site and the selective CK2 inhibitor CAM4066</span></div><div class="casAuthors">De Fusco, Claudia; Brear, Paul; Iegre, Jessica; Georgiou, Kathy Hadje; Sore, Hannah F.; Hyvonen, Marko; Spring, David R.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3471-3482</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Recently the authors reported the discovery of a potent and selective CK2α inhibitor CAM4066.  This compd. inhibits CK2 activity by exploiting a pocket located outside the ATP binding site (αD pocket).  Here the authors describe in detail the journey that led to the discovery of CAM4066 using the challenging fragment linking strategy.  Specifically, the authors aimed to develop inhibitors by linking a high-affinity fragment anchored in the αD site to a weakly binding warhead fragment occupying the ATP site.  Moreover, the authors describe the remarkable impact that mol. modeling had on the development of this novel chem. tool.  The work described herein shows potential for the development of a novel class of CK2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-es_MXrRt5bVg90H21EOLACvtfcHk0ljsqTqoeDuJww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXntlWktbc%253D&md5=2c4bf2e6b0528149dc09d04badfdeab3</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.04.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.04.037%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BFusco%26aufirst%3DC.%26aulast%3DBrear%26aufirst%3DP.%26aulast%3DIegre%26aufirst%3DJ.%26aulast%3DGeorgiou%26aufirst%3DK.%2BH.%26aulast%3DSore%26aufirst%3DH.%2BF.%26aulast%3DHyv%25C3%25B6nen%26aufirst%3DM.%26aulast%3DSpring%26aufirst%3DD.%2BR.%26atitle%3DA%2520fragment-based%2520approach%2520leading%2520to%2520the%2520discovery%2520of%2520a%2520novel%2520binding%2520site%2520and%2520the%2520selective%2520CK2%2520inhibitor%2520CAM4066%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26spage%3D3471%26epage%3D3482%26doi%3D10.1016%2Fj.bmc.2017.04.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Iegre, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brear, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Fusco, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carro, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sore, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyvönen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spring, D. R.</span></span> <span> </span><span class="NLM_article-title">Second-generation CK2α inhibitors targeting the αD pocket</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">3041</span>– <span class="NLM_lpage">3049</span>, <span class="refDoi"> DOI: 10.1039/C7SC05122K</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1039%2FC7SC05122K" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=29732088" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC1cXivFGls7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=3041-3049&author=J.+Iegreauthor=P.+Brearauthor=C.+De+Fuscoauthor=M.+Yoshidaauthor=S.+L.+Mitchellauthor=M.+Rossmannauthor=L.+Carroauthor=H.+F.+Soreauthor=M.+Hyv%C3%B6nenauthor=D.+R.+Spring&title=Second-generation+CK2%CE%B1+inhibitors+targeting+the+%CE%B1D+pocket&doi=10.1039%2FC7SC05122K"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Second-generation CK2α inhibitors targeting the αD pocket</span></div><div class="casAuthors">Iegre, Jessica; Brear, Paul; De Fusco, Claudia; Yoshida, Masao; Mitchell, Sophie L.; Rossmann, Maxim; Carro, Laura; Sore, Hannah F.; Hyvonen, Marko; Spring, David R.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3041-3049</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">CK2 is a crit. cell cycle regulator that also promotes various anti-apoptotic mechanisms.  Development of ATP-non-competitive inhibitors of CK2 is a very attractive strategy considering that the ATP binding site is highly conserved among other kinases.  We have previously utilized a pocket outside the active site to develop a novel CK2 inhibitor, CAM4066.  While CAM4066 bound to this new pocket it was also interacting with the ATP site: herein, we describe an example of a CK2α inhibitor that binds completely outside the active site.  This second generation αD-site binding inhibitor, compd. CAM4712 (IC50 = 7 μM, GI50 = 10.0 ± 3.6 μM), has numerous advantages over the previously reported CAM4066, including a redn. in the no. of rotatable bonds, the absence of amide groups susceptible to the action of proteases and improved cellular permeability.  Unlike with CAM4066, there was no need to facilitate cellular uptake by making a prodrug.  Moreover, CAM4712 displayed no drop off between its ability to inhibit the kinase in vitro (IC50) and the ability to inhibit cell proliferation (GI50).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprPLu-nG6dLLVg90H21EOLACvtfcHk0ljsqTqoeDuJww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXivFGls7w%253D&md5=4d57e89546e1c7bcac4868e3a02ba2f8</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1039%2FC7SC05122K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7SC05122K%26sid%3Dliteratum%253Aachs%26aulast%3DIegre%26aufirst%3DJ.%26aulast%3DBrear%26aufirst%3DP.%26aulast%3DDe%2BFusco%26aufirst%3DC.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DMitchell%26aufirst%3DS.%2BL.%26aulast%3DRossmann%26aufirst%3DM.%26aulast%3DCarro%26aufirst%3DL.%26aulast%3DSore%26aufirst%3DH.%2BF.%26aulast%3DHyv%25C3%25B6nen%26aufirst%3DM.%26aulast%3DSpring%26aufirst%3DD.%2BR.%26atitle%3DSecond-generation%2520CK2%25CE%25B1%2520inhibitors%2520targeting%2520the%2520%25CE%25B1D%2520pocket%26jtitle%3DChem.%2520Sci.%26date%3D2018%26volume%3D9%26spage%3D3041%26epage%3D3049%26doi%3D10.1039%2FC7SC05122K" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frank, A. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldkamp, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterson, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelz, N. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patrone, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vangamudi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camper, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossanese, O. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chazin, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of a potent inhibitor of replication protein A protein-protein interactions using a fragment-linking approach</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">9242</span>– <span class="NLM_lpage">9250</span>, <span class="refDoi"> DOI: 10.1021/jm401333u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401333u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1CktrzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=9242-9250&author=A.+O.+Frankauthor=M.+D.+Feldkampauthor=J.+P.+Kennedyauthor=A.+G.+Watersonauthor=N.+F.+Pelzauthor=J.+D.+Patroneauthor=B.+Vangamudiauthor=D.+V.+Camperauthor=O.+W.+Rossaneseauthor=W.+J.+Chazinauthor=S.+W.+Fesik&title=Discovery+of+a+potent+inhibitor+of+replication+protein+A+protein-protein+interactions+using+a+fragment-linking+approach&doi=10.1021%2Fjm401333u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent Inhibitor of Replication Protein A Protein-Protein Interactions Using a Fragment-Linking Approach</span></div><div class="casAuthors">Frank, Andreas O.; Feldkamp, Michael D.; Kennedy, J. Phillip; Waterson, Alex G.; Pelz, Nicholas F.; Patrone, James D.; Vangamudi, Bhavatarini; Camper, DeMarco V.; Rossanese, Olivia W.; Chazin, Walter J.; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9242-9250</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Replication protein A (RPA), the major eukaryotic single-stranded DNA (ssDNA)-binding protein, is involved in nearly all cellular DNA transactions.  The RPA N-terminal domain (RPA70N) is a recruitment site for proteins involved in DNA-damage response and repair.  Selective inhibition of these protein-protein interactions has the potential to inhibit the DNA-damage response and to sensitize cancer cells to DNA-damaging agents without affecting other functions of RPA.  To discover a potent, selective inhibitor of the RPA70N protein-protein interactions to test this hypothesis, we used NMR spectroscopy to identify fragment hits that bind to two adjacent sites in the basic cleft of RPA70N.  High-resoln. X-ray crystal structures of RPA70N-ligand complexes revealed how these fragments bind to RPA and guided the design of linked compds. that simultaneously occupy both sites.  We have synthesized linked mols. that bind to RPA70N with submicromolar affinity and minimal disruption of RPA's interaction with ssDNA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgZEDSY6TA3rVg90H21EOLACvtfcHk0ligM5niuWxK5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1CktrzL&md5=ee3a60f76302dcb30fec7d88a1a386c5</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjm401333u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401333u%26sid%3Dliteratum%253Aachs%26aulast%3DFrank%26aufirst%3DA.%2BO.%26aulast%3DFeldkamp%26aufirst%3DM.%2BD.%26aulast%3DKennedy%26aufirst%3DJ.%2BP.%26aulast%3DWaterson%26aufirst%3DA.%2BG.%26aulast%3DPelz%26aufirst%3DN.%2BF.%26aulast%3DPatrone%26aufirst%3DJ.%2BD.%26aulast%3DVangamudi%26aufirst%3DB.%26aulast%3DCamper%26aufirst%3DD.%2BV.%26aulast%3DRossanese%26aufirst%3DO.%2BW.%26aulast%3DChazin%26aufirst%3DW.%2BJ.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520inhibitor%2520of%2520replication%2520protein%2520A%2520protein-protein%2520interactions%2520using%2520a%2520fragment-linking%2520approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D9242%26epage%3D9250%26doi%3D10.1021%2Fjm401333u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swayze, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jefferson, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sannes-Lowery, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blyn, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Risen, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arakawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osgood, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofstadler, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffey, R. H.</span></span> <span> </span><span class="NLM_article-title">SAR by MS: a ligand based technique for drug lead discovery against structured RNA targets</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">3816</span>– <span class="NLM_lpage">3819</span>, <span class="refDoi"> DOI: 10.1021/jm0255466</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0255466" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BD38XlsFyns78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=3816-3819&author=E.+E.+Swayzeauthor=E.+A.+Jeffersonauthor=K.+A.+Sannes-Loweryauthor=L.+B.+Blynauthor=L.+M.+Risenauthor=S.+Arakawaauthor=S.+A.+Osgoodauthor=S.+A.+Hofstadlerauthor=R.+H.+Griffey&title=SAR+by+MS%3A+a+ligand+based+technique+for+drug+lead+discovery+against+structured+RNA+targets&doi=10.1021%2Fjm0255466"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">SAR by MS: A Ligand Based Technique for Drug Lead Discovery Against Structured RNA Targets</span></div><div class="casAuthors">Swayze, Eric E.; Jefferson, Elizabeth A.; Sannes-Lowery, Kristin A.; Blyn, Lawrence B.; Risen, Lisa M.; Arakawa, Satoshi; Osgood, Stephen A.; Hofstadler, Steven A.; Griffey, Richard H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">3816-3819</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A technique for lead discovery vs. RNA targets utilizing mass spectrometry (MS) screening methods is described.  The structure-activity relationships (SAR) derived from assaying weak binding motifs allows the pharmacophores discovered to be elaborated via "SAR by MS" to higher affinity ligands.  Application of this strategy to a subdomain of the 23S rRNA afforded a new class of compds. with functional activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtzo3bJvTJKLVg90H21EOLACvtfcHk0ligM5niuWxK5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlsFyns78%253D&md5=b2cd9789c58b1b39479e0cbecdfd1afe</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fjm0255466&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0255466%26sid%3Dliteratum%253Aachs%26aulast%3DSwayze%26aufirst%3DE.%2BE.%26aulast%3DJefferson%26aufirst%3DE.%2BA.%26aulast%3DSannes-Lowery%26aufirst%3DK.%2BA.%26aulast%3DBlyn%26aufirst%3DL.%2BB.%26aulast%3DRisen%26aufirst%3DL.%2BM.%26aulast%3DArakawa%26aufirst%3DS.%26aulast%3DOsgood%26aufirst%3DS.%2BA.%26aulast%3DHofstadler%26aufirst%3DS.%2BA.%26aulast%3DGriffey%26aufirst%3DR.%2BH.%26atitle%3DSAR%2520by%2520MS%253A%2520a%2520ligand%2520based%2520technique%2520for%2520drug%2520lead%2520discovery%2520against%2520structured%2520RNA%2520targets%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D3816%26epage%3D3819%26doi%3D10.1021%2Fjm0255466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Green, N. M.</span></span> <span> </span><span class="NLM_article-title">Avidin</span>. <i>Adv. Protein Chem.</i> <span class="NLM_year" style="font-weight: bold;">1975</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">85</span>– <span class="NLM_lpage">133</span>, <span class="refDoi"> DOI: 10.1016/S0065-3233(08)60411-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1016%2FS0065-3233%2808%2960411-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=237414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADyaE2MXksleltrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1975&pages=85-133&author=N.+M.+Green&title=Avidin&doi=10.1016%2FS0065-3233%2808%2960411-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Avidin</span></div><div class="casAuthors">Green, N. Michael</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Protein Chemistry</span>
        (<span class="NLM_cas:date">1975</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">85-133</span>CODEN:
                <span class="NLM_cas:coden">APCHA2</span>;
        ISSN:<span class="NLM_cas:issn">0065-3233</span>.
    </div><div class="casAbstract">A review with 127 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeixkEWQrkbrVg90H21EOLACvtfcHk0ligM5niuWxK5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2MXksleltrg%253D&md5=3b3e99d46d44ad504a2b20a18c325f31</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2FS0065-3233%2808%2960411-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0065-3233%252808%252960411-8%26sid%3Dliteratum%253Aachs%26aulast%3DGreen%26aufirst%3DN.%2BM.%26atitle%3DAvidin%26jtitle%3DAdv.%2520Protein%2520Chem.%26date%3D1975%26volume%3D29%26spage%3D85%26epage%3D133%26doi%3D10.1016%2FS0065-3233%2808%2960411-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maly, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choong, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellman, J. A.</span></span> <span> </span><span class="NLM_article-title">Combinatorial target-guided ligand assembly: identification of potent subtype-selective c-SRC inhibitors</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">2419</span>– <span class="NLM_lpage">2424</span>, <span class="refDoi"> DOI: 10.1073/pnas.97.6.2419</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1073%2Fpnas.97.6.2419" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10716979" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BD3cXitVaitL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=2419-2424&author=D.+J.+Malyauthor=I.+C.+Choongauthor=J.+A.+Ellman&title=Combinatorial+target-guided+ligand+assembly%3A+identification+of+potent+subtype-selective+c-SRC+inhibitors&doi=10.1073%2Fpnas.97.6.2419"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Combinatorial target-guided ligand assembly: identification of potent subtype-selective c-Src inhibitors</span></div><div class="casAuthors">Maly, Dustin J.; Choong, Ingrid C.; Ellman, Jonathan A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2419-2424</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">A method for the rapid and efficient identification of ligands to biol. targets is reported.  The combinatorial method does not require structural or mechanistic information and is accomplished in four straightforward steps.  (i) A set of potential binding elements is prepd. wherein each mol. incorporates a common chem. linkage group.  (ii) The set of potential binding elements is screened to identify all binding elements that interact even weakly with the biol. target.  (iii) A combinatorial library of linked binding elements is prepd. whereby the binding elements are connected by the common chem. linkage groups through a set of flexible linkers.  (iv) The combinatorial library is screened to identify the tightest-binding ligands.  The utility of the method was demonstrated by the identification of a potent and subtype-selective small mol. inhibitor of the non-receptor tyrosine kinase c-Src (IC50 = 64 nM).  Because the method relies on connecting two distinct binding elements, the relative contributions of the two binding elements to the potency and selectivity of the inhibitor were readily detd.  This information provides valuable insight into the mol. basis of inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd5dUv6_L16bVg90H21EOLACvtfcHk0ljjDucimK-XKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXitVaitL0%253D&md5=26efc511950ea54f41780cb10779dfea</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1073%2Fpnas.97.6.2419&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.97.6.2419%26sid%3Dliteratum%253Aachs%26aulast%3DMaly%26aufirst%3DD.%2BJ.%26aulast%3DChoong%26aufirst%3DI.%2BC.%26aulast%3DEllman%26aufirst%3DJ.%2BA.%26atitle%3DCombinatorial%2520target-guided%2520ligand%2520assembly%253A%2520identification%2520of%2520potent%2520subtype-selective%2520c-SRC%2520inhibitors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2000%26volume%3D97%26spage%3D2419%26epage%3D2424%26doi%3D10.1073%2Fpnas.97.6.2419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huc, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehn, J. M.</span></span> <span> </span><span class="NLM_article-title">Virtual combinatorial libraries: Dynamic generation of molecular and supramolecular diversity by self-assembly</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">2106</span>– <span class="NLM_lpage">2110</span>, <span class="refDoi"> DOI: 10.1073/pnas.94.6.2106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1073%2Fpnas.94.6.2106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=9122156" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADyaK2sXhvF2ltrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1997&pages=2106-2110&author=I.+Hucauthor=J.+M.+Lehn&title=Virtual+combinatorial+libraries%3A+Dynamic+generation+of+molecular+and+supramolecular+diversity+by+self-assembly&doi=10.1073%2Fpnas.94.6.2106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Virtual combinatorial libraries: dynamic generation of molecular and supramolecular diversity by self-assembly</span></div><div class="casAuthors">Huc, Ivan; Lehn, Jean-Marie</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2106-2110</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Mol. and supramol. diversity may be generated, resp., by reversible, covalent or noncovalent self-assembly of basic components whose various potential combinations in no. and nature represent a virtual combinatorial library.  This concept is applied to the induction of inhibitors of carbonic anhydrase (CA) by reversible recombination of aldehyde and amine components.  The presence of CA favors the formation of those condensation compds. that may be expected to present the strongest binding to the CA active site.  The virtual combinatorial library approach may represent a powerful methodol. for the discovery of substrates, inhibitors, receptors, catalysts, and carriers for a variety of processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQ2QpGhf5oDLVg90H21EOLACvtfcHk0ljjDucimK-XKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhvF2ltrs%253D&md5=158c74081199c7363a16130ad13cc884</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1073%2Fpnas.94.6.2106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.94.6.2106%26sid%3Dliteratum%253Aachs%26aulast%3DHuc%26aufirst%3DI.%26aulast%3DLehn%26aufirst%3DJ.%2BM.%26atitle%3DVirtual%2520combinatorial%2520libraries%253A%2520Dynamic%2520generation%2520of%2520molecular%2520and%2520supramolecular%2520diversity%2520by%2520self-assembly%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1997%26volume%3D94%26spage%3D2106%26epage%3D2110%26doi%3D10.1073%2Fpnas.94.6.2106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hochgürtel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroth, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piecha, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofmann, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicolau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krause, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaaf, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonnenmoser, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eliseev, A. V.</span></span> <span> </span><span class="NLM_article-title">Target-induced formation of neuraminidase inhibitors from in vitro virtual combinatorial libraries</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">3382</span>– <span class="NLM_lpage">3387</span>, <span class="refDoi"> DOI: 10.1073/pnas.052703799</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1073%2Fpnas.052703799" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=11891312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BD38Xis1Kmurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=3382-3387&author=M.+Hochg%C3%BCrtelauthor=H.+Krothauthor=D.+Piechaauthor=M.+W.+Hofmannauthor=C.+Nicolauauthor=S.+Krauseauthor=O.+Schaafauthor=G.+Sonnenmoserauthor=A.+V.+Eliseev&title=Target-induced+formation+of+neuraminidase+inhibitors+from+in+vitro+virtual+combinatorial+libraries&doi=10.1073%2Fpnas.052703799"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Target-induced formation of neuraminidase inhibitors from in vitro virtual combinatorial libraries</span></div><div class="casAuthors">Hochguertel, Matthias; Kroth, Heiko; Piecha, Dorothea; Hofmann, Michael W.; Nicolau, Claude; Krause, Sonja; Schaaf, Otmar; Sonnenmoser, Gabriele; Eliseev, Alexey V.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3382-3387</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Neuraminidase, a key enzyme responsible for influenza virus propagation, has been used as a template for selective synthesis of small subsets of its own inhibitors from theor. highly diverse dynamic combinatorial libraries.  We show that the library building blocks, aldehydes and amines, form significant amts. of the library components resulting from their coupling by reductive amination only in the presence of the enzyme.  The target amplifies the best hits at least 120-fold.  The dynamic libraries synthesized and screened in such an in vitro virtual mode form the components that possess high inhibitory activity, as confirmed by enzyme assays with independently synthesized individual compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJp4OM54ydgLVg90H21EOLACvtfcHk0ljjDucimK-XKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xis1Kmurg%253D&md5=38f68ebcb32969193663941ac874d778</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1073%2Fpnas.052703799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.052703799%26sid%3Dliteratum%253Aachs%26aulast%3DHochg%25C3%25BCrtel%26aufirst%3DM.%26aulast%3DKroth%26aufirst%3DH.%26aulast%3DPiecha%26aufirst%3DD.%26aulast%3DHofmann%26aufirst%3DM.%2BW.%26aulast%3DNicolau%26aufirst%3DC.%26aulast%3DKrause%26aufirst%3DS.%26aulast%3DSchaaf%26aufirst%3DO.%26aulast%3DSonnenmoser%26aufirst%3DG.%26aulast%3DEliseev%26aufirst%3DA.%2BV.%26atitle%3DTarget-induced%2520formation%2520of%2520neuraminidase%2520inhibitors%2520from%2520in%2520vitro%2520virtual%2520combinatorial%2520libraries%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2002%26volume%3D99%26spage%3D3382%26epage%3D3387%26doi%3D10.1073%2Fpnas.052703799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hochgürtel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biesinger, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroth, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piecha, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofmann, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krause, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaaf, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicolau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eliseev, A. V.</span></span> <span> </span><span class="NLM_article-title">Ketones as building blocks for dynamic combinatorial libraries: highly active neuraminidase inhibitors generated via selection pressure of the biological target</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">356</span>– <span class="NLM_lpage">358</span>, <span class="refDoi"> DOI: 10.1021/jm025589m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm025589m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BD3sXotlWh" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=356-358&author=M.+Hochg%C3%BCrtelauthor=R.+Biesingerauthor=H.+Krothauthor=D.+Piechaauthor=M.+W.+Hofmannauthor=S.+Krauseauthor=O.+Schaafauthor=C.+Nicolauauthor=A.+V.+Eliseev&title=Ketones+as+building+blocks+for+dynamic+combinatorial+libraries%3A+highly+active+neuraminidase+inhibitors+generated+via+selection+pressure+of+the+biological+target&doi=10.1021%2Fjm025589m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Ketones as Building Blocks for Dynamic Combinatorial Libraries: Highly Active Neuraminidase Inhibitors Generated via Selection Pressure of the Biological Target</span></div><div class="casAuthors">Hochguertel, Matthias; Biesinger, Ralf; Kroth, Heiko; Piecha, Dorothea; Hofmann, Michael W.; Krause, Sonja; Schaaf, Otmar; Nicolau, Claude; Eliseev, Alexey V.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">356-358</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">New and potent inhibitors of neuraminidase, a key enzyme in the influenza virus activity, have been discovered in dynamic combinatorial libraries based on ketones and amines as building blocks.  Selective synthesis of a no. of inhibitors among multiple theor. possible combinations of building blocks is driven by the presence of the target enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhUyA6CfOz_LVg90H21EOLACvtfcHk0lj135PVsxDr7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXotlWh&md5=13a0925f444ac4837b288f0233c6a13e</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Fjm025589m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm025589m%26sid%3Dliteratum%253Aachs%26aulast%3DHochg%25C3%25BCrtel%26aufirst%3DM.%26aulast%3DBiesinger%26aufirst%3DR.%26aulast%3DKroth%26aufirst%3DH.%26aulast%3DPiecha%26aufirst%3DD.%26aulast%3DHofmann%26aufirst%3DM.%2BW.%26aulast%3DKrause%26aufirst%3DS.%26aulast%3DSchaaf%26aufirst%3DO.%26aulast%3DNicolau%26aufirst%3DC.%26aulast%3DEliseev%26aufirst%3DA.%2BV.%26atitle%3DKetones%2520as%2520building%2520blocks%2520for%2520dynamic%2520combinatorial%2520libraries%253A%2520highly%2520active%2520neuraminidase%2520inhibitors%2520generated%2520via%2520selection%2520pressure%2520of%2520the%2520biological%2520target%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D356%26epage%3D358%26doi%3D10.1021%2Fjm025589m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mondal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radeva, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Köster, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potamitis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zervou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klebe, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirsch, A. K.</span></span> <span> </span><span class="NLM_article-title">Structure-based design of inhibitors of the aspartic protease endothiapepsin by exploiting dynamic combinatorial chemistry</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">3259</span>– <span class="NLM_lpage">3263</span>, <span class="refDoi"> DOI: 10.1002/anie.201309682</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1002%2Fanie.201309682" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisFOgtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=3259-3263&author=M.+Mondalauthor=N.+Radevaauthor=H.+K%C3%B6sterauthor=A.+Parkauthor=C.+Potamitisauthor=M.+Zervouauthor=G.+Klebeauthor=A.+K.+Hirsch&title=Structure-based+design+of+inhibitors+of+the+aspartic+protease+endothiapepsin+by+exploiting+dynamic+combinatorial+chemistry&doi=10.1002%2Fanie.201309682"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of Inhibitors of the Aspartic Protease Endothiapepsin by Exploiting Dynamic Combinatorial Chemistry</span></div><div class="casAuthors">Mondal, Milon; Radeva, Nedyalka; Koester, Helene; Park, Ahyoung; Potamitis, Constantinos; Zervou, Maria; Klebe, Gerhard; Hirsch, Anna K. H.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3259-3263</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Structure-based design (SBD) can be used for the design and/or optimization of new inhibitors for a biol. target.  Whereas de novo SBD is rarely used, most reports on SBD are dealing with the optimization of an initial hit.  Dynamic combinatorial chem. (DCC) has emerged as a powerful strategy to identify bioactive ligands given that it enables the target to direct the synthesis of its strongest binder.  We have designed a library of potential inhibitors (acylhydrazones) generated from five aldehydes and five hydrazides and used DCC to identify the best binder(s).  After addn. of the aspartic protease endothiapepsin, we characterized the protein-bound library member(s) by satn.-transfer difference NMR spectroscopy.  Cocrystn. expts. validated the predicted binding mode of the two most potent inhibitors, thus demonstrating that the combination of de novo SBD and DCC constitutes an efficient starting point for hit identification and optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0ZicAgqlVQLVg90H21EOLACvtfcHk0lj135PVsxDr7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisFOgtrg%253D&md5=45587303d496fb3fe39f80da5d8c277e</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1002%2Fanie.201309682&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201309682%26sid%3Dliteratum%253Aachs%26aulast%3DMondal%26aufirst%3DM.%26aulast%3DRadeva%26aufirst%3DN.%26aulast%3DK%25C3%25B6ster%26aufirst%3DH.%26aulast%3DPark%26aufirst%3DA.%26aulast%3DPotamitis%26aufirst%3DC.%26aulast%3DZervou%26aufirst%3DM.%26aulast%3DKlebe%26aufirst%3DG.%26aulast%3DHirsch%26aufirst%3DA.%2BK.%26atitle%3DStructure-based%2520design%2520of%2520inhibitors%2520of%2520the%2520aspartic%2520protease%2520endothiapepsin%2520by%2520exploiting%2520dynamic%2520combinatorial%2520chemistry%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2014%26volume%3D53%26spage%3D3259%26epage%3D3263%26doi%3D10.1002%2Fanie.201309682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Congreve, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devine, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Granata, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Reilly, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyatt, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jhoti, H.</span></span> <span> </span><span class="NLM_article-title">Detection of ligands from a dynamic combinatorial library by X-ray crystallography</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">4479</span>– <span class="NLM_lpage">4482</span>, <span class="refDoi"> DOI: 10.1002/anie.200351951</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1002%2Fanie.200351951" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BD3sXot1Kqu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2003&pages=4479-4482&author=M.+S.+Congreveauthor=D.+J.+Davisauthor=L.+Devineauthor=C.+Granataauthor=M.+O%E2%80%99Reillyauthor=P.+G.+Wyattauthor=H.+Jhoti&title=Detection+of+ligands+from+a+dynamic+combinatorial+library+by+X-ray+crystallography&doi=10.1002%2Fanie.200351951"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Detection of ligands from a dynamic combinatorial library by X-ray crystallography</span></div><div class="casAuthors">Congreve, Miles S.; Davis, Deborah J.; Devine, Lindsay; Granata, Cesare; O'Reilly, Marc; Wyatt, Paul G.; Jhoti, Harren</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">4479-4482</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Dynamic combinatorial chem. (DCC) is an approach to mol. recognition in which specific members of a combinatorial library are selected and amplified with the use of a template.  The principle difference between DCC and traditional combinatorial chem. is that the reaction linking the building blocks together in DCC is reversible and there is an ongoing interchange between the different members of the dynamic combinatorial library (DCL) under thermodn. control.  A DCL. is therefore able to respond to mol. recognition events owing to the presence of a template, such as a protein, which can stabilize a particular member of the library and induce a shift in the equil., favoring the formation of the selected species.  Also, the effect can only be detected by R comparison of identical libraries, generated R N with and without the protein component R3 present, using either mass spectrometric H anal. or HPLC chromatograms as a fingerprint.  We now report a complimentary approach in which ligands are obsd. directly by X-ray crystallog. by interpretation of electron-d. maps from crystals exposed to a dynamic combinatorial library mixt.  We call this technol. dynamic combinatorial X-ray crystallog. or DCX.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqN6ubgxyFWELVg90H21EOLACvtfcHk0lj135PVsxDr7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXot1Kqu7w%253D&md5=1a084e609f5b3c7b98d97c3594ad9f46</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1002%2Fanie.200351951&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200351951%26sid%3Dliteratum%253Aachs%26aulast%3DCongreve%26aufirst%3DM.%2BS.%26aulast%3DDavis%26aufirst%3DD.%2BJ.%26aulast%3DDevine%26aufirst%3DL.%26aulast%3DGranata%26aufirst%3DC.%26aulast%3DO%25E2%2580%2599Reilly%26aufirst%3DM.%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26aulast%3DJhoti%26aufirst%3DH.%26atitle%3DDetection%2520of%2520ligands%2520from%2520a%2520dynamic%2520combinatorial%2520library%2520by%2520X-ray%2520crystallography%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2003%26volume%3D42%26spage%3D4479%26epage%3D4482%26doi%3D10.1002%2Fanie.200351951" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Dahshan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rademann, J.</span></span> <span> </span><span class="NLM_article-title">Selective identification of cooperatively binding fragments in a high-throughput ligation assay enables development of a picomolar caspase-3 inhibitor</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">6346</span>– <span class="NLM_lpage">6349</span>, <span class="refDoi"> DOI: 10.1002/anie.200901647</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1002%2Fanie.200901647" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpvFyhu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=6346-6349&author=M.+F.+Schmidtauthor=A.+El-Dahshanauthor=S.+Kellerauthor=J.+Rademann&title=Selective+identification+of+cooperatively+binding+fragments+in+a+high-throughput+ligation+assay+enables+development+of+a+picomolar+caspase-3+inhibitor&doi=10.1002%2Fanie.200901647"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Identification of Cooperatively Binding Fragments in a High-Throughput Ligation Assay Enables Development of a Picomolar Caspase-3 Inhibitor</span></div><div class="casAuthors">Schmidt, Marco F.; El-Dahshan, Adeeb; Keller, Sandro; Rademann, Joerg</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">6346-6349, S6346/1-S6346/13</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Fragment-based lead discovery has become popular over the past years, allowing for a more efficient sampling of the chem. space and thus resulting in higher hit rates than that for the screening of non-fragment chem. libraries.  Reported detection methods for protein-binding fragments, however, do not answer the most challenging question in fragment-based ligand discovery: How can a primary ligand as the starting point be extended optimally by a secondary fragment.  While "second-site screening" by NMR spectroscopy or crystallog. delivers fragment hits for different binding sites, it does not provide information regarding the optimal, bioactive combination of fragments.  Evidently, for a thermodynamically optimized extension of a primary ligand (A) by a secondary fragment (B), cooperative binding of both components is required.  Cooperative binding in this context results if the binding of A is amplified by the binding of B.  Cooperative binding therefore is distinct from additive binding (in which A and B bind independently without mutual influence) and competitive binding where the secondary fragment B inhibits the binding of A.  Cooperatively binding fragments result in strongly increased binding affinities if the two components are connected by a suitable covalent linkage.  The authors developed and implemented the differential detection of cooperative and competitive fragments in one FP expt. operable in high-throughput format.  Cooperative fragment binding can be verified and distinguished from merely additive effects.  By employing a model for the ligation equil. we could est. the ligation const. and the Gibbs free energy of the reversible ligation reaction on the protein surface.  A chem. stable combination of the best fragment hits yielded the most potent inhibitor of caspase-3 reported to date.  Thus, the described dynamic method for cooperativity screening can be used to dissect and analyze binding contributions of single fragments in a ligation system.  As it is based on FP detection, the method is broadly applicable to enzyme targets as well as to protein-protein interactions.  The information gained from this assay can be utilized directly for the construction of improved protein ligands by a rational approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopsSF_8gOhA7Vg90H21EOLACvtfcHk0lhh40L3XIsIyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpvFyhu7k%253D&md5=6d2567d3f6ec9837df92f89202ca6a79</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1002%2Fanie.200901647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200901647%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidt%26aufirst%3DM.%2BF.%26aulast%3DEl-Dahshan%26aufirst%3DA.%26aulast%3DKeller%26aufirst%3DS.%26aulast%3DRademann%26aufirst%3DJ.%26atitle%3DSelective%2520identification%2520of%2520cooperatively%2520binding%2520fragments%2520in%2520a%2520high-throughput%2520ligation%2520assay%2520enables%2520development%2520of%2520a%2520picomolar%2520caspase-3%2520inhibitor%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2009%26volume%3D48%26spage%3D6346%26epage%3D6349%26doi%3D10.1002%2Fanie.200901647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jaegle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinmetzer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rademann, J.</span></span> <span> </span><span class="NLM_article-title">Protein-templated formation of an inhibitor of the blood coagulation factor Xa through a background-free amidation reaction</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">3718</span>– <span class="NLM_lpage">3722</span>, <span class="refDoi"> DOI: 10.1002/anie.201611547</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1002%2Fanie.201611547" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC2sXislGgu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2017&pages=3718-3722&author=M.+Jaegleauthor=T.+Steinmetzerauthor=J.+Rademann&title=Protein-templated+formation+of+an+inhibitor+of+the+blood+coagulation+factor+Xa+through+a+background-free+amidation+reaction&doi=10.1002%2Fanie.201611547"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Protein-Templated Formation of an Inhibitor of the Blood Coagulation Factor Xa through a Background-Free Amidation Reaction</span></div><div class="casAuthors">Jaegle, Mike; Steinmetzer, Torsten; Rademann, Joerg</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3718-3722</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Protein-templated reactions enable the target-guided formation of protein ligands from reactive fragments, ideally with no background reaction.  Herein, we investigate the templated formation of amides.  A nucleophilic fragment that binds to the coagulation factor Xa was incubated with the protein and thirteen differentially activated dipeptides.  The protein induced a non-catalytic templated reaction for the Ph and trifluoroethyl esters; the latter was shown to be a completely background-free reaction.  Starting from two fragments with millimolar affinity, a 29 nM superadditive inhibitor of factor Xa was obtained.  The fragment ligation reaction was detected with high sensitivity by an enzyme activity assay and by mass spectrometry.  The reaction progress and autoinhibition of the templated reaction by the formed ligation product were detd., and the structure of the protein-inhibitor complex was elucidated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMW8n0HDtHjrVg90H21EOLACvtfcHk0lhh40L3XIsIyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXislGgu7g%253D&md5=30bf632a374bb45d67262a812a62988d</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1002%2Fanie.201611547&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201611547%26sid%3Dliteratum%253Aachs%26aulast%3DJaegle%26aufirst%3DM.%26aulast%3DSteinmetzer%26aufirst%3DT.%26aulast%3DRademann%26aufirst%3DJ.%26atitle%3DProtein-templated%2520formation%2520of%2520an%2520inhibitor%2520of%2520the%2520blood%2520coagulation%2520factor%2520Xa%2520through%2520a%2520background-free%2520amidation%2520reaction%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2017%26volume%3D56%26spage%3D3718%26epage%3D3722%26doi%3D10.1002%2Fanie.201611547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grynszpan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radić, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlier, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finn, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharpless, K. B.</span></span> <span> </span><span class="NLM_article-title">Click chemistry in situ: acetylcholinesterase as a reaction vessel for the selective assembly of a femtomolar inhibitor from an array of building blocks</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">1053</span>– <span class="NLM_lpage">1057</span>, <span class="refDoi"> DOI: 10.1002/1521-3773(20020315)41:6<1053::AID-ANIE1053>3.0.CO;2-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1002%2F1521-3773%2820020315%2941%3A6%3C1053%3A%3AAID-ANIE1053%3E3.0.CO%3B2-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BD38XisVeisbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2002&pages=1053-1057&author=W.+G.+Lewisauthor=L.+G.+Greenauthor=F.+Grynszpanauthor=Z.+Radi%C4%87author=P.+R.+Carlierauthor=P.+Taylorauthor=M.+G.+Finnauthor=K.+B.+Sharpless&title=Click+chemistry+in+situ%3A+acetylcholinesterase+as+a+reaction+vessel+for+the+selective+assembly+of+a+femtomolar+inhibitor+from+an+array+of+building+blocks&doi=10.1002%2F1521-3773%2820020315%2941%3A6%3C1053%3A%3AAID-ANIE1053%3E3.0.CO%3B2-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Click chemistry in situ: Acetylcholinesterase as a reaction vessel for the selective assembly of a femtomolar inhibitor from an array of building blocks</span></div><div class="casAuthors">Lewis, Warren G.; Green, Luke G.; Grynszpan, Flavio; Radic, Zoran; Carlier, Paul R.; Taylor, Palmer; Finn, M. G.; Sharpless, K. Barry</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1053-1057</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH</span>)
        </div><div class="casAbstract">Form-fitting chem. in a protein mold is enabled by the use of the 1,3-dipolar cycloaddn. of azides and alkynes.  The enzyme acetylcholinesterase preferentially assembles one pair of these reactants, each of which bears a group that binds to adjacent positions on the protein structure, into a 1,2,3-triazole adduct that is the most potent noncovalent inhibitor of the enzyme yet developed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYVFLD1n2QrbVg90H21EOLACvtfcHk0lick2oNqSN5Wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XisVeisbo%253D&md5=e1ff6aedcbf7ae1523f4e3082e801c86</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1002%2F1521-3773%2820020315%2941%3A6%3C1053%3A%3AAID-ANIE1053%3E3.0.CO%3B2-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1521-3773%252820020315%252941%253A6%253C1053%253A%253AAID-ANIE1053%253E3.0.CO%253B2-4%26sid%3Dliteratum%253Aachs%26aulast%3DLewis%26aufirst%3DW.%2BG.%26aulast%3DGreen%26aufirst%3DL.%2BG.%26aulast%3DGrynszpan%26aufirst%3DF.%26aulast%3DRadi%25C4%2587%26aufirst%3DZ.%26aulast%3DCarlier%26aufirst%3DP.%2BR.%26aulast%3DTaylor%26aufirst%3DP.%26aulast%3DFinn%26aufirst%3DM.%2BG.%26aulast%3DSharpless%26aufirst%3DK.%2BB.%26atitle%3DClick%2520chemistry%2520in%2520situ%253A%2520acetylcholinesterase%2520as%2520a%2520reaction%2520vessel%2520for%2520the%2520selective%2520assembly%2520of%2520a%2520femtomolar%2520inhibitor%2520from%2520an%2520array%2520of%2520building%2520blocks%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2002%26volume%3D41%26spage%3D1053%26epage%3D1057%26doi%3D10.1002%2F1521-3773%2820020315%2941%3A6%3C1053%3A%3AAID-ANIE1053%3E3.0.CO%3B2-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ota, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasuya, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mutsuga, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsumoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakagawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finn, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyata, N.</span></span> <span> </span><span class="NLM_article-title">An unexpected example of protein-templated click chemistry</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">6817</span>– <span class="NLM_lpage">6820</span>, <span class="refDoi"> DOI: 10.1002/anie.201002205</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1002%2Fanie.201002205" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFGnsbnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=6817-6820&author=T.+Suzukiauthor=Y.+Otaauthor=Y.+Kasuyaauthor=M.+Mutsugaauthor=Y.+Kawamuraauthor=H.+Tsumotoauthor=H.+Nakagawaauthor=M.+G.+Finnauthor=N.+Miyata&title=An+unexpected+example+of+protein-templated+click+chemistry&doi=10.1002%2Fanie.201002205"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">An Unexpected Example of Protein-Templated Click Chemistry</span></div><div class="casAuthors">Suzuki, Takayoshi; Ota, Yosuke; Kasuya, Yuki; Mutsuga, Motoh; Kawamura, Yoko; Tsumoto, Hiroki; Nakagawa, Hidehiko; Finn, M. G.; Miyata, Naoki</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">6817-6820, S6817/1-S6817/10</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The authors have established that a Cu(I) complex of HDAC8 (human recombinant histone deacetylase) accelerates a selective azide-alkyne cycloaddn. (AAC) between an azide and an alkyne, thereby forming a triazole deriv. with greater inhibitory power towards the enzyme than either of the reactants alone.  In this case, the unwavering regioselectivity of the CuAAC process overrides the tendency of the Cu-free in situ click reaction to form the more potent (syn-isomer, 1,5-triazolyl) of the two triazole isomers.  Thus, regiospecific formation of triazole adducts from alkyne I and azide II in presence of HDAC8 gave rise to a significant peak in HPLC corresponding to anti-isomer (1,4-triazolyl) adduct III along with a smaller peak being the syn-isomer (1,5-triazolyl) adduct IV.  To examine whether Cu(I) is required for the cycloaddn., AAC was conducted using I and II in presence of HDAC8 and bathocuproine disulfonic acid [BCDSA; a Cu(I)-specific chelator and inhibitor of the CuAAC reaction].  The results showed that BCDSA inhibited the triazole formation.  In addn., Zn(OAc)2 was added to the mixt. of reactants I and II along with HDAC8 to displace Cu from the protein.  This treatment completely suppressed the formation of anti-isomer III, whereas in soln., Zn(II) had no effect on the CuAAC reaction.  In summary, the authors regard this study as an important precedent in the search for highly active protein catalysts of the CuAAC reaction, as well as an interesting and potentially useful example of in situ inhibitor formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF5wSD48iQp7Vg90H21EOLACvtfcHk0lick2oNqSN5Wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFGnsbnK&md5=f6e6a2b9aa0a51df9a9828c8a4c1f92c</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1002%2Fanie.201002205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201002205%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DOta%26aufirst%3DY.%26aulast%3DKasuya%26aufirst%3DY.%26aulast%3DMutsuga%26aufirst%3DM.%26aulast%3DKawamura%26aufirst%3DY.%26aulast%3DTsumoto%26aufirst%3DH.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DFinn%26aufirst%3DM.%2BG.%26aulast%3DMiyata%26aufirst%3DN.%26atitle%3DAn%2520unexpected%2520example%2520of%2520protein-templated%2520click%2520chemistry%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2010%26volume%3D49%26spage%3D6817%26epage%3D6820%26doi%3D10.1002%2Fanie.201002205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hirose, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maita, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gouda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koseki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugawara, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakano, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirono, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiomi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taniguchi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharpless, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sunazuka, T.</span></span> <span> </span><span class="NLM_article-title">Observation of the controlled assembly of preclick components in the in situ click chemistry generation of a chitinase inhibitor</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">15892</span>– <span class="NLM_lpage">15897</span>, <span class="refDoi"> DOI: 10.1073/pnas.1315049110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1073%2Fpnas.1315049110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=24043811" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1SqtbrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=15892-15897&author=T.+Hiroseauthor=N.+Maitaauthor=H.+Goudaauthor=J.+Kosekiauthor=T.+Yamamotoauthor=A.+Sugawaraauthor=H.+Nakanoauthor=S.+Hironoauthor=K.+Shiomiauthor=T.+Watanabeauthor=H.+Taniguchiauthor=K.+B.+Sharplessauthor=S.+Omuraauthor=T.+Sunazuka&title=Observation+of+the+controlled+assembly+of+preclick+components+in+the+in+situ+click+chemistry+generation+of+a+chitinase+inhibitor&doi=10.1073%2Fpnas.1315049110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Observation of the controlled assembly of preclick components in the in situ click chemistry generation of a chitinase inhibitor</span></div><div class="casAuthors">Hirose, Tomoyasu; Maita, Nobuo; Gouda, Hiroaki; Koseki, Jun; Yamamoto, Tsuyoshi; Sugawara, Akihiro; Nakano, Hirofumi; Hirono, Shuichi; Shiomi, Kazuro; Watanabe, Takeshi; Taniguchi, Hisaaki; Sharpless, K. Barry; Omura, Satoshi; Sunazuka, Toshiaki</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">15892-15897,S15892/1-S15892/5</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The Huisgen cycloaddn. of azides and alkynes, accelerated by target biomols., termed "in situ click chem.," has been successfully exploited to discover highly potent enzyme inhibitors.  We have previously reported a specific Serratia marcescens chitinase B (SmChiB)-templated syn-triazole inhibitor generated in situ from an azide-bearing inhibitor and an alkyne fragment.  Several in situ click chem. studies have been reported.  Although some mechanistic evidence has been obtained, such as X-ray anal. of [protein]-["click ligand"] complexes, indicating that proteins act as both mold and template between unique pairs of azide and alkyne fragments, to date, observations have been based solely on "postclick" structural information.  Here, we describe crystal structures of SmChiB complexed with an azide ligand and an O-allyl oxime fragment as a mimic of a click partner, revealing a mechanism for accelerating syn-triazole formation, which allows generation of its own distinct inhibitor.  We have also performed d. functional theory calcns. based on the X-ray structure to explore the acceleration of the Huisgen cycloaddn. by SmChiB.  The d. functional theory calcns. reasonably support that SmChiB plays a role by the cage effect during the pre-translation and post-translation states of selective syn-triazole click formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvlga4V4v-ZbVg90H21EOLACvtfcHk0lick2oNqSN5Wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1SqtbrL&md5=b605dc38fae207c49cd915ac28f2d2f1</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1315049110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1315049110%26sid%3Dliteratum%253Aachs%26aulast%3DHirose%26aufirst%3DT.%26aulast%3DMaita%26aufirst%3DN.%26aulast%3DGouda%26aufirst%3DH.%26aulast%3DKoseki%26aufirst%3DJ.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DSugawara%26aufirst%3DA.%26aulast%3DNakano%26aufirst%3DH.%26aulast%3DHirono%26aufirst%3DS.%26aulast%3DShiomi%26aufirst%3DK.%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DTaniguchi%26aufirst%3DH.%26aulast%3DSharpless%26aufirst%3DK.%2BB.%26aulast%3DOmura%26aufirst%3DS.%26aulast%3DSunazuka%26aufirst%3DT.%26atitle%3DObservation%2520of%2520the%2520controlled%2520assembly%2520of%2520preclick%2520components%2520in%2520the%2520in%2520situ%2520click%2520chemistry%2520generation%2520of%2520a%2520chitinase%2520inhibitor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D15892%26epage%3D15897%26doi%3D10.1073%2Fpnas.1315049110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mondal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unver, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berrier, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirsch, A. K. H.</span></span> <span> </span><span class="NLM_article-title">Fragment-based drug design facilitated by protein-templated click chemistry: fragment linking and optimization of inhibitors of the aspartic protease endothiapepsin</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">14826</span>– <span class="NLM_lpage">14830</span>, <span class="refDoi"> DOI: 10.1002/chem.201603001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1002%2Fchem.201603001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=27604032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVymt7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2016&pages=14826-14830&author=M.+Mondalauthor=M.+Y.+Unverauthor=A.+Palauthor=M.+Bakkerauthor=S.+P.+Berrierauthor=A.+K.+H.+Hirsch&title=Fragment-based+drug+design+facilitated+by+protein-templated+click+chemistry%3A+fragment+linking+and+optimization+of+inhibitors+of+the+aspartic+protease+endothiapepsin&doi=10.1002%2Fchem.201603001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Drug Design Facilitated by Protein-Templated Click Chemistry: Fragment Linking and -Optimization of Inhibitors of the Aspartic Protease Endothiapepsin</span></div><div class="casAuthors">Mondal, Milon; Unver, M. Yagiz; Pal, Asish; Bakker, Matthijs; Berrier, Stephan P.; Hirsch, Anna K. H.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">14826-14830</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">There is an urgent need for the development of efficient methodologies that accelerate drug discovery.  The authors demonstrate that the strategic combination of fragment linking/optimization and protein-templated click chem. is an efficient and powerful method that accelerates the hit-identification process for the aspartic protease endothiapepsin.  The best binder, which inhibits endothiapepsin with an IC50 value of 43 μM, represents the first example of triazole-based inhibitors of endothiapepsin.  The authors' strategy could find application on a whole range of drug targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUHCQeKvPBdbVg90H21EOLACvtfcHk0ljG_Z_xvC8D-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVymt7fN&md5=adbc2c39fd6f750d420e89e6e01d5ebb</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1002%2Fchem.201603001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201603001%26sid%3Dliteratum%253Aachs%26aulast%3DMondal%26aufirst%3DM.%26aulast%3DUnver%26aufirst%3DM.%2BY.%26aulast%3DPal%26aufirst%3DA.%26aulast%3DBakker%26aufirst%3DM.%26aulast%3DBerrier%26aufirst%3DS.%2BP.%26aulast%3DHirsch%26aufirst%3DA.%2BK.%2BH.%26atitle%3DFragment-based%2520drug%2520design%2520facilitated%2520by%2520protein-templated%2520click%2520chemistry%253A%2520fragment%2520linking%2520and%2520optimization%2520of%2520inhibitors%2520of%2520the%2520aspartic%2520protease%2520endothiapepsin%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2016%26volume%3D22%26spage%3D14826%26epage%3D14830%26doi%3D10.1002%2Fchem.201603001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manetsch, R.</span></span> <span> </span><span class="NLM_article-title">Bcl-X<sub>L</sub>-templated assembly of its own protein-protein interaction modulator from fragments decorated with thio acids and sulfonyl azides</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>130</i></span>,  <span class="NLM_fpage">13820</span>– <span class="NLM_lpage">13821</span>, <span class="refDoi"> DOI: 10.1021/ja802683u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja802683u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFGntrjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2008&pages=13820-13821&author=X.+Huauthor=J.+Sunauthor=H.+G.+Wangauthor=R.+Manetsch&title=Bcl-XL-templated+assembly+of+its+own+protein-protein+interaction+modulator+from+fragments+decorated+with+thio+acids+and+sulfonyl+azides&doi=10.1021%2Fja802683u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Bcl-XL-Templated Assembly of Its Own Protein-Protein Interaction Modulator from Fragments Decorated with Thio Acids and Sulfonyl Azides</span></div><div class="casAuthors">Hu, Xiangdong; Sun, Jiazhi; Wang, Hong-Gang; Manetsch, Roman</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">13820-13821</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Protein-protein interactions have key importance in various biol. processes and modulation of particular protein-protein interactions has been shown to have therapeutic effects.  However, disrupting or modulating protein-protein interactions with low-mol.-wt. compds. is extremely difficult due to the lack of deep binding pockets on protein surfaces.  Herein the authors describe the development of an unprecedented lead synthesis and discovery method that generates only biol. active compds. from a library of reactive fragments.  Using the protein Bcl-XL, a central regulator of programmed cell death, the authors demonstrated that an amidation reaction between thio acids and sulfonyl azides is applicable for Bcl-XL-templated assembly of inhibitory compds.  The authors have demonstrated for the first time that kinetic target-guided synthesis can be applied not only on enzymic targets but also for the discovery of small mols. modulating protein-protein interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrALNx42CCC0rVg90H21EOLACvtfcHk0ljG_Z_xvC8D-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFGntrjI&md5=df38484d872f0ab7203c1e69ec8ea1d9</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1021%2Fja802683u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja802683u%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DH.%2BG.%26aulast%3DManetsch%26aufirst%3DR.%26atitle%3DBcl-XL-templated%2520assembly%2520of%2520its%2520own%2520protein-protein%2520interaction%2520modulator%2520from%2520fragments%2520decorated%2520with%2520thio%2520acids%2520and%2520sulfonyl%2520azides%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2008%26volume%3D130%26spage%3D13820%26epage%3D13821%26doi%3D10.1021%2Fja802683u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kulkarni, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manetsch, R.</span></span> <span> </span><span class="NLM_article-title">Screening of protein-protein interaction modulators via sulfo-click kinetic target-guided synthesis</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">724</span>– <span class="NLM_lpage">723</span>, <span class="refDoi"> DOI: 10.1021/cb200085q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb200085q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlsFyqt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=724-723&author=S.+S.+Kulkarniauthor=X.+Huauthor=K.+Doiauthor=H.+G.+Wangauthor=R.+Manetsch&title=Screening+of+protein-protein+interaction+modulators+via+sulfo-click+kinetic+target-guided+synthesis&doi=10.1021%2Fcb200085q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Screening of Protein-Protein Interaction Modulators via Sulfo-Click Kinetic Target-Guided Synthesis</span></div><div class="casAuthors">Kulkarni, Sameer S.; Hu, Xiangdong; Doi, Kenichiro; Wang, Hong-Gang; Manetsch, Roman</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">724-732</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Kinetic target-guided synthesis (TGS) and in situ click chem. are among unconventional discovery strategies having the potential to streamline the development of protein-protein interaction modulators (PPIMs).  In kinetic TGS and in situ click chem., the target is directly involved in the assembly of its own potent, bidentate ligand from a pool of reactive fragments.  Herein, we report the use and validation of kinetic TGS based on the sulfo-click reaction between thio acids and sulfonyl azides as a screening and synthesis platform for the identification of high-quality PPIMs.  Starting from a randomly designed library consisting of 9 thio acids and 9 sulfonyl azides leading to 81 potential acylsulfonamides, the target protein, Bcl-XL, selectively assembled four PPIMs, acylsulfonamides SZ4TA2, SZ7TA2, SZ9TA1, and SZ9TA5, which have been shown to modulate Bcl-XL/BH3 interactions.  To further investigate the Bcl-XL templation effect, control expts. were carried out using two mutants of Bcl-XL.  In one mutant, phenylalanine Phe131 and aspartic acid Asp133, which are crit. for the BH3 domain binding, were substituted by alanines, while arginine Arg139, a residue identified to play a crucial role in the binding of ABT-737, a BH3 mimetic, was replaced by an alanine in the other mutant.  Incubation of these mutants with the reactive fragments and subsequent LC/MS-SIM anal. confirmed that these building block combinations yield the corresponding acylsulfonamides at the BH3 binding site, the actual "hot spot" of Bcl-XL.  These results validate kinetic TGS using the sulfo-click reaction as a valuable tool for the straightforward identification of high-quality PPIMs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonWmMNREV6MrVg90H21EOLACvtfcHk0ljG_Z_xvC8D-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlsFyqt7Y%253D&md5=c57b60a88631ce37bd5dbeaa3b2e2f35</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fcb200085q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb200085q%26sid%3Dliteratum%253Aachs%26aulast%3DKulkarni%26aufirst%3DS.%2BS.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DDoi%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DH.%2BG.%26aulast%3DManetsch%26aufirst%3DR.%26atitle%3DScreening%2520of%2520protein-protein%2520interaction%2520modulators%2520via%2520sulfo-click%2520kinetic%2520target-guided%2520synthesis%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2011%26volume%3D6%26spage%3D724%26epage%3D723%26doi%3D10.1021%2Fcb200085q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span> <span> </span><span class="NLM_article-title">Evolutions in fragment-based drug design: the deconstruction-reconstruction approach</span>. <i>Drug Discov. Today</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">105</span>– <span class="NLM_lpage">113</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2014.09.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1016%2Fj.drudis.2014.09.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=25263697" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1KgtL%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2015&pages=105-113&author=H.+Chenauthor=X.+Zhouauthor=A.+Wangauthor=Y.+Zhengauthor=Y.+Gaoauthor=J.+Zhou&title=Evolutions+in+fragment-based+drug+design%3A+the+deconstruction-reconstruction+approach&doi=10.1016%2Fj.drudis.2014.09.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Evolutions in fragment-based drug design: the deconstruction-reconstruction approach</span></div><div class="casAuthors">Chen, Haijun; Zhou, Xiaobin; Wang, Ailan; Zheng, Yunquan; Gao, Yu; Zhou, Jia</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">105-113</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Recent advances in the understanding of mol. recognition and protein-ligand interactions have facilitated rapid development of potent and selective ligands for therapeutically relevant targets.  Over the past two decades, a variety of useful approaches and emerging techniques have been developed to promote the identification and optimization of leads that have high potential for generating new therapeutic agents.  Intriguingly, the innovation of a fragment-based drug design (FBDD) approach has enabled rapid and efficient progress in drug discovery.  In this crit. review, we focus on the construction of fragment libraries and the advantages and disadvantages of various fragment-based screening (FBS) for constructing such libraries.  We also highlight the deconstruction-reconstruction strategy by utilizing privileged fragments of reported ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVWzbA5c5707Vg90H21EOLACvtfcHk0lh4z8BeoXJqTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1KgtL%252FO&md5=13ce52517b336a860136ac3eb4151b16</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2014.09.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2014.09.015%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DJ.%26atitle%3DEvolutions%2520in%2520fragment-based%2520drug%2520design%253A%2520the%2520deconstruction-reconstruction%2520approach%26jtitle%3DDrug%2520Discov.%2520Today%26date%3D2015%26volume%3D20%26spage%3D105%26epage%3D113%26doi%3D10.1016%2Fj.drudis.2014.09.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mousnier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swieboda, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morales-Sanfrutos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-Dorado, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brannigan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritzefeld, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutton, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guedán, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asfor, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins-Navratilova, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnston, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leatherbarrow, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuthill, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solari, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, E. W.</span></span> <span> </span><span class="NLM_article-title">Fragment-derived inhibitors of human N-myristoyltransferase block capsid assembly and replication of the common cold virus</span>. <i>Nat. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">599</span>– <span class="NLM_lpage">606</span>, <span class="refDoi"> DOI: 10.1038/s41557-018-0039-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1038%2Fs41557-018-0039-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=29760414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC1cXps1KktLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&pages=599-606&author=A.+Mousnierauthor=A.+S.+Bellauthor=D.+P.+Swiebodaauthor=J.+Morales-Sanfrutosauthor=I.+P%C3%A9rez-Doradoauthor=J.+A.+Branniganauthor=J.+Newmanauthor=M.+Ritzefeldauthor=J.+A.+Huttonauthor=A.+Gued%C3%A1nauthor=A.+S.+Asforauthor=S.+W.+Robinsonauthor=I.+Hopkins-Navratilovaauthor=A.+J.+Wilkinsonauthor=S.+L.+Johnstonauthor=R.+J.+Leatherbarrowauthor=T.+J.+Tuthillauthor=R.+Solariauthor=E.+W.+Tate&title=Fragment-derived+inhibitors+of+human+N-myristoyltransferase+block+capsid+assembly+and+replication+of+the+common+cold+virus&doi=10.1038%2Fs41557-018-0039-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-derived inhibitors of human N-myristoyltransferase block capsid assembly and replication of the common cold virus</span></div><div class="casAuthors">Mousnier, Aurelie; Bell, Andrew S.; Swieboda, Dawid P.; Morales-Sanfrutos, Julia; Perez-Dorado, Inmaculada; Brannigan, James A.; Newman, Joseph; Ritzefeld, Markus; Hutton, Jennie A.; Guedan, Anabel; Asfor, Amin S.; Robinson, Sean W.; Hopkins-Navratilova, Iva; Wilkinson, Anthony J.; Johnston, Sebastian L.; Leatherbarrow, Robin J.; Tuthill, Tobias J.; Solari, Roberto; Tate, Edward W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">599-606</span>CODEN:
                <span class="NLM_cas:coden">NCAHBB</span>;
        ISSN:<span class="NLM_cas:issn">1755-4330</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Rhinoviruses (RVs) are the pathogens most often responsible for the common cold, and are a frequent cause of exacerbations in asthma, chronic obstructive pulmonary disease and cystic fibrosis.  Here we report the discovery of IMP-1088, a picomolar dual inhibitor of the human N-myristoyltransferases NMT1 and NMT2, and use it to demonstrate that pharmacol. inhibition of host-cell N-myristoylation rapidly and completely prevents rhinoviral replication without inducing cytotoxicity.  The identification of cooperative binding between weak-binding fragments led to rapid inhibitor optimization through fragment reconstruction, structure-guided fragment linking and conformational control over linker geometry.  We show that inhibition of the co-translational myristoylation of a specific virus-encoded protein (VP0) by IMP-1088 potently blocks a key step in viral capsid assembly, to deliver a low nanomolar antiviral activity against multiple RV strains, poliovirus and foot and-mouth disease virus, and protection of cells against virus-induced killing, highlighting the potential of host myristoylation as a drug target in picornaviral infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfyeVtScn0oLVg90H21EOLACvtfcHk0lh4z8BeoXJqTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXps1KktLY%253D&md5=4142792d359c5344041c1f28b7cb813f</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1038%2Fs41557-018-0039-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41557-018-0039-2%26sid%3Dliteratum%253Aachs%26aulast%3DMousnier%26aufirst%3DA.%26aulast%3DBell%26aufirst%3DA.%2BS.%26aulast%3DSwieboda%26aufirst%3DD.%2BP.%26aulast%3DMorales-Sanfrutos%26aufirst%3DJ.%26aulast%3DP%25C3%25A9rez-Dorado%26aufirst%3DI.%26aulast%3DBrannigan%26aufirst%3DJ.%2BA.%26aulast%3DNewman%26aufirst%3DJ.%26aulast%3DRitzefeld%26aufirst%3DM.%26aulast%3DHutton%26aufirst%3DJ.%2BA.%26aulast%3DGued%25C3%25A1n%26aufirst%3DA.%26aulast%3DAsfor%26aufirst%3DA.%2BS.%26aulast%3DRobinson%26aufirst%3DS.%2BW.%26aulast%3DHopkins-Navratilova%26aufirst%3DI.%26aulast%3DWilkinson%26aufirst%3DA.%2BJ.%26aulast%3DJohnston%26aufirst%3DS.%2BL.%26aulast%3DLeatherbarrow%26aufirst%3DR.%2BJ.%26aulast%3DTuthill%26aufirst%3DT.%2BJ.%26aulast%3DSolari%26aufirst%3DR.%26aulast%3DTate%26aufirst%3DE.%2BW.%26atitle%3DFragment-derived%2520inhibitors%2520of%2520human%2520N-myristoyltransferase%2520block%2520capsid%2520assembly%2520and%2520replication%2520of%2520the%2520common%2520cold%2520virus%26jtitle%3DNat.%2520Chem.%26date%3D2018%26volume%3D10%26spage%3D599%26epage%3D606%26doi%3D10.1038%2Fs41557-018-0039-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padyana, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abeywardane, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Lombaert, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proudfoot, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farmer, B. S.,  3rd.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albaugh, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill-Drzewi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pullen, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, H.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent, selective chymase inhibitors via fragment linking strategies</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">4465</span>– <span class="NLM_lpage">4481</span>, <span class="refDoi"> DOI: 10.1021/jm400138z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400138z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnsVWjurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4465-4481&author=S.+J.+Taylorauthor=A.+K.+Padyanaauthor=A.+Abeywardaneauthor=S.+Liangauthor=M.+H.+Haoauthor=S.+De+Lombaertauthor=J.+Proudfootauthor=B.+S.+Farmerauthor=X.+Liauthor=B.+Collinsauthor=L.+Martinauthor=D.+R.+Albaughauthor=M.+Hill-Drzewiauthor=S.+S.+Pullenauthor=H.+Takahashi&title=Discovery+of+potent%2C+selective+chymase+inhibitors+via+fragment+linking+strategies&doi=10.1021%2Fjm400138z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent, Selective Chymase Inhibitors via Fragment Linking Strategies</span></div><div class="casAuthors">Taylor, Steven J.; Padyana, Anil K.; Abeywardane, Asitha; Liang, Shuang; Hao, Ming-Hong; De Lombaert, Stephane; Proudfoot, John; Farmer, Bennett S.; Li, Xiang; Collins, Brandon; Martin, Leslie; Albaugh, Daniel R.; Hill-Drzewi, Melissa; Pullen, Steven S.; Takahashi, Hidenori</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4465-4481</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Chymase plays an important and diverse role in the homeostasis of a no. of cardiovascular processes.  Herein, the identification of potent, selective chymase inhibitors I [R = H, Cl, Br; X = CH2CH2, CH(n-Pr)CH2, CH2CH(n-Pr); Y = CH2, S], developed using fragment-based, structure-guided linking and optimization techniques, is described.  High-concn. biophys. screening methods followed by high-throughput crystallog. identified an oxindole fragment bound to the S1 pocket of the protein exhibiting a novel interaction pattern hitherto not obsd. in chymase inhibitors.  X-ray crystallog. structures were used to guide the elaboration/linking of the fragment, ultimately leading to a potent inhibitor I [R = Br; X = CH(n-Pr)CH2; Y = CH2] that was >100-fold selective over cathepsin G and that mitigated a no. of liabilities assocd. with poor physicochem. properties of the series it was derived from.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrf9osg33HdDbVg90H21EOLACvtfcHk0lh4z8BeoXJqTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnsVWjurY%253D&md5=f0c17458a4c4ba0a5d316ecec937ca63</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1021%2Fjm400138z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400138z%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DS.%2BJ.%26aulast%3DPadyana%26aufirst%3DA.%2BK.%26aulast%3DAbeywardane%26aufirst%3DA.%26aulast%3DLiang%26aufirst%3DS.%26aulast%3DHao%26aufirst%3DM.%2BH.%26aulast%3DDe%2BLombaert%26aufirst%3DS.%26aulast%3DProudfoot%26aufirst%3DJ.%26aulast%3DFarmer%26aufirst%3DB.%2BS.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DCollins%26aufirst%3DB.%26aulast%3DMartin%26aufirst%3DL.%26aulast%3DAlbaugh%26aufirst%3DD.%2BR.%26aulast%3DHill-Drzewi%26aufirst%3DM.%26aulast%3DPullen%26aufirst%3DS.%2BS.%26aulast%3DTakahashi%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520potent%252C%2520selective%2520chymase%2520inhibitors%2520via%2520fragment%2520linking%2520strategies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4465%26epage%3D4481%26doi%3D10.1021%2Fjm400138z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davidson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Begley, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varani, G.</span></span> <span> </span><span class="NLM_article-title">A small molecule probe induces a conformation in HIV TAR RNA capable of binding drug-like fragments</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>410</i></span>,  <span class="NLM_fpage">984</span>– <span class="NLM_lpage">996</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2011.03.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1016%2Fj.jmb.2011.03.039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=21763501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovF2gtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=410&publication_year=2011&pages=984-996&author=A.+Davidsonauthor=D.+W.+Begleyauthor=C.+Lauauthor=G.+Varani&title=A+small+molecule+probe+induces+a+conformation+in+HIV+TAR+RNA+capable+of+binding+drug-like+fragments&doi=10.1016%2Fj.jmb.2011.03.039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">A Small-Molecule Probe Induces a Conformation in HIV TAR RNA Capable of Binding Drug-Like Fragments</span></div><div class="casAuthors">Davidson, Amy; Begley, Darren W.; Lau, Carmen; Varani, Gabriele</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">410</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">984-996</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The HIV-1 transactivation response (TAR) element-Tat interaction is a potentially valuable target for treating HIV infection, but efforts to develop TAR-binding antiviral drugs have not yet yielded a successful candidate for clin. development.  In this work, we describe a novel approach toward screening fragments against RNA that uses a chem. probe to target the Tat-binding region of TAR.  This probe fulfills two crit. roles in the screen: by locking the RNA into a conformation capable of binding other fragments, it simultaneously allows the identification of proximal binding fragments by ligand-based NMR.  Using this approach, we have discovered six novel TAR-binding fragments, three of which were docked relative to the probe-RNA structure using exptl. NMR restraints.  The consistent orientations of functional groups in our data-driven docked structures and common electrostatic properties across all fragment leads reveal a surprising level of selectivity by our fragment-sized screening hits.  These models further suggest linking strategies for the development of higher-affinity lead compds. for the inhibition of the TAR-Tat interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpntywlZpxR_LVg90H21EOLACvtfcHk0lgjJ2Dhiw62NA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovF2gtLg%253D&md5=43b63e4aa6c988773c770d9c99dbdb82</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2011.03.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2011.03.039%26sid%3Dliteratum%253Aachs%26aulast%3DDavidson%26aufirst%3DA.%26aulast%3DBegley%26aufirst%3DD.%2BW.%26aulast%3DLau%26aufirst%3DC.%26aulast%3DVarani%26aufirst%3DG.%26atitle%3DA%2520small%2520molecule%2520probe%2520induces%2520a%2520conformation%2520in%2520HIV%2520TAR%2520RNA%2520capable%2520of%2520binding%2520drug-like%2520fragments%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2011%26volume%3D410%26spage%3D984%26epage%3D996%26doi%3D10.1016%2Fj.jmb.2011.03.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pang, Y. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quiram, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jelacic, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brimijoin, S.</span></span> <span> </span><span class="NLM_article-title">Highly potent, selective, and low cost bis-tetrahydroaminacrine inhibitors of acetylcholinesterase. Steps toward novel drugs for treating Alzheimer’s disease</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>271</i></span>,  <span class="NLM_fpage">23646</span>– <span class="NLM_lpage">23649</span>, <span class="refDoi"> DOI: 10.1074/jbc.271.39.23646</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1074%2Fjbc.271.39.23646" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=8798583" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADyaK28XlvFSltL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=23646-23649&author=Y.+P.+Pangauthor=P.+Quiramauthor=T.+Jelacicauthor=F.+Hongauthor=S.+Brimijoin&title=Highly+potent%2C+selective%2C+and+low+cost+bis-tetrahydroaminacrine+inhibitors+of+acetylcholinesterase.+Steps+toward+novel+drugs+for+treating+Alzheimer%E2%80%99s+disease&doi=10.1074%2Fjbc.271.39.23646"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Highly potent, selective, and low cost bis-tetrahydroaminacrine inhibitors of acetylcholinesterase. Steps toward novel drugs for treating Alzheimer's disease</span></div><div class="casAuthors">Pang, Yuan-Ping; Quiram, Polly; Jelacic, Tanya; Hong, Feng; Brimijoin, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">271</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">23646-23649</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">We report highly potent, selective, and low cost bifunctional acetylcholinesterase (AChE) inhibitors developed by our two-step prototype optimization strategy utilizing computer modeling of ligand docking with target proteins: (1) identify low affinity sites normally missed by x-ray crystallog.; and (2) design bifunctional analogs capable of simultaneous binding at the computer-detd. low affinity site and the x-ray-identified high affinity site.  Applying this strategy to 9-amino-1,2,3,4-tetrahydroacridine (THA), a drug for Alzheimer's disease, we obtained alkylene linked bis-THA analogs.  These analogs were up to 10,000-fold more selective and 1,000-fold more potent than THA in inhibiting rat AChE and yet required one simple reaction to synthesize.  Addnl., alkylene linked benzyl-THA analogs were developed to examine the specificity of the docking-derived low affinity THA peripheral site in AChE.  The present work and our previous computational studies strongly suggest that a low affinity THA peripheral site exists in AChE.  This peripheral site provides a structural basis for design of improved cholinesterase ligands for treating Alzheimer's disease and for other health-related purposes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMjTElkdbiv7Vg90H21EOLACvtfcHk0lgjJ2Dhiw62NA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XlvFSltL0%253D&md5=d8ff73789f75d61060df44c3d5edc769</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1074%2Fjbc.271.39.23646&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.271.39.23646%26sid%3Dliteratum%253Aachs%26aulast%3DPang%26aufirst%3DY.%2BP.%26aulast%3DQuiram%26aufirst%3DP.%26aulast%3DJelacic%26aufirst%3DT.%26aulast%3DHong%26aufirst%3DF.%26aulast%3DBrimijoin%26aufirst%3DS.%26atitle%3DHighly%2520potent%252C%2520selective%252C%2520and%2520low%2520cost%2520bis-tetrahydroaminacrine%2520inhibitors%2520of%2520acetylcholinesterase.%2520Steps%2520toward%2520novel%2520drugs%2520for%2520treating%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26spage%3D23646%26epage%3D23649%26doi%3D10.1074%2Fjbc.271.39.23646" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Surade, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ty, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hengrung, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lechartier, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blundell, T. L.</span></span> <span> </span><span class="NLM_article-title">A structure-guided fragment-based approach for the discovery of allosteric inhibitors targeting the lipophilic binding site of transcription factor EthR</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>458</i></span>,  <span class="NLM_fpage">387</span>– <span class="NLM_lpage">394</span>, <span class="refDoi"> DOI: 10.1042/BJ20131127</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1042%2FBJ20131127" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=24313835" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisFSisL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=458&publication_year=2014&pages=387-394&author=S.+Suradeauthor=N.+Tyauthor=N.+Hengrungauthor=B.+Lechartierauthor=S.+T.+Coleauthor=C.+Abellauthor=T.+L.+Blundell&title=A+structure-guided+fragment-based+approach+for+the+discovery+of+allosteric+inhibitors+targeting+the+lipophilic+binding+site+of+transcription+factor+EthR&doi=10.1042%2FBJ20131127"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">A structure-guided fragment-based approach for the discovery of allosteric inhibitors targeting the lipophilic binding site of transcription factor EthR</span></div><div class="casAuthors">Surade, Sachin; Ty, Nancy; Hengrung, Narin; Lechartier, Benoit; Cole, Stewart T.; Abell, Chris; Blundell, Tom L.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">458</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">387-394</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A structure-guided fragment-based approach was used to target the lipophilic allosteric binding site of Mycobacterium tuberculosis EthR.  This elongated channel has many hydrophobic residues lining the binding site, with few opportunities for hydrogen bonding.  We demonstrate that a fragment-based approach involving the inclusion of flexible fragments in the library leads to an efficient exploration of chem. space, that fragment binding can lead to an extension of the cavity, and that fragments are able to identify hydrogen-bonding opportunities in this hydrophobic environment that are not exploited in Nature.  In the present paper, we report the identification of a 1 μM affinity ligand obtained by structure-guided fragment linking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDrPgQPCfy17Vg90H21EOLACvtfcHk0lgjJ2Dhiw62NA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisFSisL0%253D&md5=4ad9610654764f032f8928209b381d81</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1042%2FBJ20131127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20131127%26sid%3Dliteratum%253Aachs%26aulast%3DSurade%26aufirst%3DS.%26aulast%3DTy%26aufirst%3DN.%26aulast%3DHengrung%26aufirst%3DN.%26aulast%3DLechartier%26aufirst%3DB.%26aulast%3DCole%26aufirst%3DS.%2BT.%26aulast%3DAbell%26aufirst%3DC.%26aulast%3DBlundell%26aufirst%3DT.%2BL.%26atitle%3DA%2520structure-guided%2520fragment-based%2520approach%2520for%2520the%2520discovery%2520of%2520allosteric%2520inhibitors%2520targeting%2520the%2520lipophilic%2520binding%2520site%2520of%2520transcription%2520factor%2520EthR%26jtitle%3DBiochem.%2520J.%26date%3D2014%26volume%3D458%26spage%3D387%26epage%3D394%26doi%3D10.1042%2FBJ20131127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trapero, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pacitto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabbah, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coyne, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizrahi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blundell, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ascher, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abell, C.</span></span> <span> </span><span class="NLM_article-title">A fragment-based approach to targeting inosine-5′-monophosphate dehydrogenase (IMPDH) from Mycobacterium tuberculosis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">2806</span>– <span class="NLM_lpage">2822</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01622</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01622" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC1cXltVGksb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=2806-2822&author=A.+Traperoauthor=A.+Pacittoauthor=V.+Singhauthor=M.+Sabbahauthor=A.+G.+Coyneauthor=V.+Mizrahiauthor=T.+L.+Blundellauthor=D.+B.+Ascherauthor=C.+Abell&title=A+fragment-based+approach+to+targeting+inosine-5%E2%80%B2-monophosphate+dehydrogenase+%28IMPDH%29+from+Mycobacterium+tuberculosis&doi=10.1021%2Facs.jmedchem.7b01622"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Approach to Targeting Inosine-5'-monophosphate Dehydrogenase (IMPDH) from Mycobacterium tuberculosis</span></div><div class="casAuthors">Trapero, Ana; Pacitto, Angela; Singh, Vinayak; Sabbah, Mohamad; Coyne, Anthony G.; Mizrahi, Valerie; Blundell, Tom L.; Ascher, David B.; Abell, Chris</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2806-2822</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tuberculosis (TB) remains a major cause of mortality worldwide, and improved treatments are needed to combat emergence of drug resistance.  IMP dehydrogenase (IMPDH), a crucial enzyme required for de novo synthesis of guanine nucleotides, is an attractive TB drug target.  Herein, we describe the identification of potent IMPDH inhibitors using fragment-based screening and structure-based design techniques.  Screening of a fragment library for Mycobacterium thermoresistible (Mth) IMPDH ΔCBS inhibitors identified a low affinity phenylimidazole deriv.  X-ray crystallog. of the Mth IMPDH ΔCBS-IMP-inhibitor complex revealed that two mols. of the fragment were bound in the NAD binding pocket of IMPDH.  Linking the two mols. of the fragment afforded compds. with more than 1000-fold improvement in IMPDH affinity over the initial fragment hit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIloJxzRRl5bVg90H21EOLACvtfcHk0ljmXD93c6WUaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXltVGksb0%253D&md5=a0decf859d321144e41547dda2b38fbf</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01622&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01622%26sid%3Dliteratum%253Aachs%26aulast%3DTrapero%26aufirst%3DA.%26aulast%3DPacitto%26aufirst%3DA.%26aulast%3DSingh%26aufirst%3DV.%26aulast%3DSabbah%26aufirst%3DM.%26aulast%3DCoyne%26aufirst%3DA.%2BG.%26aulast%3DMizrahi%26aufirst%3DV.%26aulast%3DBlundell%26aufirst%3DT.%2BL.%26aulast%3DAscher%26aufirst%3DD.%2BB.%26aulast%3DAbell%26aufirst%3DC.%26atitle%3DA%2520fragment-based%2520approach%2520to%2520targeting%2520inosine-5%25E2%2580%25B2-monophosphate%2520dehydrogenase%2520%2528IMPDH%2529%2520from%2520Mycobacterium%2520tuberculosis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D2806%26epage%3D2822%26doi%3D10.1021%2Facs.jmedchem.7b01622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burgess, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newhouse, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibrahim, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kashem, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandhuber, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomson, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vigers, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, K.</span></span> <span> </span><span class="NLM_article-title">Potent selective nonpeptidic inhibitors of human lung tryptase</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">8348</span>– <span class="NLM_lpage">8352</span>, <span class="refDoi"> DOI: 10.1073/pnas.96.15.8348</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1073%2Fpnas.96.15.8348" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10411878" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADyaK1MXkslOksrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=8348-8352&author=L.+E.+Burgessauthor=B.+J.+Newhouseauthor=P.+Ibrahimauthor=J.+Rizziauthor=M.+A.+Kashemauthor=A.+Hartmanauthor=B.+J.+Brandhuberauthor=C.+D.+Wrightauthor=D.+S.+Thomsonauthor=G.+P.+Vigersauthor=K.+Koch&title=Potent+selective+nonpeptidic+inhibitors+of+human+lung+tryptase&doi=10.1073%2Fpnas.96.15.8348"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Potent selective nonpeptidic inhibitors of human lung tryptase</span></div><div class="casAuthors">Burgess, Laurence E.; Newhouse, Bradley J.; Ibrahim, Prabha; Rizzi, James; Kashem, Mohammed A.; Hartman, Ann; Brandhuber, Barbara J.; Wright, Clifford D.; Thomson, David S.; Vigers, Guy P. A.; Koch, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">8348-8352</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Human lung tryptase, a homotetrameric serine protease unique to mast cell secretory granules, has been implicated in the pathogenesis of asthma.  A hypothesis that tethered sym. inhibitors might bridge two adjacent active sites was explored via a rationally designed series of bisbenzamidines.  These compds. demonstrated a remarkable distanced-defined structure-activity relation against human tryptase with one series possessing subnanomolar potencies.  Addnl. evidence supporting the concept of active-site bridging is also presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvTdnETNgr1LVg90H21EOLACvtfcHk0ljmXD93c6WUaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXkslOksrc%253D&md5=e3d86ffa51565acc1b2b3f4671c5923d</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1073%2Fpnas.96.15.8348&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.96.15.8348%26sid%3Dliteratum%253Aachs%26aulast%3DBurgess%26aufirst%3DL.%2BE.%26aulast%3DNewhouse%26aufirst%3DB.%2BJ.%26aulast%3DIbrahim%26aufirst%3DP.%26aulast%3DRizzi%26aufirst%3DJ.%26aulast%3DKashem%26aufirst%3DM.%2BA.%26aulast%3DHartman%26aufirst%3DA.%26aulast%3DBrandhuber%26aufirst%3DB.%2BJ.%26aulast%3DWright%26aufirst%3DC.%2BD.%26aulast%3DThomson%26aufirst%3DD.%2BS.%26aulast%3DVigers%26aufirst%3DG.%2BP.%26aulast%3DKoch%26aufirst%3DK.%26atitle%3DPotent%2520selective%2520nonpeptidic%2520inhibitors%2520of%2520human%2520lung%2520tryptase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1999%26volume%3D96%26spage%3D8348%26epage%3D8352%26doi%3D10.1073%2Fpnas.96.15.8348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matsui, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasumatsu, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asahi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitamura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ubukata, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayasaka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takaishi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanzawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katakura, S.</span></span> <span> </span><span class="NLM_article-title">Discovery and structure-guided fragment-linking of 4-(2,3-dichlorobenzoyl)-1-methyl-pyrrole-2-carboxamide as a pyruvate kinase M2 activator</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">3540</span>– <span class="NLM_lpage">3546</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2017.05.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1016%2Fj.bmc.2017.05.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=28511909" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC2sXnsl2ntL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=3540-3546&author=Y.+Matsuiauthor=I.+Yasumatsuauthor=T.+Asahiauthor=T.+Kitamuraauthor=K.+Kanaiauthor=O.+Ubukataauthor=H.+Hayasakaauthor=S.+Takaishiauthor=H.+Hanzawaauthor=S.+Katakura&title=Discovery+and+structure-guided+fragment-linking+of+4-%282%2C3-dichlorobenzoyl%29-1-methyl-pyrrole-2-carboxamide+as+a+pyruvate+kinase+M2+activator&doi=10.1016%2Fj.bmc.2017.05.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and structure-guided fragment-linking of 4-(2,3-dichlorobenzoyl)-1-methyl-pyrrole-2-carboxamide as a pyruvate kinase M2 activator</span></div><div class="casAuthors">Matsui, Yumi; Yasumatsu, Isao; Asahi, Takashi; Kitamura, Takahiro; Kanai, Kazuo; Ubukata, Osamu; Hayasaka, Hitoshi; Takaishi, Sachiko; Hanzawa, Hiroyuki; Katakura, Shinichi</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3540-3546</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Tumor cells switch glucose metab. to aerobic glycolysis by expressing the pyruvate kinase M2 isoform (PKM2) in a low active form, providing glycolytic intermediates as building blocks for biosynthetic processes, and thereby supporting cell proliferation.  Activation of PKM2 should invert aerobic glycolysis to an oxidative metab. and prevent cancer growth.  Thus, PKM2 has gained attention as a promising cancer therapy target.  To obtain novel PKM2 activators, we conducted a high-throughput screening (HTS).  Among several hit compds., a fragment-like hit compd. with low potency but high ligand efficiency was identified.  Two mols. of the hit compd. bound at one activator binding site, and the mols. were linked based on the crystal structure.  Since this linkage succeeded in maintaining the original position of the hit compd., the obtained compd. exhibited highly improved potency in an in vitro assay.  The linked compd. also showed PKM2 activating activity in a cell based assay, and cellular growth inhibition of the A549 cancer cell line.  Discovery of this novel scaffold and binding mode of the linked compd. provides a valuable platform for the structure-guided design of PKM2 activators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo61HcdZycO27Vg90H21EOLACvtfcHk0lj_o_Cu7gk4Ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXnsl2ntL4%253D&md5=ffcb6ad85417be83c0d1e0967da78b70</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.05.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.05.004%26sid%3Dliteratum%253Aachs%26aulast%3DMatsui%26aufirst%3DY.%26aulast%3DYasumatsu%26aufirst%3DI.%26aulast%3DAsahi%26aufirst%3DT.%26aulast%3DKitamura%26aufirst%3DT.%26aulast%3DKanai%26aufirst%3DK.%26aulast%3DUbukata%26aufirst%3DO.%26aulast%3DHayasaka%26aufirst%3DH.%26aulast%3DTakaishi%26aufirst%3DS.%26aulast%3DHanzawa%26aufirst%3DH.%26aulast%3DKatakura%26aufirst%3DS.%26atitle%3DDiscovery%2520and%2520structure-guided%2520fragment-linking%2520of%25204-%25282%252C3-dichlorobenzoyl%2529-1-methyl-pyrrole-2-carboxamide%2520as%2520a%2520pyruvate%2520kinase%2520M2%2520activator%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26spage%3D3540%26epage%3D3546%26doi%3D10.1016%2Fj.bmc.2017.05.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Drapier, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geubelle, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouckaert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laulumaa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goffin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dilly, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francotte, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pochet, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kastrup, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pirotte, B.</span></span> <span> </span><span class="NLM_article-title">Enhancing action of positive allosteric modulators through the design of dimeric compounds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">5279</span>– <span class="NLM_lpage">5291</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00250</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00250" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC1cXps12lsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=5279-5291&author=T.+Drapierauthor=P.+Geubelleauthor=C.+Bouckaertauthor=L.+Nielsenauthor=S.+Laulumaaauthor=E.+Goffinauthor=S.+Dillyauthor=P.+Francotteauthor=J.+Hansonauthor=L.+Pochetauthor=J.+Kastrupauthor=B.+Pirotte&title=Enhancing+action+of+positive+allosteric+modulators+through+the+design+of+dimeric+compounds&doi=10.1021%2Facs.jmedchem.8b00250"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Enhancing Action of Positive Allosteric Modulators through the Design of Dimeric Compounds</span></div><div class="casAuthors">Drapier, Thomas; Geubelle, Pierre; Bouckaert, Charlotte; Nielsen, Lise; Laulumaa, Saara; Goffin, Eric; Dilly, Sebastien; Francotte, Pierre; Hanson, Julien; Pochet, Lionel; Kastrup, Jette Sandholm; Pirotte, Bernard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5279-5291</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The present study describes the identification of highly potent dimeric 1,2,4-benzothiadiazine 1,1-dioxide (BTD)-type pos. allosteric modulators of the AMPA receptors (AMPApams) obtained by linking two monomeric BTD scaffolds through their resp. 6-positions.  Using previous X-ray data from monomeric BTDs cocrystd. with the GluA2 ligand-binding domain (LBD), a mol. modeling approach was performed to predict the preferred dimeric combinations.  Two 6,6-ethylene-linked dimeric BTD compds. (16 and 22) were prepd. and evaluated as AMPApams on HEK293 cells expressing GluA2o(Q) (calcium flux expt.).  These compds. were found to be about 10,000 times more potent than their resp. monomers, the most active dimeric compd. being the bis-4-cyclopropyl-substituted compd. 22 [6,6'-(ethane-1,2-diyl)bis(4-cyclopropyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide], with an EC50 value of 1.4 nM.  As a proof of concept, the bis-4-methyl-substituted dimeric compd. 16 (EC50 = 13 nM) was successfully cocrystd. with the GluA2o-LBD and was found to occupy the two BTD binding sites at the LBD dimer interface.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6AJCoOPIir7Vg90H21EOLACvtfcHk0lge-U1noVCP8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXps12lsrw%253D&md5=d438a5a16c5ab50e72cda5a71f6c5550</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00250&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00250%26sid%3Dliteratum%253Aachs%26aulast%3DDrapier%26aufirst%3DT.%26aulast%3DGeubelle%26aufirst%3DP.%26aulast%3DBouckaert%26aufirst%3DC.%26aulast%3DNielsen%26aufirst%3DL.%26aulast%3DLaulumaa%26aufirst%3DS.%26aulast%3DGoffin%26aufirst%3DE.%26aulast%3DDilly%26aufirst%3DS.%26aulast%3DFrancotte%26aufirst%3DP.%26aulast%3DHanson%26aufirst%3DJ.%26aulast%3DPochet%26aufirst%3DL.%26aulast%3DKastrup%26aufirst%3DJ.%26aulast%3DPirotte%26aufirst%3DB.%26atitle%3DEnhancing%2520action%2520of%2520positive%2520allosteric%2520modulators%2520through%2520the%2520design%2520of%2520dimeric%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D5279%26epage%3D5291%26doi%3D10.1021%2Facs.jmedchem.8b00250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friberg, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camper, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olejniczak, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span> <span> </span><span class="NLM_article-title">A method for the second-site screening of K-Ras in the presence of a covalently attached first-site ligand</span>. <i>J. Biomol. NMR</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">11</span>– <span class="NLM_lpage">14</span>, <span class="refDoi"> DOI: 10.1007/s10858-014-9849-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=10.1007%2Fs10858-014-9849-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=25087006" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1KltLjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2014&pages=11-14&author=Q.+Sunauthor=J.+Phanauthor=A.+R.+Fribergauthor=D.+V.+Camperauthor=E.+T.+Olejniczakauthor=S.+W.+Fesik&title=A+method+for+the+second-site+screening+of+K-Ras+in+the+presence+of+a+covalently+attached+first-site+ligand&doi=10.1007%2Fs10858-014-9849-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">A method for the second-site screening of K-Ras in the presence of a covalently attached first-site ligand</span></div><div class="casAuthors">Sun, Qi; Phan, Jason; Friberg, Anders R.; Camper, DeMarco V.; Olejniczak, Edward T.; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular NMR</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">11-14</span>CODEN:
                <span class="NLM_cas:coden">JBNME9</span>;
        ISSN:<span class="NLM_cas:issn">0925-2738</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">K-Ras is a well-validated cancer target but is considered to be "undruggable" due to the lack of suitable binding pockets.  We previously discovered small mols. that bind weakly to K-Ras but wanted to improve their binding affinities by identifying ligands that bind near our initial hits that we could link together.  Here we describe an approach for identifying second site ligands that uses a cysteine residue to covalently attach a compd. for tight binding to the first site pocket followed by a fragment screen for binding to a second site.  This approach could be very useful for targeting Ras and other challenging drug targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpe1TZw6wmpAbVg90H21EOLACvtfcHk0lge-U1noVCP8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1KltLjM&md5=706c8878b0ee6923c3a956b89ae42d89</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1007%2Fs10858-014-9849-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10858-014-9849-8%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DQ.%26aulast%3DPhan%26aufirst%3DJ.%26aulast%3DFriberg%26aufirst%3DA.%2BR.%26aulast%3DCamper%26aufirst%3DD.%2BV.%26aulast%3DOlejniczak%26aufirst%3DE.%2BT.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DA%2520method%2520for%2520the%2520second-site%2520screening%2520of%2520K-Ras%2520in%2520the%2520presence%2520of%2520a%2520covalently%2520attached%2520first-site%2520ligand%26jtitle%3DJ.%2520Biomol.%2520NMR%26date%3D2014%26volume%3D60%26spage%3D11%26epage%3D14%26doi%3D10.1007%2Fs10858-014-9849-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c00242&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c00242%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-20%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c00242" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                6MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-b425991822a79ada59b3.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-fb88834b824b41b135ad.js"></script>

<script type="text/javascript" src="/wro/ke1q~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"667985a26995238c","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.6.0","si":10}'></script>
</body>
</html>
